Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGRP,Agouti-related protein,40058,0.240593739339995,0.00463366107011495,0.23151176364257,0.24967571503742,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL27,C-C motif chemokine 27,39868,0.226138792140939,0.00556925132007918,0.215223059553584,0.237054524728294,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN1,CCN family member 1,39758,0.333320350688807,0.00665114463176528,0.320284107210548,0.346356594167067,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F7,Coagulation factor VII,39899,0.111474415736949,0.00266050984867199,0.106259816433552,0.116689015040346,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,39913,0.126113342921722,0.00282454537159675,0.120577233993392,0.131649451850052,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,37445,0.0914598791750168,0.0018948492529338,0.0877459746392666,0.0951737837107671,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LDLR,Low-density lipoprotein receptor,39882,0.383717347115043,0.00387606014241751,0.376120269235905,0.391314424994182,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFGE8,Lactadherin,39858,0.177122528756417,0.00385201360505945,0.169572582090501,0.184672475422334,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPY,Pro-neuropeptide Y,40030,0.320235512975544,0.00567078861390072,0.309120767292299,0.331350258658789,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,39858,0.179992184477348,0.00247315889960599,0.17514479303412,0.184839575920576,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PROC,Vitamin K-dependent protein C,39908,0.105855242224116,0.00226305155012803,0.101419661185866,0.110290823262367,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39931,0.149771549932299,0.00380221937922601,0.142319199949016,0.157223899915582,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFPI,Tissue factor pathway inhibitor,39843,0.131626297536971,0.00275338762483023,0.126229657792304,0.137022937281638,0
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,40030,0.114066897427205,0.00292715886317849,0.108329666055376,0.119804128799035,1.11253692997784e-308
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APCS,Serum amyloid P-component,37333,0.118833990559441,0.00310478750131336,0.112748607056867,0.124919374062015,2.34190224113009e-304
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RARRES2,Retinoic acid receptor responder protein 2,39949,0.160768090452806,0.00423349918872501,0.152470432042905,0.169065748862707,2.73736279575393e-302
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,37388,0.250895073735119,0.00687106709760372,0.237427782223816,0.264362365246422,1.68469176196101e-278
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G10,Group 10 secretory phospholipase A2,39749,-0.189556479275036,0.00532282024376209,-0.19998920695281,-0.179123751597263,2.60207847684516e-267
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,39809,0.0612330956136769,0.00174065763925106,0.0578214066407448,0.0646447845866089,3.68935439297746e-261
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GHR,Growth hormone receptor,37124,0.0896840806555321,0.00258840323813621,0.0846108103087851,0.0947573510022791,6.65538771957274e-252
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TTR,Transthyretin,37309,0.0780592080417255,0.00226659157677102,0.0736166885512543,0.0825017275321967,3.6816814583569e-249
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCHE,Cholinesterase,37208,0.0844473439069086,0.00248222568654319,0.079582181561284,0.0893125062525333,2.30733317371379e-243
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTH,Parathyroid hormone,37039,0.241959547337522,0.007186528989492,0.227873950518118,0.256045144156927,1.8073197793692e-238
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOM,Apolipoprotein M,39908,0.0806299350598685,0.00241035417699987,0.0759056408729487,0.0853542292467882,3.16846520070863e-237
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAMR1,Inactive serine protease PAMR1,39858,0.0831169526007935,0.00251088495426095,0.078195618090442,0.0880382871111449,1.75529652826324e-232
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL23,C-C motif chemokine 23,39931,0.12194783300687,0.00373163519530422,0.114633828024074,0.129261837989666,7.57486874523215e-227
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FURIN,Furin,39913,0.100283447612638,0.00307321704001202,0.0942599422142149,0.106306953011062,3.36332124353757e-226
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFP,Properdin,37453,0.0670157668572867,0.00209582964301774,0.0629079407569719,0.0711235929576015,2.20776454255987e-216
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PROS1,Vitamin K-dependent protein S,37453,0.0704516303508405,0.00221886189026343,0.0661026610459242,0.0748005996557568,1.72921041615109e-213
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INHBC,Inhibin beta C chain,39858,0.116641303825785,0.00377135115694492,0.109249455558173,0.124033152093397,4.81895045545579e-204
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMAD1,Mothers against decapentaplegic homolog 1,39477,0.231645077459769,0.00751309839400031,0.216919404607528,0.246370750312009,1.09417962695661e-202
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA4,Kallistatin,37241,0.0655646984918223,0.00212144543056396,0.0614066654479169,0.0697227315357276,1.21383156846596e-202
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD4,T-cell surface glycoprotein CD4,39839,0.0803866146491255,0.00262546714494894,0.0752406990450255,0.0855325302532254,4.05553614368491e-200
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39846,0.315754280135273,0.0103142279818696,0.295538393290809,0.335970166979738,4.60157606860258e-200
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCS1,Neuronal calcium sensor 1,40030,0.0779935678135122,0.00256082540932001,0.072974350011245,0.0830127856157795,3.7244768826495e-198
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC39A5,Zinc transporter ZIP5,39866,0.146382994018796,0.00480811046429878,0.13695909750877,0.155806890528821,5.87220610313583e-198
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPL,Lipoprotein lipase,39868,-0.130583212047218,0.00430199840840089,-0.139015128927684,-0.122151295166752,8.02332504028838e-197
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINF2,Alpha-2-antiplasmin,37224,0.0371373510610665,0.00122540435847171,0.0347355585184619,0.039539143603671,3.52284673296592e-195
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFH,Complement factor H,36763,0.0640399259966133,0.00213555095089835,0.0598542461328525,0.0682256058603741,4.7087402682916e-191
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA5,Plasma serine protease inhibitor,37283,0.085428820608528,0.0028951751057964,0.0797542774011671,0.091103363815889,1.81181345619011e-185
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB1,DnaJ homolog subfamily B member 1,39788,0.232686084679035,0.00792873539713199,0.217145763300656,0.248226406057414,2.02628754283545e-184
NMR metabolomics,X23503.Total Lipids in Medium VLDL,P4HB,Protein disulfide-isomerase,39776,0.103439651074824,0.0035525391827945,0.0964766742765463,0.110402627873101,1.21803809987488e-181
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,39383,0.0512017088019433,0.00175900660646951,0.047754055853263,0.0546493617506235,2.02867819603972e-181
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL6,C-X-C motif chemokine 6,40058,0.203785964467766,0.00700538106316883,0.190055417583955,0.217516511351577,2.15125845584556e-181
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CES1,Liver carboxylesterase 1,39854,0.21072015556728,0.00727278688265428,0.196465493277278,0.224974817857282,6.06197513041166e-180
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,39931,0.0731931798114564,0.00252663201268615,0.0682409810665916,0.0781453785563213,6.64237420225154e-180
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOC1,Apolipoprotein C-I,37424,0.0986170329982061,0.00341172646387471,0.0919300491290117,0.105304016867401,2.46408739524728e-178
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFI,Complement factor I,37453,0.0525838786694374,0.00181930390237717,0.0490180430207781,0.0561497143180966,2.53833021021708e-178
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN3,Contactin-3,39858,0.0858285007520689,0.00298212124899255,0.0799835431040435,0.0916734584000943,1.2076537531999e-177
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPIND1,Heparin cofactor 2,37424,0.0739598986406968,0.00256722077476291,0.0689281459221615,0.0789916513592321,3.36080251912639e-177
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLKB1,Plasma kallikrein,37187,0.065522871551013,0.00227740514997121,0.0610591574570695,0.0699865856449566,1.17674181669735e-176
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F10,Coagulation factor X,37445,0.0693661322171967,0.00241424171860961,0.0646342184487219,0.0740980459856715,2.68939868562593e-176
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,39788,0.278298614188663,0.00974179656005852,0.259204692930948,0.297392535446378,4.29410796429644e-175
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCG,Pro-glucagon,39477,0.318562863620709,0.0112046229979794,0.29660180254467,0.340523924696749,2.0935885462729e-173
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39585,0.219185152142913,0.00773082140270673,0.204032742193608,0.234337562092218,1.66897904995605e-172
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATRN,"Attractin, Isoform 2",37453,0.0422033430119793,0.00148566616555951,0.0392914373274826,0.0451152486964759,1.7213045337472e-172
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,39585,0.375218041179261,0.0132416541411968,0.349264399062516,0.401171683296007,2.56564390673593e-172
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,39788,0.171138211916672,0.00608717926602205,0.159207340555269,0.183069083278076,8.84832384678579e-170
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,39788,0.204351408226935,0.00726908324465754,0.190104005067406,0.218598811386464,9.36850737620621e-170
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40058,0.0665172504347636,0.00237523036142309,0.0618617989263743,0.0711727019431528,1.44518424960645e-168
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOST,Sclerostin,39846,0.0978228085480761,0.00349615392709304,0.0909703468509737,0.104675270245178,3.1246171548237e-168
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLAT,Tissue-type plasminogen activator,40002,0.126458269433337,0.00453822584954059,0.117563346768238,0.135353192098437,6.14903674972752e-167
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHMP6,Charged multivesicular body protein 6,37437,0.143614022806514,0.00517137176643248,0.133478134144306,0.153749911468721,3.83414833999738e-165
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRP1,Neuropilin-1,39949,-0.0699693523548052,0.00253411060292071,-0.0749362091365298,-0.0650024955730806,5.33034610879669e-164
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,39913,0.0630254542793025,0.0022963433579763,0.058524621297669,0.0675262872609361,4.18109489868312e-162
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,37388,0.0919394655174684,0.00334856277336197,0.0853762824816789,0.0985026485532579,1.4984036268612e-161
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNCA,Alpha-synuclein,37124,0.290434354924902,0.0106027746592081,0.269652916592854,0.31121579325695,9.63067277437726e-161
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRAP1,Proline-rich acidic protein 1,37437,0.100530147412037,0.003679123319939,0.0933190657049561,0.107741229119117,4.45903723591831e-160
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPR37,Prosaposin receptor GPR37,39585,0.159077582838042,0.00589532577088843,0.1475227443271,0.170632421348983,8.36203295734973e-157
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPM,Carboxypeptidase M,39955,0.0850103262777635,0.00315658248129685,0.0788234246144217,0.0911972279411053,2.70584992766287e-156
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SYAP1,Synapse-associated protein 1,37124,0.141761492267384,0.00525960180202083,0.131452672735424,0.152070311799345,7.98363607110172e-156
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40030,0.0832834074262616,0.00310586311856232,0.0771959157138794,0.0893708991386437,5.21218170471066e-155
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KDR,Vascular endothelial growth factor receptor 2,39913,0.0625694023372722,0.00234074005888527,0.0579815518218571,0.0671572528526874,4.79138227412242e-154
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AFM,Afamin,37453,0.0462655891732249,0.00173670531524612,0.0428616467553425,0.0496695315911073,1.85962141786559e-152
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FN1,Fibronectin,37453,0.0643312042094704,0.00243868946956721,0.0595513728491187,0.0691110355698221,1.3322014471529e-149
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSG2,Desmoglein-2,39858,-0.0643024734178893,0.00244703195052926,-0.0690986560409266,-0.0595062907948519,4.92333337804987e-149
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F9,Coagulation factor IX,39908,0.0437377350395583,0.00166682434459706,0.040470759324148,0.0470047107549685,1.24234146428525e-148
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPB2,Carboxypeptidase B2,37424,0.0543309996941599,0.00206750104104671,0.0502786976537083,0.0583833017346114,1.70143080261809e-148
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRP,Gastrin-releasing peptide,37043,0.12479869308858,0.00476145076297652,0.115466249593146,0.134131136584014,1.1906738068966e-147
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLI1,Friend leukemia integration 1 transcription factor,39477,0.26353835111483,0.0100963702880449,0.243749465350262,0.283327236879398,4.80301114546915e-147
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL4A1,Collagen alpha-1(IV) chain,39868,-0.093240454219526,0.00358210029566744,-0.100261370799034,-0.0862195376400178,2.49936959151842e-146
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMPRSS15,Enteropeptidase,39788,0.211591264789798,0.0081840656007206,0.195550496212386,0.227632033367211,2.05365932802333e-144
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KYNU,Kynureninase,40058,0.107255678053155,0.00417201180489171,0.0990785349155676,0.115432821190743,6.81362440953286e-143
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTA1,Glutathione S-transferase A1,39841,0.200191490474494,0.0077872368792265,0.18492850619121,0.215454474757778,7.57074078931289e-143
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,40002,0.0499551245980661,0.00194508424199807,0.0461427594837499,0.0537674897123823,1.31278754177422e-142
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGSF9,Protein turtle homolog A,37437,0.192521127075129,0.00754877728142085,0.177725523603544,0.207316730546714,3.4966840348553e-140
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGSF8,Immunoglobulin superfamily member 8,39868,0.0704329110595701,0.0027702904490279,0.0650031417794755,0.0758626803396648,7.95662305264617e-140
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SORT1,Sortilin,39846,0.0866258354511854,0.00342255363023528,0.0799176303359243,0.0933340405664465,1.30177049927583e-138
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTA3,Glutathione S-transferase A3,39477,0.1773808880862,0.00701834696921159,0.163624928026545,0.191136848145854,3.64728539446404e-138
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMAD5,Mothers against decapentaplegic homolog 5,39788,0.0470945457294945,0.00188604946339953,0.0433978887812314,0.0507912026777575,5.05855400168489e-135
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL22,C-C motif chemokine 22,39686,0.114689906358657,0.00463030778783732,0.105614503094495,0.123765309622818,6.43113384737308e-133
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,40052,0.0891062505756498,0.00360469188683334,0.0820410544774565,0.0961714466738432,1.86145133941119e-132
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRIP2,Cysteine-rich protein 2,39749,0.0815175771954568,0.00330080605362589,0.07504799733035,0.0879871570605635,3.5985171351684e-132
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGR3,Anterior gradient protein 3,39464,0.133843857795241,0.00541883180766004,0.123222947452227,0.144464768138254,3.66628117658423e-132
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37382,0.31899888107886,0.0129396256631624,0.293637214779062,0.344360547378658,2.6579504988203e-131
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37124,0.0488892800363389,0.0019846970305813,0.0449992738563995,0.0527792862162782,4.80312567510303e-131
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINF1,Pigment epithelium-derived factor,37254,0.0576800040366736,0.00234979555872942,0.0530744047415639,0.0622856033317832,3.44472518130893e-130
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMAD2,Mothers against decapentaplegic homolog 2,37368,0.156121922757197,0.00636453879816542,0.143647426712793,0.168596418801601,4.85129428225426e-130
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADIPOQ,Adiponectin,37453,-0.148623287807212,0.006072569184533,-0.160525523408896,-0.136721052205527,1.71594610494752e-129
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMBP,Protein AMBP,40003,0.0432618736746319,0.00177711664876173,0.039778725043059,0.0467450223062049,1.38658030566622e-128
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNAPIN,SNARE-associated protein Snapin,37411,0.129805873420628,0.00532415577415312,0.119370528103288,0.140241218737969,1.58284065521323e-128
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LATS1,Serine/threonine-protein kinase LATS1,37056,0.19240305682479,0.0079083523378572,0.17690268624259,0.20790342740699,6.21302552339934e-128
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37043,0.0579329455078362,0.00238316561120474,0.0532619409098749,0.0626039501057975,9.93181107009606e-128
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCN2,Ficolin-2,39810,0.090382324229565,0.00372594386247566,0.0830794742591127,0.0976851742000173,1.11927809867853e-127
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,40012,-0.13777919360965,0.00571707453255287,-0.148984659693453,-0.126573727525846,4.21011129780291e-126
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDHR5,Cadherin-related family member 5,39868,0.0858953039559943,0.00356616991416942,0.0789056109242223,0.0928849969877664,6.02318655678089e-126
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAB2,Stabilin-2,37437,0.0619692696122228,0.00257504349560002,0.0569221843608468,0.0670163548635989,2.39034102664564e-125
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40009,0.115013977072281,0.00481278791198829,0.105580912764784,0.124447041379778,4.58393717638081e-124
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39749,0.162612143815021,0.00682118803656809,0.149242615263348,0.175981672366695,1.90599498945382e-123
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELN,Elastin,37437,0.0735542560261573,0.0030846885522135,0.0675082664638188,0.0796002455884958,3.81943147379432e-123
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUMB,Protein numb homolog,37056,0.185436101413825,0.00777814278166299,0.170190941561766,0.200681261265885,4.96023621349516e-123
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDHR2,Cadherin-related family member 2,39788,0.159746851393943,0.00672155920217293,0.146572595357684,0.172921107430202,1.00984605741645e-122
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENO3,Beta-enolase,37043,0.131762283094901,0.00554220483693887,0.120899561614501,0.142625004575301,2.27305394083474e-122
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAA80,N-alpha-acetyltransferase 80,37039,0.26370569472195,0.0111046506343988,0.241940579478528,0.285470809965372,4.21934713687413e-122
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39477,0.147165022364451,0.0062205666826044,0.134972711666546,0.159357333062356,1.33771765558169e-121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBP5,Retinol-binding protein 5,39788,0.121949800441012,0.00515771400732926,0.111840680986646,0.132058919895377,1.66497836468122e-121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAT2,Linker for activation of T-cells family member 2,39788,0.270691513553839,0.0114741229271688,0.248202232616588,0.29318079449109,5.55133654097777e-121
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F13B,Coagulation factor XIII B chain,37380,0.0548357325540728,0.00234711858479309,0.0502353801278783,0.0594360849802672,2.21729154322679e-118
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL17,C-C motif chemokine 17,39836,0.193849164658161,0.00831049773323523,0.17756058910102,0.210137740215302,2.28794822601038e-118
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,39477,0.12693660492657,0.00544982015807988,0.116254957416734,0.137618252436407,5.44937441878093e-118
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MLN,Promotilin,39866,0.190829657889248,0.00819641442541195,0.17476468561544,0.206894630163055,6.09058530355029e-118
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37437,0.0625427724985796,0.00269124563123343,0.0572679310613621,0.0678176139357971,3.48126603248635e-117
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,40052,-0.0725984106608441,0.00312939440630933,-0.0787320236972104,-0.0664647976244778,3.77593611981362e-117
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39788,0.0644016476691026,0.00277639080749454,0.0589599216864133,0.0698433736517919,4.30769274903548e-117
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL17,C-X-C motif chemokine 17,40058,0.0912521566291855,0.00395300636682371,0.083504264150211,0.0990000491081599,4.93816182176808e-116
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UPB1,Beta-ureidopropionase,37437,0.194427153282352,0.00846667616792326,0.177832467993223,0.211021838571482,1.60878270657007e-114
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YTHDF3,YTH domain-containing family protein 3,39587,0.179656559046746,0.00785932358155336,0.164252284826901,0.19506083326659,8.43829387301378e-114
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,39948,0.0652685126234802,0.00286051143479688,0.0596619102112783,0.0708751150356821,1.94735132486903e-113
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACY1,Aminoacylase-1,39868,0.129545844726019,0.00568440717094434,0.118404406670968,0.14068728278107,3.64331942970273e-113
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AP1G2,AP-1 complex subunit gamma-like 2,37368,0.167599694391269,0.00735989700299537,0.153174296265398,0.18202509251714,1.1340344497057e-112
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTD,Biotinidase,37453,0.0430146602880202,0.00189154269943176,0.039307236597134,0.0467220839789065,2.19872911516076e-112
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINC1,Antithrombin-III,37424,0.0304822783422906,0.00134153946987669,0.0278528609813323,0.0331116957032489,3.34395931676194e-112
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37382,0.0618500376139164,0.00272841558400402,0.0565023430692685,0.0671977321585642,1.08379651411537e-111
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASGR1,Asialoglycoprotein receptor 1,39749,0.0607054808631744,0.0026829129119593,0.0554469715557342,0.0659639901706147,1.36289131896688e-111
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNAP29,Synaptosomal-associated protein 29,39913,0.190407345159333,0.00842165431957597,0.173900902692964,0.206913787625701,1.91989358305871e-111
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YES1,Tyrosine-protein kinase Yes,39788,0.237394703005544,0.0105221705454828,0.216771248736398,0.25801815727469,5.65638748414395e-111
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EEF1D,Elongation factor 1-delta,37437,0.189706216881746,0.0083986848827884,0.173244794511481,0.206167639252011,6.27445850427195e-111
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADH1B,All-trans-retinol dehydrogenase,37124,0.157170314869129,0.00698411477466331,0.143481449910789,0.170859179827469,4.31287272227877e-110
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GUSB,Beta-glucuronidase,39919,0.121549203264283,0.00541012818519633,0.110945352021298,0.132153054507268,4.31803499645547e-110
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFR2,Fibroblast growth factor receptor 2,39913,0.044658490763328,0.00198976605354685,0.0407585492983762,0.0485584322282798,7.12339728682717e-110
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTYMK,Thymidylate kinase,37437,0.141918514616224,0.00631965162032814,0.129531997440381,0.154305031792067,1.08231396692454e-109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL2,Angiopoietin-related protein 2,39877,0.0814102843961004,0.00363174381982606,0.0742920665092413,0.0885285022829594,1.31623882310432e-109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NT5E,5'-nucleotidase,39913,0.113554416178335,0.00510346871245259,0.103551617501928,0.123557214854742,4.77610254811228e-108
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39788,0.0803690706479952,0.0036143759364879,0.0732848938124789,0.0874532474835115,6.72453870444799e-108
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEG1,Protein HEG homolog 1,37124,0.0552951253408398,0.00249932104645952,0.0503964560897791,0.0601937945919005,1.54996886925052e-106
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40052,0.058914894125316,0.00267180252892692,0.0536781611686193,0.0641516270820128,3.42652567301395e-106
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERP44,Endoplasmic reticulum resident protein 44,39758,0.0529117936670009,0.00240114326152018,0.0482055528744214,0.0576180344595805,4.9937211114596e-106
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGT1,Glutathione hydrolase 1 proenzyme,39826,0.100903993643314,0.0045871298209087,0.0919132191943329,0.109894768092295,1.13090189929941e-105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RTBDN,Retbindin,39788,0.0594065183353758,0.00270827848589342,0.0540982925030247,0.0647147441677269,4.29236990126042e-105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYH9,Myosin-9,37437,0.225410250303605,0.0102692594751216,0.205282501732367,0.245537998874844,5.73653309756693e-105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL16,C-C motif chemokine 16,40052,0.105287213890115,0.00481157809145288,0.0958565208308677,0.114717906949363,1.25777990502777e-104
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37388,0.0831893330301998,0.00380236829777991,0.0757366911665511,0.0906419748938484,2.6638235611169e-104
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,40017,-0.246977684648207,0.0113390994053794,-0.269202319482751,-0.224753049813664,1.08348465740437e-103
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABL1,Tyrosine-protein kinase ABL1,39788,0.137544821084633,0.00631723785199913,0.125163034894715,0.149926607274552,1.35099108720757e-103
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EHBP1,EH domain-binding protein 1,37437,0.150089209079311,0.00691801683207078,0.136529896088452,0.163648522070169,1.24346541973804e-102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FYB1,FYN-binding protein 1,39836,0.18304898511531,0.00847107514214342,0.166445677836709,0.199652292393911,4.28749560540861e-102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F2,Prothrombin,37453,0.0291873284615514,0.00135566826503113,0.0265302186620904,0.0318444382610124,3.96488504920259e-101
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTSS1,Protein MTSS 1,37382,0.219343992418702,0.010188642423841,0.199374253267973,0.23931373156943,4.17856587766593e-101
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SARG,Specifically androgen-regulated gene protein,37390,0.217082793466336,0.0100979784458716,0.197290755712428,0.236874831220244,7.89596254768366e-101
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,37437,0.127658187828241,0.00595030127847685,0.115995597322426,0.139320778334056,1.93037762015386e-100
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,37368,0.166890118557097,0.00779709169937298,0.151607818826326,0.182172418287868,5.54946365643473e-100
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HBEGF,Proheparin-binding EGF-like growth factor,39984,0.142865048948221,0.0066893179045389,0.129753985855324,0.155976112041117,8.0407531858631e-100
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DKK1,Dickkopf-related protein 1,40009,0.117356728122507,0.00551451826504066,0.106548272323027,0.128165183921987,3.86488059932965e-99
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPPC,C-type natriuretic peptide,39866,0.0895968358102359,0.00421673258009333,0.0813320399532529,0.0978616316672188,7.95120197904246e-99
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL5,C-X-C motif chemokine 5,39805,0.222345436930131,0.0105160998981179,0.20173388112982,0.242956992730442,6.98291684989173e-98
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TJAP1,Tight junction-associated protein 1,39913,0.162179328027493,0.00767593696102951,0.147134491583875,0.17722416447111,9.33157940477564e-98
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MME,Neprilysin,39788,0.152954208730767,0.00727637604718643,0.138692511678281,0.167215905783252,8.72209674160832e-97
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SORD,Sorbitol dehydrogenase,39963,0.132630537944231,0.0063295234698428,0.12022467194334,0.145036403945123,3.28808074887743e-96
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39788,0.0844683471430362,0.00403611386379415,0.0765575639699996,0.0923791303160727,5.78885958931666e-96
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GH1,Somatotropin,39846,-0.348464256415652,0.0166672729873314,-0.381132111470821,-0.315796401360482,8.80014187178769e-96
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHBG,Sex hormone-binding globulin,37445,-0.0994239547131426,0.00475951378014634,-0.108752601722229,-0.0900953077040558,2.0938679826998e-95
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP20,Centrosomal protein 20,39477,0.142417081247405,0.0068249500945701,0.129040179062047,0.155793983432762,2.12677242188691e-95
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,39720,0.172679150550878,0.00827672634306991,0.156456766918461,0.188901534183295,2.20131133000036e-95
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F11R,Junctional adhesion molecule A,39858,0.109030883763204,0.00522832332518989,0.0987833700458323,0.119278397480577,2.5958970252857e-95
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEP,Leptin,39868,0.130218528599919,0.00625830598002,0.11795224887908,0.142484808320759,6.67892351241476e-95
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40058,0.0552513582338719,0.00266511341748513,0.0500277359356011,0.0604749805321428,3.01529405901907e-94
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLA,Alpha-galactosidase A,37088,0.0722726670045443,0.00349219192462384,0.0654279708322816,0.0791173631768071,1.15060377203836e-93
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,39597,0.0430789753088621,0.00209102486509444,0.038980566573277,0.0471773840444472,4.45272290046563e-93
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAB2,Disabled homolog 2,40030,0.212331835467845,0.0103123749560681,0.192119580553952,0.232544090381739,5.24582025810596e-93
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CANT1,Soluble calcium-activated nucleotidase 1,39816,0.0378300493965204,0.00184005251381853,0.0342235464694361,0.0414365523236047,1.00944135934669e-92
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL16,Pro-interleukin-16,40058,0.0781985850563489,0.00380569696392339,0.070739419007059,0.0856577511056388,1.21989151300026e-92
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMP4,Metalloproteinase inhibitor 4,39858,-0.0744449557801449,0.00362718549798524,-0.081554239356196,-0.0673356722040938,2.02495414095166e-92
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37411,0.18554030226062,0.00903123574754218,0.167839080195438,0.203241524325803,2.19977177900448e-92
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCLY,Selenocysteine lyase,39984,0.093094733580959,0.004548044818599,0.084180565736505,0.102008901425413,5.9630504609801e-92
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TARBP2,RISC-loading complex subunit TARBP2,39489,0.150548189551971,0.00735762106642254,0.136127252261783,0.164969126842159,7.55342619672126e-92
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37382,0.0490276121993527,0.00239654904089427,0.0443303760791999,0.0537248483195055,1.24668903748506e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCXR,L-xylulose reductase,39913,0.101812998498154,0.00498426052897523,0.0920438478613622,0.111582149134945,1.40381752250451e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THPO,Thrombopoietin,39585,0.0720556871927582,0.00352810688683827,0.0651405976945552,0.0789707766909612,1.59256378530963e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE4,Ribonuclease 4,37051,0.0490591393003413,0.00239949388569081,0.0443561312843873,0.0537621473162953,1.71027475778822e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOS3,"Nitric oxide synthase, endothelial",39489,0.0961964265003866,0.00471808220783766,0.0869489853730248,0.105443867627748,3.2159665305554e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL3,Angiopoietin-related protein 3,39892,0.0663236690292994,0.00325667682979303,0.0599405824429051,0.0727067556156937,4.79398828269723e-91
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELPLG,P-selectin glycoprotein ligand 1,39866,0.0520204356590782,0.00256987260922874,0.0469834853449898,0.0570573859731665,5.52936649823546e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD63,CD63 antigen,39720,0.0963388942310235,0.00476161857909115,0.0870061218160048,0.105671666646042,6.90304169655589e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39866,0.183324406463525,0.0090648544126869,0.165557291814659,0.201091521112392,8.01501856284784e-90
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KHK,Ketohexokinase,37043,0.120721382104301,0.00597761996655118,0.10900524696986,0.132437517238741,2.39246025921452e-89
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB11FIP3,Rab11 family-interacting protein 3,37437,0.200762519486389,0.00994557663407608,0.181269189283599,0.220255849689178,2.63688778799243e-89
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,39919,0.0618090175784376,0.00306707609758694,0.0557975484271672,0.067820486729708,3.24145918171359e-89
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,39817,0.0606660875441032,0.00301109663240608,0.0547643381445873,0.0665678369436191,3.62860297401736e-89
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXNA4,Plexin-A4,39866,0.15116534773728,0.00750335048936869,0.136458780778117,0.165871914696442,3.68161957086769e-89
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,39866,0.197813133061922,0.00982334148816655,0.178559383745116,0.217066882378728,4.42399804525764e-89
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37169,0.210702494711273,0.010463956489711,0.190193139991439,0.231211849431106,7.47312000499362e-89
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLIN1,Perilipin-1,39489,0.0643243349757758,0.0032007941687261,0.0580507784050726,0.070597891546479,1.04538694712516e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPD52L2,Tumor protein D54,37124,0.203162293991862,0.0100992190299344,0.18336782469319,0.222956763290533,1.10349736407194e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CKB,Creatine kinase B-type,37437,-0.10812213277001,0.00537647912683913,-0.118660031858615,-0.0975842336814055,1.16824446738752e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPK9,Mitogen-activated protein kinase 9,39866,0.0806045151487968,0.00401394306691506,0.0727371867376432,0.0884718435599503,1.32838561871151e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37366,0.152479366549772,0.00758563706262128,0.137611517907035,0.16734721519251,1.41883675096437e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SKAP1,Src kinase-associated phosphoprotein 1,39713,0.133699115414295,0.0066640732268186,0.12063753188973,0.146760698938859,1.95423907957727e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KAZN,Kazrin,37382,0.193480364940057,0.00963386949451449,0.174597980730809,0.212362749149306,1.99934844887689e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDC4,Syndecan-4,39868,0.0839496378349372,0.00419469058706995,0.0757280442842801,0.0921712313855943,5.01925381939112e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL18A1,Collagen alpha-1(XVIII) chain,39893,0.0418150437952786,0.00208956298763775,0.0377195003395086,0.0459105872510486,5.19236301533009e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC1B,C-type lectin domain family 1 member B,40009,0.178035932064186,0.0089094060162314,0.160573496272373,0.195498367856,8.90441733177141e-88
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VEGFC,Vascular endothelial growth factor C,39913,0.102748972012431,0.0051436140047261,0.0926674885631682,0.112830455461695,1.03355068775103e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37043,0.156691917998048,0.00783934637849641,0.141326799096195,0.172057036899901,1.38512669962853e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOMO1,Nodal modulator 1,39858,0.043798916227012,0.00219487853943918,0.0394969542897112,0.0481008781643128,1.56972366211402e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPC5,Glypican-5,39749,0.103169504227156,0.00517525326745254,0.0930260078229495,0.113313000631363,2.35244482608241e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL13,C-X-C motif chemokine 13,40009,0.108349298764335,0.005442077872275,0.0976828261346755,0.119015771393994,3.7279149487416e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,37388,0.199943492048784,0.0100433474346263,0.180258531076917,0.219628453020652,6.06154959270594e-87
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXLNA,Alpha-taxilin,39749,0.163962455729906,0.00825607918574997,0.147780540525836,0.180144370933976,1.02367610544711e-86
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL18R1,Interleukin-18 receptor 1,40058,0.0597050981518256,0.0030104216062867,0.0538046718035036,0.0656055245001475,1.64631180123206e-86
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,39489,0.0943437912350505,0.00476987873984581,0.0849948289049527,0.103692753565148,5.07240698077101e-86
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPY30,Protein dpy-30 homolog,39979,0.108392922171295,0.0054829381417397,0.0976463634134853,0.119139480929105,5.71948039182025e-86
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AXIN1,Axin-1,39866,0.174342966608427,0.00882245224856511,0.157050960201239,0.191634973015615,6.76649875217909e-86
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,37368,0.0956486270489965,0.0048410638282472,0.086160141945632,0.105137112152361,1.11013511130226e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGRN,Agrin,39931,0.0594739248498223,0.00301962125891839,0.0535554671823422,0.0653923825173023,2.3729281490173e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL5,C-C motif chemokine 5,39931,0.183800099108012,0.00934150045886394,0.165490758208639,0.202109440007386,3.50038188350383e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDLIM7,PDZ and LIM domain protein 7,39931,0.229919735807725,0.0116931288453289,0.20700120327088,0.252838268344569,4.48254713804259e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTSS2,Protein MTSS 2,37368,0.181483997758231,0.00922312487129648,0.163406673010489,0.199561322505972,5.23456084612386e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM20A,Pseudokinase FAM20A,37437,0.0513624613419227,0.00261062731445807,0.0462456318055849,0.0564792908782605,5.43662673594685e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJA2,DnaJ homolog subfamily A member 2,40009,0.149577452945509,0.00761903911615919,0.134644136277837,0.164510769613181,8.01023714814983e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELP,P-selectin,39931,0.104167972652487,0.0053086412377868,0.0937630358264253,0.11457290947855,9.76104261369589e-85
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MINK1,Misshapen-like kinase 1,37388,0.168812911541011,0.00860335289354091,0.151950339869671,0.185675483212352,1.50376865564199e-84
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,37124,0.149672819565827,0.00765235068820928,0.134674212216937,0.164671426914717,5.24621312063379e-84
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLTP,Phospholipid transfer protein,39976,-0.0647397646532293,0.0033249069172651,-0.0712565822110689,-0.0582229470953897,1.75298186008143e-83
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39788,0.176067771693377,0.00904720337554877,0.158335253077301,0.193800290309452,2.1818395384577e-83
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39585,0.0982089225871215,0.00505726173790269,0.0882966895808322,0.108121155593411,4.95722830688421e-83
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,39477,0.120534287006491,0.00622367010576786,0.108335893599186,0.132732680413796,1.35899602042358e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRHBP,Corticotropin-releasing factor-binding protein,39862,0.050155776113463,0.00259611941116461,0.0450673820675804,0.0552441701593457,3.17475241632971e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CMIP,C-Maf-inducing protein,37368,0.148218983137223,0.00767532197772474,0.133175352060882,0.163262614213563,5.49793421770375e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39477,0.11146521975297,0.00577825256296023,0.100139844729568,0.122790594776372,5.79297904769378e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP10,Stromelysin-2,39857,-0.104841359511703,0.00543595826628236,-0.115495837713617,-0.0941868813097898,5.91675978932612e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUOM,Fucose mutarotase,37124,0.113503013897275,0.00588049177177774,0.101977250024591,0.12502877776996,6.88226793959935e-82
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F11,Coagulation factor XI,37249,0.0557244513975621,0.00289612965121819,0.0500480372811745,0.0614008655139498,2.10074013652532e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFC,Platelet-derived growth factor C,39477,0.0518828721664751,0.00269994723825254,0.0465909755795001,0.0571747687534501,2.34813320621873e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARF6,ADP-ribosylation factor 6,37382,0.189211556321848,0.00985048701853271,0.169904601765524,0.208518510878173,3.78381891927397e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39683,0.0824921483756457,0.00430553888950137,0.074053292152223,0.0909310045990683,6.63430726433077e-81
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATG16L1,Autophagy-related protein 16-1,37382,0.152446468906505,0.00796435710694991,0.136836328976883,0.168056608836127,1.33245985402781e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MXRA8,Matrix remodeling-associated protein 8,37124,-0.0533158546050036,0.00278638765094266,-0.0587771744008512,-0.047854534809156,1.58212563824241e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHACTR2,Phosphatase and actin regulator 2,37411,0.20268501986564,0.0106091388504865,0.181891107718686,0.223478932012593,2.6123025917463e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37411,0.149521861769366,0.00782669447401318,0.1341815406003,0.164862182938432,2.64509666121138e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,37043,0.128361671233285,0.00672367005995756,0.115183277915768,0.141540064550802,3.60707026016018e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSNK2A1,Casein kinase II subunit alpha,37411,-0.079211396592287,0.00416050549809886,-0.0873659873685607,-0.0710568058160132,8.90833678386329e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C9,Complement component C9,37445,-0.0934491104390814,0.00490907922391487,-0.103070905717955,-0.0838273151602082,9.3488194631674e-80
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPP4,Dipeptidyl peptidase 4,39575,0.0527427529701015,0.00277512964863353,0.0473034988587798,0.0581820070814232,1.19953816361121e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN2,CCN family member 2,39880,0.1028668690585,0.00541680378399487,0.0922499336418703,0.11348380447513,1.53151153301635e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39805,0.0471077850719205,0.00248089964286554,0.0422452217719041,0.051970348371937,1.60867333505383e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OTUD7B,OTU domain-containing protein 7B,37411,0.112870221792532,0.00594048838360921,0.101226864560658,0.124513579024406,1.82910832091526e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39749,0.0938867330092974,0.00495139926536754,0.084181990449177,0.103591475569418,2.65389041570262e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL3,C-X-C motif chemokine 3,39859,0.166008976671961,0.00877926606094269,0.148801615192513,0.183216338151408,6.93389208068101e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39931,-0.067299312978021,0.00355977180659667,-0.0742764657189505,-0.0603221602370915,7.36124003424786e-79
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1S,Complement C1s subcomponent,37453,0.0365784341108073,0.00194014864092381,0.0327757427745967,0.040381125447018,2.73888062134683e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCR,Breakpoint cluster region protein,39866,0.160133964337923,0.00850741800613135,0.143459425045905,0.17680850362994,3.42466373475699e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA3F,Semaphorin-3F,39868,0.044429344603938,0.00236292704990262,0.0397980075861288,0.0490606816217471,4.97001920846216e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXNB3,Plexin-B3,39812,0.0828883476643639,0.00441140016726389,0.0742420033365266,0.0915346919922011,6.36997738272141e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,37043,0.129726402494563,0.00689657160990146,0.116209122139156,0.143243682849969,6.49576419697858e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AP3S2,AP-3 complex subunit sigma-2,37388,0.0819804328404469,0.00436284366306568,0.0734292592608382,0.0905316064200557,8.79249370175804e-78
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300LG,CMRF35-like molecule 9,39858,-0.063685330769565,0.00339414450119792,-0.0703378539919129,-0.0570328075472171,1.02815649757166e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGA5,Integrin alpha-5,39858,0.0430771762603243,0.00229727314968489,0.0385745208869419,0.0475798316337067,1.27886390157589e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39866,0.1067007618637,0.00569762451111228,0.0955334178219202,0.11786810590548,1.99387146340434e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUCB2,Nucleobindin-2,39995,0.0650396450785194,0.00347333354753039,0.0582319113253599,0.071847378831679,2.03068791113704e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNAP23,Synaptosomal-associated protein 23,39868,0.150786539158049,0.00805400166946135,0.135000695885905,0.166572382430193,2.19715080149893e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,37043,0.178585868139726,0.00953376275393253,0.159899693142019,0.197272043137434,2.7312337592803e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CIRBP,Cold-inducible RNA-binding protein,37382,0.167305202480509,0.00893460649537993,0.149793373749565,0.184817031211454,2.90173041217676e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD6,T-cell differentiation antigen CD6,40040,0.090835170010384,0.00485605498731824,0.0813173022352403,0.100353037785528,2.91055681848384e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37021,0.118600103486355,0.00633843126682204,0.106176778203384,0.131023428769326,4.00093907354684e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C4BPB,C4b-binding protein beta chain,39913,0.0686297358573959,0.00367644734892667,0.0614238990534996,0.0758355726612922,5.94482748134506e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AAMDC,Mth938 domain-containing protein,37043,0.0923675908332425,0.00494725423785424,0.0826709725270482,0.102064209139437,8.39534092680335e-77
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39868,-0.159975062421583,0.00858539501737474,-0.176802436655638,-0.143147688187529,1.11374208143342e-76
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPL,N-acetylneuraminate lyase,37437,0.0757968177791671,0.00407240896500204,0.0678148962077631,0.083778739350571,2.27254336585762e-76
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,39866,0.178832782161719,0.00961813925119184,0.159981229229383,0.197684335094055,2.31838368740774e-76
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERBIN,Erbin,39788,0.176986151286025,0.00953137673990811,0.158304652875805,0.195667649696244,3.65646919314188e-76
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUGP1,SURP and G-patch domain-containing protein 1,37382,0.0689069632461573,0.00372128455655182,0.0616132455153157,0.0762006809769988,1.29332993366565e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,39477,0.1215973554918,0.00657479097302544,0.108710765184671,0.13448394579893,1.46458836920144e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP85,Centrosomal protein of 85 kDa,39477,0.108995064184176,0.0059189434202561,0.0973939350804742,0.120596193287878,6.22294772088726e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNIP1,TNFAIP3-interacting protein 1,37388,0.150686366748797,0.00817965883953064,0.134654235423317,0.166718498074277,7.17703328706852e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DOK2,Docking protein 2,39868,0.209039075821522,0.0113645898303136,0.186764479754107,0.231313671888936,8.66076862301286e-75
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANG,Angiogenin,39843,0.0575460402282452,0.00312987443498963,0.0514114863356656,0.0636805941208249,1.00058375633163e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL10,C-X-C motif chemokine 10,39931,0.112279596321516,0.00611030596314915,0.100303396633744,0.124255796009289,1.20026269441295e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCK2,Cytoplasmic protein NCK2,39931,0.180504147673926,0.00984860000118686,0.1612008916716,0.199807403676252,2.82840822548125e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39913,0.160561278224188,0.00877883932336096,0.1433547531504,0.177767803297975,5.64581864641837e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CES2,Cocaine esterase,39788,0.091753311856734,0.00502360244299832,0.0819070510684573,0.101599572645011,8.98517695271063e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37358,0.185051682464541,0.0101253937769311,0.165205910661756,0.204897454267326,9.93364388904785e-74
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLA2,Src-like-adapter 2,37411,0.178399207203342,0.00976883693802358,0.159252286804816,0.197546127601868,1.2642952211868e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39885,0.045128807177081,0.00247406267144153,0.0402796443410556,0.0499779700131064,1.35967886148188e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCTN3,Tectonic-3,37437,0.0498154520206254,0.0027312322624843,0.0444622367861562,0.0551686672550946,1.89572468601459e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHSG,Alpha-2-HS-glycoprotein,37445,0.0450391135984477,0.0024702590709196,0.0401974058194453,0.0498808213774501,2.13178556229891e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD99L2,CD99 antigen-like protein 2,39858,0.0405628129035838,0.00223369660544743,0.0361847675569068,0.0449408582502608,5.83321180456159e-73
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,39858,0.039461370442336,0.00217711011919013,0.0351942346087233,0.0437285062759487,1.06811484818398e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHA1,Ephrin type-A receptor 1,39904,0.0560772615972794,0.00309607604729564,0.0500089525445799,0.0621455706499788,1.34499541041762e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GDF2,Growth/differentiation factor 2,39868,0.0592098758924747,0.00326985213416463,0.052800965709512,0.0656187860754374,1.46388864117732e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37382,0.181979624813772,0.0100404741748105,0.162300295431143,0.201658954196401,1.4692976903009e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGFR,Epidermal growth factor receptor,40052,0.0269119414801558,0.00148686033424568,0.0239976952250343,0.0298261877352773,1.6557512887643e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,39866,0.189817597193763,0.010487588343071,0.169261924041344,0.210373270346182,1.70489933186444e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THOP1,Thimet oligopeptidase,39798,0.0510241018211931,0.00281949874874265,0.0454978842736575,0.0565503193687287,1.79147476035077e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEC31A,Protein transport protein Sec31A,37043,0.129161709718755,0.00713462807501206,0.115177838691731,0.143145580745779,2.24558478012523e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GHRL,Appetite-regulating hormone,39868,0.128276307361307,0.00711002577555407,0.114340656841221,0.142211957881393,4.74632355271345e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLSCR3,Phospholipid scramblase 3,37373,0.0996481565996907,0.00552417664495808,0.0888207703755728,0.110475542823809,6.752273313172e-72
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAK4,Serine/threonine-protein kinase PAK 4,39489,0.102626447879865,0.00570394495058257,0.0914467157767234,0.113806179983007,1.18418357414382e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USO1,General vesicular transport factor p115,39788,0.149672818524416,0.0083305419509933,0.133344956300469,0.166000680748363,1.79995101913401e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R9B,Neurabin-2,40058,0.157468365076045,0.00877909737637723,0.140261334218346,0.174675395933745,2.9774180641155e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINH1,Serpin H1,37169,0.213485874467021,0.0118972021861726,0.190167358182122,0.236804390751919,3.66467693981367e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESM1,Endothelial cell-specific molecule 1,39862,-0.0565936854573526,0.00316018886639762,-0.0627876556354919,-0.0503997152792132,5.00782576059649e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,37382,0.150952060155037,0.00843432095070612,0.134420791091653,0.167483329218421,8.09696147221635e-71
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFB,Platelet-derived growth factor subunit B,39931,0.141981290695336,0.00794803581242897,0.126403140502975,0.157559440887697,1.09060350250128e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMOX2,Heme oxygenase 2,39489,0.0781473199550858,0.00438324549177595,0.069556158791205,0.0867384811189667,2.10769848012009e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS1,Galectin-1,39868,0.0553762903205867,0.00310732144343618,0.0492859402914518,0.0614666403497216,2.3119064140101e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL13,C-C motif chemokine 13,40024,0.113532726157063,0.00637747578616833,0.101032873616173,0.126032578697953,3.18249937642198e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BECN1,Beclin-1,37043,0.0998907299767265,0.00560717082637943,0.0889006751570228,0.11088078479643,3.59654411443954e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CMC1,COX assembly mitochondrial protein homolog,37437,0.149255740419108,0.00839772972381557,0.13279619016043,0.165715290677787,7.02413004777594e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,39587,0.115928753182927,0.00653124005235654,0.103127522680308,0.128729983685546,8.2769520398194e-70
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37114,0.0781261006504256,0.00440088160296861,0.0695003727086071,0.0867518285922441,1.05697177654174e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP5,Fatty acid-binding protein 5,39972,0.112115672646475,0.00632471068752157,0.0997192396989328,0.124512105594017,1.19740274230117e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUSD1,Sushi domain-containing protein 1,39585,0.079997036732725,0.00451495566718925,0.0711477236250341,0.0888463498404159,1.4378064104574e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAT5B,Signal transducer and activator of transcription 5B,39788,0.226435502545503,0.0127808090110771,0.201385116883792,0.251485888207215,1.44467552405632e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,39866,0.0602660146691262,0.00340848060583354,0.0535853926816924,0.0669466366565599,2.66750646441305e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IKBKG,NF-kappa-B essential modulator,39866,0.150889007773543,0.0085385603017193,0.134153429582174,0.167624585964913,3.15856926361871e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLG,Plasminogen,37162,0.0370431479870882,0.00209864023340467,0.0329298131296151,0.0411564828445614,6.09322109096059e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOXO1,Forkhead box protein O1,39866,0.140433799507607,0.00796826644356558,0.124815997278218,0.156051601736995,7.18755511556958e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTN1,Dynactin subunit 1,40030,0.106277971438598,0.00603262233145555,0.094454031668945,0.118101911208251,7.98419231212007e-69
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37021,0.122379102206942,0.00695219020926978,0.108752809396774,0.136005395017111,1.42481395675183e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37169,0.173100743191973,0.0098489568981153,0.153796787671667,0.192404698712279,2.24124220745595e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK10,Kallikrein-10,39856,0.0641849457813953,0.00365702961152196,0.0570171677428122,0.0713527238199783,2.54624602905593e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCBP2,Poly(rC)-binding protein 2,37411,0.118070123366944,0.00672924358034917,0.10488080594946,0.131259440784428,3.62427718228142e-68
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFX1,Transcriptional repressor NF-X1,37021,0.109107745179991,0.00625424324334617,0.0968494284230324,0.121366061936949,2.13476639741241e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEFTY2,Left-right determination factor 2,40011,0.0862407650621553,0.00495120848602695,0.0765363964295424,0.0959451336947681,2.4782956746792e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CES3,Carboxylesterase 3,39788,0.111285627941253,0.00639391034902466,0.0987535636571644,0.123817692225341,3.16818792000033e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACE2,Angiotensin-converting enzyme 2,39585,0.0805612563964365,0.00463374272029464,0.071479120664659,0.089643392128214,4.47899597668848e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP45,Rho GTPase-activating protein 45,37124,0.133734858753852,0.00768717720362561,0.118667991434746,0.148801726072959,4.80498852456794e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB6,DnaJ homolog subfamily B member 6,37013,0.138194319605232,0.00794460554195255,0.122622892743005,0.153765746467459,5.07742287554803e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37124,0.0789424984498897,0.00454783916538637,0.0700287336857325,0.087856263214047,9.32436328896154e-67
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37043,0.0922087065220445,0.00531777411573296,0.0817858692552079,0.102631543788881,1.29118899565778e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAS6,Growth arrest-specific protein 6,39947,-0.0410286952255222,0.00237081175299915,-0.0456754862614005,-0.0363819041896438,1.70211386267848e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,37368,0.183890183870456,0.0106211576141026,0.163072714946815,0.204707652794098,1.93459049224099e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EZR,Ezrin,40009,0.0385436394211687,0.00222937457877862,0.0341740652467626,0.0429132135955748,2.25307566404176e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RILPL2,RILP-like protein 2,37437,0.158210556279351,0.00915638213395525,0.140264047296799,0.176157065261903,3.46746413260115e-66
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4B,Eukaryotic translation initiation factor 4B,39749,0.0926181657644836,0.00538896779218277,0.0820557888918054,0.103180542637162,1.30987318386808e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BACH1,Transcription regulator protein BACH1,39866,0.117981738984426,0.00687393473004267,0.104508826913543,0.13145465105531,1.91362574256213e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37411,0.123513928855402,0.00719105354148334,0.109419463914094,0.137608393796709,1.97476011998664e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FETUB,Fetuin-B,39908,0.053584433469856,0.0031226769353814,0.0474639866765085,0.0597048802632036,2.03574862117393e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,39788,0.186458010529036,0.0108700540900106,0.165152704512615,0.207763316545457,2.29147684732623e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39913,0.0554667116829274,0.00323397512238811,0.0491281204430467,0.0618053029228081,2.35037151097773e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40058,0.158509315382766,0.00924241025053092,0.140394191291725,0.176624439473807,2.36363915864139e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,37169,0.0853163800146745,0.00497305376258069,0.0755691946400163,0.0950635653893326,2.86178295016353e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTBS,Di-N-acetylchitobiase,37296,0.0438953876213852,0.0025618089444023,0.0388742420903567,0.0489165331524137,4.02840907136461e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,37388,0.144274629456748,0.00842737909372106,0.127756966433055,0.160792292480441,5.1103288518327e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD2AP,CD2-associated protein,39868,0.100479478756322,0.00587593532813235,0.0889626455131823,0.111996311999461,5.58601825123858e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SRPK2,SRSF protein kinase 2,39866,0.133283205073887,0.00779752177555581,0.118000062393797,0.148566347753976,6.30173996751428e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37382,0.162596796983797,0.00951102238555659,0.143955193108106,0.181238400859487,7.67100709384194e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4G,C-type lectin domain family 4 member G,39866,0.0525263333044713,0.00307779576165695,0.0464938536116236,0.0585588129973189,9.89422943423067e-65
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBPL,FK506-binding protein-like,37382,0.0942908357442957,0.00553029171880706,0.0834514639754338,0.105130207513157,1.65164354192278e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP4,"Fatty acid-binding protein, adipocyte",40052,0.0766971407685992,0.00450533441840849,0.0678666853085185,0.0855275962286798,1.99366532119578e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDLIM5,PDZ and LIM domain protein 5,37411,0.189368446859954,0.0111163408623819,0.167580418769685,0.211156474950222,2.10710685120559e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBC1D23,TBC1 domain family member 23,39788,0.142173955874912,0.00836719999707009,0.125774243880654,0.158573667869169,3.47042407728319e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39713,0.176716764586074,0.0104001662050607,0.156332438824155,0.197101090347994,3.49715970633549e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SKAP2,Src kinase-associated phosphoprotein 2,39931,0.164109309192886,0.00966461018840207,0.145166673223618,0.183051945162154,4.15128486405949e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MASP1,Mannan-binding lectin serine protease 1,39713,0.0371150957255734,0.00218653038192498,0.0328294961770005,0.0414006952741464,4.6716139451176e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37437,0.100752106588899,0.00593473217588645,0.0891200315241616,0.112384181653636,5.57923089684566e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PENK,Proenkephalin-A,37124,0.0459463663314272,0.00270630206572474,0.0406420142826067,0.0512507183802477,5.69797493998045e-64
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VNN1,Pantetheinase,37445,0.113685407363219,0.00672571764750559,0.100503000774108,0.12686781395233,1.89799272494188e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSO,Cathepsin O,40058,0.0469140384200522,0.00277805346355838,0.0414690536314778,0.0523590232086266,1.94385704562451e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HJV,Hemojuvelin,37411,0.0696186792027551,0.0041198973433326,0.0615436804098232,0.077693677995687,2.0675934240032e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPON2,Spondin-2,39775,-0.0525174390336592,0.00311070661917005,-0.0586144240072325,-0.0464204540600859,2.14432306307478e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPING1,Plasma protease C1 inhibitor,37424,0.0295280293645648,0.00174765366264105,0.0261026281857884,0.0329534305433413,2.14669139472583e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A4,Protein S100-A4,39913,0.0891018373757071,0.00528076068521388,0.0787515464326879,0.0994521283187262,2.50053659529749e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39866,0.158563883646533,0.00941156676997639,0.140117212777379,0.177010554515687,3.8123558009727e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39477,0.129825503014891,0.00770525196311756,0.11472320916718,0.144927796862601,3.85441043475989e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39749,0.14792952625507,0.00878644050046737,0.130708102874154,0.165150949635987,4.66846438791574e-63
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,37338,0.0697764325309666,0.00416753279669357,0.0616080682494472,0.077944796812486,2.71609711605284e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39977,0.160153746085744,0.00957608752663544,0.141384614533539,0.17892287763795,2.91700765209372e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39585,0.150628507582733,0.00901572516606496,0.132957686257245,0.16829932890822,3.97903573361915e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEXIM1,Protein HEXIM1,39866,0.126275852163059,0.00757306983183564,0.111432635292661,0.141119069033457,6.70349805618987e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39763,0.161817586281119,0.00970476073883845,0.142796255232996,0.180838917329243,6.78719166206416e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAT,Linker for activation of T-cells family member 1,40058,0.117370282640559,0.00704151899750022,0.103568905405459,0.13117165987566,7.29645869134015e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLK1,Protein delta homolog 1,40052,0.0862971094374344,0.00517781385792149,0.0761485942759083,0.0964456245989605,7.49561618550035e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BID,BH3-interacting domain death agonist,39866,0.102179313015459,0.00613530176816947,0.090154121549847,0.114204504481071,9.31333817476803e-62
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPOCK1,Testican-1,39749,0.0392304916537409,0.00235798755996728,0.034608836036205,0.0438521472712768,1.24296293724756e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MVK,Mevalonate kinase,39587,0.122228294034691,0.00734890743728743,0.107824435457608,0.136632152611775,1.3681556209262e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BPIFB1,BPI fold-containing family B member 1,39786,-0.0977208432118486,0.00588063367042317,-0.109246885205878,-0.0861948012178192,1.71731592535486e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VAMP8,Vesicle-associated membrane protein 8,37056,0.136652691991582,0.00822113185815777,0.120539273549592,0.152766110433571,2.02740172159473e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39419,0.0840807653747174,0.00506472692361454,0.0741539006044329,0.0940076301450019,2.30060864241673e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,39477,0.0759460419874167,0.00457872184297205,0.0669717471751915,0.0849203367996419,2.90421817936084e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TANK,TRAF family member-associated NF-kappa-B activator,39587,0.10912171796777,0.00657927311471981,0.0962263426629193,0.122017093272621,2.93020003125956e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HYOU1,Hypoxia up-regulated protein 1,40052,0.0330467291755297,0.0019948192337418,0.0291368834773958,0.0369565748736636,3.8901484693429e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,40003,0.0922275757801136,0.00556990251194811,0.0813105668566953,0.103144584703532,4.45443766792112e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37388,0.10690772116053,0.00645167438639493,0.0942624393631958,0.119553002957864,4.54518665195601e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAG1,Dystroglycan,39931,0.0744881450035777,0.00450903810691715,0.0656504303140201,0.0833258596931354,8.38772543456701e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIT1,ARF GTPase-activating protein GIT1,37056,0.15002631149946,0.00907563297926739,0.132238070860096,0.167814552138824,8.99960432917646e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD36,Platelet glycoprotein 4,37056,0.0702068904137584,0.0042486150160939,0.0618796049822144,0.0785341758453024,9.92434193126701e-61
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37411,0.100797277175732,0.00610954717337403,0.0888225647159187,0.112771989635545,1.46794553378926e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH2B3,SH2B adapter protein 3,39477,0.150615571299248,0.00915163136667935,0.132678373820556,0.168552768777939,2.37533983656563e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPY,Pancreatic prohormone,39826,0.153091672083085,0.00930557227413055,0.134852750425789,0.171330593740381,2.56017259227813e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF21,Fibroblast growth factor 21,40011,0.182125133317304,0.0110726779147293,0.160422684604434,0.203827582030173,2.6731656082846e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNMBP,Dynamin-binding protein,39749,0.0947120486171665,0.00576255448531953,0.0834174418259403,0.106006655408393,3.32864543652907e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGCC,Regulator of cell cycle RGCC,37411,0.115723526810656,0.00703792152409659,0.101929200623426,0.129517852997885,3.60664581549947e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HCLS1,Hematopoietic lineage cell-specific protein,40058,0.085443766215036,0.0052023092690076,0.0752472400477811,0.0956402923822909,3.93038678295386e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIGYF2,GRB10-interacting GYF protein 2,37411,0.116877189903074,0.00711882515014013,0.1029242926088,0.130830087197349,5.38672389834597e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDNF,Cerebral dopamine neurotrophic factor,39788,0.0481477060514959,0.00293490879325447,0.0423952848167171,0.0539001272862747,5.4501380174421e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37437,0.116324319584836,0.00708568434223282,0.102436378274059,0.130212260895612,5.48161757055368e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YOD1,Ubiquitin thioesterase OTU1,37021,0.0936674245004144,0.00570585091243743,0.082483956712037,0.104850892288792,5.78588165653463e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37411,0.162641053903601,0.00991151084626707,0.143214492644918,0.182067615162285,6.20298214146855e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",39931,0.167676677433739,0.0102275584266824,0.147630662917442,0.187722691950037,6.40472186036198e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIA1,Nucleolysin TIA-1 isoform p40,39374,0.187228450060793,0.0114232954052353,0.164838791066531,0.209618109055054,7.17203264703168e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,39477,0.0970536439020385,0.00592225029406996,0.0854460333256613,0.108661254478416,7.36259623286622e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASAH2,Neutral ceramidase,39749,0.0797428405821718,0.00486726280045919,0.0702030054932718,0.0892826756710718,7.76058472524184e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37382,0.135712738155865,0.00828365528113577,0.119476773804839,0.151948702506891,9.48052210928737e-60
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AP3B1,AP-3 complex subunit beta-1,37382,0.116826157207127,0.00713307209101674,0.102845335908735,0.13080697850552,1.02923287592271e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39913,0.110544158621174,0.00675508911656807,0.0973041839527004,0.123784133289647,1.04197881429887e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RTN4R,Reticulon-4 receptor,40030,0.050341000459229,0.00307833941552399,0.044307455204802,0.0563745457136561,1.24023899995455e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STK11,Serine/threonine-protein kinase STK11,39585,0.111363962261452,0.00681580017739291,0.0980049939137614,0.124722930609142,1.60860918009902e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39858,0.0369519324992906,0.00226404294859949,0.0325144083200356,0.0413894566785457,2.10533033147806e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ORM1,Alpha-1-acid glycoprotein 1,37389,0.0301579096500914,0.00184712308616972,0.0265375484011987,0.033778270898984,2.34239628697657e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,39788,0.128082534814843,0.00786026198465003,0.112676421324929,0.143488648304757,3.22920005324362e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39868,0.126203516389381,0.00774716933287095,0.111019064496954,0.141387968281808,3.46222070855088e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,37382,0.0806805803732269,0.00495029031456617,0.0709780113566772,0.0903831493897766,3.72280653713544e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBCC,Tubulin-specific chaperone C,39749,0.122956827756386,0.00755565798768437,0.108147738100524,0.137765917412247,4.57241959563857e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GOLM2,Protein GOLM2,40009,0.0334577012563683,0.00205624252481229,0.0294274659077362,0.0374879366050003,4.65439014233376e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39477,0.128599206574022,0.00790453543150264,0.113106317128276,0.144092096019767,5.00398837209788e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPHOSPH8,M-phase phosphoprotein 8,39585,0.114841496298873,0.00705928241438093,0.101005302766686,0.128677689831059,5.03732453261706e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNST,Consortin,39868,0.163106257563548,0.0100288790745232,0.143449654577482,0.182762860549613,5.31054676049122e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MITD1,MIT domain-containing protein 1,39749,0.146864016779118,0.00903175436844228,0.129161778216971,0.164566255341265,5.60029427919365e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37411,0.118009163150449,0.00725418775339269,0.103790955153799,0.132227371147099,6.04606466362671e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GTPBP2,GTP-binding protein 2,37039,0.12223103350196,0.00751911072445555,0.107493576482027,0.136968490521893,7.55424922842763e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,39585,0.14216478469732,0.00875563966246999,0.125003730958879,0.159325838435761,8.31202048708357e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,39477,0.0977633931921024,0.00602171824661983,0.0859608254287276,0.109565960955477,8.62083512710027e-59
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1R2,Interleukin-1 receptor type 2,39830,0.02955465330484,0.00182167507719411,0.0259841701535396,0.0331251364561405,1.00759565892843e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMP3,Metalloproteinase inhibitor 3,39931,0.195041237259649,0.0120423269782389,0.171438276382301,0.218644198136997,1.55643401832963e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SYTL4,Synaptotagmin-like protein 4,37437,0.108677792179732,0.00670951038653274,0.0955271518221273,0.121828432537336,1.85099643580009e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C3,Complement C3,36816,0.069301047134545,0.00428352373669304,0.0609053406106267,0.0776967536584634,2.66163919822167e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT5,"Keratin, type II cytoskeletal 5",39489,0.0757995684953117,0.00469072577972308,0.0666057459670545,0.084993391023569,2.88885755575686e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COMMD1,COMM domain-containing protein 1,37043,0.0929988358128589,0.00575552198190207,0.0817180127283308,0.104279658897387,3.59659109457392e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA11,Annexin A11,39829,0.10011141861649,0.00620485883104887,0.0879498953076341,0.112272941925346,4.21305304583776e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST3,Cystatin-C,39897,0.0397996620041865,0.00246751934124015,0.0349633240953558,0.0446359999130172,4.53765261474952e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP43,Centrosomal protein 43,39476,0.104768410693393,0.00650375209746594,0.09202105658236,0.117515764804426,6.46757785010446e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP1BB,Platelet glycoprotein Ib beta chain,37021,0.101600823793036,0.00630276669191333,0.0892474010768863,0.113954246509187,6.60802570302536e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1RL2,Interleukin-1 receptor-like 2,39587,0.0594713265570577,0.00369244155601321,0.0522341411072719,0.0667085120068436,6.69929741193952e-58
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCD5,Programmed cell death protein 5,40009,0.0865571502067102,0.00538641959878361,0.0759997677930943,0.0971145326203261,1.16822506231773e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,39931,0.0566205536737007,0.00352764199175155,0.0497063753698676,0.0635347319775337,1.58650036027723e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNPY4,Protein canopy homolog 4,39788,0.112943219647082,0.00703734832390941,0.0991500169322195,0.126736422361944,1.63759544215582e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,37368,0.0626980945659029,0.00390576184594979,0.0550428013478413,0.0703533877839645,1.85883816220229e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINE1,Plasminogen activator inhibitor 1,40052,0.100830275482133,0.00628750202055568,0.088506771521844,0.113153779442422,1.963222182167e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDHD2,Phospholipase DDHD2,37411,0.0995319568068506,0.00620291210643916,0.0873742490782299,0.111689664535471,2.05909219588105e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC27,Cell division cycle protein 27 homolog,39477,0.0913674884388748,0.00569787276620798,0.0801996578171071,0.102535319060642,2.07816557737982e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRAP,BRCA1-associated protein,37249,0.164380797264199,0.0102444038438657,0.144301765730222,0.184459828798176,2.09233311177788e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,37124,0.107463693558131,0.00671131161102957,0.0943095228005133,0.120617864315749,3.59639443745291e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RABEP1,Rab GTPase-binding effector protein 1,37124,0.116044331393819,0.00724869313086518,0.101836892857323,0.130251769930315,3.78987088051196e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37368,0.124562038701723,0.00778794774660335,0.10929766111838,0.139826416285065,4.6813754662764e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AZI2,5-azacytidine-induced protein 2,37411,0.0824223171301658,0.00515395889392023,0.0723205576980822,0.0925240765622495,4.82562654437235e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DBNL,Drebrin-like protein,39931,0.138208992349897,0.00864965269504736,0.121255673067604,0.155162311632189,4.95561575865357e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYN,Tyrosine-protein kinase Lyn,39788,0.125728126572879,0.00787502661217132,0.110293074413023,0.141163178732735,6.15232152068361e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39788,0.0415998341534161,0.00260569126126749,0.0364926792813318,0.0467069890255003,6.19446320110565e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFB1,Transforming growth factor beta-1 proprotein,40040,0.0570576732365539,0.00357529445696774,0.0500500961008971,0.0640652503722107,6.71580978160791e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT18,"Keratin, type I cytoskeletal 18",39788,0.120709660117343,0.00756507965617825,0.105882103991234,0.135537216243453,7.11940504341475e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARA5,Scavenger receptor class A member 5,40009,0.043262525013344,0.0027118996315878,0.0379472017354319,0.0485778482912561,7.39921471835701e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37411,0.119180456456869,0.00747054287856123,0.104538192414889,0.133822720498849,8.86661791879983e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFRA1,GDNF family receptor alpha-1,40011,0.0398284089711348,0.00249956149274079,0.0349292684453629,0.0447275494969068,9.93207614227343e-57
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HS1BP3,HCLS1-binding protein 3,37043,0.135587162843848,0.00850602482721631,0.118915354182504,0.152258971505192,1.12824029655341e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYDGF,Myeloid-derived growth factor,37437,0.149940153767874,0.00940784387914545,0.131500779764748,0.168379527770999,1.13051753155267e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,37043,0.0462658004466157,0.00290474852593839,0.0405724933357765,0.051959107557455,1.37252557541184e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NIT2,Omega-amidase NIT2,37377,0.111523159426454,0.00700324256530246,0.0977968039984616,0.125249514854447,1.39975869603621e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C2,Complement C2,39908,0.0349170944313294,0.00219587228853679,0.0306131847457973,0.0392210041168615,1.6775806000279e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APPL2,DCC-interacting protein 13-beta,37124,0.167165861259939,0.0105164325113062,0.146553653537779,0.1877780689821,2.24866218728281e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAXX,Protein PAXX,37124,0.0679434035316041,0.00427553494729338,0.0595633550349091,0.0763234520282991,2.4119172665172e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAX,Protein max,39489,0.155455068035348,0.0097958063741697,0.136255287541975,0.17465484852872,2.83212885293157e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,A1BG,Alpha-1B-glycoprotein,37453,0.0252152677110837,0.00158913894132847,0.0221005553860799,0.0283299800360875,3.4100389298987e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39788,0.113219407694889,0.00714083359903615,0.0992233738407777,0.127215441548999,3.48027299572092e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IST1,IST1 homolog,37287,0.147203662108324,0.00928574558475598,0.129003600762202,0.165403723454446,4.34550140168065e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DOK1,Docking protein 1,37388,0.202172243316061,0.0127694366480023,0.177144147485976,0.227200339146145,5.90010238497682e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,36995,0.074784297261448,0.00472469057324112,0.0655239037378955,0.0840446907850006,6.50925223430925e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRKL,Crk-like protein,39881,0.157348609813654,0.00995091613735394,0.13784481418444,0.176852405442868,6.75499275875886e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OPHN1,Oligophrenin-1,37388,0.158862154593821,0.0100471856107089,0.139169670796832,0.17855463839081,8.17418868123018e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,39866,0.110177045720396,0.00697677413461845,0.0965025684165435,0.123851523024248,9.31298779948235e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STC1,Stanniocalcin-1,40009,0.0614993318084399,0.00389555529400194,0.0538640434321961,0.0691346201846837,9.97204042509344e-56
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37437,0.104054614100725,0.00660127017818327,0.0911161245514855,0.116993103649964,1.73965162542448e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKT1S1,Proline-rich AKT1 substrate 1,39489,0.0983531112601324,0.00625518797219188,0.0860929428346363,0.110613279685628,2.77092354888697e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAP,Prolyl endopeptidase FAP,40052,0.0397499633816046,0.00253604662322264,0.0347793120000882,0.0447206147631209,5.77467228674746e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL16,C-X-C motif chemokine 16,40034,0.0338219454988125,0.00216028718126255,0.0295877826235379,0.0380561083740871,7.61168868142193e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM5,Tripartite motif-containing protein 5,39866,0.125422297336915,0.00801536764798218,0.10971217674687,0.14113241792696,8.76574462798994e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRELD2,Protein disulfide isomerase CRELD2,39908,0.0757027676021568,0.0048386052647721,0.0662191012832034,0.0851864339211101,9.04068685976296e-55
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BGLAP,Osteocalcin,37437,0.12548362368092,0.00803843293420449,0.109728295129879,0.14123895223196,1.83677140146216e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39866,0.134178186201923,0.00860166661777147,0.117318919631091,0.151037452772755,1.85849624735069e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM13A,Protein FAM13A,37382,0.0982722120951808,0.00630489761057351,0.0859146127784568,0.110629811411905,2.66109638346742e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,METAP2,Methionine aminopeptidase 2,40011,0.0836084821752613,0.0053687317390188,0.0730857679667844,0.0941311963837381,2.74650635261117e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMN,Protein amnionless,39587,0.0688865367453152,0.0044317678304339,0.0602002717976648,0.0775728016929657,4.42495884812983e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DIABLO,"Diablo homolog, mitochondrial",39818,0.15854166590223,0.0102119254173819,0.138526292084161,0.178557039720298,5.81626191857425e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSNL1,Visinin-like protein 1,37388,0.0545748026048098,0.003515355153859,0.0476847065032461,0.0614648987063734,6.8824138340497e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKG1,cGMP-dependent protein kinase 1,37124,0.182645448600248,0.0117798108491735,0.159557019335867,0.205733877864628,9.50648653187815e-54
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC3B,Tetranectin,37138,0.0304869253872869,0.00196779173820637,0.0266300535804024,0.0343437971941714,1.14063106766889e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",39585,0.131145085747342,0.00848153970049047,0.114521267934381,0.147768903560304,1.54146156032925e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",37088,0.124297488345213,0.00803972080633749,0.108539635564792,0.140055341125635,1.88197126908754e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,37388,0.0899798773930582,0.00583129280355728,0.078550543498086,0.101409211288031,2.8993915751442e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GORASP2,Golgi reassembly-stacking protein 2,37382,0.0680814615508208,0.00441250306086542,0.0594329555515246,0.0767299675501171,2.95887959914903e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39788,0.0630805097293033,0.00409924690539294,0.0550459857947331,0.0711150336638734,4.72158290455125e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,39477,0.109760326315549,0.00714815531102012,0.0957499419059499,0.123770710725149,7.96642322738522e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37043,0.0999039013439052,0.00650395791404317,0.0871561438323806,0.11265165885543,8.62977552758603e-53
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PON2,Serum paraoxonase/arylesterase 2,39585,0.0491255591325928,0.00320252326027161,0.0428486135424605,0.0554025047227252,1.00067060076968e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37382,0.210395417349805,0.0137281499309125,0.183488243485217,0.237302591214393,1.42067338921583e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD69,Early activation antigen CD69,39785,0.125082812383471,0.00816704706941945,0.109075400127409,0.141090224639533,1.42644114920826e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37368,0.103647422237774,0.00676764947389202,0.0903828292689454,0.116912015206602,1.67220251881234e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB27B,Ras-related protein Rab-27B,37437,0.116684632239091,0.00762313029282495,0.101743296865154,0.131625967613028,1.89099596409587e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPART,Spartin,37124,0.111187453454342,0.0072658714332836,0.0969463454451062,0.125428561463578,2.05515297295674e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TWF2,Twinfilin-2,37437,0.120065624510725,0.00786447674536405,0.104651250089812,0.135479998931639,3.44925897225027e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EREG,Proepiregulin,39713,0.113228410935779,0.0074261014334378,0.098673252126241,0.127783569745317,4.0164202829757e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VASP,Vasodilator-stimulated phosphoprotein,37445,0.103423377678513,0.00678769360364224,0.0901194982153738,0.116727257141651,5.41056701041494e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40009,0.0792228644666393,0.00520335252023698,0.0690242935269749,0.0894214354063038,5.51173375640395e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAVS,Mitochondrial antiviral-signaling protein,39477,0.131013970884059,0.00860819808418702,0.114141902639052,0.147886039129066,6.17444397383183e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHMP1A,Charged multivesicular body protein 1a,39749,0.112622422541916,0.00740985222441909,0.0980991121820547,0.127145732901778,8.30594936384132e-52
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39477,0.081454339373745,0.00536892916227246,0.070931238215691,0.091977440531799,1.2754952325034e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPP,Lipoma-preferred partner,37021,0.0948609644938978,0.00625420982880792,0.0826027132294343,0.107119215758361,1.58076090534456e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MGLL,Monoglyceride lipase,39908,0.123130249443345,0.00812498747146736,0.107205273999269,0.139055224887421,1.60762037095709e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VEGFA,Vascular endothelial growth factor A,39993,0.0802750979743107,0.00529739261709793,0.0698922084447988,0.0906579875038226,1.62046061965425e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA4D,Semaphorin-4D,40009,0.0421538707211252,0.00278447463522675,0.0366963004360808,0.0476114410061696,2.02173170177874e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOP2B,DNA topoisomerase 2-beta,37056,0.112032049077994,0.00740686397606958,0.0975145956848973,0.12654950247109,2.95879114324973e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,37056,0.128189522153434,0.00848219211444542,0.111564425609121,0.144814618697747,3.57389755051037e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBM17,Splicing factor 45,37411,0.107702222787492,0.00712795555827866,0.0937314298932658,0.121673015681718,3.64053729871791e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAX1BP1,Tax1-binding protein 1,37388,0.0887143175236622,0.00587540397821816,0.0771985257263546,0.10023010932097,4.26875597688021e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GYS1,"Glycogen [starch] synthase, muscle",39585,0.131047710456757,0.0086873026186765,0.114020597324151,0.148074823589363,4.62916265738492e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAMDC4,Apical endosomal glycoprotein,37368,0.0782612536546504,0.00518566493293116,0.0680973503861053,0.0884251569231954,4.77521999187062e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,QDPR,Dihydropteridine reductase,39790,0.0608727902169307,0.00404016408534306,0.0529540686096583,0.0687915118242031,5.99853713851744e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAMBP,STAM-binding protein,39713,0.0902141438854992,0.00599125934965925,0.0784712755601671,0.101957012210831,6.91625347449517e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F12,Coagulation factor XII,37453,0.0581543116897954,0.00386017905119481,0.0505883607494536,0.0657202626301372,7.061279426358e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,37021,0.0877028951614158,0.00582238449049093,0.0762910215600536,0.099114768762778,7.51566438703461e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ISM1,Isthmin-1,39866,0.0557517289363139,0.00370454578287207,0.0484908192018846,0.0630126386707431,7.74214119899658e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36846,0.0461095856166547,0.00306304223126416,0.040106022843377,0.0521131483899325,8.77249795189594e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R2,Protein phosphatase inhibitor 2,39868,0.112835982659019,0.00750580750702494,0.0981245999452499,0.127547365372788,9.88193606991296e-51
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39699,0.0563025200483173,0.00374675388972685,0.0489588824244527,0.0636461576721819,1.09198028287523e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNAP25,Synaptosomal-associated protein 25,36991,0.0660369657029576,0.00439524474711287,0.0574222859986164,0.0746516454072989,1.33271894367031e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OGA,Protein O-GlcNAcase,37382,0.0995205345456347,0.00662763480911361,0.0865303703197721,0.112510698771497,1.47374059877381e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37124,0.089799080416902,0.00598270361015539,0.0780729813409974,0.101525179492807,1.64536562439678e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AFP,Alpha-fetoprotein,39699,0.0942989512126543,0.00628716499809679,0.0819761078163846,0.106621794608924,1.66489448117377e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX15,Sorting nexin-15,37124,0.075300243754565,0.00501813523530371,0.0654646986933697,0.0851357888157603,1.75000964352381e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PMVK,Phosphomevalonate kinase,39480,0.154829122789711,0.0103251902554591,0.134591749889011,0.175066495690411,1.76968186650859e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,39699,0.0414148840492895,0.0027693191036139,0.0359870186062062,0.0468427494923727,3.18562663570301e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,37043,0.102284697847157,0.0068362435856985,0.0888856604191881,0.115683735275126,3.35067966588622e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GASK1A,Golgi-associated kinase 1A,37021,0.0596541228928652,0.00398734945574394,0.0518389179596071,0.0674693278261233,3.419694682775e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GMPR,GMP reductase 1,40058,0.0689164651786304,0.00461408227433235,0.059872863920939,0.0779600664363218,4.13480721531143e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FIS1,Mitochondrial fission 1 protein,39855,0.108577031277582,0.00728160498737992,0.0943050855023178,0.122848977052847,6.03960489670419e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39788,0.0530033999941588,0.00355691120919117,0.0460318540241441,0.0599749459641735,6.9834728285347e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPDC1,Neural proliferation differentiation and control protein 1,39868,0.0408579203010213,0.00274226071929091,0.0354830892912111,0.0462327513108315,7.18302151112959e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNCG,Gamma-synuclein,39749,0.0900603884504745,0.00604580961619103,0.0782106016027401,0.101910175298209,7.55390329264115e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WASHC3,WASH complex subunit 3,37388,0.105157300553842,0.00706053405462254,0.0913186538067822,0.118995947300903,8.97908050253086e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL18,C-C motif chemokine 18,39715,0.0977242879723951,0.00656808276527302,0.08485084575246,0.11059773019233,9.81879421686301e-50
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS8,Galectin-8,40009,0.0845701268621346,0.00568920189563409,0.0734192911466918,0.0957209625775774,1.18382842237005e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OGFR,Opioid growth factor receptor,39788,0.0452125402948842,0.00304384704978229,0.0392466000773109,0.0511784805124575,1.41219517459936e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICA1,Islet cell autoantigen 1,39587,0.110751825358797,0.00746430307490292,0.0961217913319868,0.125381859385606,1.81001011475144e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COCH,Cochlin,37437,0.0631153054647978,0.00425169630011526,0.0547819807165719,0.0714486302130238,1.83734228300261e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCRG1,Scrapie-responsive protein 1,37437,0.0364510412880857,0.00245897648871418,0.0316314473702059,0.0412706352059655,2.50250745097612e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNDC5,Thioredoxin domain-containing protein 5,40009,0.0943633369767616,0.0063746511153952,0.081869020790587,0.106857653162936,2.95052590562467e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39908,0.119669157709262,0.00808805965320702,0.103816560788976,0.135521754629547,3.2905787110191e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAT2,Signal transducer and activator of transcription 2,37056,0.108579800691268,0.00733595711441512,0.0942013247470146,0.122958276635522,3.57424032498133e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGF,Pro-epidermal growth factor,39808,0.142625810200459,0.00964722795630858,0.123717243406095,0.161534376994824,3.92179818846005e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRAP2,GRB2-related adapter protein 2,39868,0.176466058452893,0.0119430813972858,0.153057618914212,0.199874497991573,4.43168140421465e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PKD2,Polycystin-2,37021,0.0820660533343769,0.00555351236699844,0.07118116909506,0.0929509375736939,5.06683681367917e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSTN,Growth/differentiation factor 8,39585,0.071279056105684,0.00482845849216649,0.0618152774610377,0.0807428347503303,5.45646467930386e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37043,0.0629788694336448,0.00426444687375937,0.0546205535610764,0.0713371853062131,5.76696819244525e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIFBP,KIF-binding protein,39788,0.114076713882667,0.00773202231125651,0.0989219501526046,0.12923147761273,6.11827902461282e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD207,C-type lectin domain family 4 member K,39496,0.0516668846445358,0.00350328217991486,0.0448004515719027,0.0585333177171689,6.73835819863596e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CREG1,Protein CREG1,39660,0.0516530538741043,0.00350249297670206,0.0447881676397683,0.0585179401084404,6.74755534406036e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39841,0.0841592174093926,0.00570870815310228,0.0729701494293121,0.0953482853894731,7.22554591500127e-49
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HAO1,Hydroxyacid oxidase 1,40030,0.176488598215934,0.0119971357302658,0.152974212184613,0.200002984247255,1.13229114189059e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NHLRC3,NHL repeat-containing protein 3,36838,0.0437040135025782,0.00297042461637383,0.0378819812544855,0.0495260457506709,1.30874853796509e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDC,Nuclear migration protein nudC,40058,0.0879916331740591,0.00598636020229349,0.0762583671775639,0.0997248991705544,1.3511582613172e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FNDC1,Fibronectin type III domain-containing protein 1,37388,0.0630805213714742,0.0042888162216076,0.0546744415771233,0.071486601165825,1.35559048043864e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YJU2,Splicing factor YJU2,37368,0.0444590196293348,0.00302277199595291,0.0385343865172671,0.0503836527414025,1.35954511821628e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH2,Cadherin-2,39868,0.0479501127844033,0.00326261667331823,0.0415553841046995,0.054344841464107,1.40008619347958e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37169,0.0680441529676638,0.00463171660599493,0.0589659884199138,0.0771223175154139,1.76586454036614e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DGKA,Diacylglycerol kinase alpha,37056,0.0749298485614597,0.00510243517578568,0.0649290756169198,0.0849306215059996,1.93525021288665e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATOX1,Copper transport protein ATOX1,39913,0.0993482652330081,0.00677705077114763,0.0860652457215588,0.112631284744457,2.40473346488632e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAG4,BAG family molecular chaperone regulator 4,37056,0.068181589259827,0.004649299853976,0.059068961546034,0.0772942169736199,2.59412870600862e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP2,Microtubule-associated protein 2,37388,0.0628870187095226,0.00428953942800773,0.0544795214306275,0.0712945159884178,2.70543667295062e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRADD,Death domain-containing protein CRADD,39713,0.104096364237271,0.00710603021509624,0.0901685450156826,0.11802418345886,2.8260496789705e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MOCS2,Molybdopterin synthase catalytic subunit,37124,0.0928984373903885,0.00634023745801564,0.0804715719726779,0.105325302808099,3.10512706952823e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MOG,Myelin-oligodendrocyte glycoprotein,40030,0.0432464990056972,0.00295782539385307,0.0374491612337452,0.0490438367776492,4.18146397087286e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM172A,Cotranscriptional regulator FAM172A,37043,0.0841619266776838,0.00575218086005143,0.072887652191983,0.0954362011633846,4.22386399611125e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,37169,0.099857661896532,0.00682955766551842,0.0864717288721159,0.113243594920948,4.83542017101174e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,37388,0.0416361749399354,0.00285432855094605,0.0360416909800812,0.0472306588997897,7.83515687127452e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,39866,0.141918424577897,0.00974203514451296,0.122824035694652,0.161012813461143,9.12166090031452e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAGK,N-acetyl-D-glucosamine kinase,37026,0.0780044598057713,0.00535209400961368,0.0675143555469285,0.0884945640646141,9.5926652680787e-48
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39887,0.0320148658415439,0.00220024897112238,0.0277023778581441,0.0363273538249438,1.16601988055188e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,39859,0.0682400280643224,0.00469016913041861,0.0590472965687019,0.0774327595599428,1.18401101632495e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASC3,Protein CASC3,37039,0.0568427587017914,0.00390531859739717,0.0491883342508929,0.0644971831526898,1.26650653502932e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MIA,Melanoma-derived growth regulatory protein,39913,0.0489281167359676,0.00336598382007497,0.0423307884486206,0.0555254450233145,1.43586585096817e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL7,Interleukin-7,39866,0.0880616794630178,0.0060624935983655,0.0761791920102214,0.0999441669158141,1.67135248802339e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTDH,Protein LYRIC,37056,0.125292869167371,0.00862124506563777,0.108395228838721,0.142190509496021,1.74049287365529e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD22,B-cell receptor CD22,40058,0.0541827436845456,0.00373101676944628,0.0468699508164309,0.0614955365526603,1.74112909177173e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNLR1,Interferon lambda receptor 1,39866,0.0504836035141406,0.0034770401758883,0.0436686047693995,0.0572986022588816,1.83593002452859e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP5,Platelet glycoprotein V,37124,0.0488676695897531,0.00337086270175193,0.0422607786943193,0.0554745604851868,2.90384984244648e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37388,0.132014015573401,0.00913302503590769,0.114113286503021,0.14991474464378,5.25263134460256e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARSB,Arylsulfatase B,39788,0.0741970831648987,0.00514845415740464,0.0641061130163856,0.0842880533134118,8.62405296848561e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TDRKH,Tudor and KH domain-containing protein,39489,0.114289456545035,0.00793457920071327,0.0987376813116368,0.129841231778433,9.73117787301622e-47
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,37411,0.0909158726958162,0.00631255996489818,0.0785432551646158,0.103288490227017,1.10526271733407e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPI,Mannose-6-phosphate isomerase,39788,0.115662317458278,0.00804387035048332,0.0998963315713305,0.131428303345225,1.37337176613936e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CETN3,Centrin-3,37382,0.105786104569715,0.00735882806911949,0.0913628015542407,0.120209407585189,1.62564809857043e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD226,CD226 antigen,37056,0.0560797146014201,0.0039056755852979,0.0484245904542362,0.063734838748604,2.10678868291166e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPT,Dermatopontin,40052,0.0357119470162048,0.00249427910665803,0.0308231599671551,0.0406007340652545,3.25587504767858e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOL1,Apolipoprotein L1,37445,0.0817261872140378,0.00571300002153904,0.0705287071718213,0.0929236672562543,4.38116744916048e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP7,Caspase-7,37388,0.112241063496859,0.00786302294873368,0.096829538517341,0.127652588476377,6.79115225441403e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EHD3,EH domain-containing protein 3,37043,0.156123227074254,0.0109372540384531,0.134686209158886,0.177560244989622,6.93714204488391e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STK24,Serine/threonine-protein kinase 24,39489,0.0825974220194593,0.00579013593022479,0.0712487555962187,0.0939460884426999,6.9985218378532e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRY2,Protein sprouty homolog 2,39587,0.122831577087588,0.00862450970054407,0.105927538074522,0.139735616100654,9.65476847202218e-46
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFHR5,Complement factor H-related protein 5,37267,0.0547757589909516,0.00384506902742541,0.0472394236971978,0.0623120942847054,1.02717572509156e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LBR,Delta(14)-sterol reductase LBR,40009,0.0884592957982206,0.00621480732244191,0.0762782734462345,0.100640318150207,1.07063023209709e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNDP1,Beta-Ala-His dipeptidase,39931,0.0603057357360448,0.0042384142262156,0.0519984438526622,0.0686130276194274,1.15676310033908e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,37056,0.0777074057129933,0.00545897693422949,0.0670078109219035,0.0884070005040831,1.21276141622356e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,37368,0.113202372274168,0.00795538107428704,0.0976098253685656,0.128794919179771,1.28073342218351e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,39837,0.127318486394148,0.00896201203124856,0.109752942812901,0.144884029975395,1.58165169101719e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM40,E3 ubiquitin ligase TRIM40,37039,0.0962068765310086,0.00677018459807089,0.0829373147187897,0.109476438343228,1.71184486189918e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMED8,Protein TMED8,37382,0.136773131184466,0.00964588279612596,0.117867200904059,0.155679061464873,2.59373993372147e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VAV3,Guanine nucleotide exchange factor VAV3,36991,0.13133040355523,0.0092622854982809,0.113176323978599,0.14948448313186,2.66576300869853e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTX3,Pentraxin-related protein PTX3,39866,-0.0654765424152627,0.0046223080074672,-0.0745362661098984,-0.056416818720627,2.81887745390979e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP7,Matrilysin,39563,0.0652678359388854,0.00460747821230414,0.0562371786427693,0.0742984932350015,2.84122108587951e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39908,0.101154186910784,0.00714607901389682,0.0871478720435459,0.115160501778021,3.2450538055634e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39866,0.132558562195815,0.0093669968760106,0.114199248318834,0.150917876072795,3.41609502199273e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIAE,Sialate O-acetylesterase,39875,0.0621652828679854,0.00439472985402911,0.0535516123540883,0.0707789533818825,3.72788392870331e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGL1,Fibrinogen-like protein 1,37445,-0.0816111384638279,0.00576722560776925,-0.0929149006550557,-0.0703073762726002,3.8598001522794e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39489,0.148280334741993,0.0104911465919939,0.127717687421685,0.168842982062301,4.45216751754266e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39866,0.126447698833531,0.00896852571619423,0.10886938842979,0.144026009237272,7.14295446161122e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFB,Complement factor B,37220,0.0433408360097257,0.00307243039371231,0.0373188724380496,0.0493627995814018,7.2804014946915e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37124,0.0364266917682901,0.00258485518856045,0.0313603755987116,0.0414930079378686,8.90097742793284e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39477,0.111829437849981,0.00794031130719415,0.0962664276878806,0.127392448012082,8.98200227827331e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GOLGA3,Golgin subfamily A member 3,37411,0.101934098893967,0.00723553181174757,0.0877524565429422,0.116115741244993,9.31344383709113e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39749,0.103097309047988,0.00732320847954485,0.0887438204280805,0.117450797667896,9.6096259295423e-45
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,37411,0.112062616793836,0.00796331964530639,0.0964545102890357,0.127670723298637,1.15835653569929e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLMH,Bleomycin hydrolase,40052,0.041883984451922,0.00297843655943681,0.0360462487954258,0.0477217201084181,1.18386311754464e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ROBO2,Roundabout homolog 2,40009,0.0297550140539424,0.00211612454972509,0.0256074099364812,0.0339026181714036,1.20777462405161e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37453,0.0341796742660574,0.00243388511609575,0.0294092594385098,0.0389500890936051,1.7331169714404e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37124,0.0763604733532485,0.00543815561579103,0.065701688346298,0.0870192583601989,1.80465538919532e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39506,0.103163402422483,0.00735282059116708,0.0887518740637959,0.117574930781171,1.88736715172979e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLUL1,Clusterin-like protein 1,39840,-0.0589721170446497,0.00420499858174542,-0.0672139142648707,-0.0507303198244287,2.03024818992535e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK13,Kallikrein-13,39490,0.0551407455462717,0.00393174405842301,0.0474345271917626,0.0628469639007808,2.05174116758326e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,39788,0.0738634209676617,0.00527298550261511,0.0635283693825361,0.0841984725527874,2.55555093531404e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH3GLB2,Endophilin-B2,37388,0.086419722696959,0.00616934612718452,0.0743278042876773,0.0985116411062406,2.84132099653745e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RWDD1,RWD domain-containing protein 1,40009,0.0830783387706329,0.00594198565497728,0.0714320468868774,0.0947246306543883,3.65373489141007e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRAF2,TNF receptor-associated factor 2,39866,0.0923471150589038,0.00660765384833424,0.0793961135161686,0.105298116601639,3.98082946509369e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMAD3,Mothers against decapentaplegic homolog 3,37368,0.0664532176336141,0.00475277135655199,0.0571377857747722,0.075768649492456,4.07476129344625e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1R,Complement C1r subcomponent,37453,0.0251520769785829,0.00180261395103147,0.0216189536345612,0.0286852003226046,6.0503748423314e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,39489,0.0353132203675628,0.00253257944033012,0.0303493646645158,0.0402770760706098,6.30923078717264e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37124,0.111927989914672,0.00802534594888426,0.0961983118548589,0.127657667974485,6.71493571602704e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFA,Platelet-derived growth factor subunit A,40052,0.0931900967130816,0.00668705311845827,0.0800834726009033,0.10629672082526,6.87186396907345e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSIP1,PC4 and SFRS1-interacting protein,39866,0.0818909817769303,0.00587864525522954,0.0703688370766803,0.0934131264771802,7.48097532325245e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT5,ADP-sugar pyrophosphatase,39858,0.0669034612814254,0.00480463839608886,0.0574863700250912,0.0763205525377595,8.07261595028469e-44
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBLN4,Cerebellin-4,40030,0.0401530692056585,0.00288696080180188,0.0344946260341268,0.0458115123771902,1.00559149856608e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RRAS,Ras-related protein R-Ras,37039,0.170781641760209,0.0122734251851983,0.14672572839722,0.194837555123198,1.04992386743843e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLG4,Disks large homolog 4,37388,0.0929977029752586,0.00668452165253622,0.0798960405362876,0.10609936541423,1.06503457621213e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL11,Eotaxin,40058,0.049369415810276,0.00355222579177935,0.0424070532583885,0.0563317783621636,1.15747929669468e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX6,Peroxiredoxin-6,40030,-0.0764744351058558,0.00550473363668159,-0.0872637130337517,-0.0656851571779598,1.25307331623001e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39477,0.101189442672429,0.00728435359107033,0.086912109633931,0.115466775710927,1.2990871027828e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C19orf12,Protein C19orf12,39489,0.0839451609379223,0.00604311217310221,0.072100661078642,0.0957896607972027,1.30376253877307e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB6,Serpin B6,39970,0.0778009935190305,0.00560431547546247,0.0668165351871241,0.088785451850937,1.44445146892722e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39866,0.0945503323265281,0.00681149107218826,0.0811998098250391,0.107900854828017,1.47673053884345e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFAP5,Microfibrillar-associated protein 5,40052,0.0519849390379213,0.00374540800238842,0.0446439393532399,0.0593259387226026,1.4946884529619e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39788,0.0580262916486198,0.00418772580321194,0.0498183490743244,0.0662342342229152,2.08177606480058e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BPIFB2,BPI fold-containing family B member 2,37405,0.0792564575429049,0.00571985855960799,0.0680455347660733,0.0904673803197366,2.30039449217702e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39477,0.126755382106037,0.00915809388219094,0.108805518096943,0.144705246115131,2.60506764607168e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37437,0.113178230401044,0.00817824403525285,0.0971488720919481,0.129207588710139,2.91734239717864e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL4,C-C motif chemokine 4,39882,0.0801569782203669,0.00580681982051798,0.0687756113721517,0.0915383450685821,4.25832997761359e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39758,0.0962293595130075,0.00697330349962394,0.0825616846537446,0.10989703437227,4.53413780751501e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF19,Fibroblast growth factor 19,39931,0.0983397561887566,0.00712676457260907,0.0843712976264428,0.11230821475107,4.5704124563205e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB6A,Ras-related protein Rab-6A,39866,0.0593863346552651,0.00430420913137961,0.0509500847577611,0.0678225845527691,4.66855669521707e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMEM106A,Transmembrane protein 106A,37368,0.0915531850039722,0.00663704971190895,0.0785445675686307,0.104561802439314,5.39776648159306e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPBP,Platelet basic protein,37371,0.109336308508145,0.00792795531893579,0.0937975160830306,0.124875100933259,5.62467382162334e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39477,0.0581415495418091,0.0042196193413742,0.0498710956327157,0.0664120034509026,6.09179047457494e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,39862,0.066215416622356,0.00480863581300469,0.0567904904288668,0.0756403428158452,6.77314535273961e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERP29,Endoplasmic reticulum resident protein 29,37124,0.153210485605664,0.0111368186851343,0.131382320982801,0.175038650228527,9.07318763971331e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",39913,0.0787707969142254,0.00572994688015442,0.0675401010291228,0.0900014927993281,9.24523347378776e-43
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39788,0.113639310895661,0.00827105024298802,0.0974280524194041,0.129850569371917,1.03299318693961e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39868,0.0358745395919633,0.00261287819243347,0.0307532983347937,0.0409957808491329,1.17289399568975e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFRP1,Secreted frizzled-related protein 1,39689,0.0543308358688131,0.00395870237676678,0.0465717792103502,0.0620898925272759,1.27196302137601e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BIN2,Bridging integrator 2,39858,0.114578235027341,0.00835333456176614,0.098205699286279,0.130950770768402,1.40901772465947e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STXBP1,Syntaxin-binding protein 1,37411,0.0999672218344852,0.00728685516441222,0.0856849857122373,0.114249457956733,1.50654856911413e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBCB,Tubulin-folding cofactor B,39749,0.12932228456354,0.00944112576226656,0.110817678069497,0.147826891057582,1.82468362055421e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HGF,Hepatocyte growth factor,40058,0.0432910017890155,0.00316189231902014,0.037093692843736,0.049488310734295,1.96659118197088e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VCAM1,Vascular cell adhesion protein 1,39908,-0.0339823438057606,0.00248291292976416,-0.0388488531480984,-0.0291158344634229,2.11572656844361e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F2R,Proteinase-activated receptor 1,39908,0.0741684200793918,0.00544116502207671,0.0635037366361214,0.0848331035226621,4.49394301391488e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,39850,0.0718715986025078,0.00527366112087986,0.0615352228055833,0.0822079743994323,4.66248394295298e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS9,Galectin-9,39859,0.0399754409906577,0.00293372622531744,0.0342253375890355,0.0457255443922798,4.80467567744927e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CETN2,Centrin-2,39489,0.0858787903291263,0.00630637377628115,0.0735182977276152,0.0982392829306374,5.45112538766347e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,37437,0.0629366346174582,0.00462558224769562,0.0538704934119748,0.0720027758229416,6.92149725608106e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39788,0.120337150035528,0.0088505249866123,0.102990121061768,0.137684179009288,7.18328776958718e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39587,0.0707195650362515,0.00520393165250076,0.06051985899735,0.080919271075153,7.94646815619644e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37411,0.0596071616385078,0.00438670706579333,0.0510092157895529,0.0682051074874627,8.84264179062053e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACYBP,Calcyclin-binding protein,37088,0.131434456336924,0.00967712634101273,0.112467288708539,0.150401623965309,9.7554745311534e-42
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37368,0.0612129383619671,0.00450816892012538,0.0523769272785213,0.0700489494454128,1.0125354207722e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,39913,0.124943638498195,0.00922299890105636,0.106866560652124,0.143020716344265,1.39758781385981e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPARC,SPARC,39913,0.0889947830761978,0.00657125702752639,0.076115119302246,0.101874446850149,1.47346330822979e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATXN2L,Ataxin-2-like protein,37411,0.0606518965550379,0.00447776076595989,0.0518754854537565,0.0694283076563193,1.57704951306861e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBC1D5,TBC1 domain family member 5,39866,0.0980877771689816,0.00725063032090348,0.0838765417400108,0.112299012597952,1.80246975267767e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTF1,Cardiotrophin-1,39585,0.106980623767848,0.00790937964982209,0.0914782396541963,0.122483007881499,1.87848738222736e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCDC80,Coiled-coil domain-containing protein 80,39868,0.0411092243792325,0.00303977180929558,0.0351512716330132,0.0470671771254519,1.9118397900106e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37043,0.128888821264888,0.00953400562127643,0.110202170247186,0.147575472282589,2.28302530255329e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP53,Cellular tumor antigen p53,39477,0.0555409649710308,0.00411289392346928,0.047479692881031,0.0636022370610305,2.52278746208206e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MESD,LRP chaperone MESD,39858,0.15332765727375,0.0113732075560826,0.131036170463828,0.175619144083672,3.37461262997214e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,37388,0.0448612086920088,0.0033286449128789,0.0383370646627661,0.0513853527212514,3.91826996755993e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEXN,Nexilin,37445,0.0863702746877777,0.00641305255954565,0.0738006916710683,0.0989398577044872,4.43342591040576e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL24,C-C motif chemokine 24,39908,0.103359260159541,0.00767938242099261,0.0883076706143956,0.118410849704687,4.53329207448086e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37382,0.0634081697320114,0.00471082940971108,0.0541749440889777,0.0726413953750451,4.93422978286791e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX8,Syntaxin-8,39866,0.0610384377635086,0.004538850616402,0.0521422905553607,0.0699345849716565,5.28179181936259e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRELD1,Protein disulfide isomerase CRELD1,37124,0.0466658504102525,0.00347102525789515,0.039862640904778,0.053469059915727,6.15482892384128e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39931,0.150875078032091,0.0112404998476015,0.128843698330792,0.17290645773339,7.41432215376469e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40030,0.0795791335983513,0.00592918789266278,0.0679579253287323,0.0912003418679703,7.47705047926771e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PF4,Platelet factor 4,37385,0.120929787953698,0.00900898451376022,0.103272178306728,0.138587397600668,8.06427290737779e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPB1,Heat shock protein beta-1,39617,0.086978253561788,0.00648459003195353,0.0742684570991591,0.0996880500244169,8.4875973535285e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LSP1,Lymphocyte-specific protein 1,39866,0.0504527087342523,0.00376172974454634,0.0430797184349415,0.0578256990335632,8.52944798766541e-41
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36709,0.136609335257406,0.0101939280743168,0.116629236231745,0.156589434283067,1.11781340764158e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGF,Placenta growth factor,40058,0.0320587291028958,0.00239477158128918,0.027364976803569,0.0367524814022226,1.18521703014844e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ST13,Hsc70-interacting protein,37124,0.0690084419952454,0.00515639638873599,0.0589019050733228,0.0791149789171679,1.39192673094701e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FSHB,Follitropin subunit beta,37043,0.0815112663331277,0.0060922331555556,0.0695704893482387,0.0934520433180167,1.46423847850337e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYO9B,Unconventional myosin-IXb,39587,0.0823228642405285,0.00615813536112762,0.0702529189327184,0.0943928095483386,1.54498952652641e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NIT1,Deaminated glutathione amidase,37043,0.0586878519836683,0.00438866925458,0.0500860602446914,0.0672896437226451,1.60577384430113e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39858,0.0579179353807352,0.00433687747249322,0.0494176555346485,0.0664182152268219,1.8301652082769e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1RN,Interleukin-1 receptor antagonist protein,39820,0.0665724332628133,0.00498718843844227,0.0567975439234665,0.0763473226021602,1.98597298275262e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,37368,0.11773958577791,0.00882595144889285,0.10044072093808,0.13503845061774,2.43255540828222e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,39587,0.0485362996198995,0.00364177159885376,0.0413984272861462,0.0556741719536529,2.6441147901096e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUB1,NEDD8 ultimate buster 1,39866,0.104307956276662,0.00784148067612452,0.0889386541514575,0.119677258401866,3.67836704692716e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",39858,0.096189653084067,0.00723458143935842,0.0820098734629245,0.11036943270521,3.99685206620569e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NSFL1C,NSFL1 cofactor p47,40009,0.080460665785981,0.00605221987921348,0.0685983148227226,0.0923230167492394,4.05353336763176e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39866,0.151367018784576,0.0114057862172984,0.129011677798671,0.173722359770481,5.54090578655912e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OTUD6B,Deubiquitinase OTUD6B,37382,0.072205514368266,0.00544035045728807,0.0615424274719814,0.0828686012645506,5.96355465792393e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37368,0.13360119242635,0.0100686487963481,0.113866640785507,0.153335744067192,6.22305697609308e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB9,Serpin B9,39749,0.0413127507377927,0.00311590830226479,0.0352055704653537,0.0474199310102317,6.55059112295784e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL7,C-C motif chemokine 7,39866,0.0718075077749855,0.00542404391845498,0.0611763816948137,0.0824386338551572,8.48633236370425e-40
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,37124,0.0480129626587208,0.00362821886893584,0.0409016536756065,0.055124271641835,1.00734124322347e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NACC1,Nucleus accumbens-associated protein 1,37368,0.0678578063485956,0.00512852950112855,0.0578058885263836,0.0779097241708075,1.02038373797251e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUGT1,Protein SGT1 homolog,39477,0.099833296426175,0.00755179670364669,0.0850317748870275,0.114634817965323,1.10172247403922e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37124,0.1291021141784,0.00976222524488345,0.109968152698429,0.148236075658372,1.12693641169712e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOXJ3,Forkhead box protein J3,37056,0.0553401795149079,0.00418516258264641,0.0471372608529209,0.0635430981768949,1.15598748917461e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39932,0.138177109716683,0.0104564111102891,0.117682543940516,0.158671675492849,1.16389840711908e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39587,0.0514995985913374,0.00389766894807614,0.0438601674531081,0.0591390297295666,1.20197313119385e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37043,0.0945886027066421,0.00716446617367494,0.0805462490062392,0.108630956407045,1.51305452693659e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGA2,Integrin alpha-2,37124,0.0414024580832793,0.00313753630542354,0.0352528869246491,0.0475520292419094,1.64424911736277e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS3,Galectin-3,39901,0.0362398903950759,0.00275009472462489,0.0308497047348111,0.0416300760553407,1.89091760681341e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TALDO1,Transaldolase,37415,0.0549033228427284,0.00416937955182717,0.0467313389211472,0.0630753067643096,2.33191684921079e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,37039,0.0751405889633494,0.0057120126532432,0.0639450441629927,0.0863361337637061,2.82168370015548e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNMA1,Paraneoplastic antigen Ma1,37043,0.0697682543696562,0.00531062215236191,0.0593594349510269,0.0801770737882856,3.53781385513668e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLT4,Vascular endothelial growth factor receptor 3,39913,0.041614758740466,0.00316996694452299,0.0354016235292009,0.0478278939517311,3.63030272103196e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBXN1,UBX domain-containing protein 1,37124,0.0850321056549955,0.0064765808987227,0.072338007093499,0.097726204216492,3.92999509624229e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37411,0.121840289558377,0.00928243822941731,0.10364671062872,0.140033868488035,4.05323007237719e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,37411,0.114613413978968,0.00873387592233951,0.0974950171711827,0.131731810786754,4.21677106245032e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDIA4,Protein disulfide-isomerase A4,37437,0.0751753363940137,0.00573043854389082,0.0639436768479877,0.0864069959400398,4.45265878224212e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,37039,0.0837882769941675,0.00639556551664257,0.0712529685815481,0.0963235854067869,5.69176273926938e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPT1,Angiopoietin-1,39794,0.102915848111192,0.00786216093857773,0.0875060126715801,0.118325683550805,5.96445637197799e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NID1,Nidogen-1,39892,0.0456816087120476,0.00349888589276822,0.0388237923622219,0.0525394250618733,9.25385840406235e-39
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PXN,Paxillin,39489,0.0627053559331288,0.00481514889006711,0.0532676641085973,0.0721430477576604,1.44642398502391e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH2D1A,SH2 domain-containing protein 1A,39866,0.0685447488595609,0.00526543135487843,0.0582245034039992,0.0788649943151227,1.51949986491582e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COMT,Catechol O-methyltransferase,39403,0.103270673041514,0.00793246051047389,0.0877230504409853,0.118818295642043,1.52273183309917e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINE2,Glia-derived nexin,37437,0.0782593297249464,0.00601584079947639,0.0664682817579727,0.0900503776919202,1.84916279477585e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39866,0.0991591054877439,0.00763163812581823,0.0842010947611401,0.114117116214348,2.09247162330953e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP2,Caspase-2,39866,0.0826360030601264,0.00636133525305231,0.0701677859641438,0.0951042201561089,2.16980309337289e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6AP2,Renin receptor,39477,0.0492498703402909,0.00379571739992926,0.0418102642364295,0.0566894764441522,2.67133617799961e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LACTB2,Endoribonuclease LACTB2,39868,0.080466515720704,0.00620346630233795,0.0683077217681216,0.0926253096732864,2.77831390396728e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL2L1,Bcl-2-like protein 1,37388,0.121173883399549,0.00934073868102893,0.102866035584732,0.139481731214365,2.95799673180236e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37169,0.0810985405663815,0.006255451822773,0.0688378549937464,0.0933592261390166,3.31438144342692e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37368,0.0433142564932162,0.00334121724185276,0.0367654706991848,0.0498630422872476,3.32455184005421e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRC59,Leucine-rich repeat-containing protein 59,37437,0.0563293080691834,0.00435120596878045,0.0478009443703737,0.064857671767993,4.17699554560197e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKT2,RAC-beta serine/threonine-protein kinase,37411,0.153247494907825,0.0118550782676579,0.130011541503216,0.176483448312435,5.3335547226003e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP6,Platelet glycoprotein VI,39836,0.106404854915511,0.00826510228334237,0.0902052544401602,0.122604455390862,9.71348519860615e-38
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,37124,0.105964011032728,0.00823350646466627,0.0898263383619823,0.122101683703474,1.11792901490074e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GMFG,Glia maturation factor gamma,37437,0.0862794721137481,0.00671252586159181,0.0731229214250281,0.099436022802468,1.36151068203658e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CERT,Ceramide transfer protein,39489,0.0736049119482166,0.00574051248966621,0.0623535074684708,0.0848563164279624,1.90652032920619e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GMPR2,GMP reductase 2,37124,0.0802343451162951,0.00625603726276279,0.06797251208128,0.0924961781513102,1.97917139349488e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37437,0.106458760014198,0.00830209249207061,0.0901866587297392,0.122730861298656,2.00620705906643e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTD,Deoxycytidylate deaminase,37124,0.114291394529279,0.00893728828784573,0.0967743094851015,0.131808479573457,3.16764325872798e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESYT2,Extended synaptotagmin-2,37388,0.0982363770841505,0.00768698145161061,0.0831698934389937,0.113302860729307,3.49781807005081e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGLN1,Egl nine homolog 1,39866,0.0633029841067825,0.00496656562377798,0.0535685154841777,0.0730374527293874,4.97800125452592e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37306,0.0361602018775363,0.00283756700199937,0.0305985705536175,0.041721833201455,5.55266922647509e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAEP,Glycodelin,39749,-0.171880680231413,0.0135005417350067,-0.198341742032026,-0.1454196184308,5.99660735696191e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,37411,0.0457817999167199,0.00359643464239632,0.0387327880176232,0.0528308118158167,6.57197108115611e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB14,DnaJ homolog subfamily B member 14,37382,0.0770977074254132,0.00606227409085613,0.0652156502073352,0.0889797646434912,7.67198641299925e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL1,Growth-regulated alpha protein,39839,0.112438035290624,0.00885024283438302,0.0950915593352335,0.129784511246015,8.40925417542553e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VGF,Neurosecretory protein VGF,37411,0.0346611230510277,0.00272731381684653,0.0293155879700085,0.0400066581320469,8.55871859405274e-37
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37043,0.0557763402470189,0.00439661014970664,0.0471589843535939,0.0643936961404439,1.15476556307786e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGBP1,Immunoglobulin-binding protein 1,37411,0.0714007580193476,0.00563042492124185,0.0603651251737136,0.0824363908649816,1.21333466498501e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PARP1,Poly [ADP-ribose] polymerase 1,39866,0.0645757479901213,0.00509698944066502,0.0545856486864179,0.0745658472938248,1.30989621712596e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT16,U8 snoRNA-decapping enzyme,37366,0.104359154174974,0.00823989394068107,0.0882089620512387,0.120509346298709,1.48914581741067e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HPSE,Heparanase,37306,0.111122397608936,0.00877705645815309,0.0939193669509564,0.128325428266917,1.58038690012315e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGH,Gamma-glutamyl hydrolase,39573,0.0400312035096868,0.00316419607147892,0.0338293792095881,0.0462330278097854,1.65784345516965e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,39391,0.0686908368331551,0.00543628744124777,0.0580357134483095,0.0793459602180007,2.02957895826096e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRGN,Neurogranin,37445,0.108013375861133,0.00855205330076882,0.0912513513916263,0.12477540033064,2.3062938538117e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RFC4,Replication factor C subunit 4,37368,0.0251565743566555,0.00199323202078843,0.0212498395959102,0.0290633091174008,2.59278168272091e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PALM2,Paralemmin-2,37388,0.0445774587819034,0.00353208562623168,0.0376545709544893,0.0515003466093175,2.60004084394627e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THTPA,Thiamine-triphosphatase,37345,0.103949931647724,0.00823745702303694,0.0878045158825715,0.120095347412876,2.65477369608267e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,39489,0.0873889756710665,0.00693393509359753,0.0737984628876153,0.100979488454518,3.04696324733189e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA13,Carbonic anhydrase 13,39657,0.123850643285433,0.00983108607250178,0.10458171458333,0.143119571987536,3.23960955692723e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39477,0.0800767537195763,0.00635916235143248,0.0676127955107687,0.092540711928384,3.48774709115695e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFHR4,Complement factor H-related protein 4,37409,0.0845920169542735,0.00671701794044142,0.0714266617910083,0.0977573721175386,3.64641986595953e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP3R1,Calcineurin subunit B type 1,39749,0.0487380034616542,0.00387201899764896,0.0411488462262622,0.0563271606970462,3.69312494310505e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,37437,0.0334615139034504,0.00266111592786061,0.0282457266848436,0.0386773011220572,4.64677677376581e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FRMD4B,FERM domain-containing protein 4B,37021,0.0826247920316149,0.00657050540422423,0.0697466014393354,0.0955029826238943,4.66406228258439e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAG6,Large proline-rich protein BAG6,39585,0.0432468095904352,0.00344842285410211,0.0364879007963951,0.0500057183844754,6.61131488588898e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37056,0.09397243939676,0.00749763963778663,0.0792770657066982,0.108667813086822,7.82036129769784e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",40058,0.0807529499548414,0.00644814827395894,0.0681145793378819,0.0933913205718009,8.14351691121732e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,37124,0.0432602146117712,0.00345369624481061,0.0364909699719424,0.0500294592516,8.60130809159495e-36
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,39585,0.131127108566015,0.0104836582144894,0.110579138465616,0.151675078666415,1.0014613431392e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CIAPIN1,Anamorsin,39913,0.0736130094059286,0.00588873284261399,0.0620710930344052,0.085154925777452,1.08556905595506e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JPT2,Jupiter microtubule associated homolog 2,37382,0.103020893729797,0.00824102700234539,0.0868684808052005,0.119173306654394,1.16085520297047e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MZT1,Mitotic-spindle organizing protein 1,39477,0.0621388373002793,0.00497404310012121,0.0523897128240417,0.0718879617765169,1.212552163681e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39866,0.140529998745092,0.0112531582688915,0.118473808538065,0.162586188952119,1.27145873249852e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YWHAQ,14-3-3 protein theta,37124,0.0866027717783232,0.00693206122420625,0.073015931778879,0.100189611777768,1.29191058237131e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DBN1,Drebrin,37056,0.0611140206350416,0.00489194488783191,0.0515258086548911,0.0707022326151922,1.29964582655191e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39788,0.0637006493961388,0.00510518574350483,0.0536944853388693,0.0737068134534083,1.45001313667142e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP3,Caspase-3,40052,0.103454547503703,0.00829232469600002,0.0872015910995428,0.119707503907863,1.47175996166545e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TADA3,Transcriptional adapter 3,37368,0.0461141180201091,0.00369561164478082,0.0388707191963387,0.0533575168438795,1.54371950916174e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37437,0.0724345823192823,0.00580895667090981,0.061049027244299,0.0838201373942655,1.71389944120307e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STIP1,Stress-induced-phosphoprotein 1,39826,0.0752271022975309,0.00603645903361677,0.0633956425916421,0.0870585620034198,1.75671931392003e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP170,Centrosomal protein of 170 kDa,37043,0.089657949475161,0.00719134419431846,0.0755629148542969,0.103752984096025,1.78005156581691e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39469,0.0684398547365823,0.00549229258802008,0.0576749612640629,0.0792047482091016,1.795253507515e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G4A,Cytosolic phospholipase A2,39931,0.102413035376852,0.00822517804074936,0.0862916864169835,0.118534384336721,2.00786334894074e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB33A,Ras-related protein Rab-33A,37021,0.0781455390183946,0.0062745280882078,0.0658474639655074,0.0904436140712819,2.09472878303111e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYBB1,Beta-crystallin B1,37437,0.0771826940947216,0.00620487209562966,0.0650211447872874,0.0893442434021557,2.49855832015229e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIPC3,PDZ domain-containing protein GIPC3,37382,0.1148928808916,0.0092424407321778,0.0967776970565313,0.133008064726668,2.76469629943064e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MUC13,Mucin-13,39489,0.0586131997312464,0.00471974990190782,0.0493624899235071,0.0678639095389857,3.03378539894671e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TST,Thiosulfate sulfurtransferase,39455,0.0884328078800141,0.0071262767263096,0.0744653054964473,0.102400310263581,3.4069627725479e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD164,Sialomucin core protein 24,39858,0.0302769230594353,0.0024434048831372,0.0254878494884864,0.0350659966303842,4.22139424345584e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGB3A2,Secretoglobin family 3A member 2,39908,-0.0887913955806038,0.0071932767553984,-0.102890218021185,-0.0746925731400229,7.5848310329254e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,37043,0.106437976527736,0.00862183210202478,0.0895391856077671,0.123336767447704,8.05420331987424e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PALM,Paralemmin-1,37299,0.0327597792966759,0.00265476346209204,0.0275564429109755,0.0379631156823763,8.51071167627727e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMTN,Smoothelin,37342,0.111041318164519,0.00899857977127161,0.0934041018128263,0.128678534516211,8.51238379248912e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JAM3,Junctional adhesion molecule C,37124,0.0582942257575416,0.00472476325198839,0.0490336897836443,0.0675547617314388,8.76968754375544e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSC22D1,TSC22 domain family protein 1,37411,0.0779967569566636,0.00632464353558008,0.0656004556269266,0.0903930582864005,9.33296142600105e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37043,0.0528777840021304,0.00428768090306474,0.0444739294321235,0.0612816385721373,9.41074108726671e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IDUA,Alpha-L-iduronidase,40030,0.0527140313253548,0.00427765758855239,0.0443298224517921,0.0610982401989175,9.73993747298956e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB1,Leukocyte elastase inhibitor,39811,0.102845551971597,0.00834683493707478,0.0864857554949307,0.119205348448264,9.98251973577584e-35
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARF1,Scavenger receptor class F member 1,40052,0.0491198288832021,0.00398777327222447,0.0413037932696421,0.056935864496762,1.04155679721958e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,37021,0.0747425755265303,0.00606671358543633,0.0628518168990751,0.0866333341539855,1.09619917568656e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSD,Cathepsin D,38721,0.0450790082276924,0.00366049170406552,0.037904444487724,0.0522535719676608,1.11002373531636e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,39829,0.101344260273546,0.00823645973800589,0.0852007991870544,0.117487721360038,1.23177642815004e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RP2,Protein XRP2,39788,0.0478627655946815,0.00389743647537887,0.0402237901029389,0.0555017410864241,1.64992606482486e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL8,C-C motif chemokine 8,40003,0.0690502943434523,0.00562541906601549,0.058024472974062,0.0800761157128427,1.76473350368864e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37437,0.112742102440882,0.0092061465967479,0.0946980551112564,0.130786149770508,2.66401180655626e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,39477,0.0561809505152295,0.00459388377256495,0.0471769383210022,0.0651849627094568,3.10112815322942e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APP,Amyloid-beta precursor protein,39829,0.075823064321689,0.00620509135856359,0.0636610852589043,0.0879850433844736,3.47643022843313e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEMIP2,Cell surface hyaluronidase,37056,0.036526889951295,0.00298872259008952,0.0306689936747196,0.0423847862278705,3.64740746818056e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SULT2A1,Bile salt sulfotransferase,39866,0.0634014324901585,0.00520183320591421,0.0532058394065667,0.0735970255737504,5.0785133108773e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,39868,0.0772715469997055,0.00634434337537156,0.0648366339839773,0.0897064600154338,5.64385516702083e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MICALL2,MICAL-like protein 2,37039,0.0773199635717409,0.00634946809223382,0.0648750061109626,0.0897649210325192,6.24045404869889e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALB2,Calretinin,39489,0.0330878451419839,0.00271881953304027,0.0277589588572249,0.0384167314267428,6.39980755975863e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DFFA,DNA fragmentation factor subunit alpha,40058,0.0767975179684494,0.00631755419481183,0.0644151117466183,0.0891799241902806,7.46632022147133e-34
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX4,Syntaxin-4,39788,0.0670282065855951,0.00553222532092539,0.0561850449565814,0.0778713682146089,1.22240155791121e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTNB,Dystrobrevin beta,37348,0.049715671334206,0.0041026082277837,0.0416745592077499,0.057756783460662,1.26691999594048e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39477,0.0573637519026073,0.00473891179609464,0.0480754847822618,0.0666520190229528,1.40759988169036e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AP2B1,AP-2 complex subunit beta,37039,0.0553839246120327,0.00458015788703961,0.0464068151534351,0.0643610340706303,1.74782269330701e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,39587,0.0671504334579989,0.00555587702606739,0.0562609144869068,0.078039952429091,1.75447698123691e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37437,0.0450131790929598,0.00372556711533479,0.0377110675469036,0.052315290639016,1.94599487481929e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REEP4,Receptor expression-enhancing protein 4,37411,0.0702607793590248,0.00582081103368005,0.0588519897330119,0.0816695689850377,2.23956767888057e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39885,0.0329850068474902,0.00273519841712365,0.0276240179499279,0.0383459957450526,2.4112161140169e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB2B,Ras-related protein Rab-2B,37368,0.0705796477088885,0.00585301972216658,0.059107729053442,0.082051566364335,2.58845943250856e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAG3,BAG family molecular chaperone regulator 3,39720,0.0444297186292442,0.0036878192442497,0.0372015929105147,0.0516578443479736,2.7871397541178e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNM3,Dynamin-3,37411,0.0617167750345385,0.00512316137147978,0.0516753787464382,0.0717581713226389,2.98777421794451e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37437,0.0832047596885548,0.00690920374991668,0.0696627203387181,0.0967467990383915,3.13315639833435e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37124,0.0473747372078076,0.00393670730712906,0.0396587908858347,0.0550906835297806,3.50093113055499e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDHB,Succinate dehydrogenase,37382,0.0786732346329847,0.00655145020239793,0.0658323922362848,0.0915140770296846,4.72005463112352e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPA1A,Heat shock 70 kDa protein 1A,39904,0.0798587018111839,0.00666318051779007,0.0667988679963153,0.0929185356260524,5.88302311714472e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4E,Eukaryotic translation initiation factor 4E,37056,0.101934095304637,0.0085130495709706,0.085248518145535,0.11861967246374,7.20841745931533e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39749,0.105955206954559,0.0088540238408019,0.0886013202265873,0.123309093682531,7.33309924099236e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IMPACT,Protein IMPACT,37388,0.0619016815152876,0.00517253099600253,0.0517635207631226,0.0720398422674525,7.71324018498352e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39788,0.0260449770333015,0.00217727144345686,0.021777525004126,0.0303124290624769,7.7492464870745e-33
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC37,Hsp90 co-chaperone Cdc37,39913,0.0932313973288599,0.00781112688507519,0.0779215886341125,0.108541206023607,1.06018262446472e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,37021,0.0774678593239576,0.00648985638946205,0.0647477408006119,0.0901879778473032,1.12248641426158e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INPP1,Inositol polyphosphate 1-phosphatase,39788,0.0601009802420198,0.0050380367205596,0.050226428269723,0.0699755322143166,1.14524521853214e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLOD4,Glyoxalase domain-containing protein 4,39832,0.0398360224667512,0.00333988759002738,0.0332898427902975,0.0463822021432048,1.17307383593627e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37124,0.0675971257226662,0.0056663719701062,0.0564910366612581,0.0787032147840744,1.21965293695327e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,37220,0.0620300457378503,0.00520590141912503,0.0518264789563653,0.0722336125193354,1.43967023275413e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM24,Transcription intermediary factor 1-alpha,37135,0.072381718973128,0.00607724949479368,0.0604703099633324,0.0842931279829237,1.53240931596192e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AIF1,Allograft inflammatory factor 1,39477,0.0585614463600538,0.00491930136369385,0.0489196156872138,0.0682032770328937,1.55193583857767e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAP3,Cytosol aminopeptidase,39587,0.0539796232203749,0.00453716231523141,0.0450867850825213,0.0628724613582285,1.68672705803319e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,37382,0.0663073058274483,0.00557138452692465,0.055387392154676,0.0772272195002206,1.69073481353896e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPI,Glucose-6-phosphate isomerase,37445,0.0526863277096883,0.00443017041875256,0.0440031936889333,0.0613694617304433,1.87314850380957e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD244,Natural killer cell receptor 2B4,40058,0.0295660156831233,0.00248965416261885,0.0246862935243903,0.0344457378418562,2.16114796615259e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,39587,0.0724431029783869,0.00610178948832094,0.0604835955812778,0.0844026103754959,2.26319429182824e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSL,Cathepsin L1,39868,0.0263758550864031,0.00222616695800462,0.0220125678487141,0.0307391423240922,3.00208078878317e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH9,Protocadherin-9,37382,0.0367372611111871,0.00310434729938987,0.0306527404043829,0.0428217818179912,3.74652927629606e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37021,0.0447038158307889,0.00378133068393343,0.0372924076902794,0.0521152239712984,4.35318832694363e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FADD,FAS-associated death domain protein,39868,0.0845766899066772,0.00716680279068335,0.0705297564369379,0.0986236233764166,5.22414814341772e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNDC9,Thioredoxin domain-containing protein 9,37388,0.0592477605331861,0.00502162792772611,0.0494053697948429,0.0690901512715292,5.69833934678319e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP10,Caspase-10,39489,0.0785634195498517,0.00666235438816403,0.0655052049490502,0.0916216341506532,5.8534610580401e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUS,RNA-binding protein FUS,39455,0.0431049237866005,0.00366106039047665,0.0359292454212663,0.0502806021519348,7.2599092179096e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,37021,0.0733236864903798,0.0062369026979139,0.0610993572024686,0.0855480157782911,9.43286591793928e-32
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTC,Probetacellulin,39477,0.0810476589720017,0.00690315688700284,0.0675174714734762,0.0945778464705273,1.07176906498898e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,37368,0.062490345639323,0.00532428650281996,0.0520547440937958,0.0729259471848501,1.1753402937712e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HNMT,Histamine N-methyltransferase,39669,0.0505672832304282,0.00431252709818364,0.0421147301179883,0.0590198363428682,1.27283853579215e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL15A1,Collagen alpha-1(XV) chain,37437,0.0273667541897904,0.00233388651704349,0.0227923366163852,0.0319411717631956,1.33464823560243e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGS10,Regulator of G-protein signaling 10,37411,0.0655764824629832,0.00559417200782086,0.0546119053276544,0.0765410595983121,1.3920201601273e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POMC,Pro-opiomelanocortin,37043,0.0774614928477623,0.00661952588817924,0.0644872221069309,0.0904357635885936,1.78188322690329e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",39749,0.0629256973938859,0.00538505250941448,0.0523709944754335,0.0734804003123383,2.03849972613136e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DBI,Acyl-CoA-binding protein,39793,0.0871635025975575,0.00745956978612748,0.0725427458167476,0.101784259378367,2.04787482269783e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39979,0.06268701690479,0.00536656008272591,0.0521685591426472,0.0732054746669327,2.13216319343507e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEP1B,Meprin A subunit beta,39868,0.125279434450001,0.0107373902263703,0.104234149606315,0.146324719293687,2.49935138512857e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,40002,0.0346537049973101,0.00297662894906581,0.0288195122571411,0.0404878977374791,3.36122840424274e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,39821,0.0275495272557408,0.00236699232144064,0.0229102223057171,0.0321888322057644,3.48719253043984e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH7,Protocadherin-7,37382,0.0364968213156536,0.00313723033082471,0.0303478498672371,0.04264579276407,3.91943269273718e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37411,0.0517326657254233,0.00445402873384933,0.0430027694070786,0.0604625620437679,4.86193723342025e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELE,E-selectin,40052,0.0539098478184244,0.00464357502124213,0.0448084407767899,0.063011254860059,4.89096996858772e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PON3,Serum paraoxonase/lactonase 3,39931,-0.0304899730091407,0.00262663812725441,-0.0356381837385593,-0.025341762279722,4.99156797377808e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL26,C-C motif chemokine 26,39866,0.0925254117769635,0.0079733523876979,0.0768976410970756,0.108153182456851,5.21356080104059e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMSB10,Thymosin beta-10,39858,0.0832639444170103,0.00720768417250237,0.0691368834389056,0.0973910053951149,9.53937733103256e-31
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFAT5,Nuclear factor of activated T-cells 5,37056,0.0931938903969892,0.00806803176053991,0.077380548146331,0.109007232647647,1.02508441182615e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASS1,Argininosuccinate synthase,37021,0.086293898120069,0.00747367715075371,0.0716454909045917,0.100942305335546,1.08219406804773e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUOX,"Sulfite oxidase, mitochondrial",37411,0.0676150275733212,0.00585851852235943,0.0561323312694967,0.0790977238771457,1.13600630734488e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BDNF,Brain-derived neurotrophic factor,37437,0.0888783057242584,0.00770325855493697,0.0737799189565819,0.103976692491935,1.18284074172655e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASGR2,Asialoglycoprotein receptor 2,37445,0.0272637829667093,0.00236442136251546,0.022629517096179,0.0318980488372396,1.28043660730736e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD1C,T-cell surface glycoprotein CD1c,39913,0.0252315986377097,0.00218921547468257,0.0209407363073319,0.0295224609680876,1.29655500993326e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HPGDS,Hematopoietic prostaglandin D synthase,39477,0.0399239676289766,0.00346584506474452,0.0331309113020773,0.0467170239558758,1.40237768289325e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNM1,Dynamin-1,37382,0.123380551214304,0.0107081744486827,0.102392529294886,0.144368573133722,1.41825088623693e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UROD,Uroporphyrinogen decarboxylase,37124,0.0746960761751911,0.00648322754255058,0.0619889501917919,0.0874032021585902,1.43809326887294e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,39887,0.128942867675382,0.011203378635731,0.106984245549349,0.150901489801415,1.56156917450806e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARFIP1,Arfaptin-1,37411,0.0744591430750264,0.0064681478292177,0.0617815733297597,0.0871367128202931,1.59763462862181e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP25,Rho GTPase-activating protein 25,39477,0.0648007833281375,0.00563127220137088,0.0537634898134505,0.0758380768428244,1.60901696107753e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEPTIN9,Septin-9,39788,0.0304352500590531,0.00264507230397182,0.0252509083432683,0.0356195917748379,1.61704959139334e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37027,0.0391002098510451,0.00340430650951744,0.0324277690923909,0.0457726506096993,2.17690722604271e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LARP1,La-related protein 1,37368,0.0686247576735963,0.00598509167244321,0.0568939779956076,0.0803555373515849,2.70083880553932e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGA6,Integrin alpha-6,39866,0.0566659997855964,0.00494456398348312,0.0469746543779695,0.0663573451932233,2.74183270775431e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLMAP,Sarcolemmal membrane-associated protein,37382,0.089629538965156,0.00782464695739433,0.0742932309286631,0.104965847001649,3.06809639691585e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGACT,Gamma-glutamylaminecyclotransferase,37437,0.076283857201974,0.00666079042469272,0.0632287079695763,0.0893390064343717,3.13848155750652e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MIF,Macrophage migration inhibitory factor,39826,0.0727663014835101,0.00636249589199671,0.0602958095351966,0.0852367934318237,3.59035615009974e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDZD2,PDZ domain-containing protein 2,37021,0.0640587195414575,0.00560817572124371,0.0530666951278199,0.0750507439550952,4.47907799449391e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,39931,-0.0214545020876018,0.00188036300142615,-0.0251400135703971,-0.0177689906048066,4.87739199811763e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACAN,Aggrecan core protein,39730,0.0299628014531533,0.0026269537502146,0.0248139721027327,0.0351116308035739,5.113643974633e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HRG,Histidine-rich glycoprotein,37380,0.0337347462703905,0.00295679007770241,0.0279394377180938,0.0395300548226873,5.15746804618621e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,40009,0.0501675687228793,0.00440410512371889,0.0415355226803902,0.0587996147653683,6.02622157101221e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC26,Anaphase-promoting complex subunit CDC26,37362,0.0756147844763468,0.00664319776891572,0.062594116849272,0.0886354521034216,7.01090159560991e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGA,Fibrinogen alpha chain,37149,0.0327201370550469,0.00287672288662903,0.027081760197254,0.0383585139128398,7.73228934547063e-30
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPK1,Thiamin pyrophosphokinase 1,37437,0.0291709019296807,0.0025736672237148,0.0241265141711997,0.0342152896881617,1.20488951904333e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,37165,0.0463134620597486,0.00408907809810278,0.0382988689874671,0.05432805513203,1.33073497121537e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGCT,Gamma-glutamylcyclotransferase,37430,0.0508214811174577,0.00449501869419972,0.0420112444768262,0.0596317177580891,1.65724195799166e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA3,Annexin A3,39985,0.0735858705306772,0.0065115883667791,0.0608231573317901,0.0863485837295642,1.67957209803628e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PARD3,Partitioning defective 3 homolog,37169,0.0779628756378123,0.00690221629543063,0.0644345316987683,0.0914912195768564,1.88387420743948e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGAL,Integrin alpha-L,37056,0.0449824457947936,0.00399421507222485,0.0371537842532329,0.0528111073363543,2.75222810968898e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39914,-0.0315350856501291,0.00280447072298894,-0.0370318482671874,-0.0260383230330707,3.16720569713053e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,39862,0.0420681316837519,0.00374224043161851,0.0347333404377796,0.0494029229297242,3.28393364107444e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD40LG,CD40 ligand,40058,0.0815458152121311,0.00725534909737395,0.0673253309812781,0.095766299442984,3.34929377996381e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37056,0.0603003430466762,0.0053635119387322,0.0497878596467611,0.0708128264465913,3.41466180538731e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTGDS,Prostaglandin-H2 D-isomerase,39762,0.0297080662246071,0.00264519583934319,0.0245234823794945,0.0348926500697198,3.70000558103548e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CGA,Glycoprotein hormones alpha chain,39858,0.0926735114146811,0.00825287973194484,0.0764978671400692,0.108849155689293,3.7664033035843e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSS,Cathepsin S,36543,0.0256217511645823,0.00228421375577025,0.0211446922032726,0.0300988101258919,4.6166538468002e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOXO3,Forkhead box protein O3,39477,0.102128077529699,0.00911061511506515,0.0842712719041713,0.119984883155227,4.71293684988781e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SRP14,Signal recognition particle 14 kDa protein,39788,0.0624448835018976,0.00557209305773031,0.0515235811087462,0.073366185895049,4.85378306904359e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD84,SLAM family member 5,39866,0.0325373042512088,0.00290368904137199,0.0268460737301197,0.0382285347722979,4.91428375313698e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,39868,0.0363512647411647,0.00324577082708548,0.0299895539200772,0.0427129755622523,5.25151815422241e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP53I3,Quinone oxidoreductase PIG3,36874,0.0560164413168532,0.0049998693289749,0.0462166974320624,0.065816185201644,5.31495661988035e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DYNLT1,Dynein light chain Tctex-type 1,37039,0.0835465316286272,0.0074589476370823,0.0689269942599459,0.0981660689973085,5.45918768880814e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGSF3,Immunoglobulin superfamily member 3,39788,0.0370386413057941,0.00330901201784016,0.0305529777508274,0.0435243048607608,5.64329361629591e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGF1R,Insulin-like growth factor 1 receptor,39788,0.0226649457730769,0.0020276440084984,0.01869076351642,0.0266391280297338,6.69606341888967e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCG2,Secretogranin-2,39949,0.0324150611442118,0.00290249605540474,0.0267261688756185,0.0381039534128051,7.46727597527634e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS2,Trypsin-2,39931,0.0534803098286744,0.00478889927413905,0.0440940672513619,0.0628665524059869,7.50585736561664e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37368,0.0392897672022118,0.00351911719347272,0.0323922975030052,0.0461872369014183,8.1177648061637e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATXN3,Ataxin-3,37388,0.0638986185877847,0.00573074313116255,0.0526663620507061,0.0751308751248633,9.53940279720182e-29
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39429,0.0900942658680781,0.00809959232793463,0.0742190649053262,0.10596946683083,1.23873667879913e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39489,0.0667954904389403,0.00600679638826944,0.0550221695179322,0.0785688113599484,1.2841553190666e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DXO,Decapping and exoribonuclease protein,37388,0.0472737549609838,0.00425100118186334,0.0389417926445317,0.0556057172774359,1.32479465135705e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37043,0.100901867397684,0.00907301193276528,0.0831187640094643,0.118684970785904,1.32753251640761e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39749,0.0594982971660239,0.00536492433877648,0.048983045462022,0.0700135488700258,1.77976532488309e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,39477,0.0583701571018097,0.00527078887215605,0.0480394109123838,0.0687009032912355,2.13319342833211e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASEH2A,Ribonuclease H2 subunit A,37411,0.0509222266486303,0.00460628052761528,0.0418939168145044,0.0599505364827563,2.74023392607155e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37026,0.0822945197236949,0.00744987869920906,0.0676927574732451,0.0968962819741446,3.03526487706449e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,39587,0.0564035696290662,0.00510833165961527,0.0463912395762203,0.0664158996819121,3.06053685455924e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,37437,0.0246892145998038,0.00223921851271061,0.020300346314891,0.0290780828847166,3.77696637652775e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MARCO,Macrophage receptor MARCO,39868,0.0269282924810531,0.00244519259580127,0.0221357149932826,0.0317208699688235,4.18477692431892e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FST,Follistatin,39908,0.0527390922685709,0.00480026937208174,0.0433305642992907,0.0621476202378511,5.57136931820674e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRK5,G protein-coupled receptor kinase 5,39585,0.0543142029283481,0.00494882819663675,0.0446144996629401,0.0640139061937561,6.35348854567356e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCDC134,Coiled-coil domain-containing protein 134,37368,0.0498861065835944,0.00454476987338062,0.0409783576317684,0.0587938555354204,6.49711793978165e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39585,0.0906272532708442,0.00828147285968271,0.0743955664658661,0.106858940075822,9.00335099654264e-28
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACRBP,Acrosin-binding protein,37368,0.0391746862244933,0.0035861162127489,0.0321458984475055,0.0462034740014812,1.15544418849646e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB10,Ras-related protein Rab-10,37437,0.05457865911623,0.00499683407298079,0.0447848643331876,0.0643724538992723,1.17088107633308e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS8,Prostasin,39805,0.0408582470694021,0.00374424528372684,0.0335195263132975,0.0481969678255067,1.26099721075542e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF2,Fibroblast growth factor 2,39866,0.0677939442563163,0.00621488898942867,0.0556127618370361,0.0799751266755965,1.3156978544092e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WAS,Wiskott-Aldrich syndrome protein,39587,0.0686041801786814,0.00629298379696304,0.0562699319366339,0.080938428420729,1.41982872735938e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADD1,Alpha-adducin,37124,0.0702984480603579,0.00644922125882427,0.0576579743930623,0.0829389217276534,1.5032721566433e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK6,Kallikrein-6,39889,0.0300588406790625,0.00276145947771728,0.0246463801027366,0.0354713012553884,1.69365212486342e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TTF2,Transcription termination factor 2,37039,0.0499813975310664,0.0045972213923307,0.0409708436020982,0.0589919514600346,2.04679890217259e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMOT,Angiomotin,37124,0.0419943060537882,0.00386276097419845,0.0344232945443592,0.0495653175632171,2.05467913978807e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLNK,B-cell linker protein,37056,0.0397229387226464,0.00365602609302648,0.0325571275803145,0.0468887498649783,2.2084435714853e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD5,T-cell surface glycoprotein CD5,40003,0.0333006618522654,0.00306705080665573,0.0272892422712201,0.0393120814333106,2.28285247985531e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PYY,Peptide YY,37021,0.0937128291203413,0.00864050396914797,0.0767774413408113,0.110648216899871,2.72472804795812e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSME1,Proteasome activator complex subunit 1,39738,0.0373676716955245,0.00345000412622536,0.0306056636081228,0.0441296797829262,3.04993431015864e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRG2,Bone marrow proteoglycan,37437,-0.0512792946784998,0.00473488412725721,-0.060559667567924,-0.0419989217890757,3.20235044159028e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFT20,Intraflagellar transport protein 20 homolog,37039,0.0440412696988763,0.00406969838617431,0.0360646608619747,0.052017878535778,3.53232686640801e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39477,0.043878363518692,0.00405756800777257,0.0359255302234578,0.0518311968139262,3.68957925810829e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLB1,Beta-galactosidase,39749,0.0425068769340094,0.00393625463780056,0.0347918178439203,0.0502219360240985,4.32996743434256e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C7,Complement component C7,37149,-0.0323071244157487,0.00299790061000994,-0.0381830096113681,-0.0264312392201292,5.73979197105428e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DYNLT3,Dynein light chain Tctex-type 3,37368,0.0440305510347784,0.00408643663716958,0.036021135225926,0.0520399668436308,5.82675455558079e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNRD2,Protein ZNRD2,37382,0.0683244708770683,0.00634846771808954,0.0558814741496128,0.0807674676045238,6.66070589570628e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTRB1,Chymotrypsinogen B,39858,0.0536610329183113,0.00498777628825923,0.0438849913933232,0.0634370744432994,6.6794639577603e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLU,Clusterin,37453,0.03201360716424,0.0029776492116501,0.0261774147094058,0.0378497996190742,7.49191387227546e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37043,0.0532613478577392,0.00495944662500737,0.0435408324727247,0.0629818632427536,8.58197052928891e-27
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASPN,Asporin,37437,0.0270025714206122,0.00251786135998286,0.0220675631550458,0.0319375796861786,1.00033354946321e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,40009,0.0655844383556433,0.00611945137160781,0.053590313667292,0.0775785630439946,1.03749161308028e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IMPA1,Inositol monophosphatase 1,39749,0.0613573588054387,0.00572678487980608,0.0501328604410187,0.0725818571698586,1.07816528604035e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWC2,Brorin,39684,0.0385107011621844,0.00359541482951833,0.0314636880963284,0.0455577142280403,1.1148950634637e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39477,0.0656073152881548,0.00612520907217718,0.0536019055066875,0.0776127250696221,1.11831245162357e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QA,Complement C1q subcomponent subunit A,39971,-0.0229300528977794,0.00214142596363893,-0.0271272477865117,-0.0187328580090471,1.14972355913695e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37124,0.0668220924691387,0.00625063706396099,0.0545708438237752,0.0790733411145023,1.44735917711491e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGXT,Serine--pyruvate aminotransferase,39868,0.0775403781136897,0.0072638115498003,0.0633033074760811,0.0917774487512983,1.6383400817278e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PARK7,Parkinson disease protein 7,39858,0.0522526545747088,0.00489700466627687,0.0426545254288061,0.0618507837206114,1.72036709536529e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL3,C-C motif chemokine 3,39866,0.0624453492765325,0.00585400675013767,0.0509714960462627,0.0739192025068024,1.78035057541147e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELOA,Elongin-A,39788,0.0509303850284965,0.00477487289641034,0.0415716341515322,0.0602891359054607,1.79703001356881e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39956,0.0276597468972349,0.00259429984929212,0.0225749191926224,0.0327445746018475,1.88338536409452e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCT5,T-complex protein 1 subunit epsilon,39477,0.0444583002927101,0.00417948381056385,0.0362665120240049,0.0526500885614152,2.46012202838662e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL18,Interleukin-18,39795,0.0452056159689653,0.00425142871820393,0.0368728156812856,0.053538416256645,2.56290541906563e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CORO1A,Coronin-1A,39520,0.0888092262048454,0.00835621681047551,0.0724310412563134,0.105187411153377,2.71605914737656e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNAR1,Interferon alpha/beta receptor 1,37382,0.0253414524582372,0.0023837481734508,0.0206693060382736,0.0300135988782007,2.71739758480999e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGFL7,Epidermal growth factor-like protein 7,39477,0.0390816142325849,0.00367916543514392,0.0318704499797029,0.046292778485467,2.88168717294243e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENO2,Gamma-enolase,40009,0.0654967134308976,0.00617680399433151,0.0533901776020079,0.0776032492597874,3.49385430067847e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCRN1,Secernin-1,39866,0.0555773402597172,0.0052457517669336,0.0452956667965274,0.0658590137229071,3.84787399447284e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TREH,Trehalase,37437,0.0742138542009654,0.00703999065765629,0.060415472511959,0.0880122358899717,6.98106171817373e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAD23B,UV excision repair protein RAD23 homolog B,39477,0.0463055081279273,0.00440097666938312,0.0376795938559364,0.0549314223999182,8.37659388934579e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",37382,0.0861355610986788,0.00818770399078188,0.0700876612767463,0.102183460920611,8.77758164013571e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37382,0.0639786962919166,0.00608570369252468,0.0520507170545682,0.0759066755292649,9.46475201358605e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OCLN,Occludin,37411,0.0421635889346091,0.00401097610427194,0.0343020757702361,0.0500251020989821,9.54991332599383e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL6R,Interleukin-6 receptor subunit alpha,39805,0.0330164507039911,0.00314184647499042,0.0268584316130099,0.0391744697949723,9.5701478076792e-26
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABHD14B,Protein ABHD14B,39687,0.0563553566281378,0.00536897958393691,0.0458321566436214,0.0668785566126541,1.08897839151967e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITPA,Inosine triphosphate pyrophosphatase,37021,0.0665649618439824,0.00634290354332873,0.0541328708990581,0.0789970527889067,1.157399341253e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEP1A,Meprin A subunit alpha,37382,0.0700398131241685,0.00669167918817836,0.0569241219153389,0.0831555043329981,1.53802273006387e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRI1,Methylthioribose-1-phosphate isomerase,37039,0.065885079321738,0.00629952700688911,0.0535380063882354,0.0782321522552407,1.68158155407388e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37382,0.0748897925916671,0.00717633347941289,0.0608241789720178,0.0889554062113163,2.12802851903758e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBCA,Tubulin-specific chaperone A,37124,0.0841206040270614,0.00808566116203855,0.0682727081494658,0.0999684999046569,2.98338145481478e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39998,0.0292719764965989,0.00281684627425738,0.0237509577990544,0.0347929951941433,3.24674623716198e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,39858,0.0559004822277901,0.0053814011296669,0.045352936013643,0.0664480284419372,3.3915315677916e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DMD,Dystrophin,37043,0.0501433710861081,0.00483621506008125,0.0406643895683489,0.0596223526038674,4.31496992326741e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,39788,-0.0525558494126188,0.00508170819575901,-0.0625159974763064,-0.0425957013489311,5.44886495686796e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XG,Glycoprotein Xg,39985,0.0289941910652608,0.00280690402038771,0.0234926591853009,0.0344957229452207,6.19275565663318e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39866,0.0801080974245896,0.0077561974486501,0.0649059504252354,0.0953102444239438,6.28688292171615e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37124,0.0864331706945331,0.00837644367210974,0.070015341097198,0.102851000291868,7.21001458186044e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMA4,Laminin subunit alpha-4,39931,0.0323885662236505,0.00314019941014588,0.0262337753797646,0.0385433570675365,7.2687627516036e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,39788,0.0431314461376485,0.00418220500970773,0.0349343243186213,0.0513285679566756,7.36270009862239e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIP,Gastric inhibitory polypeptide,37043,0.0419708422225282,0.00407103088246706,0.0339916216928928,0.0499500627521636,7.91980150132167e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA4,Annexin A4,39783,0.0696338294079628,0.00675940653938641,0.0563853925907654,0.0828822662251601,8.27690168836171e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL5RA,Interleukin-5 receptor subunit alpha,39866,-0.0521305324482833,0.00506162496281353,-0.0620513173753978,-0.0422097475211688,8.49406084002159e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOLR2,Folate receptor beta,40009,-0.0277013442033752,0.0026901285766034,-0.0329739962135179,-0.0224286921932326,8.63661401495341e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,39858,0.0255485870750054,0.00248282224670291,0.0206822554714677,0.0304149186785431,9.32462978236554e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37021,0.026617783982464,0.00258611702378337,0.0215489946158486,0.0316865733490794,9.44748224479746e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB2,DnaJ homolog subfamily B member 2,37124,0.0513062030795189,0.00498502810529459,0.0415355479931415,0.0610768581658963,9.48128871890125e-25
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTRK2,BDNF/NT-3 growth factors receptor,39868,0.0245105716093272,0.00238363768357556,0.0198386417495191,0.0291825014691353,1.00523283198827e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPPB,Natriuretic peptides B,39585,-0.121590426419736,0.0118292232989726,-0.144775704085723,-0.0984051487537503,1.05114760476554e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJC9,DnaJ homolog subfamily C member 9,37382,0.0729255558126241,0.00709611694387968,0.0590171666026199,0.0868339450226283,1.1046859229357e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPXM1,Probable carboxypeptidase X1,39913,0.065071400797947,0.00634189416443781,0.0526412882356489,0.0775015133602451,1.26390216970165e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS27,Serine protease 27,39818,0.0383968690910558,0.00374870703712179,0.0310494032982971,0.0457443348838145,1.5202821866122e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STXBP3,Syntaxin-binding protein 3,39477,0.0422140959377992,0.00412564174621968,0.0341278381152087,0.0503003537603898,1.70093214842273e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB6,Integrin beta-6,39587,0.0283298655228889,0.00276963236255655,0.0229013860922781,0.0337583449534997,1.75880584437688e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37411,0.0872275821245706,0.00853071945203033,0.0705073719985912,0.10394779225055,1.87768664794705e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS3BP,Galectin-3-binding protein,37453,0.0287394603861773,0.00281802383044654,0.023216133678502,0.0342627870938525,2.46508591767518e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OPLAH,5-oxoprolinase,37043,0.065925109438755,0.00647716682455753,0.0532298624626222,0.0786203564148877,3.05352125924321e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSAP,Prosaposin,37347,0.0265868380836344,0.0026141114397421,0.0214631796617398,0.0317104965055289,3.28326476877304e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIF22,Kinesin-like protein KIF22,37021,0.115323019124156,0.0113491278651678,0.0930787285084273,0.137567309739885,3.62021065811878e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD46,Membrane cofactor protein,39777,0.0268585356813795,0.00264687695384107,0.021670656851851,0.032046414510908,4.03572233341519e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSR1,Macrophage scavenger receptor types I and II,40009,0.0432644292649809,0.00426413393128368,0.0349067267596649,0.0516221317702969,4.07261771223293e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAFA5,Chemokine-like protein TAFA-5,39788,0.0322644714334565,0.00318129192356418,0.0260291392632707,0.0384998036036423,4.25951195596356e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AK2,"Adenylate kinase 2, mitochondrial",37388,0.101140686226932,0.0099760959344019,0.0815875381955046,0.12069383425836,4.55330783365201e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36764,0.0469930678194427,0.00463731934627629,0.0379039219007412,0.0560822137381442,4.81823681130023e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37382,-0.0312538176562381,0.0030897801089719,-0.037309786669823,-0.0251978486426532,5.75529914681887e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UNC79,Protein unc-79 homolog,36962,0.0534933533488897,0.00529162111275126,0.0431217759678972,0.0638649307298821,6.16415310529635e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C5,Complement C5,37453,0.0143814854919803,0.00142301185390028,0.0115923822583358,0.0171705887256249,6.28896760908458e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39845,0.0227914041423679,0.00226472701280262,0.0183525391972748,0.0272302690874611,9.41317602799797e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RILP,Rab-interacting lysosomal protein,39984,0.0557328358071949,0.0055412452059323,0.0448719952035676,0.0665936764108222,9.96934202924008e-24
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FRZB,Secreted frizzled-related protein 3,39695,0.0247621584483865,0.00246229721209432,0.0199360559126816,0.0295882609840913,1.01296733823455e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGMB,RGM domain family member B,40009,0.0239244998564413,0.00237922504170734,0.019261218774695,0.0285877809381877,1.01939933621532e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL25,C-C motif chemokine 25,40058,0.046723213816667,0.00465211669308752,0.0376050650982155,0.0558413625351185,1.15176149216253e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TREML1,Trem-like transcript 1 protein,37445,0.0497624924409828,0.00495476000153613,0.040051162837972,0.0594738220439936,1.1881815197882e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD72,B-cell differentiation antigen CD72,37124,0.0389937069907894,0.00388364213439369,0.0313817684073777,0.046605645574201,1.22862317454819e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PER3,Period circadian protein homolog 3,37056,0.110260312808173,0.0109883519596798,0.0887231429672005,0.131797482649145,1.30910756585584e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSR,"Glutathione reductase, mitochondrial",37403,0.0211081248134056,0.00210543670368005,0.0169814688741927,0.0252347807526185,1.42249940487226e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37382,0.0448222352385627,0.00447845303760075,0.0360444672848653,0.0536000031922602,1.68967441147298e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",37397,0.0376181490294345,0.00376151586016139,0.0302455779435182,0.0449907201153508,1.82355362654966e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLAMF6,SLAM family member 6,39477,0.0352125790089558,0.00352428416248696,0.0283049820504813,0.0421201759674302,1.95427868273236e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEBPB,CCAAT/enhancer-binding protein beta,39585,0.0348691448052141,0.00349127911326949,0.0280262377432059,0.0417120518672223,2.03023901557027e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPM1F,Protein phosphatase 1F,37437,0.0495501981623088,0.00497454148122076,0.0398000968591161,0.0593002994655015,2.72057740411333e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GET3,ATPase GET3,37437,0.0520696816467158,0.00523048321179976,0.0418179345515883,0.0623214287418434,2.88030200709337e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,39477,0.0713515709503725,0.00717961675221669,0.0572795221160277,0.0854236197847172,3.33135210352278e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPHS1,Nephrin,37056,0.0318447910325887,0.00320341916994999,0.0255660894594867,0.0381234926056907,3.33488355038119e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37056,0.0445594422124096,0.00448558361954984,0.0357676983180919,0.0533511861067272,3.57403458814578e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHAD,Chondroadherin,37124,0.0468132404514112,0.00471490636907497,0.0375720239680243,0.0560544569347981,3.75843155467566e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCEMP1,Mast cell-expressed membrane protein 1,37056,0.0837405363336432,0.00843418226517459,0.067209539093901,0.100271533573385,3.76447930874665e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPA1,Carboxypeptidase A1,40052,0.054718035231704,0.00552209721997027,0.0438947246805622,0.0655413457828457,4.42900546640479e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALDH1A1,Retinal dehydrogenase 1,39858,0.0485890381337014,0.00490803823556379,0.0389692831919964,0.0582087930754064,4.85403953769009e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,39720,0.0214658660851022,0.00216840828905399,0.0172157858385564,0.025715946331648,4.88585683021409e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,37097,0.026204052966685,0.00264732263924584,0.0210153005937631,0.0313928053396068,5.08873239751477e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD83,CD83 antigen,39866,0.0302625868017607,0.00306084702229404,0.0242633266380643,0.036261846965457,5.51670233553603e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HGFAC,Hepatocyte growth factor activator,37318,0.026067903371901,0.00264596946627277,0.0208818032180064,0.0312540035257956,8.03203101108691e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX9,Sorting nexin-9,39868,0.0636156186939603,0.00647166110198975,0.0509311629340604,0.0763000744538602,9.7099263362747e-23
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA9,Carbonic anhydrase 9,40030,-0.0396790576095283,0.00404167293255549,-0.047600736557337,-0.0317573786617195,1.09561873146333e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOE,Apolipoprotein E,37453,0.066558943457087,0.0067825936810989,0.0532650598421332,0.0798528270720409,1.17474625739144e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINT2,Kunitz-type protease inhibitor 2,39931,0.0375012564793875,0.00383821636373439,0.0299783524064681,0.045024160552307,1.74091094633117e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37437,0.0295717905576507,0.00302593337773924,0.0236409611372818,0.0355026199780196,1.74768294751616e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LONP1,"Lon protease homolog, mitochondrial",37043,0.0797250956454173,0.0081610268675491,0.0637294829850211,0.0957207083058135,1.82287201186881e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDT,D-dopachrome decarboxylase,37437,0.0366371260687392,0.0037529134729773,0.0292814156617036,0.0439928364757747,1.9364592422208e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GZMA,Granzyme A,40058,0.0307460491709706,0.00315599569918242,0.0245602976005731,0.0369318007413681,2.29656051484238e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39587,0.037812967092625,0.00389019765586029,0.0301881796871389,0.0454377544981112,2.86070142305119e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,37056,0.0470032607160606,0.00483658477701186,0.0375235545531173,0.0564829668790038,2.9923251424288e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,39477,0.0498649734633636,0.005135545514702,0.0397993042545477,0.0599306426721795,3.16607735665197e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37056,0.0411159171089636,0.00423604698017916,0.0328132650278124,0.0494185691901147,3.36594048582169e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37437,0.0684455762303257,0.00706926061481097,0.0545898254252962,0.0823013270353552,4.23326992469966e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37169,0.0757635871000333,0.00783085287553631,0.0604151154639821,0.0911120587360844,4.55175372326689e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39788,0.0293714432197905,0.00304668787984815,0.0233999349752882,0.0353429514642929,6.19304950491133e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WDR46,WD repeat-containing protein 46,37368,0.0324521040578585,0.00337257099022786,0.0258418649170119,0.0390623431987051,7.55997653843005e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AREG,Amphiregulin,39788,-0.0420453183820566,0.00437221334104025,-0.0506148565304955,-0.0334757802336177,7.80900779962812e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARAF,Serine/threonine-protein kinase A-Raf,37169,0.0601482486230639,0.00625346248546803,0.0478914621515466,0.0724050350945812,7.87444070106829e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MANSC1,MANSC domain-containing protein 1,39913,-0.0242709055824509,0.00252442485813463,-0.0292187783043948,-0.019323032860507,7.95708379437825e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWA1,von Willebrand factor A domain-containing protein 1,40011,0.0382812709404638,0.00398760949830251,0.0304655563237909,0.0460969855571367,9.13412448425252e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM3C,Protein FAM3C,39846,0.025924660659335,0.00270190543888635,0.0206289259991178,0.0312203953195523,9.60784585660963e-22
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MATN2,Matrilin-2,39885,0.026640769557033,0.00277921839623054,0.0211935015004212,0.0320880376136449,1.05001369486132e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TREML2,Trem-like transcript 2 protein,39858,0.0296329171287578,0.00309491221297351,0.0235668891913298,0.0356989450661859,1.16741522982696e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BMPER,BMP-binding endothelial regulator protein,37124,0.0201321292335637,0.00210282613838859,0.0160105900023221,0.0242536684648053,1.21002057072252e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1RL,Complement C1r subcomponent-like protein,37432,0.0172238659076215,0.00179980942606037,0.0136962394325432,0.0207514923826998,1.25306526562306e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC27A4,Long-chain fatty acid transport protein 4,39489,0.0603975718471211,0.00631799379877751,0.0480143040015172,0.072780839692725,1.35413960331118e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTGR1,Prostaglandin reductase 1,37437,0.0711106339241981,0.00743968010877996,0.0565288609109894,0.0856924069374068,1.39975633353423e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK7,Kallikrein-7,36818,0.0348881748165436,0.00365343433530111,0.0277274435193534,0.0420489061137337,1.53543428004584e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NID2,Nidogen-2,39858,0.0647587975891636,0.00678758905362874,0.0514551230440513,0.0780624721342759,1.61757997622718e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C8B,Complement component C8 beta chain,37453,0.0270069904792941,0.00283660486498904,0.0214472449439156,0.0325667360146726,2.00249794854121e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FXN,"Frataxin, mitochondrial",40030,0.0651549208159396,0.00685677512530075,0.0517156415703501,0.078594200061529,2.33491601970094e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37388,0.0687861683340426,0.00724030496623428,0.0545951706002234,0.0829771660678618,2.43578393744627e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39587,0.0640856841505952,0.00675847428881945,0.0508390745445091,0.0773322937566813,2.83593791435589e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESAM,Endothelial cell-selective adhesion molecule,40052,0.027677165738955,0.00291959128672589,0.0219547668169722,0.0333995646609377,2.89243993578795e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,39477,0.0302614123293118,0.00319359546322797,0.024001965221385,0.0365208594372386,3.02319111564425e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD34,Hematopoietic progenitor cell antigen CD34,39945,0.0212170916644783,0.00224405902137622,0.0168187359825809,0.0256154473463757,3.67341396524261e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STK4,Serine/threonine-protein kinase 4,39868,0.0769851863848837,0.00814374791822131,0.0610234404651699,0.0929469323045975,3.72828666863598e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PKN3,Serine/threonine-protein kinase N3,37169,0.0671715734201047,0.0071043986665886,0.0532469520335911,0.0810961948066184,3.76603094803149e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NGRN,Neugrin,37388,0.0188646848345954,0.0019959629081804,0.0149525975345618,0.022776772134629,3.88395105946503e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37031,0.0247418800955745,0.00261845100803693,0.0196097161198221,0.0298740440713268,3.98835130544591e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJC21,DnaJ homolog subfamily C member 21,37388,0.0339758277716984,0.00359867202684036,0.0269224305990913,0.0410292249443055,4.27891247631273e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENAH,Protein enabled homolog,39587,0.0421898902708072,0.00448321911602283,0.0334027808034025,0.050976999738212,5.59986044371575e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPPK1,Epiplakin,37043,0.0655836120485737,0.00696979414999151,0.0519228155145904,0.0792444085825571,5.78898117680091e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39866,0.0533475857479768,0.00568223821739518,0.0422103988418823,0.0644847726540714,6.8882807543536e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,37437,0.0280800155746962,0.00299028602508632,0.022219054965527,0.0339409761838653,6.91463083398094e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRDT,Bromodomain testis-specific protein,37021,0.0320906846203357,0.0034242258408237,0.0253792019723212,0.0388021672683501,8.28872177372897e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PMM2,Phosphomannomutase 2,37021,0.0527256675228384,0.00563570457187542,0.0416796865619626,0.0637716484837142,9.63602831375823e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSNAX,Translin-associated protein X,37021,0.0343578756806571,0.00367323938720677,0.0271583264817318,0.0415574248795823,9.8266773723968e-21
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,37124,0.0319049912731569,0.00341249732488681,0.0252164965163788,0.038593486029935,1.02015897444996e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGMN,Legumain,39931,0.0313307180119481,0.00335539504516396,0.0247541437234267,0.0379072923004694,1.11357314991547e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,40052,-0.026856537575817,0.00287931102285591,-0.0324999871806145,-0.0212130879710194,1.2220391684764e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BMP6,Bone morphogenetic protein 6,39568,0.0364427233118803,0.00390896184333572,0.0287811580989423,0.0441042885248184,1.28002187543053e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDCP1,CUB domain-containing protein 1,39749,0.0433806106837492,0.00466204671010959,0.0342429991319344,0.052518222235564,1.51029859303573e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBKS,Ribokinase,39504,0.0429493847676425,0.00462693810239339,0.0338805860869515,0.0520181834483336,1.86894226061127e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPL,Periplakin,37056,0.0278834326247425,0.00300313470855075,0.0219972885959831,0.033769576653502,1.87038400751832e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39713,0.0636363208583814,0.00685766174323938,0.0501953038416322,0.0770773378751305,1.91663008892741e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IDS,Iduronate 2-sulfatase,40058,0.00780153698544387,0.000840849305175943,0.00615347234729902,0.00944960162358872,1.93750495711678e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THBD,Thrombomodulin,39868,0.0235451522438327,0.00253871091771955,0.0185692788451024,0.0285210256425631,2.00854686181892e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLAMF7,SLAM family member 7,39866,-0.0498997005681996,0.00538533475213123,-0.0604549566823769,-0.0393444444540224,2.17635083565356e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANPEP,Aminopeptidase N,39891,0.0241676059807831,0.00260846620672705,0.019055012215598,0.0292801997459681,2.19194406161653e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39749,0.0384040224388387,0.00415213853085352,0.0302658309183658,0.0465422139593116,2.54320299494783e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPB6,Heat shock protein beta-6,40030,0.0322799101426136,0.0035016089461592,0.0254167566081416,0.0391430636770857,3.37328969633629e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39749,0.0297753743685437,0.00323740606438668,0.0234300584823458,0.0361206902547416,4.11744476840142e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IMMT,MICOS complex subunit MIC60,37368,0.0377361624196443,0.00410382812121881,0.0296926593020555,0.0457796655372332,4.27720041337026e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",39788,0.0527330270134343,0.00573618303896566,0.0414901082570616,0.063975945769807,4.28106325175291e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TF,Serotransferrin,37453,0.0187790835036822,0.00204349171962597,0.0147738397332153,0.0227843272741491,4.50279290356485e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL19,C-C motif chemokine 19,40009,0.0992309820708544,0.0108034221830702,0.0780562745920368,0.120405689549672,4.59868603304509e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39477,0.0508165573634809,0.00553533225912368,0.0399673061355985,0.0616658085913633,4.82313101999933e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHRDL1,Chordin-like protein 1,39908,0.0262888038355446,0.00286393613182922,0.0206754890171593,0.0319021186539298,4.85919553461237e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BST2,Bone marrow stromal antigen 2,40009,0.0456275121768795,0.00497149672963763,0.0358833785867897,0.0553716457669692,4.92053912232936e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNAS,Neuroendocrine secretory protein 55,37411,0.077605829637554,0.00845568100277828,0.0610326948721085,0.0941789644029994,5.02093984110968e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ING1,Inhibitor of growth protein 1,39453,0.0384741279044323,0.00420356490687264,0.030235140686962,0.0467131151219027,6.225978595935e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,40058,0.0284139163563779,0.00311075429627514,0.0223168379356787,0.0345109947770772,7.35993882728448e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMOTL2,Angiomotin-like protein 2,37333,0.0412987210809792,0.00452989853025134,0.0324201199616866,0.0501773222002718,8.80839112773331e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFCAB2,Dynein regulatory complex protein 8,37169,0.0298478253701754,0.0032739408956234,0.0234309012147536,0.0362647495255973,8.83318229602381e-20
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XRCC4,DNA repair protein XRCC4,39489,0.0315705572531658,0.00347085367546821,0.0247676840492481,0.0383734304570834,1.04890361441061e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLTA,Clathrin light chain A,39585,0.0395655386007298,0.00435242765216941,0.0310347804024777,0.0480962967989818,1.10182854588942e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM1,Intercellular adhesion molecule 1,39822,0.0241302752803861,0.00265522658215803,0.0189260311793564,0.0293345193814158,1.12663431903623e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCAN,Neurocan core protein,40009,0.0311110633859163,0.00342862795141936,0.0243909526011343,0.0378311741706982,1.27802962959407e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TLR3,Toll-like receptor 3,40058,0.0514346861656475,0.00569105810111481,0.0402802122874625,0.0625891600438325,1.77565793079633e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPCAM,Epithelial cell adhesion molecule,39867,-0.0802420057517939,0.00888350367251194,-0.0976536729499173,-0.0628303385536705,1.86246338879948e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPT2,Angiopoietin-2,40030,-0.0321336732152329,0.00355902459974228,-0.0391093614307278,-0.025157984999738,1.92784159084835e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPAG1,Sperm-associated antigen 1,37411,0.0492078839384386,0.0054558794742743,0.038514360168861,0.0599014077080162,2.14525498813424e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL7,Angiopoietin-related protein 7,40030,0.0313698859759054,0.00348077895183736,0.0245475592303041,0.0381922127215066,2.23890836510271e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL12A_IL12B,Interleukin-12,39788,0.0619201029622456,0.00688875844417826,0.0484181364116562,0.0754220695128349,2.78088057866728e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FMNL1,Formin-like protein 1,39489,0.0511575383852415,0.00569205956648722,0.0400011016349266,0.0623139751355565,2.81291939639047e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4A,C-type lectin domain family 4 member A,39866,-0.0291237767756703,0.00324353945696036,-0.0354811141113127,-0.022766439440028,3.03059191813079e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTN,Pleiotrophin,39585,0.0422679056843655,0.00471020864152946,0.0330358967469678,0.0514999146217633,3.18607608833037e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37382,0.0355389453458134,0.00396061184499735,0.0277761461296186,0.0433017445620082,3.25815270267192e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL2,C-C motif chemokine 2,39720,0.0433182613567703,0.00482873095875475,0.033853948677611,0.0527825740359296,3.26299074834289e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,39908,-0.0412059218433708,0.0045936923324234,-0.0502095588149207,-0.032202284871821,3.28360823739211e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPB1,Carboxypeptidase B,40052,0.0481068202838932,0.00536522421251138,0.0375909808273709,0.0586226597404155,3.39195984862184e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBP1,Guanylate-binding protein 1,37376,0.0532853145245021,0.0059512478238658,0.0416208687897252,0.0649497602592791,3.8833379998383e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37388,0.0404792134961954,0.00452693587793541,0.031606419175442,0.0493520078169488,4.3173952573907e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PEPD,Xaa-Pro dipeptidase,37445,0.0214800559855942,0.00240293216197039,0.0167703089481323,0.0261898030230562,4.42351026511071e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37039,0.0440095923530014,0.00492337124516251,0.0343597847124828,0.0536593999935199,4.44733895775791e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COLEC12,Collectin-12,39862,0.0207355472051282,0.00232054874936735,0.0161872716563682,0.0252838227538882,4.48257554772669e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,37043,0.0363194358310638,0.00406626004231805,0.0283495661481204,0.0442893055140072,4.73655063424964e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP6,Gastrotropin,39564,0.04511055409968,0.00505595652169722,0.0352008793171535,0.0550202288822066,5.06468733849215e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCT,Secretin,37039,0.036865515172697,0.00413150322048547,0.0287677688605455,0.0449632614848485,5.12978813060226e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39788,0.0583553754526524,0.00654327605581802,0.0455305543832491,0.0711801965220557,5.23708679799358e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37437,0.0514710246796413,0.00577294047834396,0.0401560613420871,0.0627859880171955,5.44857381447446e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRK1,Protein BRICK1,39489,0.0370536826771931,0.00415772358283571,0.0289045444548351,0.0452028208995511,5.55563767863961e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX16,Syntaxin-16,39477,0.048364663077199,0.00544440373831897,0.0376936317500939,0.0590356944043042,7.18190189726424e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A13,Protein S100-A13,37056,0.0288943573585268,0.00325323892029901,0.0225180090747407,0.0352707056423128,7.42567945523549e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP1,Rho GTPase-activating protein 1,39477,0.0389137341261855,0.00438322524876185,0.0303226126386123,0.0475048556137587,7.54374612804257e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARB2,Lysosome membrane protein 2,39486,0.0238638356274693,0.00268864463770331,0.0185940921375708,0.0291335791173678,7.68563230125457e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RASSF2,Ras association domain-containing protein 2,39477,0.0456786219138147,0.00514697030460463,0.0355905601167896,0.0557666837108397,7.75026047355605e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCS,Copper chaperone for superoxide dismutase,39749,0.0391180463908229,0.00441365817828003,0.030467276361394,0.0477688164202517,8.60501238468007e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGER,Advanced glycosylation end product-specific receptor,39817,0.032747996876509,0.0036991931984238,0.0254975782075983,0.0399984155454196,9.42216962039547e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH3BP1,SH3 domain-binding protein 1,37382,0.0397362434669148,0.00448897266360542,0.0309378570462482,0.0485346298875814,9.65608477901857e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACYP1,Acylphosphatase-1,37073,0.0544222134743389,0.00614812390777222,0.0423718906151053,0.0664725363335724,9.69320955218285e-19
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37021,0.0543680395808662,0.00614483455914912,0.0423241638449339,0.0664119153167985,1.00564408516686e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THBS2,Thrombospondin-2,39858,-0.0297571399785144,0.00336617893716491,-0.0363548506953576,-0.0231594292616712,1.05492751458668e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39749,0.044502164327067,0.00505145723373214,0.034601308148952,0.054403020505182,1.38164392001758e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSCAM,Down syndrome cell adhesion molecule,37411,0.0290712753760154,0.00329933843950545,0.0226045720345847,0.035537978717446,1.38657049184867e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSC2,Desmocollin-2,39673,-0.0273977646852706,0.00311006711878324,-0.0334934962380858,-0.0213020331324555,1.38704326960688e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALCA,Calcitonin,39713,0.0501779884153843,0.00569711790417469,0.0390116373232019,0.0613443395075667,1.40867686586589e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PECAM1,Platelet endothelial cell adhesion molecule,39858,0.0246590545663736,0.00280537158450989,0.0191605262607342,0.030157582872013,1.64612184040956e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40009,-0.0365737894463817,0.00416438843012717,-0.044735990769431,-0.0284115881233325,1.7565164394704e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SV2A,Synaptic vesicle glycoprotein 2A,37039,0.0504595403076895,0.00574478764317084,0.0391997565270747,0.0617193240883044,1.77789380326745e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERMAP,Erythroid membrane-associated protein,37056,0.0365734695760873,0.0041709677580236,0.0283983727703611,0.0447485663818136,2.02871542045726e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL5,Fc receptor-like protein 5,39858,-0.0457360111843755,0.00522034356989676,-0.0559678845813732,-0.0355041377873779,2.12422509571901e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHB4,Ephrin type-B receptor 4,40052,-0.0192184531435033,0.00219476087719944,-0.0235201844628142,-0.0149167218241924,2.20973842981933e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSZ,Cathepsin Z,39865,0.0253696841277734,0.00289778973262957,0.0196900162518194,0.0310493520037273,2.24504903250323e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTN6,Dynactin subunit 6,39489,0.0579614332000147,0.0066337856127887,0.0449592133989488,0.0709636530010805,2.6261052690298e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX1,Peroxiredoxin-1,39434,-0.0740884640717212,0.00848484769989857,-0.0907187655635224,-0.0574581625799201,2.75617315130666e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLIT2,Slit homolog 2 protein,39489,0.0420360759895985,0.00482018139529114,0.0325885204548278,0.0514836315243691,3.03529889352034e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39749,-0.0899527535671222,0.0103313544083943,-0.110202208207575,-0.0697032989266693,3.42949510414325e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HPCAL1,Hippocalcin-like protein 1,40058,0.0602693781321012,0.00692825446319635,0.0466899993842363,0.073848756879966,3.66279494780373e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17RB,Interleukin-17 receptor B,39644,-0.0437448085313897,0.00503111659190535,-0.0536057970515241,-0.0338838200112552,3.80984933836315e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LIPF,Gastric triacylglycerol lipase,37043,0.0486610987768348,0.00559592780009905,0.0376930802886407,0.059629117265029,3.84754247010412e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37382,0.0681015231161987,0.00787046860275865,0.0526754046547918,0.0835276415776057,5.58745478064872e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VIT,Vitrin,37437,0.0297379610292468,0.00343800386952088,0.0229994734449858,0.0364764486135077,5.73383137637195e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PVALB,Parvalbumin alpha,39971,0.0921872908336906,0.010665922900253,0.0712820819491947,0.113092499718187,5.97461328463928e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF23,Fibroblast growth factor 23,40008,0.0471145476224319,0.00545728773498214,0.0364182636618669,0.0578108315829969,6.50768583321365e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MDK,Midkine,39843,0.0408236691251197,0.004728619737138,0.0315555744403292,0.0500917638099102,6.51417993121748e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYTL1,Cytokine-like protein 1,37437,0.0184647160110611,0.00214013147800888,0.0142700583141637,0.0226593737079585,6.93990490360478e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGAV,Integrin alpha-V,40030,0.013327349031235,0.00154537174665391,0.0102984204077934,0.0163562776546767,7.05450054591087e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL11,C-X-C motif chemokine 11,40009,0.0626222896377849,0.0072713504978895,0.0483704426619215,0.0768741366136483,7.82037595828148e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATG4A,Cysteine protease ATG4A,39477,0.0472842986688589,0.00550048863894813,0.0365033409365206,0.0580652564011973,8.99707329299637e-18
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OXT,Oxytocin-neurophysin 1,40009,0.111074049540832,0.0129490313072787,0.0856939481785662,0.136454150903099,1.05380842342349e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELOB,Elongin-B,37021,0.0314694718685093,0.00367887129891604,0.0242588841226338,0.0386800596143847,1.31810877998282e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",39868,0.0578508560266375,0.00679181455145785,0.0445388995057801,0.0711628125474949,1.77002341079419e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37388,0.0306315939861977,0.00359829056233787,0.0235789444840155,0.0376842434883799,1.87489304225556e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD274,Programmed cell death 1 ligand 1,39749,0.0266691373187393,0.00313691334139475,0.0205207871696056,0.032817487467873,2.03225148086371e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,39730,0.0753011674234214,0.00887312348236694,0.0579098453979822,0.0926924894488606,2.31681274905737e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37411,0.0470967112774614,0.00555096000991768,0.0362168296580228,0.0579765928969001,2.39081392726174e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAP18,Chromatin complexes subunit BAP18,37388,0.0515702143639666,0.00609666800312401,0.0396207450778436,0.0635196836500897,2.97746868234646e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ASAH1,Acid ceramidase,37340,0.0373474997098043,0.00442405013592546,0.0286763614433904,0.0460186379762182,3.43771264614881e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,40040,0.0395223141321594,0.00468765644624892,0.0303345074975116,0.0487101207668073,3.70815437749513e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLITRK2,SLIT and NTRK-like protein 2,40030,0.0303926133450647,0.003607496918281,0.0233219193852339,0.0374633073048954,3.91240299873199e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BOLA2_BOLA2B,BolA-like protein 2,37043,0.0431685925885851,0.00513160499827775,0.0331106467919607,0.0532265383852095,4.43135610508636e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,40030,0.0424759475084267,0.0050520565940813,0.0325739165840273,0.052377978432826,4.527653784701e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,40052,0.0122906280226793,0.0014641937462257,0.00942080828007691,0.0151604477652817,5.07745581795238e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS7_LGALS7B,Galectin-7,39822,0.0317568112094272,0.00380283790047297,0.0243032489245002,0.0392103734943543,7.32988105472997e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOA2,Apolipoprotein A-II,37445,-0.0371746363711892,0.00445502497236475,-0.0459064853170241,-0.0284427874253543,7.84124116274053e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GDNF,Glial cell line-derived neurotrophic factor,39489,0.0298362461381863,0.00358093785486213,0.0228176079426565,0.0368548843337161,8.60537231256076e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTN2,Dynactin subunit 2,39788,0.0739062486385152,0.00887356898906091,0.0565140534199558,0.0912984438570745,8.82382954670462e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEPR,Leptin receptor,39868,-0.0240385897059185,0.0028866558130547,-0.0296964350995057,-0.0183807443123312,8.91888812655332e-17
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,40034,0.0432135981752319,0.00520879302659011,0.0330043638431153,0.0534228325073485,1.15804687827179e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,37056,0.031585926280778,0.00380779500932591,0.0241226480624992,0.0390492044990568,1.18975292206246e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOD1,Superoxide dismutase [Cu-Zn],39487,0.0374503513239502,0.00452315950899207,0.0285849586863258,0.0463157439615747,1.33401484039186e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37437,0.0231748377194504,0.00279874931024531,0.0176892890713696,0.0286603863675312,1.34129437715384e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39585,-0.0236783217099428,0.00286243013405181,-0.0292886847726843,-0.0180679586472012,1.42061664181833e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DENR,Density-regulated protein,37056,0.0447676866087965,0.00541396940675448,0.0341563065715577,0.0553790666460353,1.48030037682469e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNF,Tumor necrosis factor,39555,0.0293672743322289,0.00355424571791635,0.0224009527251129,0.036333595939345,1.53829247240165e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCAM,Cell surface glycoprotein MUC18,39931,-0.0252236315312087,0.00305444368921938,-0.0312103411620787,-0.0192369219003387,1.59534384241544e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NBN,Nibrin,39587,0.0396693489404974,0.00481659436388137,0.0302288239872899,0.0491098738937048,1.9198602634738e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,40011,0.0502101245804987,0.00610641862091438,0.0382415440835066,0.0621787050774909,2.14290607229285e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39453,0.0365132120224461,0.00444102345611731,0.0278088060484562,0.045217617996436,2.16125755331015e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL24A1,Collagen alpha-1(XXIV) chain,37382,0.0426042302815518,0.00518529081937068,0.0324410602755852,0.0527674002875183,2.28710499779164e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SYT1,Synaptotagmin-1,37388,0.0284274904142103,0.00346736807092104,0.0216314489952051,0.0352235318332155,2.65006051816295e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLB,Beta-klotho,39489,-0.0563743960773017,0.00687912815839756,-0.0698574872677609,-0.0428913048868425,2.69878085212114e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17D,Interleukin-17D,39587,0.0259266591426736,0.00316666934284849,0.0197199872306906,0.0321333310546567,2.87339279406884e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABCA2,ATP-binding cassette sub-family A member 2,37021,0.0281724077488194,0.0034441665724638,0.0214218412667904,0.0349229742308485,3.10381158790391e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37411,0.0504268294273813,0.00619656054575224,0.0382815707577069,0.0625720880970557,4.37123637262106e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPC2,NPC intracellular cholesterol transporter 2,37268,0.0226425970394768,0.00278454220213165,0.0171848943232987,0.0281002997556548,4.60900253993329e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C2orf69,UPF0565 protein C2orf69,37039,0.0444832583097111,0.00547063552733555,0.0337608126761334,0.0552057039432888,4.62536430755387e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCN1,Ficolin-1,37430,0.0427791370981075,0.00526479947099101,0.0324601301349651,0.0530981440612499,4.83809749060392e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMB1,Laminin subunit beta-1,37043,0.0230832096069256,0.00284330277200002,0.0175103361738055,0.0286560830400456,5.13853185598974e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MILR1,Allergin-1,39587,-0.0374265174464697,0.00462718445644184,-0.0464957989810957,-0.0283572359118437,6.48313036699652e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,37453,-0.0192392541602916,0.00238005937397383,-0.0239041705332803,-0.0145743377873029,6.82100887998703e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENTR1,Endosome-associated-trafficking regulator 1,37043,0.0452121121231071,0.00559992050272799,0.0342362679377602,0.0561879563084539,7.40801633732411e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAA10,N-alpha-acetyltransferase 10,37021,0.0382015785489555,0.00473954867304999,0.0289120631497775,0.0474910939481335,8.27270526195464e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39682,0.0240084649178615,0.00298180604869785,0.0181641250624138,0.0298528047733093,8.74540342067909e-16
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,39825,0.020716276089656,0.002579824109161,0.0156598208357004,0.0257727313436116,1.04125683920504e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37043,0.0376317798088356,0.0047009941036866,0.0284178313656098,0.0468457282520613,1.29348446682838e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD101,Immunoglobulin superfamily member 2,37382,0.0314966084974339,0.0039453395395184,0.0237637429999778,0.0392294739948899,1.53975698090469e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DKK4,Dickkopf-related protein 4,39718,0.0337817133029808,0.00423959998939368,0.0254720973237692,0.0420913292821925,1.71965365801222e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39713,0.0719544326919585,0.00903168152334431,0.0542523369062037,0.0896565284777134,1.73702314031806e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFAP,Glial fibrillary acidic protein,39453,0.032519729360143,0.00408455206554447,0.0245140073116759,0.0405254514086102,1.81405457301694e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRD1,Natural killer cells antigen CD94,40058,0.0339660651065311,0.00426858432580521,0.0255996398279529,0.0423324903851093,1.87511140884809e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLF4,Krueppel-like factor 4,36991,0.029360365384382,0.00369032022175696,0.0221273377497384,0.0365933930190256,1.92112427781911e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SWAP70,Switch-associated protein 70,37382,0.0267379408452825,0.00336164083668023,0.0201491248053892,0.0333267568851757,1.95117498550148e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERI1,3'-5' exoribonuclease 1,37169,0.0249079505398314,0.00313155866005388,0.0187700955661258,0.031045805513537,1.95331590321845e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INSL3,Insulin-like 3,37388,0.0539529701344606,0.0067888896967364,0.0406467463288572,0.0672591939400639,2.05722690873538e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECE1,Endothelin-converting enzyme 1,39489,0.0259219327645342,0.00326758579005207,0.0195174646160322,0.0323264009130363,2.28223280531648e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX7,Syntaxin-7,37056,0.0366554979916968,0.00462401086467354,0.0275924366969367,0.045718559286457,2.42050813579948e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39477,0.0348457778044544,0.00440286696840324,0.0262161585463841,0.0434753970625248,2.65166533589953e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADA,Adenosine deaminase,40058,0.0256582053027048,0.00324879432092445,0.0192905684336929,0.0320258421717167,3.02057556704777e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37382,0.0757260417466252,0.00959530661335266,0.056919240784454,0.0945328427087964,3.20184639140294e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFHR2,Complement factor H-related protein 2,37364,0.0416232342357663,0.00527851652208114,0.0312773418524873,0.0519691266190453,3.374785249119e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDF1,Endothelial differentiation-related factor 1,37411,0.0508410098092873,0.0064479437297163,0.0382030400990434,0.0634789795195313,3.38910211951389e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCRIB,Protein scribble homolog,37043,0.06651770564689,0.0084400808515988,0.0499751471777563,0.0830602641160236,3.49685272168377e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOB,Apolipoprotein B-100,37445,0.016678199431087,0.0021202653340673,0.0125224793763151,0.020833919485859,3.93407353034036e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAGED1,Melanoma-associated antigen D1,39477,0.0355512988238673,0.00452607032584268,0.0266802009852156,0.0444223966625189,4.26393473626736e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37043,0.0672087969780345,0.0085638177617212,0.0504237141650609,0.0839938797910081,4.55224440535764e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,39831,-0.0278956690298654,0.00355926706980174,-0.0348718324866768,-0.020919505573054,4.88518927579861e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD276,CD276 antigen,39862,-0.0257756251254436,0.00328932168830236,-0.0322226956345162,-0.0193285546163709,4.93615323317748e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,37382,0.0836816942769808,0.0106960007017778,0.0627175329014963,0.104645855652465,5.51086166592322e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN4,CCN family member 4,40030,0.0292878233459436,0.00374522095228137,0.0219471902794721,0.0366284564124151,5.60411079002365e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40030,0.0217283438250914,0.00278007143040151,0.0162794038215044,0.0271772838286784,5.79814427562929e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECI2,Enoyl-CoA delta isomerase 2,37021,0.0451412140940251,0.00580180385624825,0.0337696785357785,0.0565127496522717,7.75769702210592e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL1,Fc receptor-like protein 1,39868,0.0318927162759871,0.00410142190498751,0.0238539293422116,0.0399315032097626,7.93801385422073e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPMT,Thiopurine S-methyltransferase,39477,0.0528857474653773,0.00680273179761496,0.039552393142052,0.0662191017887026,8.06447893637157e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD302,CD302 antigen,39788,0.0211202458538976,0.00271862889996651,0.0157917332099632,0.0264487584978319,8.40986821149616e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB1,Integrin beta-1,39862,0.0157698520178762,0.00203085081410598,0.0117893844222284,0.0197503196135239,8.64669290462395e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GC,Vitamin D-binding protein,37453,0.0188017003430492,0.00242151596846767,0.0140555290448526,0.0235478716412459,8.78555802241609e-15
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL20,C-C motif chemokine 20,40058,0.0609080265193853,0.00787161422303776,0.0454796626422312,0.0763363903965393,1.07188767898197e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALCAM,CD166 antigen,40052,0.0140304569222089,0.00181418383799509,0.0104746565997385,0.0175862572446793,1.10535015630748e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37043,0.0234457596873446,0.00303549341331489,0.0174961925972475,0.0293953267774418,1.20974861364607e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL14,C-C motif chemokine 14,39843,0.0280713303228225,0.00363540185856166,0.0209459426800417,0.0351967179656034,1.21599708543669e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FSTL1,Follistatin-related protein 1,37043,-0.0165392140669114,0.00214383448850703,-0.0207411296643852,-0.0123372984694376,1.29874681245223e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EBI3_IL27,Interleukin-27,40011,-0.0220828853796119,0.00287821476860826,-0.0277241863260841,-0.0164415844331397,1.78373897290224e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BOLA1,BolA-like protein 1,36991,0.0394425336974162,0.00514125112895119,0.0293656814846719,0.0495193859101605,1.81560702043626e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTGES2,Prostaglandin E synthase 2,36961,0.0398943999345506,0.00520804726105156,0.0296866273028896,0.0501021725662117,1.98736252973087e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADM,Pro-adrenomedullin,40030,0.018828194855109,0.00246096935949838,0.0140046949104921,0.0236516947997258,2.11075551773252e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX6,Syntaxin-6,39477,0.0485742336489935,0.00637636729802005,0.0360765537448742,0.0610719135531128,2.72680066352184e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JAM2,Junctional adhesion molecule B,40009,0.0177939734132619,0.00234376500029505,0.0132001940126836,0.0223877528138402,3.32056515939804e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37085,0.027373174524393,0.00361415432901333,0.0202894320395268,0.0344569170092591,3.86244044220705e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,39868,-0.0197980809087213,0.00262192238099091,-0.0249370487754635,-0.0146591130419791,4.55245464180458e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP12,Macrophage metalloelastase,39900,0.0354235616397155,0.00469702611163863,0.0262173904609038,0.0446297328185272,4.88672798672914e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL10RB,Interleukin-10 receptor subunit beta,39931,0.0197535058146393,0.00262122795787607,0.0146158990172022,0.0248911126120764,5.10474106036639e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',37388,0.0285256006230921,0.00379070786873531,0.0210958132003709,0.0359553880458134,5.59865327550154e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC5A,C-type lectin domain family 5 member A,39818,-0.0199466957173888,0.00265144440524558,-0.0251435267516702,-0.0147498646831075,5.6400067556703e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP8,Caspase-8,39984,0.0433706091147718,0.00576535718214785,0.032070509037762,0.0546707091917816,5.65126898742708e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37411,0.03304467169016,0.00440396544330554,0.0244128994212811,0.0416764439590389,6.60582318618065e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6V1F,V-type proton ATPase subunit F,39453,0.0462683561173427,0.00618568344096459,0.034144416573052,0.0583922956616333,7.83310305883352e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFPI2,Tissue factor pathway inhibitor 2,39864,0.0280354419374378,0.00375233196288149,0.0206808712901901,0.0353900125846855,8.33932056858702e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMP1,Metalloproteinase inhibitor 1,39698,0.0192561943691049,0.00258052808671801,0.0141983593191376,0.0243140294190722,8.95617204408432e-14
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL32,Interleukin-32,39866,-0.0297610805060753,0.0039997763378502,-0.0376006421282617,-0.0219215188838889,1.0524416584557e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS53,Serine protease 53,37388,0.0259971590775096,0.00349408712621121,0.0191487483101356,0.0328455698448835,1.06485824030644e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,39489,0.0449462647803441,0.00604722467118672,0.0330937044248181,0.0567988251358701,1.12040835789204e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM3B,Protein FAM3B,39788,0.0249675668933584,0.00336054842001166,0.0183808919901355,0.0315542417965812,1.14436693825747e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37056,0.0420671791438956,0.00566208229918963,0.030969497837484,0.0531648604503073,1.15593437797151e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NXPH1,Neurexophilin-1,39489,0.0260639119623483,0.00350924206070184,0.0191857975233728,0.0329420264013239,1.16626269099543e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PQBP1,Polyglutamine-binding protein 1,39477,0.0379629160925287,0.00511472592264205,0.0279380532841503,0.0479877789009071,1.21051821293575e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEK7,Serine/threonine-protein kinase Nek7,37169,0.0513967646062724,0.00692660429441621,0.0378206201892166,0.0649729090233281,1.24033907028397e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFTPD,Pulmonary surfactant-associated protein D,39868,0.0456250176151682,0.00615873936014414,0.0335538884692857,0.0576961467610507,1.34430183951282e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37411,0.0466571790345375,0.00629861975572181,0.0343118843133228,0.0590024737557522,1.36281429739669e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NXPH3,Neurexophilin-3,37056,0.0206038393676901,0.00278321959638751,0.0151487289587706,0.0260589497766096,1.41333027602422e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39866,-0.0267959189096195,0.00362583561840706,-0.0339025567216974,-0.0196892810975417,1.53758133599046e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLRX,Glutaredoxin-1,39771,0.0387257750059375,0.00524094306880924,0.0284535265910714,0.0489980234208036,1.55178759156857e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMIGO2,Amphoterin-induced protein 2,39788,0.0155393453610117,0.00210323936538746,0.0114169962048523,0.0196616945171711,1.56096555613486e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39868,0.0437075295108858,0.00593879365983943,0.0320674939376005,0.0553475650841711,1.9332067605275e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TEK,Angiopoietin-1 receptor,39913,0.0148575724147703,0.00202646163816972,0.0108857076039577,0.018829437225583,2.37938631965024e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRN,Progranulin,39787,0.0169318388502596,0.00230976125793089,0.012404706784715,0.0214589709158041,2.40200712041934e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGT,Angiotensinogen,37445,0.0153558591028733,0.00209898595127483,0.0112418466383746,0.0194698715673719,2.70097222056904e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,XCL1,Lymphotactin,40030,0.0375032608011366,0.00512833665945608,0.0274517209486027,0.0475548006536705,2.73580080208384e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLITRK6,SLIT and NTRK-like protein 6,39585,-0.0227365435613684,0.00310924429263846,-0.0288306623749398,-0.016642424747797,2.74718779058382e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAM,Signal transducing adapter molecule 1,37368,0.0248499956463969,0.00340860956443447,0.0181691209001053,0.0315308703926885,3.26306255726541e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL12B,Interleukin-12 subunit beta,40058,0.0356488180553987,0.00489173996176094,0.0260610077303473,0.0452366283804502,3.30181079257233e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39868,0.0332509597908077,0.00456450473051902,0.0243045305189904,0.0421973890626249,3.37450302265799e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37056,0.0305451297579994,0.00419730332191836,0.0223184152470394,0.0387718442689594,3.59756106842288e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSG4,Desmoglein-4,39725,0.033438857840544,0.0045966307430853,0.0244294615840968,0.0424482540969912,3.63567919635467e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAPK2,Death-associated protein kinase 2,37056,0.0362883068200052,0.00498889354622712,0.0265100754694,0.0460665381706103,3.69178348103926e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP9,Caspase-9,37056,0.0431154509355462,0.00593386079823884,0.031485083770998,0.0547458181000943,3.91077170110357e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD59,CD59 glycoprotein,39173,0.0143078695178941,0.00197595375333104,0.0104350001613653,0.0181807388744229,4.66596482279533e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1R1,Interleukin-1 receptor type 1,39826,-0.0151896364987598,0.00210161197653153,-0.0193087959727616,-0.011070477024758,5.13802663780112e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,39585,0.0267554767009211,0.00370448679663106,0.0194946825795242,0.0340162708223179,5.33983686606995e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL2A1,Collagen alpha-1(II) chain,37043,0.0541522928774126,0.0075273696080845,0.0393986484455669,0.0689059373092582,6.62931628787937e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFNA4,Ephrin-A4,39720,0.01862135183175,0.00258906989725879,0.0135467748331228,0.0236959288303772,6.65577932878298e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARSA,Arylsulfatase A,39858,0.030219714453677,0.00420578269257869,0.0219763803762228,0.0384630485311312,7.00292202524017e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37388,0.0585475372136813,0.00815718380635139,0.0425594569532326,0.0745356174741301,7.47412941508012e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSNK1D,Casein kinase I isoform delta,37056,0.0434432486147359,0.00605840518187071,0.0315687744582693,0.0553177227712025,7.85661640816982e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYM,Ketimine reductase mu-crystallin,36991,0.0514422775176765,0.00717840535166211,0.0373726030284188,0.0655119520069343,8.11930568441352e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRR3,Small proline-rich protein 3,37388,0.0439480287749298,0.00613891474040716,0.0319157558837318,0.0559803016661279,8.55062426972017e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37437,0.0227752313425455,0.00318898197164072,0.0165248266781297,0.0290256360069614,9.6769713677918e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LY75,Lymphocyte antigen 75,39866,0.0257759402852907,0.00361061687038398,0.0186991312193381,0.0328527493512433,9.81007952450851e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJB8,DnaJ homolog subfamily B member 8,39585,0.0380512707433715,0.00533149600167051,0.0276015385800973,0.0485010029066457,9.95055705723747e-13
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RARRES1,Retinoic acid receptor responder protein 1,39477,0.0225700028396187,0.00316766416343145,0.016361381079293,0.0287786245999443,1.0853119880345e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,37388,0.0207996616325177,0.00291907237127157,0.0150782797848254,0.0265210434802099,1.09003633706887e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDIA3,Protein disulfide-isomerase A3,37124,0.0169170714762809,0.00237424212874258,0.0122635569039454,0.0215705860486163,1.09256045365285e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C7orf50,Uncharacterized protein C7orf50,37388,0.0146315090110446,0.00205405506572814,0.0106055610822174,0.0186574569398717,1.10755331884416e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA12,Carbonic anhydrase 12,39788,-0.0211910821740662,0.00298270896841822,-0.0270371917521659,-0.0153449725959665,1.25742377558928e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLC,Galectin-10,39841,-0.0441290395981137,0.00622472923990641,-0.0563295089083302,-0.0319285702878971,1.40420825832931e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPM1A,Protein phosphatase 1A,39477,0.020239500541959,0.00285538909748896,0.0146429379108807,0.0258360631730374,1.41707983543867e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BGN,Biglycan,39448,-0.0787911004470027,0.0111525488589075,-0.100650096210461,-0.0569321046835441,1.67593287869568e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDGF,Hepatoma-derived growth factor,40014,0.0619568615374196,0.00877763132001764,0.044752704150185,0.0791610189246541,1.75161440026812e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40052,0.0149760949984441,0.00212174572799445,0.010817473371575,0.0191347166253132,1.75284491005412e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB103A_DEFB103B,Beta-defensin 103,37000,0.0265674694280053,0.00376431708976887,0.0191894079320584,0.0339455309239523,1.77759226819812e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39788,-0.013076987016278,0.00185356215531038,-0.0167099688406863,-0.00944400519186966,1.79633784616052e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,39489,0.0554378877475102,0.00786155859794707,0.040029232895534,0.0708465425994865,1.8406047768302e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INSR,Insulin receptor,37056,0.0109741162986047,0.00155913740022371,0.00791820699416625,0.0140300256030432,2.03804221145909e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LACRT,Extracellular glycoprotein lacritin,37339,0.0317433270042411,0.0045170621380442,0.0228898852136744,0.0405967687948077,2.20485712576631e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PKD1,Polycystin-1,37437,0.017223374318049,0.00245130629395305,0.0124188139819011,0.022027934654197,2.22347084959899e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37043,-0.023000450503933,0.00327636140852408,-0.0294221188646402,-0.0165787821432258,2.32529494010609e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SF3B4,Splicing factor 3B subunit 4,39788,0.0477930827757749,0.00682963175244885,0.0344070045409751,0.0611791610105746,2.7018293288708e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,39489,0.0330799707626025,0.00472785097779169,0.0238133828461307,0.0423465586790742,2.72450521616733e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGHMBP2,DNA-binding protein SMUBP-2,37021,0.0369746009687882,0.00528450515258604,0.0266169708697195,0.0473322310678568,2.74555029308051e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL31RA,Interleukin-31 receptor subunit alpha,37015,0.0261236181262807,0.00374256188628559,0.0187881968291609,0.0334590394234004,3.09018260677916e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37056,0.04616499107034,0.00661430149881851,0.0332009601326557,0.0591290220080243,3.10228459024617e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRTAC1,Cartilage acidic protein 1,40052,0.019622581593895,0.00281468991807073,0.0141057893544763,0.0251393738333136,3.25710521460638e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP1,Interstitial collagenase,39314,0.0597526596008065,0.00857565673389975,0.042944372402363,0.07656094679925,3.3516370560453e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39788,0.0374972037906917,0.00539122910049635,0.0269303947537189,0.0480640128276646,3.65694902901416e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL6ST,Interleukin-6 receptor subunit beta,39868,0.01141737633198,0.00164289197411636,0.00819730806271195,0.0146374446012481,3.80561413672774e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSTB,Cystatin-B,39619,0.0275800057703797,0.00396945459013144,0.019799874773722,0.0353601367670373,3.84847784226575e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,40009,0.0305714907813456,0.00440457828838986,0.0219385173361015,0.0392044642265897,4.04590607472716e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXADR,Coxsackievirus and adenovirus receptor,39866,0.0328598978716228,0.00473514156352542,0.023579020407113,0.0421407753361326,4.0834939494444e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD27,CD27 antigen,39913,-0.0252039090019157,0.00364014211380385,-0.0323385875449713,-0.0180692304588602,4.56090723976154e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PVR,Poliovirus receptor,40009,0.0240849840049871,0.00347856770269726,0.0172669913077005,0.0309029767022738,4.56177578682528e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DGKZ,Diacylglycerol kinase zeta,39587,0.0232421635013639,0.00336631680061294,0.0166441825721625,0.0298401444305653,5.23708070736726e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37043,0.0502388293624718,0.00728178703259401,0.0359665267785875,0.064511131946356,5.46669719022577e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG4,Regenerating islet-derived protein 4,39885,0.0301719029856803,0.00439500323124722,0.0215576966524358,0.0387861093189249,6.89085736555333e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL8,Interleukin-8,39750,0.0424250634089415,0.00618016429507158,0.0303119413906012,0.0545381854272818,6.90898111494232e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PODXL,Podocalyxin,39788,0.00966047018475958,0.00140797573207819,0.00690083774988633,0.0124201026196328,7.07765451184281e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LXN,Latexin,39682,-0.0428362466680229,0.00625350138285496,-0.0550931093784186,-0.0305793839576271,7.65916697975332e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COMP,Cartilage oligomeric matrix protein,39729,0.0214180962108124,0.00313201850167977,0.0152793399475201,0.0275568524741048,8.29862927933752e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYOM3,Myomesin-3,37124,-0.0599459660960467,0.00877721774298235,-0.0771493128722921,-0.0427426193198013,8.87860268842275e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37382,0.0758524111705181,0.0111109640373088,0.0540749216573928,0.0976299006836434,9.05286785162841e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,39453,0.0266669440729399,0.0039114561726086,0.0190004899746271,0.0343333981712528,9.59373035064962e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37056,0.0233011410579457,0.0034188784912045,0.0166001392151849,0.0300021429007065,9.80618678294203e-12
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINI1,Neuroserpin,37088,0.0196597388317688,0.00288668155374246,0.0140018429864336,0.025317634677104,1.01463773257747e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMPD1,Sphingomyelin phosphodiesterase,39912,-0.0312280766038031,0.00458933682391132,-0.0402231767786693,-0.0222329764289369,1.04996961488988e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGB3A1,Secretoglobin family 3A member 1,37124,-0.015570377521201,0.0022941056860034,-0.0200668246657676,-0.0110739303766343,1.19253143327207e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BPIFA2,BPI fold-containing family A member 2,36593,-0.0689962982164096,0.0101923639608728,-0.0889733315797203,-0.0490192648530988,1.34977426294193e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX5,Sorting nexin-5,37043,0.019284340822151,0.00285045507450982,0.0136974488761118,0.0248712327681903,1.38597037587043e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCTS1,Malignant T-cell-amplified sequence 1,37382,0.015809484037433,0.00233702922869601,0.0112289067491888,0.0203900613256772,1.39004824952088e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA2,Annexin A2,36879,0.0440809248604662,0.00652085719501012,0.0313000447582464,0.056861804962686,1.43884359051183e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSHB,Thyrotropin subunit beta,39868,0.0471991805315969,0.00699929934302285,0.0334805538192722,0.0609178072439217,1.59998989746202e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFDC1,WAP four-disulfide core domain protein 1,37123,0.0331877660935758,0.00492142763995634,0.0235417679192614,0.0428337642678902,1.60993686462146e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AFAP1,Actin filament-associated protein 1,37124,0.0535490464822801,0.00795244372177868,0.0379622567875939,0.0691358361769664,1.72261066679216e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH1,Protocadherin-1,40018,0.0130689528757286,0.00194443586315207,0.00925785858395057,0.0168800471675067,1.86255184307942e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MDM1,Nuclear protein MDM1,37039,0.0196741747892727,0.00293012838719739,0.0139311231503658,0.0254172264281796,1.96524344084102e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COPB2,Coatomer subunit beta',37021,0.026875625991298,0.00400983905671298,0.0190163414401406,0.0347349105424554,2.13347598205991e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYGD,Gamma-crystallin D,37388,0.0604645303210446,0.00902770509224451,0.0427702283402453,0.0781588323018438,2.20144767677238e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAPG,Macrophage-capping protein,39739,0.0363441103007564,0.00543196802900201,0.0256974529639125,0.0469907676376004,2.29403829348824e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXN,Thioredoxin,37289,0.0269957836005875,0.0040425068307242,0.0190724702123681,0.034919096988807,2.51786313301086e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMARCA2,Probable global transcription activator SNF2L2,39489,0.0460126707483525,0.00689249051291133,0.0325033893430463,0.0595219521536587,2.54221847771566e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37043,0.0266329454131096,0.0039914910285764,0.0188096229970998,0.0344562678291193,2.61653611737067e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39587,0.0223352027394722,0.00335280542560712,0.0157637041052822,0.0289067013736621,2.79762282037031e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PZP,Pregnancy zone protein,37453,0.0342965109923474,0.00515788776793237,0.0241870509672,0.0444059710174948,3.05670639919372e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTUS1,Microtubule-associated tumor suppressor 1,37169,0.0347607357105447,0.00522823222647421,0.0245134005466553,0.0450080708744342,3.07311992419215e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMS,Spermine synthase,36991,0.0399193485889689,0.0060050123392481,0.0281495244040426,0.0516891727738952,3.09534691398299e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCAN,Brevican core protein,39749,0.02065779451898,0.00311513780468848,0.0145521244217905,0.0267634646161694,3.43189285522188e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCOF1,Treacle protein,37437,0.0189010080309081,0.0028500827727033,0.0133148457964097,0.0244871702654066,3.44305730165207e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POSTN,Periostin,37437,-0.0230277601040249,0.00348067584648327,-0.0298498847631321,-0.0162056354449176,3.83171495326752e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37382,0.0640224471301853,0.0096840417622837,0.0450417252761092,0.0830031689842613,3.95713520255698e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLO1,Lactoylglutathione lyase,39585,0.0356773946525385,0.00541747306505024,0.02505914744504,0.0462956418600369,4.67367463623881e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40030,0.0155202486465575,0.00235685782752393,0.0109008073046106,0.0201396899885044,4.68446650813872e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPNMB,Transmembrane glycoprotein NMB,39444,0.0173406633956372,0.00264077964849325,0.0121647352845904,0.022516591506684,5.31430936938607e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37039,0.0334300202792984,0.00509380605548165,0.0234461604105544,0.0434138801480425,5.47541900082145e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,37437,0.0136782670463222,0.00208768823082437,0.00958639811390639,0.0177701359787379,5.88688456251908e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37368,0.0328058366052245,0.00500933242438387,0.0229875450534321,0.0426241281570169,6.00418991161507e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39866,0.0226120279942802,0.00345393171324316,0.0158423218363236,0.0293817341522368,6.0591285197914e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRH,Corticoliberin,39455,0.0531453788398756,0.00813462675010893,0.0372015104096621,0.0690892472700891,6.63604345309081e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA9,Serpin A9,39715,0.0444245627560258,0.00680691708593916,0.0310830052675851,0.0577661202444666,6.94197400222305e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39749,0.0178080808398022,0.00272983596484368,0.0124576023487086,0.0231585593308959,7.07614933960622e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX2,Sorting nexin-2,37368,0.0492322609969526,0.00754983390325939,0.0344345865465642,0.064029935447341,7.23375154281361e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,37043,-0.0369288844222665,0.00566465110055373,-0.0480316005793518,-0.0258261682651812,7.32670742351884e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37056,0.0278247895764237,0.00427156020698294,0.0194525315707372,0.0361970475821103,7.58476149471473e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP3,Stromelysin-1,39858,-0.0290319203161522,0.00445885089652997,-0.0377712680733509,-0.0202925725589534,7.68361064522748e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ROBO1,Roundabout homolog 1,39885,0.0143727098776449,0.00220788778952101,0.0100452498101837,0.018700169945106,7.75325841390948e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP9,Fatty acid-binding protein 9,39866,0.0335541975566442,0.0051695001614888,0.0234219772401261,0.0436864178731622,8.78913409351699e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPTX1,Neuronal pentraxin-1,39858,0.0247955162125733,0.0038207352941465,0.0173068750360461,0.0322841573891004,8.85218201669072e-11
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENSA,Alpha-endosulfine,37368,0.0318331382361855,0.00492073572305318,0.0221884962190012,0.0414777802533697,1.01929909392322e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST5,Cystatin-D,39559,0.0328401898587726,0.00507842672896559,0.02288647347,0.0427939062475452,1.03188796522269e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,39868,0.0162094116333269,0.0025081453452238,0.0112934467566882,0.0211253765099655,1.05817225190525e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEPH,Hephaestin,37437,0.0158931502692344,0.00246412677085902,0.0110634617983507,0.020722838740118,1.15784030469496e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GDF15,Growth/differentiation factor 15,40052,-0.0255333882051167,0.00396627668985229,-0.0333072905172272,-0.0177594858930062,1.24773562143672e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39477,0.0308460984745793,0.00479239351099377,0.0214530071930315,0.0402391897561271,1.25848858720457e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN3,CCN family member 3,40042,0.0194698624372757,0.00302772850941659,0.0135355145588192,0.0254042103157322,1.30733329542555e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLITRK1,SLIT and NTRK-like protein 1,37056,0.0192476658544623,0.002992859692568,0.0133816608570291,0.0251136708518956,1.30968353826131e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37043,0.0422152804980944,0.0065684388734146,0.0293411403062018,0.055089420689987,1.34636211069965e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37368,0.0220244504831737,0.00342699063317386,0.0153075488421529,0.0287413521241944,1.34727380928566e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FES,Tyrosine-protein kinase Fes/Fps,39477,0.0284530765028005,0.00442963167732534,0.0197709984152428,0.0371351545903582,1.37162323712905e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QL2,Complement C1q-like protein 2,37056,0.0252621655258827,0.00393293946000281,0.0175536041842771,0.0329707268674882,1.37991083227738e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39858,0.0225927095525775,0.00351806765522518,0.0156972969483362,0.0294881221568189,1.38370756724295e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHCHD6,MICOS complex subunit MIC25,37368,0.0174734194817047,0.00272152579195195,0.0121392289294789,0.0228076100339305,1.40415985741733e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELENOP,Selenoprotein P,37453,0.0133646132676246,0.00208272002176757,0.00928248202496015,0.017446744510289,1.43685148638369e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMPRSS11D,Transmembrane protease serine 11D,37357,0.0217001192589368,0.00339065983639248,0.0150544259796075,0.0283458125382661,1.60543750239293e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RANBP1,Ran-specific GTPase-activating protein,37043,0.0313317685253345,0.00489618030591373,0.0217352551257436,0.0409282819249254,1.61448668744473e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NADK,NAD kinase,39868,0.0319165594080017,0.00499091600833399,0.0221343640316671,0.0416987547843363,1.65072128807452e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39858,0.0215801013288747,0.00337728036426102,0.0149606318149231,0.0281995708428263,1.70709239010312e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD74,HLA class II histocompatibility antigen gamma chain,40009,0.0202269954381775,0.00316678442916368,0.0140200979570167,0.0264338929193383,1.73530046949564e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPC1,Glypican-1,40030,0.017266391458235,0.00271222587201573,0.0119504287490842,0.0225823541673858,1.99076751032331e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39477,0.0480564182224752,0.00757039678445842,0.0332184405249367,0.0628943959200137,2.24240839538734e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LBP,Lipopolysaccharide-binding protein,39931,-0.0343815919945501,0.00541712356936028,-0.0449991541904963,-0.023764029798604,2.25677419303158e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN4B,Sodium channel subunit beta-4,37043,0.0246143655082069,0.00387859678177461,0.0170123158159287,0.0322164152004852,2.27916338423212e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMOX1,Heme oxygenase 1,39691,-0.0282298264122328,0.00445318109591592,-0.036958061360228,-0.0195015914642376,2.37137966509872e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICOSLG,ICOS ligand,39788,0.0111648166528254,0.00176568230387051,0.00770407933723924,0.0146255539684116,2.62973973352651e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIGR,Polymeric immunoglobulin receptor,39677,0.0215036903327915,0.00340333080581241,0.0148331619533991,0.0281742187121838,2.71310437003348e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CR1,Complement receptor type 1,37420,0.0210871950694407,0.00333836277630624,0.0145440040278805,0.0276303861110009,2.75679801716895e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39453,0.0277249831240202,0.00439176937551033,0.0191171151480199,0.0363328511000204,2.81185016370052e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRELP,Prolargin,39862,0.0130741618435668,0.00207470681403665,0.00900773648805499,0.0171405871990786,3.02116827863105e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPP1,Tripeptidyl-peptidase 1,39767,0.0273961289775332,0.0043534037323605,0.0188634576621066,0.0359288002929598,3.19463490556837e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBLIF,Cobalamin binding intrinsic factor,39846,0.040311893157557,0.00641326668853387,0.0277418904480306,0.0528818958670834,3.34833150877025e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APRT,Adenine phosphoribosyltransferase,39738,0.0282473647729845,0.00450286697682566,0.0194217454984062,0.0370729840475628,3.6287271980386e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLSTN3,Calsyntenin-3,37388,0.0177303773579243,0.00283515875091053,0.0121734662061396,0.0232872885097089,4.12764080552637e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIF1C,Kinesin-like protein KIF1C,37021,0.0214039686054278,0.00343206404001907,0.0146771230869904,0.0281308141238652,4.61245196450061e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFA,Protransforming growth factor alpha,39866,0.0267140195419102,0.00428864354231962,0.0183082781989637,0.0351197608848566,4.81106271693868e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",37043,0.036987836594578,0.0059443442500181,0.0253369218645425,0.0486387513246134,5.04564176512593e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBS,Cystathionine beta-synthase,37043,0.0295855204202078,0.00477251347345874,0.0202313940122287,0.0389396468281869,5.84627056806787e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UMOD,Uromodulin,40012,-0.0305458578917761,0.00493051349349008,-0.0402096643390167,-0.0208820514445356,5.95952371306625e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNLIP,Pancreatic triacylglycerol lipase,37445,0.0355176168236253,0.00573654336391972,0.0242739918303426,0.0467612418169079,6.1323199386381e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH5,Cadherin-5,40052,-0.0176294851290875,0.00285215843173366,-0.0232197156552855,-0.0120392546028895,6.51797920998555e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPE,Ribulose-phosphate 3-epimerase,37169,0.0411721624727779,0.0066627102864526,0.0281132503113308,0.054231074634225,6.6184411751138e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFIC,Nuclear factor 1 C-type,37411,0.024250770845292,0.00392998610888623,0.016547998071875,0.031953543618709,6.99243273396596e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSE,Cathepsin E,37124,0.0305569711655046,0.00495268726249507,0.0208497041310143,0.0402642381999949,7.03762773567571e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LCP1,Plastin-2,37437,0.0270924184528739,0.00439550192765573,0.0184772346746686,0.0357076022310791,7.30901440356391e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFAP4,Microfibril-associated glycoprotein 4,37124,-0.0182584728300038,0.00298578690537561,-0.02411061516454,-0.0124063304954676,9.91884800865869e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1B,Interleukin-1 beta,39478,0.0319020389074047,0.00521785868155388,0.0216750358915591,0.0421290419232503,9.9470021748487e-10
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39904,0.0289843625466002,0.00475020589231517,0.0196739589976625,0.0382947660955379,1.07352575336042e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL6A3,Collagen alpha-3(VI) chain,40052,0.0182617054065169,0.00299451562943954,0.0123924547728154,0.0241309560402184,1.09579659993382e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,37411,0.0152544066334302,0.00250500707068421,0.0103445927748891,0.0201642204919712,1.16277640517048e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,39809,0.0196728964940594,0.00323475155896748,0.0133327834384832,0.0260130095496357,1.21602411891896e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLPS,Colipase,39836,0.03932248714308,0.00647450376490951,0.0266324597638574,0.0520125145223026,1.2803762579415e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSB,Cathepsin B,39847,-0.0291683481160167,0.00480291293241269,-0.0385820574635456,-0.0197546387684879,1.28340623341571e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39489,0.0171880609277458,0.00283344182076401,0.0116345149590483,0.0227416068964432,1.34039213717934e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,37056,0.0217581573062907,0.00359971031819402,0.0147027250826304,0.028813589529951,1.53992867034695e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPA2,Carboxypeptidase A2,39933,0.0363632084138891,0.0060279263288985,0.024548472809248,0.0481779440185302,1.65024989968262e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RABEPK,Rab9 effector protein with kelch motifs,39477,0.0338626633117709,0.00562290240061613,0.0228417746065633,0.0448835520169785,1.75838133552884e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MST1,Hepatocyte growth factor-like protein,37271,0.035573511575995,0.00591289829935882,0.0239842309092518,0.0471627922427383,1.83145685266647e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MENT,Protein MENT,37124,-0.0124938630344533,0.00208400143722331,-0.016578505851411,-0.00840922021749556,2.08601500349186e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SRPX,Sushi repeat-containing protein SRPX,37437,-0.019149139060501,0.0031943867900514,-0.0254101371690017,-0.0128881409520002,2.09132494056329e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37043,0.0156781950205735,0.00261931748995165,0.0105443327402682,0.0208120573008787,2.2118853482556e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD14,Monocyte differentiation antigen CD14,39564,0.0229459050787616,0.00383841484662906,0.0154226119793686,0.0304691981781545,2.30836510607562e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA6,Corticosteroid-binding globulin,37453,0.00986388217473121,0.00164998190623809,0.00662991763850456,0.0130978467109579,2.3130390129934e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL15,C-C motif chemokine 15,40052,0.0242175988806779,0.00405551043379012,0.0162687984304492,0.0321663993309065,2.39953970495398e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCAM1,Neural cell adhesion molecule 1,39931,0.0167282791056626,0.00280243234899666,0.0112355117016292,0.0222210465096961,2.43434527354206e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,37362,0.0226666588204859,0.00380616942345021,0.0152065667505234,0.0301267508904483,2.66140463185527e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39931,0.0230981877671869,0.00387936330061017,0.015494635697991,0.0307017398363829,2.6692304161306e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VAMP5,Vesicle-associated membrane protein 5,39585,0.0294300329124215,0.00494683191722866,0.0197342423546534,0.0391258234701897,2.75058259686021e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAG3,Lymphocyte activation gene 3 protein,39788,-0.0226093050628844,0.00380533765845233,-0.0300677668734509,-0.0151508432523178,2.88361379667342e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRL,Prolactin,40009,-0.0421193974423744,0.00709151967842618,-0.0560187760120897,-0.0282200188726591,2.91931678816025e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH17,Cadherin-17,39868,-0.036886756618242,0.00621096952770406,-0.049060256892542,-0.0247132563439421,2.92756780218499e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40058,0.0190454561458089,0.00321124071545401,0.012751424343519,0.0253394879480988,3.07461523217767e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITM2A,Integral membrane protein 2A,39866,-0.0326201931619787,0.00552546370038166,-0.0434501020147268,-0.0217902843092307,3.62819686849555e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37056,0.0180802659954047,0.00306770876140152,0.0120675568230578,0.0240929751677517,3.8677665774286e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,37021,0.054525720115326,0.00925194692260882,0.0363919041470127,0.0726595360836393,3.87512465386176e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDGFRB,Platelet-derived growth factor receptor beta,40052,0.0192195471226988,0.00326164552954247,0.0128267218847955,0.025612372360602,3.87727109009455e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,37437,0.0324871052325074,0.00551564080169856,0.0216764492611782,0.0432977612038366,3.95341395551455e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,37265,0.0304537924978952,0.00517240636745111,0.0203158760176911,0.0405917089780994,4.00877573457929e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL34,Interleukin-34,39456,0.0196830439935003,0.00334517413076422,0.0131265026972024,0.0262395852897981,4.08643734306337e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCN5,CCN family member 5,39858,0.0211371144612283,0.00360014900915183,0.0140808224032907,0.0281934065191659,4.41277367774969e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNGR2,Interferon gamma receptor 2,39749,0.0285946264470835,0.00487297573076862,0.019043594014777,0.0381456588793899,4.49855197034219e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD93,Complement component C1q receptor,39238,-0.0168748089774963,0.00287827841939465,-0.0225162346795098,-0.0112333832754827,4.64414136387028e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HLA_E,,39866,0.0149637626583542,0.00255949751014604,0.00994714753846797,0.0199803777782404,5.12202269271146e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REN,Renin,39868,-0.0359916726378667,0.00616364885314226,-0.0480724243900255,-0.0239109208857078,5.34214459826093e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300LF,CMRF35-like molecule 1,40030,0.0325949103742196,0.00558602787649485,0.0216462957362897,0.0435435250121495,5.47931672317123e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAGA,Alpha-N-acetylgalactosaminidase,37037,0.0329934747891148,0.0056551174822599,0.0219094445238854,0.0440775050543442,5.52961292320229e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL4,Angiopoietin-related protein 4,39908,-0.0246095267882968,0.00423098344058673,-0.0329022543318468,-0.0163167992447468,6.12347819048497e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LUZP2,Leucine zipper protein 2,37368,0.023782732042198,0.00409446324713794,0.0157575840778076,0.0318078800065883,6.44502460636626e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPR15L,Protein GPR15L,37382,0.0333572985600424,0.00575403097560174,0.022079397847863,0.0446351992722218,6.8934115047637e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,37411,0.0284081162839984,0.00491075861372167,0.018783029401104,0.0380332031668929,7.41696871314689e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,39477,0.0219572730175478,0.0037969542920247,0.0145152426051794,0.0293993034299162,7.48428379515855e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39866,0.0237651497899355,0.0041111435141319,0.015707308502237,0.031822991077634,7.57905173537582e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRSF1,G-rich sequence factor 1,36874,0.0438697861390715,0.0075903148688063,0.0289927689962111,0.0587468032819318,7.65469144368807e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSDE1,Cold shock domain-containing protein E1,37021,0.0648779245553168,0.0112417213718302,0.0428441506665295,0.086911698444104,8.04953697129549e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,40058,0.0197967421721067,0.00343181493506787,0.0130703848993737,0.0265230994448397,8.13947667753395e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINI2,Serpin I2,37382,0.0309501670527778,0.0053669297241132,0.0204309847935159,0.0414693493120397,8.25428875350078e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39587,0.0322341512785135,0.0055923728895654,0.0212731004149653,0.0431952021420616,8.37079078593619e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPTXR,Neuronal pentraxin receptor,39868,0.0183082188340254,0.00317951910386334,0.0120763613904532,0.0245400762775975,8.65884063387131e-09
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39908,0.0480286558674436,0.00838926874760045,0.0315856891221467,0.0644716226127404,1.05276083299627e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39585,0.0303171255561269,0.00530722124826511,0.0199149719095273,0.0407192792027265,1.13389662211042e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFRP4,Secreted frizzled-related protein 4,37124,0.0222314998250555,0.00389259865539005,0.014602006460491,0.02986099318962,1.14574143561977e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRSS22,Brain-specific serine protease 4,37056,0.0180010947018847,0.00315397521016211,0.0118193032899669,0.0241828861138024,1.1716207583875e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DIPK2B,Divergent protein kinase domain 2B,37124,0.0151779117092068,0.00265960779098305,0.00996508043887998,0.0203907429795335,1.17566874344757e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSH,Pro-cathepsin H,39546,0.0385737124502717,0.0067708326287417,0.025302880497938,0.0518445444026055,1.24092143532742e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGSF21,Immunoglobulin superfamily member 21,37043,0.0210509460309609,0.00370429351913271,0.0137905307334608,0.028311361328461,1.35273178756184e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTT2B,Glutathione S-transferase theta-2B,37388,0.127303011747308,0.022412789022725,0.0833739452627672,0.171232078231849,1.37526447590953e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,37021,0.02351902750376,0.00414879757542729,0.0153873842559225,0.0316506707515975,1.4675511728664e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBP2,Retinol-binding protein 2,39788,-0.0405279269224669,0.00715793845572592,-0.0545574862956897,-0.0264983675492442,1.52239285528352e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MUC2,Mucin-2,37437,0.0478405930210358,0.00844910004492425,0.0312803569329843,0.0644008291090873,1.52462512554976e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39858,-0.018428796146816,0.00325723166764212,-0.0248129702153945,-0.0120446220782374,1.55942522371279e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEPE,Matrix extracellular phosphoglycoprotein,39862,0.0130426014181052,0.00230867966446148,0.00851758927576073,0.0175676135604497,1.63771157928327e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRD1,Bromodomain-containing protein 1,37169,-0.0162576955495552,0.00288163459560086,-0.0219056993569328,-0.0106096917421775,1.71681073164272e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPQ,Carboxypeptidase Q,37430,0.0199483061691666,0.00353686311797752,0.0130160544579306,0.0268805578804025,1.73332100445076e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYZL2,Lysozyme-like protein 2,36962,0.0190938474756832,0.00338543948710428,0.0124583860809588,0.0257293088704076,1.73576799113389e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CILP,Cartilage intermediate layer protein 1,37437,0.0283728289709748,0.005036433402535,0.0185014195020062,0.0382442384399434,1.80079524403599e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL3,Fc receptor-like protein 3,39587,0.0274081922849238,0.00487894305698645,0.0178454638932304,0.0369709206766173,1.96852030599645e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DHPS,Deoxyhypusine synthase,37368,0.0215541630570553,0.00383913731308783,0.0140294539234032,0.0290788721907075,2.01219275569146e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPM3,Tropomyosin alpha-3 chain,37021,-0.0233646268288589,0.00416362636194439,-0.0315253344982699,-0.0152039191594479,2.04505230736179e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGFR4,Fibroblast growth factor receptor 4,37124,0.027732475866435,0.00494726115103612,0.0180358440104042,0.0374291077224658,2.11647318103329e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEZ6L,Seizure 6-like protein,39913,0.0141075977881423,0.00252069009249328,0.00916704520685549,0.0190481503694291,2.2201707228111e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDC,Aromatic-L-amino-acid decarboxylase,39846,-0.0254360123354936,0.00454612325613966,-0.0343464139175273,-0.0165256107534599,2.24112391870644e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMG3,Proteasome assembly chaperone 3,39866,0.0259753152943688,0.00464553212589714,0.0168700723276105,0.0350805582611272,2.28845692941526e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DGCR6,Protein DGCR6,36991,0.0226082928817384,0.00405844993792564,0.0146537310034041,0.0305628547600726,2.58748202311917e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFHD1,EF-hand domain-containing protein D1,37411,0.0180129348632791,0.00323393125668397,0.0116744296001785,0.0243514401263797,2.59617805146542e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39755,0.012532414778155,0.00225223155939993,0.00811804092173111,0.0169467886345788,2.67237626360321e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIMAP8,GTPase IMAP family member 8,36962,0.0258815108660668,0.00465446236921427,0.0167587646224068,0.0350042571097268,2.7414034570677e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,37039,0.0403719503761074,0.00726758942715522,0.0261274750988831,0.0546164256533316,2.8288118924144e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPL14,60S ribosomal protein L14,37043,0.021041957890559,0.00378836457220115,0.0136167633290447,0.0284671524520732,2.84017623814603e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKD2,Serine/threonine-protein kinase D2,37021,0.0238223826836788,0.00429024493698255,0.015413502607193,0.0322312627601646,2.86762210069478e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NELL2,Protein kinase C-binding protein NELL2,39931,0.0145964590031997,0.0026354444006384,0.00943098797794848,0.019761930028451,3.09823689235197e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDA,Cytidine deaminase,37422,0.0240445684781874,0.0043444895982649,0.0155293688655882,0.0325597680907866,3.17911918397891e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36962,-0.0157982610181597,0.00286019751661927,-0.0214042481507335,-0.010192273885586,3.38673178762114e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLMP,CXADR-like membrane protein,40030,0.0105372201350111,0.00191627480505244,0.00678132151710827,0.0142931187529139,3.88169428156926e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RSPO3,R-spondin-3,40030,0.0138546021597797,0.00252151007130522,0.0089124424200215,0.018796761899538,3.97590875176934e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,37411,0.0194796113636363,0.00355012801770955,0.0125213604489255,0.026437862278347,4.16117382629996e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPR,Nucleoprotein TPR,37021,0.0242321990823909,0.00441758399440464,0.0155737344533578,0.032890663711424,4.20161994364597e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YAP1,Transcriptional coactivator YAP1,37388,0.013116881482502,0.0023917546879666,0.00842904229408751,0.0178047206709166,4.22778612865451e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFNA1,Ephrin-A1,39826,0.0135189952738362,0.00246605121978347,0.00868553488306056,0.0183524556646118,4.26821962910011e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KITLG,Kit ligand,39868,-0.0189866884073298,0.00346569191334479,-0.0257794445574856,-0.012193932257174,4.35492748865293e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPTLC1,Serine palmitoyltransferase 1,37388,0.0183579852232357,0.00335237683303064,0.0117873266304956,0.0249286438159757,4.4253496967831e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CABP2,Calcium-binding protein 2,37039,0.0337509780684875,0.00616491845968244,0.0216677378875099,0.0458342182494651,4.46315414984787e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AK1,Adenylate kinase isoenzyme 1,39868,0.0320380700165975,0.00585734315940979,0.0205576774241543,0.0435184626090407,4.57486603232913e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39858,0.0244484710600395,0.00447037644247072,0.0156865332327969,0.0332104088872821,4.59378689926696e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALB1,Calbindin,39788,0.0213912867290673,0.00392605685980679,0.013696215283846,0.0290863581742886,5.15381214705312e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTF3,Neurotrophin-3,39866,0.0171340479248697,0.00314702664440696,0.0109658757018321,0.0233022201479074,5.27104565668613e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECM1,Extracellular matrix protein 1,37106,0.0184217388672852,0.00339469822276182,0.011768130350672,0.0250753473838983,5.84413610117656e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GM2A,Ganglioside GM2 activator,37178,0.0183487887843284,0.00338723428235887,0.011709809590905,0.0249877679777518,6.16460964822808e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VASN,Vasorin,39642,0.0138323932791734,0.00255705366507397,0.00882056809562846,0.0188442184627184,6.41199787087638e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD86,T-lymphocyte activation antigen CD86,37382,0.0148451580262443,0.00274767786268411,0.00945970941538345,0.0202306066371052,6.67192181129015e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRC25,Leucine-rich repeat-containing protein 25,39788,0.0196393721056305,0.00363566500310399,0.0125134686995467,0.0267652755117143,6.68981317244284e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYOM2,Myomesin-2,37021,-0.0260717872699051,0.00483371019305484,-0.0355458592482926,-0.0165977152915177,7.01982923403736e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSN,Gelsolin,37383,0.00940479561593985,0.00174709420503328,0.00598049097407463,0.0128291002578051,7.44331371605044e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTA,Lymphotoxin-alpha,39866,0.0198650090459715,0.00369143115814359,0.01262980397601,0.0271002141159329,7.49554698100923e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40058,0.0180255968136653,0.00337647926965062,0.01140769744515,0.0246434961821805,9.49412649899676e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM3,Intercellular adhesion molecule 3,40052,-0.0126445200215766,0.00236945882991529,-0.0172886593282105,-0.00800038071494259,9.60552895939538e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSPA2,Heat shock-related 70 kDa protein 2,37368,0.0169061181388076,0.0031687866962361,0.0106952962141848,0.0231169400634304,9.69785619003212e-08
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ODAM,Odontogenic ameloblast-associated protein,39456,0.0254951839369562,0.00478864649495353,0.0161094368068473,0.0348809310670651,1.02865481395836e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,37365,0.0209128326427565,0.00393055905918526,0.0132089368867534,0.0286167283987596,1.05092259934679e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA7,Thyroxine-binding globulin,37453,0.00922933984920229,0.00173922077035948,0.0058204671392977,0.0126382125591069,1.13446429870699e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST1,Cystatin-SN,35640,0.050203304292366,0.00946461992721839,0.0316526492350179,0.068753959349714,1.15146666613581e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37169,0.018870258945862,0.00356115921479464,0.0118903868848645,0.0258501310068595,1.1835517897575e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LY96,Lymphocyte antigen 96,39749,-0.0175042544496712,0.00330680774019401,-0.0239855976204514,-0.0110229112788909,1.21659492040801e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CX3CL1,Fractalkine,39749,-0.0164272526880719,0.00310581825245597,-0.0225146564628856,-0.0103398489132583,1.24489818080509e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,37043,-0.0128410246217798,0.00243358688936354,-0.0176108549249323,-0.00807119431862728,1.33699852865905e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC14A,C-type lectin domain family 14 member A,39858,-0.0148983005637485,0.00282746159101369,-0.0204401252821354,-0.00935647584536171,1.38839574503413e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37382,-0.0144881967463415,0.00276463105163207,-0.0199068736075404,-0.00906951988514268,1.62503233861484e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTB,Lymphotoxin-beta,37368,0.016763135257117,0.00320125121036761,0.0104886828847965,0.0230375876294375,1.66167144666869e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MUC16,Mucin-16,39788,0.0912548621493649,0.0174306116551855,0.0570908633052013,0.125418860993529,1.66790111009233e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRCAM,Neuronal cell adhesion molecule,39868,0.0135521803941269,0.00258905500215574,0.00847763258990162,0.0186267281983521,1.67601820789242e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,39788,0.0100962060876989,0.00194022107908285,0.00629337277269648,0.0138990394027013,1.97850602590338e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37043,0.0296697093007395,0.0057118790929766,0.0184744262785054,0.0408649923229736,2.08457086430911e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37388,0.0301223862463993,0.00580439574659762,0.018745770583068,0.0414990019097307,2.13816793587756e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK4,Kallikrein-4,40030,-0.0291862508605465,0.00563058037656782,-0.0402221883986195,-0.0181503133224736,2.20353094487033e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADA2,Adenosine deaminase 2,39782,-0.0199687927961939,0.00385988504231498,-0.0275341674791313,-0.0124034181132566,2.32641307424883e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RCOR1,REST corepressor 1,39585,0.0217714779362582,0.00420980930403334,0.0135202517003529,0.0300227041721635,2.3493783365224e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BMP4,Bone morphogenetic protein 4,39720,-0.0222360549488411,0.00430160990917966,-0.0306672103708333,-0.013804899526849,2.37902288618581e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA7,Carbonic anhydrase 7,37169,-0.0162951740901759,0.00315398933668813,-0.0224769931900846,-0.0101133549902672,2.4193032487798e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APLP1,Amyloid-like protein 1,39868,-0.0246513616095021,0.00478914666154298,-0.0340380890661263,-0.0152646341528778,2.6733454741862e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCD1,Programmed cell death protein 1,39998,0.0197140793952324,0.00383026045144775,0.0122067689103948,0.02722138988007,2.67892717899026e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPA4,Carboxypeptidase A4,36868,0.0209935807390044,0.00408979578998741,0.012977580990629,0.0290095804873797,2.89025892570289e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,38022,-0.0147172480345432,0.00287415948395576,-0.0203506006230965,-0.00908389544598988,3.08658801200115e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSF,Cathepsin F,39913,0.0193644749340144,0.0037865430933818,0.0119428504709861,0.0267860993970427,3.18995409229204e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37453,0.00892989899975712,0.00174687228051163,0.00550602932995433,0.0123537686695599,3.2320475852711e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL2,Apoptosis regulator Bcl-2,37382,0.0242296611202794,0.0047428625735808,0.0149336504760611,0.0335256717644978,3.28874287315573e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37043,0.0177911280331959,0.00348402209566415,0.0109624447256941,0.0246198113406976,3.3277357310815e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL2,Fc receptor-like protein 2,39990,0.0220965061948594,0.00433003340352652,0.0136096407239474,0.0305833716657714,3.3796551902942e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39809,-0.0312968803563916,0.00613810665307276,-0.0433275693964142,-0.019266191316369,3.45756445133985e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PFDN2,Prefoldin subunit 2,39489,0.0265651013229972,0.00522169171618383,0.0163305855592769,0.0367996170867175,3.67112320216663e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40009,-0.0211748350980888,0.00416582702708967,-0.0293398560711845,-0.013009814124993,3.75700752951906e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYL3,Myosin light chain 3,37043,-0.0346035971096486,0.00681876846641624,-0.0479683833038244,-0.0212388109154728,3.93272444158474e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB8,Serpin B8,40058,0.0261256430648418,0.00515095361140957,0.0160297739864791,0.0362215121432046,3.98001936675828e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37021,0.0226901991396675,0.0044738931546895,0.0139213685564761,0.0314590297228589,3.99662792175147e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA3,Alpha-1-antichymotrypsin,37407,0.00687883489049137,0.0013568604478343,0.00421938841273614,0.00953828136824661,4.03764020859755e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANGPTL1,Angiopoietin-related protein 1,39617,0.0138147584055601,0.00273629617450312,0.00845161790353396,0.0191778989075862,4.49771586606308e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRISP3,Cysteine-rich secretory protein 3,37325,-0.0126827482372234,0.00251834129643371,-0.0176186971782335,-0.00774679929621336,4.8113022511402e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHCY,Adenosylhomocysteinase,39868,0.0318973245042662,0.00633939009996521,0.0194721199083344,0.044322529100198,4.91653999708766e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37437,0.0254426347981085,0.0050580228265286,0.0155289100581125,0.0353563595381046,4.96344802065023e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NECTIN2,Nectin-2,39846,0.0132567981917166,0.00263791877519015,0.00808647739234396,0.0184271189910893,5.07608168398309e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTSL4,ADAMTS-like protein 4,37043,0.0113816849996315,0.00226643489524071,0.00693947260495972,0.0158238973943033,5.18464109288976e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,37388,0.0142316870977362,0.00284127236774519,0.00866279325695566,0.0198005809385168,5.54284389198577e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX58,Antiviral innate immune response receptor RIG-I,39477,0.026741182366731,0.00534620122835729,0.0162626279591507,0.0372197367743113,5.73833105613373e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGR,Tyrosine-protein kinase Fgr,39489,0.0263586538535895,0.00527680676002958,0.0160161126039315,0.0367011951032475,5.94121028088876e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAX,Apoptosis regulator BAX,39456,0.0427760019852812,0.00856386246455393,0.0259908315547555,0.0595611724158069,5.94896109334392e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,37437,-0.0153501697461919,0.00307843386333586,-0.0213839001183302,-0.0093164393740536,6.22880894079523e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLSTN2,Calsyntenin-2,40058,-0.0183536893542662,0.00368540951520024,-0.0255770920040586,-0.0111302867044737,6.42070311822516e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRTG,Protogenin,40030,0.0115795620242155,0.0023298868005443,0.00701298389514869,0.0161461401532824,6.76339507817692e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD28,T-cell-specific surface glycoprotein CD28,39477,0.0163351683351945,0.00329551798559924,0.00987595308342002,0.0227943835869691,7.24211057880169e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DKK3,Dickkopf-related protein 3,40052,-0.0133003778954313,0.00268800795120789,-0.0185688734797988,-0.00803188231106384,7.57160978145955e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAS2,Growth arrest-specific protein 2,37169,0.0245275122748261,0.00496121769893944,0.0148035255849048,0.0342514989647474,7.75282480865313e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DSG3,Desmoglein-3,39964,0.0153970720511311,0.00312052620795565,0.00928084068353802,0.0215133034187242,8.13140282437064e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39749,-0.0129489762980053,0.00263480394713611,-0.0181131920343921,-0.00778476056161853,8.98560106243217e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXNB2,Plexin-B2,39984,0.0108410452773317,0.0022100867030961,0.00650927533926332,0.0151728152154,9.42142803700455e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,37368,0.0190065698316241,0.00387781017053535,0.0114060618973748,0.0266070777658734,9.62771416064059e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,37368,0.0203678029574672,0.00415825160490947,0.0122176298118446,0.0285179761030897,9.78559968062453e-07
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39749,0.0319666229213591,0.00656278399472201,0.019103566291704,0.0448296795510142,1.12164289865678e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTF4,Neurotrophin-4,39477,0.0181187053003488,0.00372139511158861,0.0108247708816351,0.0254126397190625,1.133796785215e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACTN2,Alpha-actinin-2,37021,-0.0269892358740269,0.00554303415126868,-0.0378535828105135,-0.0161248889375403,1.13446353747739e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THBS4,Thrombospondin-4,39892,0.0203373032478578,0.00418172061259901,0.0121411308471637,0.0285334756485519,1.164916355615e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLSTN1,Calsyntenin-1,39489,0.0228805505746494,0.00471082121423742,0.013647340994744,0.0321137601545547,1.20319602848285e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,37043,0.0133918597184835,0.00275845486936244,0.00798528817453314,0.0187984312624339,1.21864919909693e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37437,0.0121306559721489,0.00250512485098743,0.00722061126421358,0.0170407006800843,1.29735950320917e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,39794,0.0155918059122888,0.00322535212748551,0.00927011574241724,0.0219134960821604,1.34968856769712e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LGALS4,Galectin-4,39862,-0.0238416135415373,0.00493618395189201,-0.0335165340872456,-0.014166692995829,1.37818190010459e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP2,"Fatty acid-binding protein, intestinal",39868,-0.0350754734484075,0.00728017729074119,-0.0493446209382602,-0.0208063259585547,1.46375200006336e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTPN,Myotrophin,39585,0.0146408293249536,0.00303893557689647,0.00868451559423648,0.0205971430556706,1.46540667899598e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA12,Serpin A12,39405,0.0531520109004223,0.011046206762514,0.0315014456458948,0.0748025761549498,1.50990031586913e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,39858,-0.0151272413809761,0.00314764237680531,-0.0212966204395145,-0.00895786232243771,1.55458814984048e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FEN1,Flap endonuclease 1,39477,0.0280207272758481,0.0058378091350165,0.0165786213712158,0.0394628331804804,1.60237958246086e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37043,0.0161688372435258,0.00338039463930086,0.00954326375049615,0.0227944107365555,1.74462428268206e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17C,Interleukin-17C,39587,-0.0296961634858387,0.00621776343849913,-0.0418829798252969,-0.0175093471463804,1.80410599679126e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BSG,Basigin,40040,0.00868935767725922,0.00181952036814737,0.00512309775569037,0.0122556175988281,1.80714088922822e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAA4,Serum amyloid A-4 protein,37453,0.0147794170590108,0.00309500441670826,0.00871320840226261,0.020845625715759,1.81357184530258e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHGA,Chromogranin-A,37437,-0.0350400059396646,0.00734323301719411,-0.049432742653365,-0.0206472692259641,1.845422925059e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CIT,Citron Rho-interacting kinase,37039,0.0201837358963149,0.00424757708166963,0.0118584848162425,0.0285089869763874,2.03718847852056e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA4,Carbonic anhydrase 4,40052,-0.0103832384476101,0.00219172663843675,-0.0146790226589461,-0.00608745423627403,2.18239884315891e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFC1,Cryptic protein,39477,0.0206794533407354,0.00436881432900969,0.0121165772558764,0.0292423294255944,2.22699440240859e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37382,0.0171477719246773,0.00362492931476154,0.0100429104677447,0.0242526333816099,2.26218847068222e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGB1A1,Uteroglobin,39903,0.0241662121038356,0.0051205941438693,0.0141298475818518,0.0342025766258195,2.38519607165638e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37169,0.031728430103618,0.00672308167907511,0.0185511900126308,0.0449056701946052,2.39033718864859e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNPY2,Protein canopy homolog 2,39585,0.0266374171475762,0.00564510674539955,0.0155730079265931,0.0377018263685593,2.39430358292455e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,37021,0.0154634631327324,0.00329412400381379,0.00900698008525738,0.0219199461802074,2.70277094103307e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A12,Protein S100-A12,39615,0.0328104767893254,0.00699810580277866,0.0190941894158792,0.0465267641627715,2.77548999220691e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB37,Ras-related protein Rab-37,39587,0.0365296408032304,0.00780160292456823,0.0212384990710766,0.0518207825353841,2.86008585197865e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSH3,Protein phosphatase Slingshot homolog 3,36962,0.0130316738145709,0.00278474131426083,0.0075735808386197,0.0184897667905221,2.90211994247455e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLAMF1,Signaling lymphocytic activation molecule,39587,-0.0256481934369897,0.00548212099053111,-0.0363931505784307,-0.0149032362955488,2.91364164442883e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN2,Contactin-2,40030,0.0194000593046987,0.00414733887534006,0.0112712751090322,0.0275288435003652,2.92440478050583e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,39489,0.0168778046107389,0.00363705668308418,0.00974917351189395,0.0240064357095839,3.50369546848976e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYL4,Myosin light chain 4,37043,-0.022551381393554,0.00486059255226381,-0.0320781427959911,-0.013024619991117,3.5238263685827e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,39931,0.0108253184816788,0.00233759837715121,0.00624362566246242,0.0154070113008952,3.66830259609664e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MERTK,Tyrosine-protein kinase Mer,40058,0.0109783258221119,0.00237174594094687,0.00632970377785601,0.0156269478663678,3.70653210197706e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37056,0.0183482870850284,0.00398127594880667,0.0105449862253673,0.0261515879446895,4.0910014918067e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LMNB2,Lamin-B2,37388,0.0118152051246682,0.00256561548301313,0.00678659877796246,0.0168438114713739,4.1579997932648e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEO1,RNA polymerase-associated protein LEO1,37411,0.0120367018078526,0.00262241562584593,0.00689676718119455,0.0171766364345106,4.4737977164996e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTRC,Chymotrypsin-C,39856,0.0264907269299906,0.00578045792254129,0.0151610294018097,0.0378204244581715,4.62242732833929e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFBR2,TGF-beta receptor type-2,39913,0.012759376313794,0.00279012867947184,0.00729072410202916,0.0182280285255588,4.84285168661653e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGLC2,Immunoglobulin lambda constant 2,37422,-0.010408509511663,0.00228835563675247,-0.0148936865596978,-0.00592333246362816,5.45065986484595e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LMOD1,Leiomodin-1,37411,-0.0149818065302959,0.00330168193932589,-0.0214531031313747,-0.00851050992921717,5.73793664214679e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ULBP2,UL16-binding protein 2,39749,0.0154978153153933,0.00341953116569066,0.00879553423063964,0.022200096400147,5.88132700708354e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,39585,0.0171915394373824,0.0037992498792029,0.00974500967414471,0.0246380692006201,6.08429474013752e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,39477,0.0244517241514214,0.00541111723144366,0.0138459343777918,0.035057513925051,6.26492107949895e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39931,0.0180407163933553,0.00399337131077553,0.0102137086242353,0.0258677241624753,6.29704713089024e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37056,0.0132391216226094,0.00293821609444048,0.00748021807750603,0.0189980251677127,6.66800450513668e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,40058,-0.0176363669289098,0.0039160717383932,-0.0253118675361605,-0.00996086632165913,6.72827867143748e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,39868,0.0118625853996143,0.00263427013949623,0.00669941592620168,0.0170257548730269,6.74178591322515e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFYA,Nuclear transcription factor Y subunit alpha,37021,0.0159606679609319,0.00355288223278341,0.00899701878467644,0.0229243171371874,7.1052993775164e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTSL5,ADAMTS-like protein 5,37437,-0.0164962031917199,0.00367250250456358,-0.0236943081006645,-0.00929809828277529,7.12013584625729e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUSP3,Dual specificity protein phosphatase 3,39489,0.0356038164108384,0.00793834394107126,0.0200446622863387,0.0511629705353381,7.34184590047509e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RLN1,Prorelaxin H1,37411,-0.0338873869425356,0.00756062254381312,-0.0487062071284093,-0.0190685667566619,7.45217725970497e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1RL1,Interleukin-1 receptor-like 1,40002,-0.0196459832240049,0.00438521952544451,-0.0282410134938761,-0.0110509529541337,7.51396191288802e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,37056,0.0131288238171001,0.0029376852519145,0.00737096072334772,0.0188866869108526,7.92016503168127e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRD3,Bromodomain-containing protein 3,37021,0.0194173362564668,0.00435418942562667,0.0108831249822385,0.0279515475306951,8.28465436009634e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39749,0.0161917482542882,0.00363382770442598,0.00906944595361332,0.0233140505549632,8.41371174080633e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRUNE2,Protein prune homolog 2,37169,0.0118988993184392,0.0026702524673428,0.00666520448244728,0.0171325941544311,8.41474129478816e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,39788,0.0227816519959022,0.00511481063922712,0.0127566231430171,0.0328066808487874,8.48367261728227e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39749,0.0293579598340103,0.00661022441747991,0.0164019199757497,0.042313999692271,9.00223674391392e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,37324,0.0255024306044012,0.00574295531127067,0.0142462381943107,0.0367586230144917,9.04035266525562e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGAM,Integrin alpha-M,39858,-0.013099758994778,0.00295180595642844,-0.0188852986693777,-0.00731421932017822,9.14566053688378e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39585,0.0152156072532545,0.00343132201226559,0.00849021610921396,0.0219409983972951,9.29859705236757e-06
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL2RA,Interleukin-2 receptor subunit alpha,39732,-0.0162345424089932,0.00367719303456768,-0.0234418407567459,-0.00902724406124058,1.01710870048297e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWF,von Willebrand factor,40052,-0.0301587270377567,0.00683889073310881,-0.04356295287465,-0.0167545012008634,1.04091670548873e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG3G,Regenerating islet-derived protein 3-gamma,37368,0.0161441857368275,0.00366686019643973,0.00895713975180568,0.0233312317218494,1.07719521496683e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCND2,G1/S-specific cyclin-D2,37169,0.0151718206402233,0.00344659998583031,0.00841648466799585,0.0219271566124507,1.08109438982808e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEO1,Neogenin,37411,0.00889110792098699,0.00202532211279706,0.00492147657990477,0.0128607392620692,1.14223475286599e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300E,CMRF35-like molecule 2,39991,0.0157839796772836,0.00360080408878941,0.00872640366325632,0.0228415556913108,1.1754769034254e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RHOC,Rho-related GTP-binding protein RhoC,39672,0.0483553023944564,0.0110406723001141,0.0267155846862329,0.06999502010268,1.19583445847367e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOD,Apolipoprotein D,36780,-0.0177770744088016,0.00407593659583824,-0.0257659101366446,-0.00978823868095869,1.30192457217789e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALPI,Intestinal-type alkaline phosphatase,37056,-0.0493831639660893,0.0113430182665374,-0.0716154797685025,-0.027150848163676,1.34917847306711e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRRC38,Leucine-rich repeat-containing protein 38,37039,0.0196874346338617,0.00452637845978128,0.0108157328526904,0.028559136415033,1.37480362033335e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDHB15,Protocadherin beta-15,37368,-0.0161919831260211,0.00372434417968544,-0.0234916977182045,-0.00889226853383763,1.38638542347987e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL4R,Interleukin-4 receptor subunit alpha,39866,-0.0144990681065582,0.0033433687953964,-0.0210520709455352,-0.0079460652675813,1.45545892966822e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRTAP,Cartilage-associated protein,37039,0.0199933505944348,0.00463187325776971,0.0109148790092061,0.0290718221796634,1.59700050233359e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INSL5,Insulin-like peptide INSL5,37382,0.0392145063394814,0.00908792956625861,0.0214021643896146,0.0570268482893483,1.60729488153104e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFB2,Transforming growth factor beta-2 proprotein,37368,0.0212142629854884,0.00493063912096067,0.0115502103084054,0.0308783156625713,1.70040129011651e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OBP2B,Odorant-binding protein 2b,39701,-0.025292179597715,0.00589672734846103,-0.0368497652006986,-0.0137345939947314,1.80388888605824e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,39868,0.0167953601455441,0.00391633909554224,0.00911933551828135,0.0244713847728069,1.80908617020941e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,40052,0.0114769159738319,0.0026775548288503,0.00622890850928529,0.0167249234383784,1.82689235087433e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLYR1,Putative oxidoreductase GLYR1,37368,0.0239706891172132,0.00559520030574834,0.0130040965179464,0.0349372817164799,1.84706587020219e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHGB,Secretogranin-1,39952,0.0158138992553739,0.00369206294188817,0.00857745588927313,0.0230503426214747,1.85280589613774e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39801,0.07470997457106,0.0174711786514635,0.0404664644141916,0.108953484727928,1.91230457748933e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,39587,0.0172289937667615,0.00403214212613507,0.0093259951995368,0.0251319923339863,1.94070181690505e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFASC,Neurofascin,40058,0.0110726934768391,0.00259145528575843,0.00599344111675259,0.0161519458369256,1.94161411035969e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE3,Eosinophil cationic protein,39791,0.0428790383407802,0.0100617040924891,0.0231580983195017,0.0625999783620588,2.04127747147071e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,37043,0.0201391484916086,0.00472751760932951,0.0108732139773228,0.0294050830058945,2.05860200606768e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNC,Tenascin,39931,-0.018756350423619,0.00440483623712663,-0.0273898294483872,-0.0101228713988508,2.07317985723553e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPR158,Probable G-protein coupled receptor 158,37411,0.0142194956688964,0.00334425337268755,0.00766475905842877,0.020774232279364,2.13366393365064e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF16,Fibroblast growth factor 16,37056,0.0191898953216409,0.00452978395057629,0.0103115187785113,0.0280682718647704,2.28691628562204e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LIFR,Leukemia inhibitory factor receptor,39866,-0.00965839080654124,0.00228131157527821,-0.0141297614940865,-0.00518702011899595,2.31159089488747e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37437,-0.0157374689116183,0.00372047499948214,-0.0230295999106033,-0.00844533791263325,2.35263093121512e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIAA1549L,UPF0606 protein KIAA1549L,37169,-0.0109182015837936,0.00259031767516709,-0.0159952242271211,-0.00584117894046609,2.51421229069788e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,39489,0.0159294884828253,0.00379631088889048,0.00848871914059996,0.0233702578250506,2.73117137635748e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNLY,Granulysin,39858,0.0199962914145808,0.00476926373635423,0.0106485344913265,0.0293440483378351,2.77085391325874e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",39858,0.0146438352539848,0.00349274192733087,0.00779806107641628,0.0214896094315533,2.77200665323826e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC13A1,Solute carrier family 13 member 1,37368,0.0234768742123553,0.00560450489222948,0.0124920446235856,0.0344617038011251,2.82053594467595e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37039,0.0393253019670125,0.00940447484882975,0.0208925312633062,0.0577580726707189,2.91397751999006e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN5,Contactin-5,39897,0.0140779882181178,0.00336836157744786,0.00747599952632003,0.0206799769099156,2.93729688179324e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40058,0.0141909616721406,0.00339540370446664,0.00753597041138595,0.0208459529328952,2.9373268479232e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,40030,-0.0138906492791033,0.00332555433454521,-0.0204087357748119,-0.00737256278339468,2.97003355954241e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOF,Apolipoprotein F,37445,0.0101138009696245,0.00242659474157793,0.00535767527613179,0.0148699266631173,3.0932474606222e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK8,Kallikrein-8,39315,0.0135261910194179,0.00325751711741958,0.00714145746927547,0.0199109245695602,3.30915405492756e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNX18,Sorting nexin-18,37382,0.0175939576701751,0.00424080291197201,0.00928198396270992,0.0259059313776402,3.36365203704262e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAST,Gastrin,37388,0.0451590475977848,0.0108961523557454,0.0238025889805238,0.0665155062150458,3.42637022107862e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,39489,0.0547777528017937,0.0132364508366035,0.0288343091620507,0.0807211964415366,3.51565611741376e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39984,-0.0273683167249684,0.00661509621061179,-0.0403339052977675,-0.0144027281521693,3.53273672821195e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH6,Cadherin-6,39868,-0.014720616624853,0.00355849766042754,-0.021695272039291,-0.00774596121041503,3.5405784627619e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL3A1,Collagen alpha-1(III) chain,37437,-0.00899608586303207,0.00217923825001253,-0.0132673928330566,-0.00472477889300751,3.67978902487041e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,37368,0.026668158985859,0.00647494150396753,0.0139772736380826,0.0393590443336354,3.83331254099215e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39842,0.0243693146288513,0.00592222238091075,0.0127617587622663,0.0359768704954364,3.89300015214862e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,39844,0.00854613735404204,0.00208108287594456,0.00446721491719071,0.0126250597908934,4.03554429510929e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100P,Protein S100-P,39585,0.0202578241128,0.0049356239667289,0.0105840011380113,0.0299316470875886,4.07393505720259e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHNAK2,Protein AHNAK2,37043,0.0112436190555588,0.00274835208200143,0.00585684897483595,0.0166303891362816,4.31996364225872e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",39489,0.0104301450115116,0.0025511337031982,0.00542992295324315,0.0154303670697801,4.36465166245945e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39931,-0.0164279697099315,0.00402960459576871,-0.0243259947176382,-0.00852994470222486,4.58756548458905e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX25,ATP-dependent RNA helicase DDX25,37039,-0.0143087721112394,0.00351377319378103,-0.0211957675710502,-0.00742177665142856,4.68442422842798e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZBP1,Z-DNA-binding protein 1,37056,0.0157081481106736,0.00386654776350009,0.00812971449421342,0.0232865817271338,4.8814712054529e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NINJ1,Ninjurin-1,39477,0.0214424765272265,0.00528238647851569,0.0110889990293358,0.0317959540251172,4.94724575941562e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATXN2,Ataxin-2,36991,0.0422267834244243,0.0104301304897179,0.0217837276645773,0.0626698391842713,5.18342204684118e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM5,Intercellular adhesion molecule 5,39868,0.0166877730997132,0.0041280593740294,0.00859677672661557,0.0247787694728108,5.31266273550897e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM2,Intercellular adhesion molecule 2,40052,-0.0118114195273755,0.00293104747900717,-0.0175562725862295,-0.00606656646852146,5.60888667788883e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INHBB,Inhibin beta B chain,37124,0.0187098878039388,0.00464270383977647,0.00961018827797692,0.0278095873299007,5.60989288663201e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39913,-0.0129885756274199,0.00323741981349326,-0.0193339184618667,-0.00664323279297317,6.04756859824849e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37169,0.0242767206093062,0.00605412258297319,0.0124106403466787,0.0361428008719337,6.10634965578827e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,37370,0.0138229750289339,0.00345143077353729,0.00705817071280081,0.020587779345067,6.23498314050974e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPP10,Inactive dipeptidyl peptidase 10,39866,0.0129574142238069,0.00324019689519079,0.00660662830923292,0.0193082001383808,6.39074342223567e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MATN3,Matrilin-3,39720,-0.0117022711112584,0.00293336758351147,-0.0174516715749409,-0.00595287064757589,6.65482197710528e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37021,0.0189356967527222,0.00474643053431559,0.00963269290546369,0.0282387005999808,6.65823255572603e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37411,-0.0137514527470527,0.00344811579535253,-0.0205097597059437,-0.00699314578816178,6.69525481337955e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPSAB1,Tryptase alpha/beta-1,40038,0.0194907359785554,0.00489298453192593,0.00990048629598054,0.0290809856611302,6.82324191080618e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH17,Protocadherin-17,39868,-0.0129152569850536,0.00327157267911855,-0.0193275394361259,-0.00650297453398121,7.92359671244549e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPON1,Spondin-1,39885,0.0117697829674816,0.00298182397210961,0.00592540798214672,0.0176141579528164,7.94161507298936e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39477,-0.011905304161184,0.00302519771355546,-0.0178346916797527,-0.0059759166426153,8.34247863006877e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHB6,Ephrin type-B receptor 6,39713,0.0111382575650671,0.00283147450575547,0.00558856753378641,0.0166879475963478,8.39938829797872e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BMP10,Bone morphogenetic protein 10,37124,0.0104270890470072,0.00265281833500359,0.00522756511040014,0.0156266129836142,8.51749185905488e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL9A1,Collagen alpha-1(IX) chain,39866,0.0160440916254126,0.00408859759954439,0.00803044033030557,0.0240577429205196,8.74162184013732e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39931,0.00964104001349892,0.0024609618968687,0.00481755469563627,0.0144645253313616,8.98086677998905e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NME3,Nucleoside diphosphate kinase 3,39885,0.00873208582438361,0.00223080277404441,0.00435971238725658,0.0131044592615106,9.10326612305948e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC4A1,Band 3 anion transport protein,37437,-0.017086355233127,0.00437185893904524,-0.0256551987536557,-0.00851751171259836,9.3415102154376e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDHR1,Cadherin-related family member 1,39489,0.0155853824891041,0.00399620372552618,0.0077528231870728,0.0234179417911354,9.65763069583744e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",37437,0.0153937641634581,0.00395067936048693,0.0076504326169037,0.0231370957100125,9.80671673976134e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,37411,0.0173740916108331,0.00446273341985058,0.00862713410792594,0.0261210491137402,9.94251487259016e-05
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37056,0.0218170465533894,0.00561759636012592,0.0108065576875426,0.0328275354192362,0.000103381571946494
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TDO2,"Tryptophan 2,3-dioxygenase",37039,0.0142320007582868,0.00367173955106307,0.00703539123820314,0.0214286102783704,0.000106662090986484
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,39587,0.0133659716738388,0.00345281885883355,0.00659844671052501,0.0201334966371525,0.000108813619214369
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARF2,Scavenger receptor class F member 2,40009,-0.0101828552677031,0.00263354440439672,-0.0153446023003206,-0.00502110823508548,0.000110796981189549
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,37368,0.0131607633605922,0.00341218779404889,0.00647287528425641,0.019848651436928,0.000115326223575755
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOLH1,Glutamate carboxypeptidase 2,37056,0.0396057781699528,0.0102795987658567,0.0194577645888737,0.0597537917510319,0.000117302257388277
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300A,CMRF35-like molecule 8,37124,0.010429287485264,0.00271394544299953,0.00510995441698493,0.0157486205535431,0.000122180410964764
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCAM,Basal cell adhesion molecule,39858,-0.00846612389974667,0.00220386412270411,-0.0127856975802467,-0.00414655021924662,0.000122761255447462
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PREB,Prolactin regulatory element-binding protein,39587,0.0102709052140397,0.00267915911342626,0.00501975335172422,0.0155220570763552,0.00012675783995184
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EXTL1,Exostosin-like 1,37021,0.0171831158529206,0.00448202988723626,0.00839833727393758,0.0259678944319037,0.000126776785242562
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,39477,0.0107430581963708,0.00280859711436249,0.00523820785222036,0.0162479085405213,0.000131247773753106
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA4C,Semaphorin-4C,39788,0.0101442723062404,0.00265528951607393,0.00493990485473552,0.0153486397577453,0.00013374040995122
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBP4,Guanylate-binding protein 4,39489,0.0173747384185232,0.0045747618856191,0.00840820512270977,0.0263412717143366,0.00014644710166223
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHX2,Bifunctional epoxide hydrolase 2,39585,0.0217925416122139,0.00575082094601842,0.0105209325580178,0.03306415066641,0.000151534423400074
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ROBO4,Roundabout homolog 4,37043,-0.00632482388158507,0.00167076908526503,-0.00959953128870454,-0.0030501164744656,0.000154032533268591
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,39477,0.0193193793036512,0.00511861995893856,0.00928688418413157,0.0293518744231707,0.000161029452657595
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC10A,C-type lectin domain family 10 member A,39749,-0.0126912491731925,0.00337368089827813,-0.0193036637338176,-0.00607883461256733,0.000169273300129769
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEFL,Neurofilament light polypeptide,39438,0.0152884416818152,0.00406739270673285,0.00731635197661885,0.0232605313870116,0.000171366098134203
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39885,0.011163238647003,0.00297681583526173,0.00532867960988996,0.0169977976841159,0.000177414144026116
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB104A_DEFB104B,Beta-defensin 104,36991,0.0205094365971155,0.00547205257983047,0.0097842135406478,0.0312346596535832,0.000178990357770444
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSLN,Mesothelin,39766,0.0184169862285633,0.00492007866702406,0.00877363204119618,0.0280603404159305,0.000182309354470616
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPA2,Replication protein A 32 kDa subunit,37056,0.0112048526827596,0.00299565847164977,0.00533336207832609,0.0170763432871932,0.00018453177193715
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37169,0.0204550097962301,0.00546966209446858,0.0097344720910717,0.0311755475013885,0.000184997251783058
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ICAM4,Intercellular adhesion molecule 4,39866,-0.0183005409149388,0.00490392094712649,-0.0279122259713067,-0.00868885585857085,0.000190760248985563
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSBP1,Heat shock factor-binding protein 1,37043,0.0336476916110365,0.00904998199320105,0.0159097269043624,0.0513856563177105,0.000201650472975273
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATXN10,Ataxin-10,39489,0.0253233446998363,0.00684717235735353,0.0119028868794234,0.0387438025202493,0.000217735463803471
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA2,Carbonic anhydrase 2,39821,0.0235058017482161,0.00635591481542426,0.0110482087099846,0.0359633947864477,0.000217813446928579
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGA4,Pepsin A-4,37445,0.0215347722113846,0.00583080941325009,0.0101063857614144,0.0329631586613548,0.000222253713497074
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LHB,Lutropin subunit beta,39477,0.0305648113848862,0.00828288343870839,0.0143303598450177,0.0467992629247546,0.000224912381088409
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUSD2,Sushi domain-containing protein 2,39858,-0.00971857864862209,0.00263782559622418,-0.0148887168172215,-0.00454844048002269,0.000230075311513708
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39869,0.0198556821000082,0.00539650156924962,0.0092785390242789,0.0304328251757374,0.000234584917139391
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37453,-0.00660423026826413,0.00179753257247041,-0.0101273941103061,-0.00308106642622213,0.000239650060646928
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36962,0.0233994462558717,0.00637849249178855,0.0108976009719662,0.0359012915397773,0.000244952570081791
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39881,-0.0167793179889376,0.00457598503578825,-0.0257482486590826,-0.00781038731879267,0.00024637893401281
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDN1,Endothelin-1,37043,0.00963879342930635,0.00263106890709717,0.00448189837139589,0.0147956884872168,0.00024981431623149
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A11,Protein S100-A11,39703,0.015547936035037,0.00425058915960626,0.0072167812822087,0.0238790907878652,0.000255183193191035
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MNDA,Myeloid cell nuclear differentiation antigen,39841,0.0330476520592519,0.0091162525001921,0.0151797971588754,0.0509155069596284,0.000289706976729031
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFRA2,GDNF family receptor alpha-2,39788,0.00705967174415799,0.00195116057738989,0.0032353970124738,0.0108839464758422,0.000297587405132246
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARTN,Artemin,39587,0.0151480627982979,0.00419538973750845,0.00692509891278131,0.0233710266838144,0.000306386336247796
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,40009,0.00786094190859346,0.00218006009124654,0.00358802412975025,0.0121338596874367,0.000312085651274462
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALCB,Calcitonin gene-related peptide 2,37388,0.0133135414288764,0.0036927308010182,0.00607578905888077,0.0205512937988721,0.000312868314293216
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHI3L1,Chitinase-3-like protein 1,39545,-0.0252626736613341,0.00704138006301027,-0.0390637785848342,-0.0114615687378339,0.000334566215816142
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSC,Dipeptidyl peptidase 1,39856,0.0143472600673733,0.00400536011347808,0.00649675424495628,0.0221977658897903,0.000341965964005015
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTK7,Inactive tyrosine-protein kinase 7,39489,0.0128806538044356,0.00359996307969377,0.00582472616823579,0.0199365814406354,0.000347285831584236
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLB1,"Phospholipase B1, membrane-associated",37388,0.0200774637205941,0.0056164568639624,0.0090692082672278,0.0310857191739604,0.000351775414475777
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLSPN,Claspin,39453,0.0114969368979203,0.00322313522613165,0.00517959185470228,0.0178142819411383,0.000362167781485971
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,36962,0.0199137467000687,0.00560085522895636,0.00893607045131422,0.0308914229488231,0.000378614696108286
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HBQ1,Hemoglobin subunit theta-1,40030,-0.0199298600502204,0.00561466341809239,-0.0309346003496815,-0.0089251197507593,0.000386898312274901
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEPACAM2,HEPACAM family member 2,37388,-0.0139283687556231,0.00393043958549203,-0.0216320303431875,-0.00622470716805873,0.000395857268235293
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYBPC2,"Myosin-binding protein C, fast-type",37043,-0.0281877737540015,0.00797579154829997,-0.0438203251886694,-0.0125552223193335,0.000410464517218501
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERC2,ERC protein 2,37039,0.0247773943441972,0.00702995045120461,0.0109986914598362,0.0385560972285583,0.00042564522557389
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PEAR1,Platelet endothelial aggregation receptor 1,40052,0.00745977653187432,0.00211906909217683,0.00330640111120773,0.0116131519525409,0.000432229551788877
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UNC5D,Netrin receptor UNC5D,37056,0.00878562943774117,0.00249611355389585,0.00389324687210532,0.013678012003377,0.000433452502927596
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTA4H,Leukotriene A-4 hydrolase,40030,0.0193037172059351,0.00548860939698001,0.00854604278785425,0.0300613916240159,0.000437566746497109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL22,Interleukin-22,37368,-0.021543539883267,0.00613646477384602,-0.0335710108400052,-0.00951606892652885,0.000448315996145501
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37021,-0.0134416730592882,0.00383243157007375,-0.0209532389366327,-0.00593010718194365,0.000454105037401698
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST6,Cystatin-M,39524,0.0153691588702021,0.00438536597218139,0.00677384156472661,0.0239644761756776,0.000458490331130407
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",37056,0.00977090594425999,0.00278870380476083,0.00430504648692877,0.0152367654015912,0.000460284776450567
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,37169,0.023361872995937,0.00666996058675405,0.0102887502458991,0.0364349957459749,0.000462338238359243
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PKLR,Pyruvate kinase PKLR,39881,-0.0209372731812899,0.00598597479928113,-0.0326697837878809,-0.00920476257469888,0.00047052263746495
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39913,0.0148541125689712,0.00425178001362286,0.00652062374227042,0.023187601395672,0.000477798420847928
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP3,"Fatty acid-binding protein, heart",37437,0.0160336101780228,0.00459583889900388,0.00702576593597523,0.0250414544200704,0.000486870958214106
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CR2,Complement receptor type 2,39931,0.0147388561063036,0.00424405370361834,0.00642051084721162,0.0230572013653955,0.000516365890305033
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39489,0.0158959371478534,0.00458547334011871,0.00690840940122068,0.024883464894486,0.000528529856397723
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRNN,Cornulin,39397,0.0209750325485488,0.00605337326057699,0.00911042095781786,0.0328396441392797,0.00053163166720845
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CFD,Complement factor D,37453,0.00593477584011998,0.00171312016852172,0.00257706030981742,0.00929249137042255,0.000533236309474745
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CREBZF,CREB/ATF bZIP transcription factor,36962,-0.00853934327564424,0.00246748145165326,-0.0133756069208846,-0.00370307963040386,0.000540383524856869
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40034,0.0085926088351777,0.00248761566535953,0.00371688213107302,0.0134683355392824,0.000553435425536209
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYBPC1,"Myosin-binding protein C, slow-type",37437,-0.0220693547040648,0.00639704286369225,-0.0346075587169016,-0.00953115069122799,0.000562434419901689
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MET,Hepatocyte growth factor receptor,39879,0.00629815059215176,0.0018273923758756,0.00271646153543558,0.00987983964886794,0.000569306352155599
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPO,Lactoperoxidase,39344,-0.0192731094234244,0.00560208482052056,-0.0302531956716447,-0.00829302317520415,0.000582503133930416
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPTP,Ceramide-1-phosphate transfer protein,37021,-0.0128249732484906,0.0037284929235259,-0.0201328193786014,-0.00551712711837988,0.000584120908508334
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMOD4,Tropomodulin-4,36962,-0.0131104438391951,0.00383366721120251,-0.020624431573152,-0.00559645610523821,0.000628540582031916
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,40003,0.00967004475532913,0.00283286616706406,0.00411762706788357,0.0152224624427747,0.000642870295578579
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEPTIN3,Neuronal-specific septin-3,37411,-0.0244103919518037,0.00715590116231301,-0.0384359582299372,-0.0103848256736702,0.000648604056521803
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPR101,Probable G-protein coupled receptor 101,36991,-0.0200134409091142,0.00587232724493601,-0.0315232023091888,-0.00850367950903964,0.000656148772952904
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37056,0.0286771474710562,0.00843170411329473,0.0121510074089985,0.0452032875331139,0.000673119790265102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF3,Granulocyte colony-stimulating factor,39587,0.0152576989938558,0.00449053642772243,0.00645624759551982,0.0240591503921917,0.000681120399518837
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EP300,Histone acetyltransferase p300,37056,0.00942668701501862,0.00277609741999292,0.00398553607183249,0.0148678379582048,0.000686647742619339
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIRREL2,Kin of IRRE-like protein 2,39489,0.0125480661445426,0.00370623724736818,0.00528384113970092,0.0198122911493842,0.000711815750901504
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLT1,Vascular endothelial growth factor receptor 1,39755,0.00730283143183324,0.00216764920478101,0.00305423899046245,0.011551423873204,0.000756179871809262
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL5A1,Collagen alpha-1(V) chain,37124,-0.012490377672184,0.00371237962064819,-0.0197666417286544,-0.00521411361571354,0.000768940372879334
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A14,Protein S100-A14,37411,0.0161053497100856,0.00479051874065904,0.00671593297839387,0.0254947664417773,0.000776160868746619
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPME1,Protein phosphatase methylesterase 1,39788,0.0187603161316022,0.0056145903346381,0.00775571907571148,0.0297649131874928,0.000835635231222579
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF5,Eukaryotic translation initiation factor 5,37021,0.0138108796435284,0.00413939599665429,0.00569766349008596,0.0219240957969708,0.000850912046187288
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLP1R,Glucagon-like peptide 1 receptor,36991,-0.0118191864870043,0.00355183088946663,-0.0187807750303589,-0.00485759794364973,0.000878281076381473
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,37382,0.0152195092433373,0.00457643194834964,0.00624970262457206,0.0241893158621026,0.000884545045431799
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,36991,-0.0105039634928058,0.00316453888816649,-0.0167064597136122,-0.00430146727199952,0.000904983360984635
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39788,0.0137579349590271,0.00415316656441691,0.00561772849276997,0.0218981414252843,0.000926265498590273
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GZMB,Granzyme B,39866,0.0198404271338158,0.00599405367888894,0.00809208192319351,0.0315887723444382,0.00093496041066608
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL1A1,Collagen alpha-1(I) chain,40052,-0.00766407050294475,0.00231743785051762,-0.0122062486899593,-0.00312189231593022,0.000944620437414945
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYO6,Unconventional myosin-VI,37411,0.0118112002432199,0.00357818749276733,0.00479795275739591,0.0188244477290439,0.000966279926763293
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAPS,Calcyphosin,37388,0.0269188263289425,0.00816364410295515,0.0109180838871504,0.0429195687707346,0.000978348903865289
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39788,0.0166226158054898,0.00504494164263154,0.00673453018593194,0.0265107014250476,0.000986690596182591
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRTN3,Myeloblastin,39421,-0.0142386360757352,0.00432833335670846,-0.0227221694548838,-0.00575510269658661,0.00100540361077452
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39931,0.013046725602666,0.00397923732615032,0.00524742044341132,0.0208460307619206,0.00104508004888464
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG3A,Regenerating islet-derived protein 3-alpha,40052,-0.01800712617687,0.0054937382952446,-0.0287748532355495,-0.00723939911819062,0.00104856736773009
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NECTIN1,Nectin-1,37056,0.00984953799338313,0.00301001378061307,0.00394991098338151,0.0157491650033848,0.00106966751454807
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAG,S-arrestin,36991,-0.0162929962186414,0.00498042483951634,-0.0260546289040934,-0.00653136353318941,0.00107289859622787
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39846,0.00967088296114813,0.00295756891958998,0.00387404787875177,0.0154677180435445,0.00107822274670372
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36991,0.0189022484183991,0.00578274878994287,0.00756806079011109,0.0302364360466871,0.00108308900902681
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MPO,Myeloperoxidase,39858,0.0138208957240887,0.00424334094850236,0.00550394746502406,0.0221378439831533,0.00112799649936122
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDC1,Syndecan-1,39868,0.0120818940965159,0.00371756505316869,0.00479546659230528,0.0193683216007265,0.00115664333969418
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLGN,Calmegin,37039,0.0132652461767527,0.00409351051090692,0.00524196557537513,0.0212885267781302,0.00119593286452387
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G15,Phospholipase A2 group XV,39913,0.00802483874213574,0.00247834938660109,0.0031672739443976,0.0128824035398739,0.00120624946175949
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,37056,0.0114873959666646,0.00354809951641608,0.00453312091448908,0.0184416710188401,0.00120829206170305
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRC1,Macrophage mannose receptor 1,37445,0.00834771487531406,0.00258166532018417,0.00328765084775309,0.013407778902875,0.00122591963435468
NMR metabolomics,X23503.Total Lipids in Medium VLDL,L1CAM,Neural cell adhesion molecule L1,39913,0.00865091890993227,0.00267768574500003,0.0034026548497322,0.0138991829701323,0.00123716901423926
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRRT3,Proline-rich transmembrane protein 3,37043,0.0109674451756065,0.00339670872371225,0.00430989607713053,0.0176249942740825,0.00124595600186666
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VNN2,Vascular non-inflammatory molecule 2,39788,-0.0139717742095635,0.00433399541166307,-0.0224664052164231,-0.00547714320270391,0.00126772861053495
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSPN,Persephin,39866,0.0283769400053642,0.0088145081487565,0.0111005040338014,0.0456533759769269,0.00128740152883669
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40040,0.0108013607675243,0.00336464196523297,0.00420666251566769,0.017396059019381,0.00132875876966513
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMEM25,Transmembrane protein 25,37411,-0.0134706567841718,0.00419645847959649,-0.0216957154041809,-0.00524559816416265,0.00133041550025076
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SATB1,DNA-binding protein SATB1,37411,0.00902971747833101,0.00281316736030848,0.00351590945212639,0.0145435255045356,0.00133134722067196
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC16A1,Monocarboxylate transporter 1,39489,0.0173624629099337,0.00542951698946898,0.00672060961057449,0.0280043162092929,0.00138760299343013
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOSB,Protein fosB,39489,0.0116851702247004,0.00365638989051502,0.00451864603929095,0.0188516944101098,0.00139710396769358
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGB2A2,Mammaglobin-A,37021,-0.00940475990355503,0.00294932305971233,-0.0151854331005912,-0.00362408670651886,0.00143206187247066
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCAM2,Neural cell adhesion molecule 2,39858,-0.00795073793797117,0.00250172340689713,-0.0128541158154895,-0.0030473600604528,0.00148523437590763
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUSP29,Dual specificity phosphatase 29,37039,-0.019790043869046,0.00623104428355074,-0.0320028906648055,-0.00757719707328657,0.00149644546326004
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCTPP1,dCTP pyrophosphatase 1,39868,0.00941433419284979,0.00296639846397351,0.00360019320346171,0.0152284751822379,0.00150815684194322
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSC1,Hamartin,37056,0.0227000532937898,0.00716895869418048,0.00864889425319601,0.0367512123343835,0.00154670156841819
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,39587,0.00893203096029432,0.00282188464833661,0.00340113704955457,0.0144629248710341,0.00155233738209781
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37021,0.0257631417601879,0.00818092159526506,0.00972853543346835,0.0417977480869074,0.0016409909186402
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VEGFD,Vascular endothelial growth factor D,40024,-0.010434107162181,0.00332372742143903,-0.0169486129082015,-0.00391960141616055,0.0016966900261923
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40052,0.0204785876925354,0.0065317589614365,0.00767634012811982,0.0332808352569509,0.00172024574066076
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT19,"Keratin, type I cytoskeletal 19",39842,-0.0191509941335512,0.00611498297908307,-0.031136360772554,-0.00716562749454838,0.00174042893972274
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT8,"Keratin, type II cytoskeletal 8",36991,-0.0191007725481439,0.00610653789570994,-0.0310695868237354,-0.00713195827255246,0.00176431947226025
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G2A,"Phospholipase A2, membrane associated",39826,-0.015948336757794,0.00510027156774282,-0.0259448690305699,-0.00595180448501806,0.00176942139423315
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40009,0.0206936553834245,0.00663977326871752,0.00767969977673817,0.0337076109901108,0.00183257596339608
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUP50,Nuclear pore complex protein Nup50,37021,-0.00966431699745383,0.00310444238112598,-0.0157490240644607,-0.00357960993044691,0.0018555492629821
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EGFLAM,Pikachurin,37382,0.00891030725696907,0.00287497903609382,0.00327534834622518,0.014545266167713,0.00194402932086462
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD109,CD109 antigen,39858,-0.0097287172767737,0.00315847830560598,-0.0159193347557614,-0.00353809979778598,0.00207218511740418
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG1A,Lithostathine-1-alpha,39804,-0.0133885815660619,0.00434758377692362,-0.0219098457688322,-0.00486731736329162,0.00207669268199788
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPAN8,Tetraspanin-8,37382,0.0282665210822419,0.00919225033672182,0.0102497104222672,0.0462833317422167,0.00210895315639864
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHPK,Sedoheptulokinase,37169,-0.0120566435543491,0.00392489238107946,-0.0197494326212648,-0.00436385448743334,0.00213172745660283
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MANSC4,MANSC domain-containing protein 4,37021,0.0179526646294003,0.00584959294000848,0.00648746246698371,0.029417866791817,0.00215181024225442
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLAUR,Urokinase plasminogen activator surface receptor,39757,-0.00766536983156117,0.00250928997664682,-0.0125835781857889,-0.0027471614773334,0.00225586261741935
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39587,0.034567887775864,0.011346239992758,0.0123292573900584,0.0568065181616697,0.00231799599428327
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PROCR,Endothelial protein C receptor,37021,-0.010445694316782,0.00343155472797376,-0.0171715415836106,-0.00371984704995344,0.00233906580058587
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLASP1,CLIP-associating protein 1,36962,0.0208176630112636,0.00688380088228734,0.00732541328198039,0.0343099127405468,0.00249813552863968
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,39913,-0.00674007296256416,0.00222995766085881,-0.0111107899778474,-0.00236935594728089,0.00251081779776448
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,39489,0.0198082252567309,0.00655632603955456,0.00695782621920394,0.0326586242942578,0.00252150048994156
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPTX2,Neuronal pentraxin-2,37437,-0.00953992054148463,0.00315978832197905,-0.0157331056525636,-0.00334673543040568,0.00253943656833695
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UROS,Uroporphyrinogen-III synthase,37039,0.0193888687285365,0.00642777677229374,0.00679042625484081,0.0319873112022323,0.00256267205611123
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTSV,Cathepsin L2,39967,0.011567905431474,0.00383531986681509,0.00405067849251641,0.0190851323704316,0.00256404665422642
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ABO,Histo-blood group ABO system transferase,37445,0.04056416595349,0.0134487879422702,0.0142045415866405,0.0669237903203396,0.0025644204518689
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD55,Complement decay-accelerating factor,39315,0.00716659191843752,0.0023767199509248,0.00250822081462492,0.0118249630222501,0.00257117725085224
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNDC15,Thioredoxin domain-containing protein 15,39913,-0.00766327026415548,0.00254238094441164,-0.0126463369152023,-0.00268020361310866,0.00258051577928528
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK11,Kallikrein-11,39779,0.00820035410710307,0.00272652263918415,0.00285636973430215,0.013544338479904,0.00263710171499979
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39247,0.0172946071630058,0.0057519368964988,0.00602081084586819,0.0285684034801435,0.00264487449845293
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37169,0.0197851239541577,0.00658425112516953,0.00687999174882543,0.03269025615949,0.00266148568863776
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD80,T-lymphocyte activation antigen CD80,37437,0.00942626409461042,0.00314379506023809,0.00326442577654376,0.0155881024126771,0.00271918513129332
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOA4,Apolipoprotein A-IV,37453,0.00992956550514191,0.00332147520246334,0.00341947410831377,0.01643965690197,0.00279930194049883
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK15,Kallikrein-15,37351,0.0141178657151534,0.00472325476248916,0.00486028638067465,0.0233754450496322,0.00280385307701229
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDKL5,Cyclin-dependent kinase-like 5,36991,-0.014757174651309,0.00493801008518213,-0.0244356744182659,-0.00507867488435198,0.00280881891554861
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRL6,Fc receptor-like protein 6,39866,-0.0184335328621214,0.00616972485715624,-0.0305261935821476,-0.00634087214209516,0.002814747832268
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37368,0.0189091797781327,0.00633323562291531,0.00649603795721874,0.0313223215990467,0.00283431545295668
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCGN,Secretagogin,39587,-0.0120188089568992,0.00403573561941352,-0.0199288507709497,-0.00410876714284866,0.00290487237842141
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HYAL1,Hyaluronidase-1,39747,0.0063378680572282,0.00213379567505133,0.00215562853412759,0.0105201075803288,0.00298019902606108
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TERF1,Telomeric repeat-binding factor 1,37056,-0.00813139616931772,0.00274127025493594,-0.0135042858689922,-0.00275850646964327,0.00301958390687414
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFF3,Trefoil factor 3,39839,-0.013445729454105,0.0045396482671329,-0.0223434400576855,-0.00454801885052457,0.00306252716310324
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA1,Alpha-1-antitrypsin,37247,-0.00224647973450923,0.000759356866677338,-0.00373481919319682,-0.000758140275821651,0.00309783518166194
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4M,C-type lectin domain family 4 member M,37410,0.0133828054395893,0.00453961706596352,0.00448515599030075,0.0222804548888778,0.00320379369063179
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17RA,Interleukin-17 receptor A,39858,0.0121207028263809,0.00412548967541318,0.00403474306257111,0.0202066625901908,0.00330804725095456
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNGR1,Interferon gamma receptor 1,39931,0.00555458654199959,0.00189072093622476,0.00184877350699907,0.00926039957700011,0.00331004597188241
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39587,0.0115990322090651,0.0039503704335142,0.00385630615937728,0.0193417582587529,0.00332753568603733
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPTN,Neuroplastin,39477,0.023052233328966,0.00786026535389738,0.00764611323532715,0.0384583534226049,0.00336456701637115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLL4,Delta-like protein 4,37043,0.0236431221854461,0.00806590877859235,0.00783394097940512,0.0394523033914871,0.00338190574970273
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37411,0.0192689685487014,0.0065937829372601,0.00634515399167166,0.0321927831057312,0.00348038088157696
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MBL2,Mannose-binding protein C,37257,-0.0293826651745657,0.0100786782279605,-0.0491368745013682,-0.00962845584776319,0.00355902162835984
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLNS1A,Methylosome subunit pICln,37039,-0.0092023761387145,0.0031581127892791,-0.0153922772057015,-0.00301247507172746,0.00357561956700013
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",39489,0.0118658177684524,0.00407739054258916,0.00387413230497765,0.0198575032319271,0.00361765114797599
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA1,Annexin A1,37072,0.0119382686546529,0.00410541353878987,0.00389165811862472,0.019984879190681,0.00364431540086903
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHRM1,Muscarinic acetylcholine receptor M1,37039,-0.00998251866412117,0.00344341182938971,-0.016731605849725,-0.00323343147851734,0.00374949104339521
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MELTF,Melanotransferrin,37437,0.00788872914676126,0.0027220366628997,0.00255353728747785,0.0132239210060447,0.00376033861683661
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDIA5,Protein disulfide-isomerase A5,36962,0.0167112929589407,0.00577288181710645,0.00539644459741206,0.0280261413204693,0.00380036108658036
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37411,0.0113175427435062,0.00391055403357918,0.00365285683769101,0.0189822286493214,0.00380850950145986
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB5,Integrin beta-5,39913,0.0102648402495187,0.00355472319722871,0.00329758278295041,0.017232097716087,0.00388634603174453
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CKAP4,Cytoskeleton-associated protein 4,39991,0.00686070760616961,0.00237883279570345,0.00219819532659085,0.0115232198857484,0.00393097517412278
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRR4,Proline-rich protein 4,37031,-0.0188392188077262,0.00655365807404176,-0.031684388632848,-0.00599404898260432,0.00405173068486662
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NGF,Beta-nerve growth factor,39749,0.00330459661743676,0.00115147244549848,0.00104771062425974,0.00556148261061378,0.00411159352568697
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HTR1B,5-hydroxytryptamine receptor 1B,36991,-0.0115169708686287,0.00401364125963409,-0.0193837077375116,-0.00365023399974592,0.00411833412449052
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM171B,Protein FAM171B,37368,0.00745536743138856,0.00259851709917942,0.00236227391699689,0.0125484609457802,0.00412298914928454
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE10,Inactive ribonuclease-like protein 10,37043,-0.0125586143651106,0.0043917966732857,-0.0211665358447505,-0.0039506928854706,0.00424892534912952
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCP2,Non-specific lipid-transfer protein,39477,0.0208660385414061,0.0072999239297596,0.00655818763907728,0.0351738894437349,0.00426358377120284
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEL1L,Protein sel-1 homolog 1,37043,0.00837391432761069,0.00293496477051394,0.00262138337740336,0.014126445277818,0.00433546708761458
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LY6D,Lymphocyte antigen 6D,39761,0.00966555589852001,0.0033881426318266,0.00302479634013987,0.0163063154569002,0.00433973312131858
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39351,-0.0227068130472281,0.00797235690356083,-0.0383326325782073,-0.00708099351624883,0.00440261065021085
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKCQ,Protein kinase C theta type,39587,0.0115086217392027,0.00406133103332356,0.00354841291388851,0.0194688305645169,0.00460700914756173
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PMS1,PMS1 protein homolog 1,37039,0.0132085132222957,0.00466524075400559,0.00406464134444475,0.0223523851001467,0.00464351254406413
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GKN1,Gastrokine-1,39123,0.00744476687017017,0.00262988341619646,0.0022901953744251,0.0125993383659152,0.00464872989026557
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL7R,Interleukin-7 receptor subunit alpha,39858,-0.0137584821934488,0.00487456486832165,-0.0233126293353593,-0.00420433505153841,0.00477089138937936
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA6C,Semaphorin-6C,37056,0.0069180161854922,0.0024559296039398,0.00210439416177018,0.0117316382092142,0.00485672887450226
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37039,0.00962457922059086,0.00341894165828729,0.00292345357034778,0.0163257048708339,0.0048838107996758
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCDH12,Protocadherin-12,37411,0.00664049264624724,0.00237328819087865,0.00198884779212508,0.0112921375003694,0.00514905224711443
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA1,Carbonic anhydrase 1,39531,0.0155353670259823,0.00555274768270983,0.00465198156787108,0.0264187524840936,0.00515179103978567
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39214,0.00987456049300308,0.00353235116578818,0.00295115220805825,0.0167979687779479,0.00518896206231944
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIMAP7,GTPase IMAP family member 7,37124,-0.00854333360161074,0.00306149973162492,-0.0145438730755956,-0.00254279412762589,0.00526902406341109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH1,Cadherin-1,39315,0.0105264469942898,0.00377777904002065,0.00312200007584934,0.0179308939127303,0.00533601410005152
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37139,-0.0167792604794428,0.00604268142044053,-0.0286229160635062,-0.00493560489537931,0.00549754827742006
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJA4,DnaJ homolog subfamily A member 4,37388,-0.0181517075280505,0.00653927825432763,-0.0309686929065327,-0.00533472214956839,0.00551422671206754
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39862,0.00771058725520485,0.00277871866760361,0.00226429866670178,0.0131568758437079,0.0055287578667209
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL28,C-C motif chemokine 28,39815,0.0154219033089468,0.00557261294611159,0.00449958193456809,0.0263442246833255,0.00565625660773309
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP152,Centrosomal protein of 152 kDa,36962,0.0108388892595913,0.00392305669412582,0.00314969813910467,0.0185280803800779,0.00573757859585679
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLIC5,Chloride intracellular channel protein 5,37039,-0.00829870012360574,0.00300660725022245,-0.0141916503340417,-0.00240574991316974,0.00578538873224387
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CENPF,Centromere protein F,37169,0.0139271398557018,0.00505775563566349,0.00401393880980139,0.0238403409016023,0.00590200212039472
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",37411,0.0101867911895548,0.00370016698034983,0.00293446390806918,0.0174391184710405,0.00591192224211657
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,37169,0.0112618127367703,0.00410268566342606,0.00322054883645524,0.0193030766370854,0.0060594741880592
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL15RA,Interleukin-15 receptor subunit alpha,39587,0.00881504982957152,0.00321183067145198,0.00251986171352565,0.0151102379456174,0.00606615174653921
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NMRK2,Nicotinamide riboside kinase 2,36962,-0.0105113314675084,0.00383759417307076,-0.0180330160467271,-0.00298964688828971,0.00617018192351153
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37411,0.00656694740915247,0.00240712510635,0.00184898220070646,0.0112849126175985,0.00637768032521553
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37043,-0.00678241264414802,0.00248915927700544,-0.0116611648270787,-0.00190366046121736,0.00644291038850806
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39749,0.00980463052500922,0.00361000352818675,0.00272902360976318,0.0168802374402553,0.00661550721440664
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYOM1,Myomesin-1,36991,0.0120639201208595,0.00444213490135901,0.00335733571419588,0.0207705045275232,0.0066203692208593
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37021,0.009128073522955,0.00336117741511475,0.00254016578933009,0.0157159812565799,0.00662147637445657
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,39836,0.0216873249275135,0.00798696681187475,0.00603286997623901,0.037341779878788,0.00662790499996777
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TK1,"Thymidine kinase, cytosolic",37169,0.0116970918119972,0.004318636060332,0.00323256513374645,0.0201616184902479,0.00676714041204586
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP6V1D,V-type proton ATPase subunit D,39788,0.00660152027614341,0.0024412657717158,0.00181663936358045,0.0113864011887064,0.00685545103050964
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TTN,Titin,37021,-0.0173519449356839,0.00642278088355198,-0.0299405954674457,-0.00476329440392198,0.00690899515747884
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",39931,0.00678995589879302,0.00251708902863597,0.00185646140266651,0.0117234503949195,0.00699261475754444
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FRMD7,FERM domain-containing protein 7,37039,0.00846750941241107,0.00315230472778759,0.00228899214594739,0.0146460266788747,0.00723749238177582
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAT,Catalase,37252,0.013295227262348,0.00495408385622353,0.00358522290414989,0.0230052316205461,0.00729040132257508
NMR metabolomics,X23503.Total Lipids in Medium VLDL,QPCT,Glutaminyl-peptide cyclotransferase,39862,0.00661644597115112,0.00247630632264886,0.00176288557875936,0.0114700063635429,0.00754992175807312
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGBL1,Integrin beta-like protein 1,37437,-0.00894683499665308,0.00334891460603714,-0.0155107076244859,-0.00238296236882028,0.00755890638308352
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37368,-0.0209480794383419,0.00785008357347971,-0.0363342432423622,-0.0055619156343217,0.00762779685694201
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBM19,Probable RNA-binding protein 19,37021,-0.011896546246397,0.00446434079204196,-0.0206466541987992,-0.00314643829399478,0.0077129571182857
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,39866,-0.0154394154132693,0.00580747468827603,-0.0268220658022903,-0.00405676502424829,0.00785576086225848
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOBR,Apolipoprotein B receptor,37043,-0.0105745515948408,0.00398578585598897,-0.0183866918725792,-0.00276241131710242,0.00798599546843094
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSAPL1,Proactivator polypeptide-like 1,37382,0.0123200481896959,0.00466575512342644,0.00317516814778009,0.0214649282316118,0.00828725184299677
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSB,Lupus La protein,39489,0.0149679940339171,0.00568228054264505,0.00383072417033283,0.0261052638975014,0.00844306901810331
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37022,0.0096124338284129,0.00365239448569574,0.00245374063644925,0.0167711270203766,0.00850286695152319
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF9,Fibroblast growth factor 9,36931,0.00997358317986312,0.00380762735158802,0.00251063357075061,0.0174365327889756,0.00881941949070027
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MORF4L2,Mortality factor 4-like protein 2,36962,-0.00912034784747659,0.0034912081985492,-0.015963115916633,-0.00227757977832015,0.00900179697604137
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,39788,0.00648191667271977,0.00248395251638133,0.00161336974061237,0.0113504636048272,0.00907548863657162
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCUN1D1,DCN1-like protein 1,36991,-0.0183253157613954,0.00702724505171146,-0.0320987160627499,-0.00455191546004098,0.00912419585169745
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBPMS,RNA-binding protein with multiple splicing,37056,0.0158463114662706,0.0060910979256725,0.00390775953195254,0.0277848634005887,0.00929064537960882
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39985,0.0068286382266795,0.00262540464086225,0.00168284513058949,0.0119744313227695,0.00930413678195505
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL9,C-X-C motif chemokine 9,39931,0.0158073956358097,0.0061040761320435,0.00384340641700449,0.027771384854615,0.00961613523240593
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LEG1,Protein LEG1 homolog,36703,-0.0169727892521411,0.00656591088174187,-0.0298419745803552,-0.00410360392392707,0.00974920903293879
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VEGFB,Vascular endothelial growth factor B,37056,0.00687483717499996,0.00266084225472961,0.00165958635572993,0.01209008799427,0.00978512388223787
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RALY,RNA-binding protein Raly,37368,0.0117597562729069,0.00456491321869789,0.00281252636425899,0.0207069861815547,0.0100021703700616
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX3,Syntaxin-3,37388,0.00918791094853936,0.00356737584602159,0.00219585429033705,0.0161799676067417,0.0100189537028293
NMR metabolomics,X23503.Total Lipids in Medium VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,37043,0.00993907912164941,0.00386213642385603,0.0023692917308916,0.0175088665124072,0.0100793625814034
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SBSN,Suprabasin,37420,-0.0081791517279671,0.00318464399415142,-0.0144210539565039,-0.00193724949943032,0.0102301911281197
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPS10,40S ribosomal protein S10,37021,-0.0103297825347534,0.00403098122388954,-0.0182305057335769,-0.00242905933592987,0.0104002632361046
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,37169,0.014140133981253,0.00552351995224947,0.003314034874844,0.0249662330876619,0.0104785796462259
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NELL1,Protein kinase C-binding protein NELL1,39913,0.0097793174240599,0.00382650062759139,0.00227937619398078,0.017279258654139,0.0106071333816053
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAMDC2,MAM domain-containing protein 2,37437,-0.00791538146005447,0.00309723484438646,-0.0139859617550519,-0.00184480116505702,0.0106104200400823
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD248,Endosialin,37437,-0.00949043263683445,0.0037188943219605,-0.016779465507877,-0.00220139976579187,0.0107230424934516
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SNU13,NHP2-like protein 1,37021,0.0148182704806736,0.00581325540068313,0.00342428989533466,0.0262122510660125,0.0108129719649617
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC1,Sialoadhesin,39931,-0.0099646584203201,0.00391270941089178,-0.017633568865668,-0.00229574797497221,0.0108826442236786
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JCHAIN,Immunoglobulin J chain,39587,-0.0144232654216629,0.00566969843589471,-0.0255358743560166,-0.0033106564873093,0.0109710675029854
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOS1,"Nitric oxide synthase, brain",39489,-0.0128506235972175,0.00505265999849628,-0.0227538371942703,-0.00294741000016484,0.010989437701198
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYH7B,Myosin-7B,36962,-0.0104667581827025,0.00413550643862294,-0.0185723508024035,-0.00236116556300155,0.0113870217836197
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39835,-0.0172055564009968,0.0068095735502347,-0.0305523205594568,-0.00385879224253678,0.0115244840023845
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DRAXIN,Draxin,39749,0.00995198708999303,0.00393894192625252,0.00223166091453809,0.017672313265448,0.011528081602067
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BABAM1,BRISC and BRCA1-A complex member 1,37056,0.00702859724759485,0.00278678989911108,0.00156648904533713,0.0124907054498526,0.0116769106444987
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,37368,0.0126102795042997,0.00500402309095495,0.00280239424602802,0.0224181647625714,0.0117459731655503
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRLF1,Cytokine receptor-like factor 1,39931,0.00615535180366937,0.00244377903358458,0.0013655448978436,0.0109451587094951,0.0117857086125933
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENO1,Alpha-enolase,39830,0.0186289777533292,0.00739880360533727,0.00412732268686813,0.0331306328197902,0.0118175111245797
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRIM26,Tripartite motif-containing protein 26,36962,0.0131970341996385,0.0052506360630767,0.00290578751600814,0.0234882808832688,0.011968712823925
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POF1B,Protein POF1B,37056,-0.0106684430370654,0.00424474634770661,-0.0189881458785703,-0.00234874019556042,0.0119715970918168
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,36991,-0.00813726584978121,0.00323779229601167,-0.0144833387499641,-0.00179119294959834,0.0119755390283117
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FABP1,"Fatty acid-binding protein, liver",39862,0.0220115928772061,0.0087687219138082,0.00482489792614205,0.0391982878282702,0.0120747126968464
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HEBP1,Heme-binding protein 1,39585,-0.0126353437156108,0.00503460733348519,-0.0225031740892418,-0.0027675133419798,0.0120934123696456
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GGT5,Glutathione hydrolase 5 proenzyme,39749,0.00539431628183941,0.00215166425685878,0.0011770543383962,0.00961157822528262,0.0121844663814118
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAL,Galanin peptides,39931,0.0151018465373869,0.00602842668948625,0.00328613022599384,0.0269175628487799,0.0122512923778283
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37056,0.0101938546414299,0.00407324835100029,0.00221028787346934,0.0181774214093905,0.0123392490288968
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHA10,Ephrin type-A receptor 10,39489,0.0149981516151577,0.00600462884514371,0.00322907907867601,0.0267672241516393,0.0125080997358019
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AIF1L,Allograft inflammatory factor 1-like,37043,0.0136907996447738,0.00549305871210613,0.00292440456904583,0.0244571947205019,0.0127011366487055
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,39931,-0.00654616850745593,0.00262748609661864,-0.0116960412568285,-0.0013962957580834,0.0127334068440039
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37445,0.01091759372363,0.00438380315932898,0.00232533953134524,0.0195098479159148,0.0127703978258175
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OMG,Oligodendrocyte-myelin glycoprotein,39788,0.0151328881534281,0.00608601079538777,0.00320430699446808,0.0270614693123882,0.0129106889654324
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39477,0.0279496148495839,0.0112676434873092,0.00586503361445784,0.05003419608471,0.0131295447514204
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37382,-0.0163529613806689,0.00660519914080548,-0.0292991516966477,-0.00340677106469019,0.0133070302148963
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCF2,Neutrophil cytosol factor 2,39843,0.0192192947706791,0.00776719696471189,0.00399558871984382,0.0344430008215144,0.0133556325460508
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,37411,0.00854286869951854,0.00347068458737981,0.0017403269082541,0.015345410490783,0.0138505676474043
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37056,0.0082708826708916,0.00336907916627143,0.0016674875049996,0.0148742778367836,0.0141036752712331
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAYN,Layilin,39713,-0.00741130088219957,0.00302137377778596,-0.01333319348666,-0.00148940827773909,0.0141794083009932
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HLA_DRA,,39799,-0.00813868369237515,0.0033181949407254,-0.0146423457761969,-0.00163502160855336,0.0141877461558597
NMR metabolomics,X23503.Total Lipids in Medium VLDL,METAP1,Methionine aminopeptidase 1,39489,0.00699804450917348,0.00285330994766966,0.00140555701174094,0.012590532006606,0.0141934180789645
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD300C,CMRF35-like molecule 6,40009,0.00761711453760297,0.00311359826595551,0.00151446193633017,0.0137197671388758,0.014439571908676
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RELB,Transcription factor RelB,37056,0.0112654597620562,0.00461481420264356,0.00222042392487482,0.0203104955992376,0.0146535696224559
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17A,Interleukin-17A,39558,-0.00967922536472753,0.00396591908745041,-0.0174524267761303,-0.00190602395332472,0.0146738309715899
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD48,CD48 antigen,39908,-0.00660376575434921,0.00271075740494878,-0.0119168502680488,-0.00129068124064961,0.0148560250122464
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBP2,Guanylate-binding protein 2,39587,0.0135196672999019,0.00555232266015675,0.00263711488599469,0.0244022197138091,0.0149045971179929
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37039,-0.00718655380223973,0.00297805089470802,-0.0130235335558674,-0.00134957404861201,0.0158278407022489
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,39962,-0.00672283416474067,0.00278831284192238,-0.0121879273349085,-0.00125774099457281,0.0159166583287524
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDRG1,p53 and DNA damage-regulated protein 1,37039,0.0119665157616624,0.00497786911250436,0.0022098923011539,0.021723139222171,0.0162330000321711
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,37382,-0.0121027968036061,0.00503618738830946,-0.0219737240846926,-0.00223186952251955,0.0162671676877273
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,37056,0.0153679077375981,0.00641725658351278,0.00279008483391306,0.0279457306412832,0.0166442710557476
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PXDNL,Peroxidasin-like protein,37368,0.0133483572029511,0.00558023876557845,0.00241108922241737,0.0242856251834849,0.0167669429832303
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,39788,0.0077060492826532,0.00322476349988142,0.00138551282288561,0.0140265857424208,0.0168760898615154
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACE,Angiotensin-converting enzyme,37445,-0.00573993594298259,0.00240445525902092,-0.0104526682506636,-0.00102720363530158,0.0169904540435413
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDAN1,Codanin-1,37388,0.00502858253750866,0.00211518382583712,0.000882822238867914,0.00917434283614941,0.0174502281895155
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIL1,Nucleotide exchange factor SIL1,37043,0.00741631302590688,0.00312713501339161,0.00128712839965933,0.0135454976521544,0.0177255404946299
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB116,Beta-defensin 116,36991,-0.0172039041489266,0.00725421142968206,-0.0314221585511034,-0.00298564974674975,0.0177268054107374
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBC1D17,TBC1 domain family member 17,39489,0.00976213089002387,0.00411709299664551,0.00169262861659866,0.0178316331634491,0.0177462166347468
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCRLB,Fc receptor-like B,39477,0.0128394946822181,0.00541910136398106,0.00221805600881519,0.0234609333556209,0.0178337221537298
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REG1B,Lithostathine-1-beta,40052,-0.0120305614743622,0.00508710095433366,-0.0220012793448562,-0.00205984360386826,0.0180459315563683
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCN,Decorin,39585,-0.00481529475292439,0.0020365254582936,-0.00880688465117985,-0.000823704854668928,0.0180681734945712
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNN,Tenascin-N,37437,0.00950441915206378,0.00402928926330995,0.00160701219597627,0.0174018261081513,0.0183466055664092
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40030,0.00730286789051742,0.00309795331541171,0.00123087939231045,0.0133748563887244,0.0184192159697742
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD7,T-cell antigen CD7,37037,0.00942741220379654,0.0040150244324797,0.00155796431613633,0.0172968600914568,0.0188875234554816
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40009,0.010201793808316,0.00435200742972999,0.00167185924604518,0.0187317283705867,0.0190821351898591
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OLFM4,Olfactomedin-4,36654,0.0270953903073709,0.0115584772137308,0.00444077496845852,0.0497500056462833,0.0190831217644769
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSMB,Beta-microseminoprotein,39780,0.0146890486974488,0.00628380237965145,0.0023727960333319,0.0270053013615656,0.0194200639990526
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPK13,Mitogen-activated protein kinase 13,36962,0.0093656469518802,0.00400949080030398,0.00150704498328441,0.017224248920476,0.0195130522431109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC39A14,Zinc transporter ZIP14,39489,0.00712110428493137,0.00305682857110739,0.00112972028556089,0.0131124882843019,0.0198414198587083
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37368,0.00989316751778478,0.00424904193836596,0.0015650453185875,0.0182212897169821,0.0199093241357064
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL9A2,Collagen alpha-2(IX) chain,37169,0.0100382825203509,0.004324251900023,0.00156274879630578,0.018513816244396,0.020280736286392
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIAA1549,UPF0606 protein KIAA1549,37169,0.0149359172420178,0.00644283738818258,0.00230795596117997,0.0275638785228557,0.0204524236816482
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LMNB1,Lamin-B1,37348,0.0125939280918611,0.00543898426415595,0.00193351893411547,0.0232543372496068,0.0206009124596996
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GUCA2A,Guanylin,39796,-0.00695320645714038,0.00301828419168683,-0.0128690434728466,-0.00103736944143418,0.0212525711521635
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOX9,Transcription factor SOX-9,37039,0.00582394977441701,0.0025340471941591,0.000857217273865166,0.0107906822749689,0.0215614425038425
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CADPS,Calcium-dependent secretion activator 1,37039,-0.00933292543139655,0.00406410073362598,-0.0172985628693035,-0.00136728799348962,0.0216668833321395
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP290,Centrosomal protein of 290 kDa,37169,0.0111056464319398,0.00486373724559038,0.0015727214305826,0.0206385714332969,0.0224250605830991
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37021,-0.0144595692826194,0.0063432079515008,-0.0268922568675609,-0.0020268816976778,0.0226511689026445
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,37437,0.0126356000340713,0.00556383135512978,0.00173049057801689,0.0235407094901256,0.0231610536897252
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL10RA,Interleukin-10 receptor subunit alpha,39587,0.0123771585973397,0.00547139578867333,0.00165322285153997,0.0231010943431394,0.0237012662446539
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39881,-0.0103652124186455,0.00460779502335556,-0.0193964906644224,-0.00133393417286864,0.0244945331712939
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYAR,Cell growth-regulating nucleolar protein,39477,0.0108551888114283,0.00482730501817091,0.00139367097581327,0.0203167066470432,0.0245451013177628
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBA,Lysosomal acid glucosylceramidase,37039,0.0111096856636971,0.00494068274053363,0.00142594749225116,0.020793423835143,0.0245535513991351
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,37437,0.00458175247174531,0.00203985645838978,0.000583633813301336,0.00857987113018929,0.0247126453985687
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXDC2,Plexin domain-containing protein 2,37388,0.00564311675075785,0.00251602749542821,0.000711702859718551,0.0105745306417971,0.0249214731371904
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",36942,0.00531904448313761,0.00237913844873291,0.000655933123621103,0.00998215584265411,0.0253881009211137
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SULT1A1,Sulfotransferase 1A1,40009,-0.0269349971457813,0.0120790223083171,-0.0506098808700828,-0.0032601134214798,0.0257678546780291
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMG4,Proteasome assembly chaperone 4,37056,-0.0115817479400677,0.00520178978593957,-0.0217772559205093,-0.00138623995962617,0.0259979997460956
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PODXL2,Podocalyxin-like protein 2,39913,0.00573017754723281,0.00257407109359234,0.000684998203791832,0.0107753568906738,0.0260203255593933
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37021,0.00539982275173437,0.00243404872999453,0.000629087240945094,0.0101705582625236,0.0265409582665454
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COMMD9,COMM domain-containing protein 9,37368,0.00815798651882271,0.00368065939865515,0.000943894097458616,0.0153720789401868,0.0266774989703298
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE6,Ribonuclease K6,37386,0.00574002393323814,0.00259044883955001,0.000662744207720121,0.0108173036587562,0.0267189459317198
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX1B,Syntaxin-1B,37039,0.00883155123610091,0.00398573919592181,0.00101950241209416,0.0166436000601077,0.0267230779182791
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLAU,Urokinase-type plasminogen activator,39858,0.00593219718403005,0.0026784561456023,0.000682423138649549,0.0111819712294105,0.0267890489545555
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SDK2,Protein sidekick-2,37124,0.00770948040532445,0.00348760624911824,0.000873772157052701,0.0145451886535962,0.0270849627215984
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAP1,Antigen peptide transporter 1,37169,-0.0121856881320001,0.00551413078597927,-0.0229933844725195,-0.00137799179148071,0.0271289267048098
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,37056,-0.0123857895226563,0.00564415663027264,-0.0234483365179907,-0.00132324252732197,0.0282208223669437
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,39786,-0.00547471153247906,0.00250740622185204,-0.0103892277273091,-0.000560195337649058,0.0290197137294927
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37368,0.0104393145209547,0.0047820649391893,0.00106646724014363,0.0198121618017657,0.0290519370373351
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37039,-0.00966392853410337,0.00442687208176982,-0.0183405978143722,-0.000987259253834522,0.029052282477007
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,37039,0.00601100321541268,0.00276216183170756,0.000597166025265861,0.0114248404055595,0.0295583696579571
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STC2,Stanniocalcin-2,39831,-0.00537487028255861,0.00247732111325543,-0.0102304196645392,-0.000519320900577979,0.0300495810059554
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39749,0.0207776324544445,0.00958121139926102,0.00199845811189293,0.0395568067969961,0.0301293002987109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN2B,Sodium channel subunit beta-2,37039,-0.00585818049091732,0.0027034492350207,-0.0111569409915579,-0.000559419990276758,0.0302581821143204
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDA1,DET1- and DDB1-associated protein 1,37021,0.00806795906605533,0.00373120694014533,0.000754793463370485,0.0153811246687402,0.0306136312994929
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCUN1D2,DCN1-like protein 2,36962,-0.016288112958956,0.00755878005360673,-0.0311033218640252,-0.00147290405388679,0.0311909542395815
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD177,CD177 antigen,39844,-0.0251708439199653,0.0116866900527784,-0.048076756423411,-0.00226493141651968,0.0312704219980153
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STX5,Syntaxin-5,37056,0.00820058719555099,0.00382080065271989,0.00071181791622001,0.015689356474882,0.0318671720997779
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIT,Mast/stem cell growth factor receptor Kit,39908,0.00577073513985914,0.00269179330568166,0.000494820260723085,0.0110466500189952,0.0320618520884192
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GH2,Growth hormone variant,39477,0.0329288636340478,0.0153887431353735,0.0027669270887158,0.0630908001793798,0.0323862208671697
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSRP3,Cysteine and glycine-rich protein 3,37021,-0.019567358276814,0.00914645492135077,-0.0374944099226615,-0.00164030663096649,0.0324266490284107
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAFB2,Scaffold attachment factor B2,37411,0.00548306543962041,0.0025703006963623,0.000445276074750306,0.0105208548044905,0.0329230454873356
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39585,0.00636085049650346,0.00299030019311982,0.000499862117988611,0.0122218388750183,0.03342221267481
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADRA2A,Alpha-2A adrenergic receptor,37021,-0.0142897390412573,0.00672898788692219,-0.0274785552996247,-0.00110092278288977,0.0337214563550938
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MORF4L1,Mortality factor 4-like protein 1,37169,-0.00802827370637663,0.00378074557463905,-0.0154385350326692,-0.000618012380084085,0.0337334617763161
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1A,Interleukin-1 alpha,39587,0.0106156232284239,0.00500044641894114,0.000814748247299301,0.0204164982095486,0.0337748661444951
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RETN,Resistin,39790,-0.00810000905270656,0.00381899898037556,-0.0155852470542427,-0.000614771051170469,0.0339391404961097
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SELL,L-selectin,37453,0.00450165822213236,0.00212380392883012,0.000339002521625323,0.00866431392263939,0.03405614073584
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OMD,Osteomodulin,39931,-0.00863339191962739,0.00407323655617812,-0.0166169355697365,-0.000649848269518269,0.034060059600714
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFF1,Trefoil factor 1,39789,-0.0149312499531187,0.00704698550656798,-0.028743341545992,-0.00111915836024549,0.0341216421092967
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RYR1,Ryanodine receptor 1,37021,-0.00672589148532794,0.00317877398786468,-0.0129562885015427,-0.000495494469113173,0.0343740859301633
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA6,Carbonic anhydrase 6,39817,-0.0125740284358956,0.00595284092955036,-0.0242415966578143,-0.000906460213976917,0.0346784879232672
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTP1,Glutathione S-transferase P,39393,-0.0137089945376113,0.00649743309333575,-0.0264439634005494,-0.000974025674673248,0.0348821188499464
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SH3GL3,Endophilin-A3,37083,0.0162966265082692,0.00773633473750501,0.00113341042275938,0.031459842593779,0.0351793154499998
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIMP2,Metalloproteinase inhibitor 2,37437,-0.00503179450934866,0.00238925161960354,-0.0097147276837716,-0.000348861334925714,0.0352215492822498
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PON1,Serum paraoxonase/arylesterase 1,37445,0.00502187503337172,0.002398585473214,0.000320647505872278,0.00972310256087117,0.0363068154758322
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39868,0.00601697573923668,0.00287638932781491,0.000379252656719448,0.0116546988217539,0.0364676293433779
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRPB1,Signal-regulatory protein beta-1,39835,-0.00864440790577995,0.0041462135110364,-0.0167709863874113,-0.000517829424148613,0.0370949330642489
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFDC2,WAP four-disulfide core domain protein 2,39017,0.00699094234139028,0.00335656043648415,0.000412083885881352,0.0135698007968992,0.0372889452362823
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CENPJ,Centromere protein J,37169,0.0141465442828096,0.00680738710292229,0.000804065561081882,0.0274890230045372,0.0377177377703127
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",37021,0.00771764974417988,0.00372795769862979,0.000410852654865492,0.0150244468334943,0.0384522806692212
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,37021,0.00725149488755426,0.00350436535665756,0.000382938788505445,0.0141200509866031,0.0385397802916385
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37021,-0.0111782709794547,0.00541169640357382,-0.0217851959304594,-0.000571346028449984,0.0388880491271753
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37411,0.00929800225336922,0.00452666762517465,0.000425733708026906,0.0181702707987115,0.0399899804972369
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA14,Carbonic anhydrase 14,40030,0.00675038275590501,0.00328756560931719,0.000306754161643328,0.0131940113501667,0.0400588247663014
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,39372,-0.00696430336595935,0.00341062916119877,-0.0136491365219089,-0.00027947021000975,0.0411742666665024
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMC3,26S proteasome regulatory subunit 6A,36962,-0.0057520530056506,0.00281777614681469,-0.0112748942534074,-0.000229211757893806,0.0412365475172187
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37388,0.0105868976422657,0.00519018693411462,0.000414131251401042,0.0207596640331304,0.0413905116418481
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB39B,Ras-related protein Rab-39B,37021,0.0169746765236001,0.00833227318775811,0.000643421075594192,0.033305931971606,0.0416479296594578
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFAP3L,Microfibrillar-associated protein 3-like,37039,-0.0122764402843897,0.00604457848750272,-0.024123814119895,-0.000429066448884328,0.0422766805277309
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPR1,Atrial natriuretic peptide receptor 1,37021,-0.00789881848473846,0.00389915187963847,-0.0155411561688299,-0.000256480800647056,0.0428076123562163
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37039,-0.00915539094006945,0.00452824989367312,-0.0180307607316688,-0.000280021148470139,0.0432131834761338
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37021,-0.00581307890424687,0.0028881427380529,-0.0114738386708306,-0.000152319137663177,0.0441623719466344
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LTO1,Protein LTO1 homolog,39587,0.00759491434896078,0.00377888784327641,0.000188294176139028,0.0150015345217825,0.0444664498371609
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MN1,Transcriptional activator MN1,37039,-0.0111434002759884,0.00555017573409658,-0.0220217447148177,-0.000265055837159094,0.0446895677187957
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36962,0.00953671145064368,0.00477126261416182,0.000185036726886524,0.0188883861744008,0.0456526225680865
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,37368,0.00529494535592011,0.00266617321437538,6.92458557443555e-05,0.0105206448560959,0.0470566125525743
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCNA,Proliferating cell nuclear antigen,36962,0.0119319879871118,0.00600965456675865,0.00015306503626485,0.0237109109379587,0.0471130328076183
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL19,Interleukin-19,39419,-0.0127338709641834,0.00641630872670761,-0.0253098360685303,-0.00015790585983648,0.0472054059062927
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TEX33,Testis-expressed protein 33,37169,-0.00737748578340004,0.00372226120414456,-0.0146731177435234,-8.1853823276707e-05,0.0475008574658309
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39984,0.00629008542828214,0.00318167377045795,5.40048381845563e-05,0.0125261660183797,0.0480616090771599
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39585,0.00498282662993424,0.00252101570338339,4.16358513028034e-05,0.00992401740856568,0.0481138663259769
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK14,Kallikrein-14,40030,0.00831394513176592,0.00422686384780094,2.92919900760861e-05,0.0165985982734558,0.0492083584359611
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP1,Caspase-1,39489,0.012277550473346,0.00625988446206298,8.17692770259566e-06,0.0245469240189895,0.049861037037716
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VIM,Vimentin,39585,0.0215305450729675,0.0109876901393675,-5.3276001927248e-06,0.0430664177461278,0.0500701292643529
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLL1,Delta-like protein 1,39913,-0.00518791290611775,0.00266222738812147,-0.0104058785868358,3.00527746003336e-05,0.0513472948863422
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RALB,Ras-related protein Ral-B,37056,0.0053410439080387,0.00274460223794182,-3.8376478327262e-05,0.0107204642944047,0.0516738403785175
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPM1B,Protein phosphatase 1B,37056,0.0116241330501,0.00598196887839661,-0.000100525951557328,0.0233487920517574,0.0520138174930517
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF12,Fibroblast growth factor 12,37056,0.00851094358036985,0.00439692797787202,-0.000107035256259311,0.017128922416999,0.0529310817161599
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSAP,Gamma-secretase-activating protein,39477,0.0159213700211532,0.00823877397297636,-0.000226626965880501,0.0320693670081868,0.0533167913449095
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL31,Interleukin-31,37056,-0.0104072415044557,0.00539093029235616,-0.0209734648774738,0.00015898186856233,0.0535651539828341
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37368,0.00881459044810418,0.00458066818349415,-0.000163519191544358,0.0177927000877527,0.054337681553654
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C9orf40,Uncharacterized protein C9orf40,37382,-0.0143114128928001,0.00744155783068618,-0.028896866240945,0.000274040455344784,0.054479136339949
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37124,-0.00701872044974063,0.00365148917123389,-0.0141756392253591,0.000138198325877789,0.0546079185104186
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHRDL2,Chordin-like protein 2,39868,-0.0101216686112995,0.0052712500925621,-0.0204533187927212,0.00020998157012226,0.054854841105253
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COPE,Coatomer subunit epsilon,39489,0.00848510963648527,0.00442921985514022,-0.000196161279589565,0.0171663805525601,0.0554199893888861
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP164,Centrosomal protein of 164 kDa,39587,0.0108601041256972,0.00567120439928868,-0.000255456496908595,0.021975664748303,0.0555162971516888
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37021,0.00898745145498841,0.00471010458014489,-0.00024435352209558,0.0182192564320724,0.0563972611105604
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36962,0.00470523372723067,0.00246699694345368,-0.00013008028193854,0.00954054773639988,0.0565072435932143
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL10,Interleukin-10,39587,-0.0141330318146523,0.00741346295535721,-0.0286634192071524,0.000397355577847801,0.0566164308224509
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMIGO1,Amphoterin-induced protein 1,37039,0.00892901944583156,0.0046841627782018,-0.000251939599443959,0.0181099784911071,0.0566440998358288
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VCAN,Versican core protein,40009,-0.00527339352528151,0.00276803539792829,-0.010698742905221,0.000151955854657941,0.0567843819924025
NMR metabolomics,X23503.Total Lipids in Medium VLDL,H2AP,Huntingtin-interacting protein M,36962,-0.00894191256060657,0.00470939011384243,-0.0181723171837377,0.000288492062524594,0.0576204734010245
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NME1,Nucleoside diphosphate kinase A,37056,-0.00387685017357973,0.00204858857073396,-0.00789208377221829,0.000138383425058838,0.0584529984833948
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPT,Microtubule-associated protein tau,39489,0.00932569921832792,0.00492915557899771,-0.00033544571650759,0.0189868441531634,0.058516561408205
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,39585,0.0093399696491096,0.00494804838313139,-0.000358205181827926,0.0190381444800471,0.0590971572753158
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36675,0.0086411772059355,0.00458131231446902,-0.000338194930423778,0.0176205493422948,0.0592933669955231
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRK1,NKG2-D type II integral membrane protein,37388,0.00783484240228583,0.00416823177690814,-0.00033489188045412,0.0160045766850258,0.0601764329298684
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,37056,0.00660907174768878,0.00351690578751393,-0.000284063595838523,0.0135022070912161,0.0602352355819024
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TEF,Thyrotroph embryonic factor,37021,0.00748547688030754,0.0039833446053589,-0.000321878546195893,0.015292832306811,0.0602401010261672
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,37388,0.00678918003881021,0.0036141688719547,-0.000294590950221,0.0138729510278414,0.060335652996063
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LIF,Leukemia inhibitory factor,39489,0.00899489675901162,0.00480762109088401,-0.000428040579121047,0.0184178340971443,0.0613684309365565
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37021,0.00985243539560354,0.00527368916108491,-0.000483995360122877,0.02018886615133,0.0617529848408065
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAP1A,Ras-related protein Rap-1A,37056,-0.011886645152353,0.006380061210433,-0.0243915651248016,0.000618274820095703,0.0624714319789098
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPP1,Osteopontin,40012,-0.00785325349496012,0.0042158213668234,-0.016116263373934,0.00040975638401373,0.0625078334548686
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RCC1,Regulator of chromosome condensation,37368,0.00884022038161464,0.00474934591461603,-0.000468497611032778,0.0181489383742621,0.0627157185710076
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37021,-0.00638383860447681,0.00343224773855777,-0.01311104417205,0.000343366963096428,0.0629136805749534
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASET2,Ribonuclease T2,39974,0.00443376629121423,0.00238440829745022,-0.000239673971788201,0.00910720655421665,0.0629769426353627
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PI16,Peptidase inhibitor 16,37445,0.00414733180228048,0.00223861663517456,-0.000240356802661664,0.00853502040722262,0.0639568612919875
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GHRHR,Growth hormone-releasing hormone receptor,39489,0.00931295506596404,0.00505307773133709,-0.000591077287456651,0.0192169874193847,0.0653440976214923
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRHR1,Corticotropin-releasing factor receptor 1,39585,0.0106953355343112,0.00581471799474172,-0.000701511735382625,0.0220921828040049,0.0658817046120582
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40052,-0.00463628071383561,0.00252379867489317,-0.00958292611662622,0.000310364688954996,0.0662245534176896
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37021,0.00795894240987402,0.00434960813717788,-0.00056628953899463,0.0164841743587427,0.0673014461697551
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH23,Cadherin-23,37388,-0.00461180164369616,0.00252053934269872,-0.00955205875538565,0.000328455467993326,0.0673185393424038
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP5,Rho GTPase-activating protein 5,36962,0.0126957400173944,0.00695796616676982,-0.000941873669474402,0.0263333537042633,0.068079075354872
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A3,Protein S100-A3,37368,0.00769237563331541,0.00423227582075101,-0.000602884975356575,0.0159876362419874,0.0691549855031475
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,39862,0.0500033457253712,0.0275356103228779,-0.00396645050746946,0.103973141958212,0.0693964459532641
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCP11,T-complex protein 11 homolog,37169,-0.0101249567218721,0.00558222374071312,-0.0210661152536698,0.00081620180992565,0.0697332596717406
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPVL,Probable serine carboxypeptidase CPVL,39990,0.00681725674200901,0.00376627301611385,-0.000564638369574136,0.0141991518535922,0.07030193147835
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL20,Interleukin-20,39587,0.00826996213880846,0.00457282650893636,-0.000692777818706813,0.0172327020963237,0.0705476245206134
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39913,0.00431721088781665,0.00239170274878424,-0.000370526499800448,0.00900494827543375,0.0710811495690391
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMBN,Ameloblastin,39587,-0.00481948776247444,0.00267254976863385,-0.0100576853089968,0.000418709784047901,0.0713556179761569
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37388,-0.00428600873966718,0.00237918516957823,-0.00894921167204051,0.000377194192706153,0.0716525434074105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEPTIN8,Septin-8,37357,0.0053886611406922,0.00299148517840988,-0.000474649808991171,0.0112519720903756,0.0716727104373215
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASP4,Caspase-4,37169,-0.0278357336460663,0.0154537179486004,-0.0581250208253232,0.00245355353319053,0.0716889225380313
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PADI4,Protein-arginine deiminase type-4,39456,0.0118366927870895,0.00658059759145212,-0.00106127849215664,0.0247346640663357,0.0720813418711484
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPAN1,Tetraspanin-1,39585,0.0067988678765157,0.00378365598955946,-0.00061709786302083,0.0142148336160522,0.0723699895341966
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA3G,Semaphorin-3G,37124,0.00738501112072213,0.00411271574107462,-0.000675911731784132,0.0154459339732284,0.0725724441587533
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMEM132A,Transmembrane protein 132A,37043,0.010536347023038,0.00587586624386867,-0.000980350814944606,0.0220530448610206,0.0729708376275194
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKAP12,A-kinase anchor protein 12,37124,0.00354572207952771,0.00197924379024067,-0.000333595749344013,0.00742503990839942,0.0732434316008319
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUMF1,Formylglycine-generating enzyme,37056,0.0114904914075274,0.00641518256830924,-0.00108326642635868,0.0240642492414135,0.073293708628458
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD70,CD70 antigen,39866,0.00707039762053703,0.00395258841876425,-0.000676675680240899,0.014817470921315,0.0736656313221103
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL20RA,Interleukin-20 receptor subunit alpha,39587,0.00760804381760989,0.00426876100892377,-0.000758727759880699,0.0159748153951005,0.0747260594936998
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAT1,Diamine acetyltransferase 1,37021,-0.0082775683703136,0.00466512095405848,-0.0174212054402682,0.000866068699641018,0.0760279978339246
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,39585,0.0130083409965328,0.00734952683228174,-0.0013967315947394,0.027413413587805,0.0767538023901456
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FBLN2,Fibulin-2,37437,-0.00498517062797912,0.0028381029403544,-0.0105478523910737,0.000577511135115513,0.0790230394845134
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFRAL,GDNF family receptor alpha-like,36942,-0.0102416471929138,0.00583927469858887,-0.021686625602148,0.00120333121632041,0.0794668521412739
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,37445,0.00648923509396923,0.00370199531273473,-0.000766675718990849,0.0137451459069293,0.079641380016638
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TLR2,Toll-like receptor 2,37169,-0.00372474748953949,0.00212767195533793,-0.00789498452200184,0.000445489542922852,0.0800342317685328
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTRL,Chymotrypsin-like protease CTRL-1,37388,-0.0107719416088316,0.00617972389698441,-0.0228842004469211,0.00134031722925781,0.0813370343594497
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TLR4,Toll-like receptor 4,37056,0.00450555149150281,0.00258708569519988,-0.000565136471088958,0.00957623945409457,0.0816096797232621
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36931,-0.00858578038989255,0.00495277501421368,-0.0182932194177514,0.00112165863796627,0.0830252231330584
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCAR,Immunoglobulin alpha Fc receptor,39866,-0.00758828103474501,0.00437766105129015,-0.0161684966952737,0.000991934625783673,0.0830420957458424
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDK1,Cyclin-dependent kinase 1,36962,0.00589333129199048,0.00340314015277068,-0.000776823407440062,0.012563485991421,0.0833445876638609
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEDD9,Enhancer of filamentation 1,37056,0.00542427416493837,0.00313421670531748,-0.000718790577483889,0.0115673389073606,0.083535192314737
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39962,0.005573081698043,0.00322571732821514,-0.000749324265258684,0.0118954876613447,0.0840606489182861
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TYMP,Thymidine phosphorylase,39764,0.0109444001083751,0.00633852712563132,-0.00147911305786226,0.0233679132746125,0.0842504624239222
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36962,-0.0135227064821477,0.00784774790119007,-0.0289042923684802,0.00185887940418487,0.0848882299552753
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPA,Apolipoprotein(a),37186,0.0284185912454177,0.0165094539121971,-0.00393993842248858,0.060777120913324,0.0852100710817728
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,39477,0.00640357383670326,0.00375216895017331,-0.000950677305636431,0.0137578249790429,0.0879102429871756
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37039,-0.00825357054334208,0.00484176262864546,-0.0177434252954872,0.00123628420880302,0.088280981876599
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FUCA1,Tissue alpha-L-fucosidase,39928,0.0128107471167876,0.00753738863389794,-0.00196253460565234,0.0275840288392276,0.0892205164338883
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,36991,-0.0113653941061807,0.00669314185344197,-0.024483952138927,0.00175316392656552,0.0895190696479782
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDSN,Corneodesmosin,39992,0.00672160277561188,0.00396092664392989,-0.00104181344649071,0.0144850189977145,0.0897202344177187
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRND,Prion-like protein doppel,37388,-0.0080560258732803,0.00476721540589924,-0.0173997680688428,0.00128771632228222,0.0910737987106967
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37437,0.0115580947188498,0.00687580944621583,-0.00191849179573321,0.0250346812334328,0.0927898981514776
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39885,-0.0052095596466003,0.00310074918762323,-0.0112870280543418,0.000867908761141229,0.0929579208276347
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL18RAP,Interleukin-18 receptor accessory protein,39639,0.0269715009798976,0.0160732707981915,-0.00453210978455769,0.0584751117443529,0.093360191316806
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYH4,Myosin-4,37021,-0.00750300374300483,0.00448769588875019,-0.0162988876849552,0.00129288019894555,0.0945667163050087
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39489,0.00854190065163427,0.00512153250175923,-0.00149630305181382,0.0185801043550823,0.0953673756572488
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UNG,Uracil-DNA glycosylase,37368,0.0053988851170295,0.00325250882156541,-0.000976032173238716,0.0117738024072977,0.0969549547647968
NMR metabolomics,X23503.Total Lipids in Medium VLDL,INSL4,Early placenta insulin-like peptide,37368,-0.00831143680142342,0.00501288182601314,-0.0181366851804092,0.00151381157756232,0.0973375156344847
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD209,CD209 antigen,39885,0.00601367930767971,0.00363926904923958,-0.00111928802882986,0.0131466466441893,0.0984641662773807
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP9,Matrix metalloproteinase-9,39843,-0.00931557806453358,0.00567296366472514,-0.0204345868473949,0.0018034307183277,0.100588792953865
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA5,Annexin A5,39415,0.00462716845605538,0.00283218122026497,-0.000923906735663956,0.0101782436477747,0.102324740420761
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39585,0.00738413823770625,0.00452106085640992,-0.0014771410408572,0.0162454175162697,0.102431073030451
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC44A4,Choline transporter-like protein 4,37039,-0.0103692957887473,0.00635937464557895,-0.0228336700940821,0.0020950785165874,0.10300862305015
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PCARE,Photoreceptor cilium actin regulator,36991,-0.0130217170319171,0.00799426481042435,-0.0286904760603488,0.00264704199651468,0.103361910772734
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD99,CD99 antigen,39858,0.00291371106843741,0.00179260176347718,-0.000599788387977854,0.00642721052485267,0.104095133773248
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ELAVL4,ELAV-like protein 4,36991,0.0127925187281336,0.00792129714541857,-0.00273322367688684,0.028318261133154,0.106345004755877
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36991,0.00872651068945836,0.00540846572141916,-0.0018740821245232,0.0193271035034399,0.106661909322179
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37056,0.00420217043048523,0.00260676519494561,-0.000907089351608163,0.00931143021257863,0.10698043340575
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPSG1,Tryptase gamma,37056,0.00406484572520339,0.00252423688775093,-0.00088265857478843,0.0090123500251952,0.107350500190892
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCLRE1C,Protein artemis,36962,-0.00469488671500988,0.00291752174772551,-0.0104132293405519,0.00102345591053211,0.107595905584803
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL11,Interleukin-11,39587,0.00936411831352566,0.00582792939154121,-0.00205862329389512,0.0207868599209464,0.108125802868412
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GZMH,Granzyme H,39585,0.0113372363427283,0.00705920172389598,-0.00249879903610779,0.0251732717215645,0.108289059861323
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYL6B,Myosin light chain 6B,37039,-0.0139146118486211,0.00867171640779472,-0.0309111760078988,0.00308195231065651,0.108606439614364
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TAGLN3,Transgelin-3,36962,-0.00901968052798146,0.00562199925585745,-0.0200387990694621,0.00199943801349914,0.108660008364373
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37039,-0.00943611113294079,0.00588466602203081,-0.0209700565361212,0.0020978342702396,0.108846429275409
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36991,-0.00882598585685421,0.0055110700763569,-0.0196276832065137,0.0019757114928053,0.109289988443742
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37437,-0.020103793207775,0.0126106124332548,-0.0448205935769544,0.00461300716140442,0.110915324773432
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36991,-0.00985431017741738,0.00618678615830496,-0.0219804110476951,0.00227179069286034,0.11122923695297
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37021,-0.00615365250716922,0.00386631654173935,-0.0137316329289784,0.0014243279146399,0.111497283449607
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAD51,DNA repair protein RAD51 homolog 1,37169,0.00786458787489128,0.0049419827531016,-0.00182169832118786,0.0175508740709704,0.111547133332319
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPP7,Dipeptidyl peptidase 2,39754,0.00892691816371827,0.0056272219818865,-0.00210243692077927,0.0199562732482158,0.112672795618787
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZP3,Zona pellucida sperm-binding protein 3,37043,-0.0382917882928277,0.0241965003367222,-0.0857169289528032,0.00913335236714782,0.113551669311616
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESPL1,Separin,36962,-0.00799971167257761,0.00505808992094372,-0.0179135679176273,0.00191414457247209,0.113772429068496
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37169,-0.00971146795198234,0.00614145798059559,-0.0217487255939497,0.00232578968998502,0.113833949978453
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37021,-0.00701609554985153,0.00444321208896892,-0.0157247912442306,0.00169260014452756,0.114346479024362
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTNAP2,Contactin-associated protein-like 2,39866,0.00604833048602673,0.00383331014726915,-0.00146495740262081,0.0135616183746743,0.114623308318912
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFF2,Trefoil factor 2,39908,-0.00838614303264064,0.00534359681534817,-0.0188595927907231,0.00208730672544177,0.116578741908742
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39749,0.00885365430333348,0.00564338804424743,-0.00220738626339149,0.0199146948700585,0.116701776446898
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL12,Stromal cell-derived factor 1,39587,0.00585416207000793,0.00373378620342534,-0.00146405888870573,0.0131723830287216,0.116927173351416
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDAC8,Histone deacetylase 8,37056,0.00927627797544682,0.0059294257321274,-0.00234539645952288,0.0208979524104165,0.11773638468666
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA3,Carbonic anhydrase 3,40017,-0.0087596170974537,0.00564118061303391,-0.0198163310990002,0.00229709690409278,0.120490854672057
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LCN15,Lipocalin-15,37411,-0.00900387031640818,0.0058150558610635,-0.0204013798040927,0.00239363917127628,0.12155608436373
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNR,Tenascin-R,39749,0.00608370681694214,0.00393093192094368,-0.00162091974810748,0.0137883333819918,0.121726500578469
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37411,0.00940848332295974,0.00608122017058867,-0.00251070821139404,0.0213276748573135,0.12185346292658
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOLR1,Folate receptor alpha,39809,0.00396516016189208,0.0025656231717733,-0.00106346125478358,0.00899378157856774,0.122246194011981
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FMR1,Synaptic functional regulator FMR1,39477,0.00514878240650859,0.00333400649250945,-0.00138587031880993,0.0116834351318271,0.122530401920018
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCARB1,Scavenger receptor class B member 1,39489,0.00821480411425575,0.00533495093668065,-0.00224169972163833,0.0186713079501498,0.12362722406084
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ID4,DNA-binding protein inhibitor ID-4,37169,-0.0063880898963713,0.00414970277388673,-0.0145215073331893,0.00174532754044669,0.123728245933053
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPN1,Epsin-1,37169,0.00619484121679482,0.00403747579408037,-0.0017186113396027,0.0141082937731923,0.124970981217771
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC6A,C-type lectin domain family 6 member A,39477,-0.00667162095995165,0.00435165991786564,-0.0152008743989683,0.00185763247906501,0.125266314648157
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36991,-0.00464929793325561,0.00303866379244178,-0.0106050789664415,0.00130648309993027,0.126029223884738
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CST7,Cystatin-F,39882,0.0132283895544673,0.00864590933318746,-0.00371759273858013,0.0301743718475147,0.126032226109217
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSH1,Chorionic somatomammotropin hormone 1,37445,0.00497085143018708,0.00326396873346111,-0.00142652728739668,0.0113682301477709,0.127795238832054
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OGN,Mimecan,39858,-0.00562600526126199,0.00369732781828587,-0.0128727677851023,0.00162075726257832,0.128118845336779
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH15,Cadherin-15,39973,0.00763048143385671,0.00501934844773723,-0.00220744152370826,0.0174684043914217,0.128476938854919
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFBR3,Transforming growth factor beta receptor type 3,40052,-0.00448128737026471,0.00295954177665184,-0.0102819892525023,0.0013194145119729,0.129998991414027
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37021,-0.00721372112130042,0.00476821797995702,-0.0165594283620162,0.00213198611941535,0.130335246586288
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL18BP,Interleukin-18-binding protein,39931,0.00418314440022807,0.00276609896972438,-0.00123840958043172,0.00960469838088786,0.130479712688748
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGMA,Repulsive guidance molecule A,40009,-0.00438248240234308,0.00289902025650854,-0.0100645621050998,0.00129959730041366,0.13062682654506
NMR metabolomics,X23503.Total Lipids in Medium VLDL,QSOX1,Sulfhydryl oxidase 1,37186,0.00596214806344557,0.00394552549393306,-0.00177108190466322,0.0136953780315544,0.130782522320578
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,36962,-0.0204490161174509,0.013535802573573,-0.046979189161654,0.00608115692675211,0.130879995328279
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39587,0.00771803050868521,0.00512272201285898,-0.00232250463651839,0.0177585656538888,0.131926416832057
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B2M,Beta-2-microglobulin,37453,0.00434328187012011,0.00288991266477744,-0.00132094695284368,0.0100075106930839,0.132885196646631
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNASE1,Ribonuclease pancreatic,37445,0.00313253062057488,0.00210002459709938,-0.000983517589739897,0.00724857883088966,0.135810529570344
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NLGN2,Neuroligin-2,36991,-0.00656665863940436,0.0044187084946121,-0.0152273272888441,0.00209401001003535,0.137275725977744
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BEX3,Protein BEX3,36962,-0.00653853204526157,0.00440004651199267,-0.0151626232087672,0.00208555911824407,0.137299399056277
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL9,Interleukin-9,37169,-0.00795614140339728,0.00536852906004598,-0.0184784583610874,0.00256617555429285,0.138364895592103
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGR2,Anterior gradient protein 2 homolog,39364,0.0139016075203999,0.00938044344642076,-0.00448406163458482,0.0322872766753845,0.13836656607755
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,39788,0.00426830141929915,0.00288439044921798,-0.00138510386116809,0.00992170669976638,0.138948217076162
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDDM3B,Epididymal secretory protein E3-beta,37368,0.00713910354518406,0.00482817698357303,-0.00232412334261908,0.0166023304329872,0.139261649455376
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF1,Macrophage colony-stimulating factor 1,39931,-0.00362467829431317,0.00245415441458781,-0.00843482094690527,0.00118546435827894,0.139707004000322
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ESR1,Estrogen receptor,37056,0.0082305014080783,0.00557814132909878,-0.0027026555969553,0.0191636584131119,0.140104248471365
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AGBL2,Cytosolic carboxypeptidase 2,36991,0.0126781107271103,0.00859385764257351,-0.00416585025233376,0.0295220717065544,0.140168624147159
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WNT9A,Protein Wnt-9a,39587,0.00388239929365173,0.00263426219407722,-0.00128075460673961,0.00904555319404308,0.140553042865697
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,39489,0.00663766105369547,0.00452024924490413,-0.00222202746631663,0.0154973495737076,0.14200809596755
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPESP1,Sperm equatorial segment protein 1,37437,0.00401365804232207,0.00273413460438166,-0.00134524578226599,0.00937256186691013,0.142132510474381
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39788,0.00526698562345927,0.00359040980015075,-0.00177021758483619,0.0123041888317547,0.142406826965941
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPLX2,Complexin-2,36962,-0.00412930382938195,0.00282007607971672,-0.00965665294562672,0.00139804528686281,0.14314892568194
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGLON5,IgLON family member 5,36962,0.0126501367014472,0.00866985076707512,-0.00434277080202005,0.0296430442049144,0.144562909877107
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDRG1,Protein NDRG1,39489,0.00944535007662161,0.00648498039192428,-0.00326521149154999,0.0221559116447932,0.145275554634085
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BSND,Barttin,36962,-0.00460966715857823,0.00316997395549338,-0.0108228161113453,0.00160348179418879,0.145924346452209
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40052,0.00372632413598963,0.00256467309470576,-0.00130043512963367,0.00875308340161292,0.146258925034245
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FDX2,"Ferredoxin-2, mitochondrial",37021,0.00768080301498995,0.00529293406059761,-0.00269334774378136,0.0180549537737613,0.1467639419709
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGFBR1,TGF-beta receptor type-1,37056,0.0029651257285303,0.00204336784176663,-0.0010398752413323,0.0069701266983929,0.146776515677132
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHL1,Neural cell adhesion molecule L1-like protein,39900,0.00420476682055725,0.0029173241725913,-0.00151318855772169,0.00992272219883619,0.149516807701389
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,37169,-0.0105825281327327,0.00734354222914692,-0.0249758709018606,0.00381081463639528,0.149589598238573
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UPK3BL1,Uroplakin-3b-like protein 1,37149,-0.00731730262094533,0.00509054274308848,-0.0172947663973988,0.0026601611555081,0.150619184454895
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF5,Fibroblast growth factor 5,39587,0.00441236229965722,0.0031015675038698,-0.00166671000792757,0.010491434607242,0.154865210011399
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39674,0.00778614757872658,0.00553561310089626,-0.00306365409903009,0.0186359492564833,0.159578858449445
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37021,0.00646330206830263,0.00459953006912411,-0.00255177686718062,0.0154783810037859,0.159982676094521
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOH,Beta-2-glycoprotein 1,39858,0.00465993531775582,0.0033247391384459,-0.00185655339359814,0.0111764240291098,0.161055839603522
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK12,Kallikrein-12,39477,-0.0180408303933475,0.0128977803347196,-0.0433204798493979,0.00723881906270291,0.161906424234617
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPAN15,Tetraspanin-15,37021,-0.00645418437324989,0.00463739599195455,-0.0155434805174808,0.00263511177098103,0.164015854692451
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCN1,Transcobalamin-1,37235,0.00446175694258948,0.00320907792361304,-0.00182803578769209,0.010751549672871,0.164444294984496
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,39868,-0.00735427435040001,0.00531437335558609,-0.0177704461273488,0.00306189742654873,0.166424906213637
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37169,0.00674813346663357,0.00488171901714766,-0.00282003580697585,0.016316302740243,0.166894423873648
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL17F,Interleukin-17F,39587,-0.0100216095966925,0.0072584223499113,-0.0242481174025187,0.00420489820913362,0.167394831659443
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NEB,Nebulin,37021,-0.00486779942362151,0.00352610815532348,-0.0117789714080555,0.00204337256081251,0.167455573642053
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIF20B,Kinesin-like protein KIF20B,36991,0.00968626458631331,0.00704131438497641,-0.00411471160824045,0.0234872407808671,0.168958742062505
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCNE1,G1/S-specific cyclin-E1,37056,0.0123350081481337,0.00897680313682438,-0.0052595260000421,0.0299295422963095,0.169434566608286
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37039,-0.00621450281377681,0.00453275496343585,-0.0150987025421111,0.00266969691455746,0.170391716313193
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAPRT,Nicotinate phosphoribosyltransferase,37388,0.00420328828612952,0.00306810226520212,-0.00181019215366664,0.0102167687259257,0.170710840261347
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39489,0.00631304650167511,0.00463293915177891,-0.00276751423581156,0.0153936072391618,0.173014384571677
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTTG1,Securin,37169,0.00531527813867891,0.00391231039764047,-0.00235285024069642,0.0129834065180542,0.174295328546997
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37021,-0.00424908698552304,0.00314220172523506,-0.0104078023669838,0.00190962839593768,0.176314038843467
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100A16,Protein S100-A16,39456,-0.00786302453708915,0.00581547441288141,-0.0192613543863367,0.00353530531215841,0.176367246409987
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WIF1,Wnt inhibitory factor 1,40030,0.00422822510231382,0.00313900320201206,-0.00192422117362981,0.0103806713782575,0.178000362121849
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRR1B,Cornifin-B,37169,0.0110686104248877,0.00821771042648462,-0.00503810201102219,0.0271753228607975,0.178028466858011
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENDOU,Poly(U)-specific endoribonuclease,36430,0.00651602499981303,0.00485846266000303,-0.0030065618137929,0.016038611813419,0.179889453948409
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37021,-0.00638349138026213,0.00477148860550821,-0.0157356090470582,0.00296862628653396,0.180971505890107
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40009,0.00335448295069166,0.00250931331146498,-0.00156377113977969,0.00827273704116302,0.181302477978464
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39788,0.00422250807897428,0.00318556705958695,-0.00202120335781615,0.0104662195157647,0.185020328681198
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39489,0.00853118475372274,0.00645765987199098,-0.00412582859537959,0.0211881981028251,0.186488897563916
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP8,Neutrophil collagenase,39985,-0.00884985794981683,0.00670790022055475,-0.0219973423821041,0.00429762648247049,0.187081333870617
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMC3,Structural maintenance of chromosomes protein 3,36962,0.00655950480532131,0.00497325724558942,-0.00318807939603395,0.0163070890066766,0.1872070543076
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNPEP,Aspartyl aminopeptidase,37388,0.00728286284586327,0.00554660557966278,-0.00358848409027577,0.0181542097820023,0.189194909436555
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,37021,0.00390405333426466,0.00297448410538983,-0.00192593551229941,0.00973404218082873,0.189369505722142
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LMOD2,Leiomodin-2,36991,-0.00788165193905645,0.00601264724738213,-0.0196664405439254,0.00390313666581253,0.189932871403389
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAMT,Guanidinoacetate N-methyltransferase,37021,-0.00453437892897565,0.00345985678091858,-0.0113156982195761,0.00224694036162476,0.190026494191557
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,36962,-0.0112472893080112,0.0085916454390355,-0.0280869143685208,0.00559233575249839,0.190524767513888
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRISP2,Cysteine-rich secretory protein 2,40030,0.00679761568399839,0.0052501953231768,-0.00349276714942814,0.0170879985174249,0.195429883247278
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYB5A,Cytochrome b5,36962,0.00868473209679708,0.00673748661295339,-0.00452074166459156,0.0218902058581857,0.197415072600873
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OPTC,Opticin,39788,0.00531304318725339,0.00413601201647215,-0.00279354036503203,0.0134196267395388,0.198957361305861
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,37021,0.00394860838436981,0.00307475591698845,-0.00207791321292756,0.00997512998166718,0.199093812949041
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36991,-0.00735686406427281,0.0057407116185754,-0.0186086588366806,0.00389493070813498,0.20003203852686
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TBR1,T-box brain protein 1,37039,-0.00579000537772217,0.00452122492764802,-0.0146516062359123,0.00307159548046794,0.200347041662781
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHD,SH2 domain-containing adapter protein D,37002,0.00997866728710891,0.00781172800538728,-0.00533231960345016,0.025289654177668,0.201485169414071
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNL2,Interferon lambda-2,36991,-0.00741160421453968,0.00580873703370057,-0.0187967288005928,0.00397352037151344,0.201999038035767
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THY1,Thy-1 membrane glycoprotein,40009,-0.00322185132039119,0.0025286295916516,-0.00817796532002833,0.00173426267924595,0.202628887349059
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37169,-0.00860918501132004,0.00678287109583076,-0.0219036123591483,0.00468524233650824,0.204372748214497
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,39477,-0.00359043363100078,0.00285301483145341,-0.00918234270064947,0.00200147543864791,0.208240636191151
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC2L,C-type lectin domain family 2 member L,37039,-0.00602093562057413,0.00478881492403501,-0.0154070128716827,0.00336514163053449,0.208670431969074
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ART5,Ecto-ADP-ribosyltransferase 5,36991,-0.00724771929330594,0.00577459179889332,-0.0185659192191369,0.00407048063252498,0.209462965915399
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNF75D,Zinc finger protein 75D,37169,0.00696167211460011,0.00554951229901222,-0.00391537199146384,0.0178387162206641,0.209694862425435
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGA11,Integrin alpha-11,39866,-0.0039875736413384,0.00318185002929412,-0.0102239996987549,0.00224885241607806,0.210142181929913
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH3,Cadherin-3,40009,0.00403891954874492,0.00324345011606162,-0.00231824267873586,0.0103960817762257,0.213056430944072
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL36A,Interleukin-36 alpha,37056,-0.00687583646342892,0.00552211526893268,-0.017699182390537,0.00394750946367914,0.213100416058832
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF7,Fibroblast growth factor 7,36962,-0.00927328549772573,0.00748206606582036,-0.0239381349867336,0.00539156399128218,0.215218967354727
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39585,0.00369222417007795,0.00298257353837864,-0.00215361996514418,0.00953806830530007,0.215759640421863
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,37039,-0.00703975911060729,0.00570853327459636,-0.0182284843288162,0.00414896610760159,0.217523419820212
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGM2,Phosphoglucomutase-2,37039,0.00699745085713718,0.00567894023268841,-0.0041332719989321,0.0181281737132064,0.217905526383298
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDNRB,Endothelin receptor type B,37056,0.00539080674180417,0.00437674975537141,-0.00318762277872379,0.0139692362623321,0.21808618592923
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37093,0.00563907517205478,0.00460673930361461,-0.00339013386302985,0.0146682842071394,0.220939116385249
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENOPH1,Enolase-phosphatase E1,37368,0.00639431920933908,0.00523297458172491,-0.00386231097084174,0.0166509493895199,0.221756103062286
NMR metabolomics,X23503.Total Lipids in Medium VLDL,APOA1,Apolipoprotein A-I,37453,-0.00312540032886564,0.00256387101936741,-0.00815058752682577,0.00189978686909449,0.222859194345066
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36962,0.00649381819041672,0.00533720005248933,-0.00396709391246236,0.0169547302932958,0.223736952300786
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SKIV2L,Helicase SKI2W,37021,0.00458317763260772,0.00378128442815318,-0.00282813984657251,0.011994495111788,0.225507728279624
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT14,"Keratin, type I cytoskeletal 14",39064,0.00328755326829482,0.00271304842132661,-0.00203002163750534,0.00860512817409497,0.225624547546825
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,36991,0.00556652488045801,0.00460620918286013,-0.00346164511794785,0.0145946948788639,0.226883343863682
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,39858,-0.00375400595007084,0.00311482344918237,-0.00985905991046828,0.00235104801032661,0.228141360578429
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,37437,-0.00334584865245996,0.00279659308469618,-0.00882717109846447,0.00213547379354455,0.23156073965555
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37021,-0.00952571105142257,0.00798584539889547,-0.0251779680332577,0.00612654593041255,0.232959665498159
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36991,-0.00513687318780796,0.00434602592867229,-0.0136550840080057,0.00338133763238973,0.23723892444841
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,37056,0.00249473216333483,0.00211413646687336,-0.00164897531173697,0.00663843963840662,0.238011867040922
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CORO6,Coronin-6,36991,-0.00419131738899886,0.00355338915247667,-0.0111559601278531,0.00277332534985541,0.238209880115691
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGLYRP1,Peptidoglycan recognition protein 1,39962,-0.00463841769127406,0.00393315275223549,-0.0123473970856556,0.0030705617031075,0.2382910366097
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37021,0.00513594698850679,0.00438590650642201,-0.00346042976408036,0.0137323237410939,0.241615352827483
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTNNA1,Catenin alpha-1,36991,-0.00385086408275809,0.00329280634829983,-0.0103047645254258,0.00260303635990959,0.242232388638015
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37039,-0.0060752188325979,0.00519612539004085,-0.016259624597078,0.00410918693188218,0.242351259587794
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,36991,-0.00328935531564636,0.00281476004621586,-0.00880628500622945,0.00222757437493673,0.242582216196622
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TEX101,Testis-expressed protein 101,37039,0.00532116678551843,0.00456092555438745,-0.00361824730108096,0.0142605808721178,0.243358415809762
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC7A,C-type lectin domain family 7 member A,40058,0.00617973736815769,0.00535916090605384,-0.00432421800770785,0.0166836927440232,0.248879547150844
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL36G,Interleukin-36 gamma,37021,0.00726667695200872,0.00633017039034565,-0.00514045701306876,0.0196738109170862,0.25101281945783
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NLGN1,Neuroligin-1,37039,-0.007226953957507,0.00631025231375032,-0.0195950484924576,0.00514114057744363,0.252117385168361
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA8,Carbonic anhydrase-related protein,37056,0.00280252175807887,0.00244770335764179,-0.00199497682289905,0.00760002033905679,0.252246607685662
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TET2,Methylcytosine dioxygenase TET2,37161,-0.0106062131421176,0.00927054348402954,-0.0287764783708155,0.0075640520865803,0.252612402568729
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUSD5,Sushi domain-containing protein 5,37064,-0.00362115699570165,0.00317975494778155,-0.00985347669335349,0.00261116270195019,0.254800412039794
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,36991,-0.00522021831714055,0.00458397917081898,-0.0142048174919458,0.00376438085766465,0.254808918943776
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HSP90B1,Endoplasmin,39405,0.00716709581885657,0.00631195310696138,-0.00520433227078773,0.0195385239085009,0.256191809545698
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HIP1,Huntingtin-interacting protein 1,37021,0.00357584278478144,0.00315044255926695,-0.00259902463138178,0.00975071020094467,0.256383955753543
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,37169,0.00462573702118428,0.00407695746128345,-0.00336509960293128,0.0126165736452998,0.256561219478028
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,36962,-0.00700268169993609,0.00619469974849324,-0.0191442932069828,0.00513892980711066,0.258315277975085
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEMA7A,Semaphorin-7A,40002,-0.00285014377395591,0.00252276759237312,-0.00779476825500724,0.00209448070709541,0.258590502827814
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NXPE4,NXPE family member 4,37021,-0.00370300673728413,0.00328226194199555,-0.0101362401435954,0.00273022666902715,0.259261327601253
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,37021,-0.00547458454474449,0.00486039117230818,-0.0150009512424685,0.00405178215297955,0.260030718302496
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRP2BP,LRP2-binding protein,37039,-0.00840067004427855,0.00747907636298747,-0.023059659715734,0.0062583196271769,0.2613632881514
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTF,Ciliary neurotrophic factor,36991,0.0035709027234914,0.00318126899261046,-0.0026643845020251,0.0098061899490079,0.261680011610403
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,39749,-0.0051958575716719,0.00463362771661801,-0.0142777678962432,0.0038860527528994,0.262161446186617
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRXN3,Neurexin-3,37039,0.00368741131703276,0.00329075030614485,-0.00276245928301115,0.0101372819170767,0.262504916177093
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMPD3,AMP deaminase 3,37388,0.00743008825421106,0.00664766964851371,-0.00559934425687581,0.0204595207652979,0.263715769751589
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPARCL1,SPARC-like protein 1,39871,0.0028503899883798,0.00255046576046828,-0.00214852290213804,0.00784930287889763,0.263756404662174
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36962,-0.00667416101268906,0.00598864336707822,-0.0184119020121624,0.00506357998678425,0.265098219403007
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRTN,Neurturin,39587,0.00516421746218627,0.00464973926614044,-0.003949271499449,0.0142777064238215,0.26673744303264
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL2RG,Cytokine receptor common subunit gamma,37368,0.00389551398661861,0.00353417071589832,-0.0030314606165421,0.0108224885897793,0.270375796867201
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOP56,Nucleolar protein 56,37021,0.0113385129164829,0.010364769443817,-0.00897643519339836,0.0316534610263641,0.273998055384162
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37437,-0.00265226457518386,0.00242510165428009,-0.00740546381757284,0.00210093466720513,0.274118479467418
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINA11,Serpin A11,40052,-0.00418731947419658,0.00383071992348173,-0.0116955305242208,0.0033208915758276,0.274370796534604
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HCG22,Protein PBMUCL2,37021,-0.00555940358382543,0.00508926597871537,-0.0155343649021076,0.00441555773445669,0.274686864086621
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,36962,-0.00513914116673759,0.00471256246797913,-0.0143757636039767,0.0040974812705015,0.275504432508741
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,37169,-0.00638530509454545,0.00585729906430273,-0.0178656112605788,0.00509500107148789,0.275669027870573
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCDC50,Coiled-coil domain-containing protein 50,37411,-0.00789268513361825,0.00724857409136227,-0.0220998903526883,0.00631452008545181,0.276234824508314
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC51B,Organic solute transporter subunit beta,37021,-0.00770730864833575,0.0071195622578636,-0.0216616506737484,0.00624703337707691,0.279026389575245
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL21R,Interleukin-21 receptor,37056,-0.00548054267208864,0.00510128535885337,-0.0154790619754413,0.00451797663126397,0.282687529303205
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37411,-0.00299020224293924,0.00279182403256472,-0.0084621773467661,0.00248177286088762,0.284162945723097
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFL4,Insulin growth factor-like family member 4,37056,-0.007705000020037,0.00721040313167309,-0.0218373901581162,0.00642739011804225,0.285271794246678
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DOCK9,Dedicator of cytokinesis protein 9,36991,0.0116649003328406,0.0109219597283784,-0.00974214073478106,0.0330719414004622,0.285529930589591
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TCN2,Transcobalamin-2,40012,0.00291383175157778,0.00274010930470323,-0.00245678248564055,0.00828444598879612,0.287616570437709
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NTRK3,NT-3 growth factor receptor,40009,0.00212012901165116,0.00199629982886343,-0.00179261865292117,0.0060328766762235,0.288238242401226
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOX2,Transcription factor SOX-2,37391,0.00236324800444185,0.0022288165240474,-0.00200523238269106,0.00673172839157476,0.289020159176572
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP15,Matrix metalloproteinase-15,37437,0.00490935401372783,0.00464213726190173,-0.00418923501959955,0.0140079430470552,0.290273396302929
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DOC2B,Double C2-like domain-containing protein beta,37039,0.00358657378810076,0.00340833927509698,-0.00309377119108932,0.0102669187672908,0.292684135788755
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37169,0.00337275423486285,0.0032125572966766,-0.0029238580666233,0.00966936653634899,0.293798852176885
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOS,Proto-oncogene c-Fos,36931,-0.00348137506899208,0.00332180227437967,-0.00999210752677624,0.00302935738879208,0.294640469805424
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36991,-0.00551646660964903,0.00528828219242567,-0.0158814997068034,0.00484856648750529,0.296898464825139
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37021,-0.00575053385176247,0.00552902329735721,-0.0165874195145826,0.00508635181105766,0.298329629574759
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PI3,Elafin,39594,0.00515201747356067,0.00496132763602073,-0.00457218469303996,0.0148762196401613,0.299083426273102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,37056,-0.00534477288049005,0.00517391942030366,-0.0154856549442852,0.00479610918330511,0.301612508153833
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAMTSL2,ADAMTS-like protein 2,37437,0.00307076402039497,0.00297921944815426,-0.00276850609798737,0.00891003413877732,0.302686890118696
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37021,-0.00615404232208435,0.00597943783214096,-0.0178737404730806,0.00556565582891193,0.303404230709074
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TJP3,Tight junction protein ZO-3,36991,-0.00414470952574123,0.00407374322946846,-0.0121292462554994,0.00383982720401695,0.308972219742159
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39858,-0.00395658752052142,0.00389000392434221,-0.0115809952122322,0.00366782017118931,0.309113351247205
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINT3,Kunitz-type protease inhibitor 3,37382,0.0139046695071168,0.0136723930997137,-0.0128932209683221,0.0407025599825556,0.309176992895727
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4C,C-type lectin domain family 4 member C,39866,0.00436469578378873,0.0043040063537289,-0.00407115666951991,0.0128005482370974,0.310550040972954
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DENND2B,DENN domain-containing protein 2B,37021,-0.00491020153368963,0.00484302162908342,-0.0144025239266931,0.00458212085931388,0.310662717411107
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",36962,-0.00461601930971433,0.00458675499119197,-0.0136060590924506,0.00437402047302192,0.314251309807028
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERCC1,DNA excision repair protein ERCC-1,36962,0.00310647688944529,0.00309220862728499,-0.00295425202003328,0.00916720579892386,0.315101179780012
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AIDA,"Axin interactor, dorsalization-associated protein",37039,0.00796795400818915,0.00794117450601339,-0.00759674802359709,0.0235326560399754,0.3156997173035
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36991,0.00514277183000424,0.0051279220413696,-0.00490795537108018,0.0151934990310887,0.315929586547535
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,36991,-0.00380307542781232,0.00381685559810771,-0.0112841124001034,0.00367796154447879,0.319079218486489
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RLN2,Prorelaxin H2,37095,-0.0132680665726535,0.0133254734220705,-0.0393859944799116,0.0128498613346047,0.319418047570962
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMY2B,Alpha-amylase 2B,38832,0.00447933739399317,0.0045079026994455,-0.00435615189692,0.0133148266849064,0.320402882635642
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMY2A,Pancreatic alpha-amylase,39246,0.00437308106706056,0.00440577091999565,-0.00426222993613092,0.013008392070252,0.320930177603375
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",36962,0.0086188487995629,0.00871547803966398,-0.0084634881581785,0.0257011857573043,0.322724012792768
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF6,Fibroblast growth factor 6,37056,0.00376959672105091,0.0038459387001225,-0.0037684431311892,0.011307636573291,0.327030062389992
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGLYRP4,Peptidoglycan recognition protein 4,37021,0.00570600443990852,0.00586406893722108,-0.0057875706770448,0.0171995795568618,0.330548694961632
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRYBB2,Beta-crystallin B2,37388,0.00518178366760807,0.00532970102051556,-0.00526443033260243,0.0156279976678186,0.330945268625919
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MMP13,Collagenase 3,39489,-0.00291783694546183,0.00300421771390489,-0.00880610366471543,0.00297042977379176,0.33144040718966
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37382,-0.0154965560700637,0.0159773151812719,-0.0468120938253565,0.0158189816852292,0.33210875607896
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC12A,C-type lectin domain family 12 member A,37056,0.00183186750783404,0.00189044545236274,-0.00187340557879694,0.00553714059446502,0.33255612261456
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRDX2,Peroxiredoxin-2,37249,-0.00551985371308182,0.00570856323015163,-0.016708637644179,0.00566893021801538,0.333590129320071
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CSF2RB,Cytokine receptor common subunit beta,37056,-0.00390957573950712,0.0040696291468486,-0.0118860488673304,0.00406689738831613,0.336735090544751
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,36962,0.00780612142027699,0.00812849518192539,-0.00812572913629678,0.0237379719768508,0.336901700504074
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HTR1A,5-hydroxytryptamine receptor 1A,36991,-0.00681180063419753,0.00712145370630382,-0.020769849898553,0.00714624863015795,0.338828064018321
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FZD8,Frizzled-8,36991,0.00381458266085018,0.00399064736170396,-0.00400708616808958,0.0116362514897899,0.339150124826499
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BOC,Brother of CDO,39585,0.00209419815524447,0.00219579843011783,-0.00220956676778647,0.00639796307827542,0.340235147563528
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DLGAP5,Disks large-associated protein 5,37411,-0.00467853355277895,0.00492118741524279,-0.0143240608866548,0.00496699378109693,0.341777700920931
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHIT1,Chitotriosidase-1,39906,0.0134092163311109,0.0141284015285713,-0.0142824506648888,0.0411008833271106,0.342585832097807
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GBP6,Guanylate-binding protein 6,37021,-0.00410577687276789,0.00433752931108662,-0.0126073343224977,0.00439578057696189,0.34387510936821
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMPRSS11B,Transmembrane protease serine 11B,36991,-0.0067982220407146,0.00719582960107419,-0.02090204805882,0.0073056039773908,0.34480660161682
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHH,Sonic hedgehog protein,37056,-0.00386604063680933,0.004095533286536,-0.0118932858784199,0.00416120460480123,0.345204746658863
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CPE,Carboxypeptidase E,39906,-0.00340728853071534,0.00361506021223657,-0.010492806546699,0.00367822948526834,0.345937555124713
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL1RAP,Interleukin-1 receptor accessory protein,39858,-0.00378000706888609,0.00401381924047077,-0.0116470927802088,0.00408707864243663,0.346335788355903
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,39477,0.00462632855202415,0.00491694919743213,-0.00501089187494284,0.0142635489789911,0.346773678089042
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACTA2,"Actin, aortic smooth muscle",39585,-0.0038051096523339,0.00404856526455738,-0.0117402975708664,0.00413007826619856,0.347300633029236
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37437,-0.00224042772828494,0.00239315500820908,-0.00693101154437472,0.00245015608780485,0.349196336988725
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37039,0.00672975378071506,0.00721193521990797,-0.00740563925030456,0.0208651468117347,0.350764171910146
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,40052,-0.00212820978991995,0.00228734361242678,-0.00661140327027645,0.00235498369043654,0.352163115809357
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HLA_A,,37411,0.00280922996729094,0.00302868496262987,-0.00312699255946361,0.00874545249404549,0.353662150807109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HBZ,Hemoglobin subunit zeta,37437,-0.00915792557222082,0.00988602755536081,-0.028534539580728,0.0102186884362864,0.354280377706903
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36962,-0.00475745905291675,0.0051451902554795,-0.0148420319536566,0.00532711384782307,0.35516918288466
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSMA1,Proteasome subunit alpha type-1,39477,-0.00401901965457959,0.00435193639690006,-0.0125488149925037,0.00451077568334452,0.355760203203518
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPEP1,Dipeptidase 1,39713,-0.00409054594387041,0.00443781531767227,-0.0127886639665081,0.00460757207876723,0.356674234277203
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENPEP,Glutamyl aminopeptidase,37021,0.00360043623334854,0.00393449415387633,-0.00411117230824906,0.0113120447749461,0.36015848427033
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,37039,-0.0032902489124944,0.00359892002470897,-0.010344132160924,0.00376363433593519,0.36061152365507
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,37056,0.00513268567470091,0.00564131896174526,-0.00592429949031979,0.0161896708397216,0.362924632825968
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DHODH,Dihydroorotate dehydrogenase,37021,0.00395854553459321,0.00435974254019158,-0.00458654984418228,0.0125036409133687,0.363907049176002
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TUBB3,Tubulin beta-3 chain,36991,-0.00239258796811767,0.00263887179374667,-0.00756477668386114,0.00277960074762579,0.364597552848014
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMBS,Porphobilinogen deaminase,40030,0.00360573021290418,0.00402507511593634,-0.00428341701433105,0.0114948774401394,0.370363910675342
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AZU1,Azurocidin,39344,0.0064253573336829,0.00717920196595691,-0.00764587851959265,0.0204965931869584,0.370803116609904
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRP2,Neuropilin-2,39858,-0.00239009544789197,0.0026710734055409,-0.00762539932275213,0.00284520842696818,0.370903676241828
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNAJA1,DnaJ homolog subfamily A member 1,36962,-0.00383280988495566,0.00434224334169567,-0.0123436068346792,0.00467798706476785,0.377425567956601
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RASA1,Ras GTPase-activating protein 1,39489,0.00269303682756687,0.00305678370827112,-0.00329825924064454,0.00868433289577827,0.3783295295202
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,37169,-0.00713490494869647,0.00811182663806211,-0.0230340851592982,0.00876427526190526,0.379109139820001
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIPC2,PDZ domain-containing protein GIPC2,37388,-0.00236696373121951,0.00269446929824494,-0.0076481235557796,0.00291419609334057,0.379713717498576
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FSTL3,Follistatin-related protein 3,39803,-0.00246341819327666,0.00280740761257017,-0.00796593711391418,0.00303910072736087,0.380244196557105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACTN4,Alpha-actinin-4,39587,0.00257979102910085,0.00294082135510033,-0.00318421882689581,0.0083438008850975,0.380372481525743
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39585,-0.00176364598317699,0.00201257670463195,-0.0057082963242556,0.00218100435790162,0.380873595415974
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EVPL,Envoplakin,37169,0.00269979438846063,0.00308591544076832,-0.00334859987544527,0.00874818865236653,0.381656984625012
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SUSD4,Sushi domain-containing protein 4,37368,0.00342477715806588,0.00391516571393393,-0.00424894764124462,0.0110985019573764,0.381727453495083
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JUN,Transcription factor AP-1,39587,0.00422814923471871,0.00486182356556403,-0.00530102495378679,0.0137573234232242,0.384497739120976
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD2,T-cell surface antigen CD2,37021,-0.00312668687101738,0.00360498850929843,-0.0101924643492423,0.00393909060720754,0.385781262642418
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMPRSS5,Transmembrane protease serine 5,39667,0.00307416912434945,0.00356404291502435,-0.00391135498909829,0.0100596932377972,0.388397413761735
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MUCL3,Mucin-like protein 3,36962,-0.00364246507022627,0.00422844028313758,-0.0119302080251759,0.00464527788472337,0.389022263254271
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,37021,-0.00936798563499626,0.0108806894838968,-0.030694137023434,0.0119581657534414,0.389268306511529
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MYOC,Myocilin,39858,0.00368474314676736,0.00430245263904939,-0.00474806402576945,0.0121175503193042,0.391773622459086
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PALLD,Palladin,37056,0.00326405001701068,0.00382246851046668,-0.00422798826350402,0.0107560882975254,0.39316949895328
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CXCL14,C-X-C motif chemokine 14,39587,0.00492705061061342,0.00578723865094438,-0.00641593714523756,0.0162700383664644,0.394579765482265
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KEL,Kell blood group glycoprotein,39489,-0.00281736847173934,0.0033222121112556,-0.00932890420980031,0.00369416726632164,0.39642872974861
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD200,OX-2 membrane glycoprotein,39866,0.0020291770014206,0.00240705107967986,-0.00268864311475193,0.00674699711759314,0.399233387146027
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RRP15,RRP15-like protein,36991,0.00709628015288001,0.00847613861004633,-0.0095169515228108,0.0237095118285708,0.402491620826654
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39877,-0.00444684757107261,0.00535792100432634,-0.0149483727395522,0.006054677597407,0.406575093152884
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39858,0.0019678296574879,0.00237670872688992,-0.00269051944721635,0.00662617876219215,0.407703145103871
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCC,Netrin receptor DCC,37039,0.00175070391774602,0.00212122330190236,-0.0024068937539826,0.00590830158947464,0.409200623825915
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39812,0.00451155466943398,0.00548523343682648,-0.00623950286674593,0.0152626122056139,0.410809849081521
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37368,0.00341542603480237,0.00416409563035472,-0.00474620140069289,0.0115770534702976,0.412111811508777
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL33,Interleukin-33,39587,0.00300201668760136,0.00366616895607466,-0.00418367446630498,0.0101877078415077,0.412888416861059
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM3D,Protein FAM3D,37382,0.00640289415375149,0.00783193442985864,-0.00894769732877145,0.0217534856362744,0.413636165798186
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHEK2,Serine/threonine-protein kinase Chk2,39585,0.00256238999020483,0.00313977258933523,-0.00359156428489221,0.00871634426530188,0.414451375196095
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP73,Tumor protein p73,37039,-0.00262568486132176,0.00324694335001376,-0.00898969382734874,0.00373832410470521,0.418723274987684
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PROK1,Prokineticin-1,39866,0.00489219436123546,0.00605916682562292,-0.00698377261698547,0.0167681613394564,0.419445872382794
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,36991,-0.00301259234448919,0.00373263341495925,-0.0103285538378093,0.00430336914883095,0.419625973119449
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OFD1,Oral-facial-digital syndrome 1 protein,37169,-0.00511739898686701,0.0063733247608464,-0.0176091155181259,0.00737431754439192,0.422023607973109
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,39858,0.00301139321479365,0.00375795539238331,-0.00435419935427763,0.0103769857838649,0.422947782370791
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSCA,Prostate stem cell antigen,37382,0.019048522628379,0.0238110837175027,-0.0276212014579264,0.0657182467146843,0.423733229456296
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEZ6,Seizure protein 6 homolog,37039,0.00232887973278728,0.00291626606585526,-0.00338700175628903,0.0080447612218636,0.424546791954945
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39904,-0.00481135627431101,0.00602864999764884,-0.0166275102697027,0.00700479772108072,0.424834792918093
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EXOSC10,Exosome component 10,37021,-0.00455557248051246,0.00572587584549322,-0.0157782891376792,0.00666714417665425,0.426272248408672
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37043,-0.00302191203742149,0.00382298038913063,-0.0105149536001175,0.00447112952527454,0.429273551541002
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNL1,Interferon lambda-1,39489,-0.00332006372172882,0.00420313078113081,-0.0115582000527452,0.00491807260928757,0.42959666604352
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37368,-0.00563469479448077,0.00719194438946303,-0.0197309057978283,0.00846151620886678,0.433363094581798
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPGN,Epigen,37368,-0.00364868186300843,0.00468020432946472,-0.0128218823487593,0.00552451862274243,0.435640697799357
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT17,"Keratin, type I cytoskeletal 17",37021,0.00284961360011866,0.00366310712034731,-0.00433007635576207,0.0100293035559994,0.436628662617315
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLAMF8,SLAM family member 8,39477,-0.00378734434946671,0.00487236860466002,-0.0133371868146003,0.00576249811566692,0.436987245910742
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,39477,0.00370954763265661,0.00478203346251652,-0.00566323795387577,0.013082333219189,0.437922538535788
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN4,Contactin-4,39858,-0.00173208247460588,0.00223470853509993,-0.00611211120340175,0.00264794625418999,0.43830263290415
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCL21,C-C motif chemokine 21,39931,0.00283772072569555,0.00366654350199633,-0.00434870453821727,0.0100241459896084,0.438971844183896
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,36962,-0.00408290058030453,0.0052811918479203,-0.0144340366022283,0.00626823544161926,0.439475897218218
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD33,Myeloid cell surface antigen CD33,39913,0.00564867067595468,0.00735395476002068,-0.00876508065368584,0.0200624220055952,0.442431157039773
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,37039,0.00490424998943967,0.00638977954663915,-0.00761971792197307,0.0174282179008524,0.442789282729574
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NRN1,Neuritin,37411,-0.00252753458163077,0.00330242463267192,-0.00900028686166772,0.00394521769840619,0.44407218093661
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39477,-0.0053116674460318,0.00698904787257957,-0.0190102012762878,0.00838686638422416,0.447266821842165
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37169,0.00447187579623327,0.00592790632797039,-0.00714682060658869,0.0160905721990552,0.450636265460112
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDAC9,Histone deacetylase 9,36991,-0.0045282065255386,0.00602159471439172,-0.0163305321657464,0.00727411911466917,0.452067803131268
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TOP1,DNA topoisomerase 1,37382,0.00800544628821625,0.0106803613758671,-0.0129280620084833,0.0289389545849158,0.453539861976528
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39858,0.00192572085508557,0.00257223042354594,-0.00311585077506447,0.00696729248523561,0.454074377526092
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFRA3,GDNF family receptor alpha-3,39709,0.00193206481574631,0.00259054961900381,-0.00314541243750115,0.00700954206899377,0.455791625695742
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDIA2,Protein disulfide-isomerase A2,36962,0.00277970309898791,0.00373331842630069,-0.00453760101656144,0.0100970072145373,0.456547299144387
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PPT1,Palmitoyl-protein thioesterase 1,37039,0.00544803997097357,0.00732859964882279,-0.00891601534071911,0.0198120952826662,0.457256182907408
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LY9,T-lymphocyte surface antigen Ly-9,39699,0.00197152969134845,0.00265423211950534,-0.00323076526288202,0.00717382464557893,0.45762153134985
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCD6,Programmed cell death protein 6,39868,-0.00483782177296382,0.00652217582646623,-0.0176212863928376,0.00794564284690998,0.45824990103493
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RTKN2,Rhotekin-2,37021,-0.0036205558785394,0.00488115634127851,-0.0131876223074453,0.00594651055036649,0.458257249536412
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL25,Interleukin-25,36903,-0.00239160239674599,0.00322711130394568,-0.00871674055247953,0.00393353575898755,0.458647991063411
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HDDC2,5'-deoxynucleotidase HDDC2,37382,-0.00300363984265339,0.00405768257799307,-0.0109566976955198,0.00494941801021303,0.459170089494934
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37124,0.00260683493616428,0.00352283890196011,-0.00429792931167753,0.00951159918400608,0.459324433576628
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MTR,Methionine synthase,37021,0.00447312620438776,0.00604920396908187,-0.00738331357501272,0.0163295659837882,0.459642731283898
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSTN,Osteocrin,37039,-0.00290071373119055,0.00392278075222204,-0.0105893640055458,0.00478793654316464,0.459644871212513
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TG,Thyroglobulin,37368,0.00749728655105913,0.0101905861577554,-0.0124762623181414,0.0274708354202597,0.461921744268246
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OTOA,Otoancorin,36991,-0.00364688559536321,0.00496701967410207,-0.0133822441566033,0.00608847296587685,0.46282772571176
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAMA1,Laminin subunit alpha-1,37021,-0.00373742669185239,0.00509281457631588,-0.0137193432614315,0.00624448987772673,0.463045490615556
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FAM171A2,Protein FAM171A2,37411,0.0108104817618607,0.0147385697021684,-0.0180771148543893,0.0396980783781107,0.463276935592494
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRG3,Proteoglycan 3,37437,-0.00343050441654686,0.00468477990375265,-0.0126126730279021,0.00575166419480833,0.464018948853075
NMR metabolomics,X23503.Total Lipids in Medium VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37388,-0.00246485511114675,0.00338974101620381,-0.00910874750290621,0.00417903728061271,0.467145763880986
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL2,Interleukin-2,39587,0.00212164077832315,0.00291856027463897,-0.00359873735996922,0.00784201891661552,0.467268794186055
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REST,RE1-silencing transcription factor,36962,-0.0024292028512314,0.00335553471269417,-0.00900605088811198,0.00414764518564918,0.469116036396372
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39477,0.00234985913437397,0.00326664787696177,-0.0040527707044711,0.00875248897321904,0.471936816996521
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHISA5,Protein shisa-5,37437,0.00154012197579364,0.0021493779250487,-0.0026726587573018,0.00575290270888908,0.473668373695685
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KDM3A,Lysine-specific demethylase 3A,37056,-0.00614929939821507,0.00873769641507702,-0.023275184371766,0.0109765855753359,0.481590518810643
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ISM2,Isthmin-2,37437,-0.00293494421495784,0.00417214085820708,-0.0111123402970437,0.00524245186712805,0.48177969486628
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,36991,-0.00483038510913238,0.00687228005222156,-0.0183000540114866,0.00863928379322188,0.482143277239236
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MB,Myoglobin,40052,-0.0034086310632189,0.00485541524941074,-0.012925244952064,0.00610798282562615,0.4826726137975
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB44,Ras-related protein Rab-44,37368,0.00276513798104259,0.00396132127862831,-0.00499905172506889,0.0105293276871541,0.485167782003844
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC1A4,Neutral amino acid transporter A,37039,-0.00335552822083065,0.00481490628416439,-0.0127927445377928,0.00608168809613155,0.485875066097176
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCR1,Natural cytotoxicity triggering receptor 1,39835,0.00231019431203718,0.00332115912355392,-0.0041992775701285,0.00881966619420286,0.486690234324932
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,36975,-0.00224030910698141,0.00324230424246139,-0.00859522542220574,0.00411460720824292,0.489601634667778
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLXDC1,Plexin domain-containing protein 1,39477,0.00222460785647211,0.00322237940502589,-0.00409125577737863,0.00854047149032285,0.489976911464697
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHA4,Ephrin type-A receptor 4,37124,0.00181530516806935,0.00264289012849905,-0.0033647594837888,0.0069953698199275,0.492180661284212
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37411,-0.00152718772932264,0.00224043329375223,-0.00591843698507702,0.00286406152643173,0.495472963397591
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMCN2,Hemicentin-2,37100,-0.00362409323526107,0.00533116980654514,-0.0140731860560895,0.0068249995855674,0.496647267878515
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXNL1,Thioredoxin-like protein 1,36971,0.00622066503802818,0.00917196927680999,-0.0117563947445194,0.0241977248205758,0.497640586383878
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ENG,Endoglin,40052,-0.0010645265092419,0.00158655977206015,-0.0041741836624798,0.002045130643996,0.502252223728695
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPB41L5,Band 4.1-like protein 5,37039,-0.00404129488673688,0.00602391324083488,-0.0158481648387732,0.00776557506529948,0.502311699416932
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,37056,-0.00298594776269193,0.00449539371926805,-0.0117969194524573,0.00582502392707345,0.506558650829887
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",37021,0.00250769530388283,0.0037849391161781,-0.00491078536382624,0.00992617597159191,0.507633130336902
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALPP,"Alkaline phosphatase, placental type",39788,0.00653944131770658,0.00990026730720577,-0.0128650826044167,0.0259439652398299,0.508922175235865
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CHP1,Calcineurin B homologous protein 1,36991,0.0044828232633698,0.00680415302410228,-0.00885331666387066,0.0178189631906103,0.510012422122865
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TLR1,Toll-like receptor 1,37056,-0.00161180433559774,0.00244884046707175,-0.00641153165105837,0.00318792297986289,0.510426999662394
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39866,-0.00513585185465732,0.00781446892927166,-0.0204522109560298,0.0101805072467151,0.511046730356463
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNG,Interferon gamma,39587,0.0070370962852797,0.0107118852346976,-0.0139581987747276,0.028032391345287,0.511227285115027
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37382,0.00308421896208437,0.00472284439439957,-0.00617255605093878,0.0123409939751075,0.513739866343742
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,36991,-0.00421888842108933,0.00649978904126532,-0.0169584749419694,0.00852069809979069,0.516297488503404
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNF830,Zinc finger protein 830,37368,-0.00490034848240229,0.00755770639653665,-0.0197134530196141,0.00991275605480954,0.51674313932705
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATP1B4,Protein ATP1B4,36962,-0.00253840674209973,0.00393749197293218,-0.0102558910090468,0.00517907752484734,0.519148431766964
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNPO1,Transportin-1,37169,-0.00213620378835295,0.00331991858238868,-0.00864324420983476,0.00437083663312885,0.51994280987161
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB7,Integrin beta-7,40030,0.00270510690225283,0.00426114526233373,-0.00564673781192128,0.0110569516164269,0.525547656201254
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IFNW1,Interferon omega-1,37021,0.00211110247294707,0.00332615834742311,-0.00440816788800222,0.00863037283389635,0.52563713276403
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36991,-0.00333928036048206,0.00526286341047216,-0.0136544926450075,0.00697593192404337,0.525766423215151
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RANGAP1,Ran GTPase-activating protein 1,39477,-0.0029188435304462,0.00463657821387669,-0.0120065368296445,0.00616884976875211,0.529014385963049
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TXK,Tyrosine-protein kinase TXK,37169,-0.00435598494031027,0.00695627772266109,-0.017990289276726,0.00927831939610547,0.531197916351029
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PSME2,Proteasome activator complex subunit 2,39666,-0.00212063762142483,0.00339116956718462,-0.00876732997310669,0.00452605473025702,0.53175625531988
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CALY,Neuron-specific vesicular protein calcyon,37021,0.00222417223762235,0.0035576913459666,-0.00474890280047219,0.00919724727571688,0.531868421283917
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,39949,-0.00118103983913701,0.00189216525807163,-0.0048896837449574,0.00252760406668337,0.532522349850205
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,37021,-0.00329987824153139,0.00528683954832657,-0.0136620837562515,0.00706232727318869,0.53252780851984
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBX2,Chromobox protein homolog 2,37021,-0.00236983053742824,0.00379952130028241,-0.00981689228598176,0.00507723121112528,0.532823486405227
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HRAS,GTPase Hras,37161,0.00569885006388409,0.0091629189269071,-0.0122604710328538,0.023658171160622,0.533987369955972
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39858,-0.00689345466764944,0.0111089441597541,-0.0286669852207674,0.0148800758854685,0.534916472152245
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL24,Interleukin-24,39587,-0.00272393454844866,0.00442245887069234,-0.0113919539350056,0.00594408483810834,0.537948223150826
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37021,-0.00372945774795853,0.00606852578779442,-0.0156237682920356,0.00816485279611853,0.538857644204061
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,36962,-0.00468344967689717,0.00765508984128589,-0.0196874257658175,0.0103205264120232,0.540675025538341
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CBLN1,Cerebellin-1,36991,-0.00550934881156006,0.00901437858295787,-0.0231775308341575,0.0121588332110374,0.541095341154911
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FBN2,Fibrillin-2,37039,0.00344428706771087,0.00563751038197694,-0.00760523328096394,0.0144938074163857,0.541237335296483
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF3,Fibroblast growth factor 3,37056,0.00176370374785145,0.00288857042212856,-0.00389789427952053,0.00742530177522344,0.541488085856483
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRR5,Proline-rich protein 5,37056,0.00272676817082159,0.00446765030378562,-0.00602982642459822,0.0114833627662414,0.541649712076907
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NECTIN4,Nectin-4,39913,-0.00167331953856982,0.00275550397299927,-0.00707410732564839,0.00372746824850875,0.543684031759248
NMR metabolomics,X23503.Total Lipids in Medium VLDL,YY1,Transcriptional repressor protein YY1,37056,0.00157252950597401,0.00260553935409476,-0.00353432762805171,0.00667938663999974,0.546164409353747
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37056,-0.0025906152098578,0.00430679301983228,-0.0110319295287291,0.00585069910901346,0.547505099040821
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,37169,-0.00304410061418179,0.00506445615408207,-0.0129704346761826,0.00688223344781906,0.547802554390703
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDCL2,Phosducin-like protein 2,36962,-0.00298926834179842,0.00499348730320569,-0.0127765034560816,0.00679796677248473,0.549427719179047
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KCNIP4,Kv channel-interacting protein 4,39489,0.00293411316537838,0.00491212782960461,-0.00669365738064667,0.0125618837114034,0.550302275597771
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CYTH3,Cytohesin-3,36962,0.00405454050767303,0.00679912624641235,-0.00927174693529518,0.0173808279506412,0.550963371581917
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FDX1,"Adrenodoxin, mitochondrial",37021,0.00355635155746456,0.00596391257941882,-0.00813291709819632,0.0152456202131254,0.55097719284997
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GLI2,Zinc finger protein GLI2,37056,-0.00192333487386917,0.00322830805659212,-0.00825081866478972,0.00440414891705138,0.551337908622446
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UPK3A,Uroplakin-3a,36991,0.0026626553088639,0.00447490781197357,-0.0061081640026043,0.0114334746203321,0.551841003334846
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,36991,0.00269123710293763,0.00455062000843151,-0.00622797811358812,0.0116104523194634,0.554262557491697
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACRV1,Acrosomal protein SP-10,37056,0.00403653270897724,0.00684735995733144,-0.00938429280739239,0.0174573582253469,0.555534631883526
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAGE2A,G antigen 2A,36962,-0.00335927169500297,0.00573492309588572,-0.014599720962939,0.00788117757293305,0.558048872319223
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GUK1,Guanylate kinase,37021,-0.00227441777450781,0.00389160090954814,-0.00990195555722216,0.00535312000820654,0.558932517904581
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZNF174,Zinc finger protein 174,37056,0.00209277242206643,0.0035834370556416,-0.0049307642069911,0.00911630905112397,0.559221811808897
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37382,0.00116427376940028,0.00200586163882265,-0.00276721504269213,0.00509576258149268,0.561630486806321
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EVI2B,Protein EVI2B,36962,0.00223345922513737,0.00387686478056566,-0.00536519574477133,0.00983211419504607,0.564557935776609
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36962,-0.00234837775629223,0.0040911021482314,-0.0103669379668258,0.00567018245424131,0.565963575130783
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPT1,Translationally-controlled tumor protein,39587,0.00344886492541977,0.0061110730589675,-0.00852883827015653,0.0154265681209961,0.572515006586181
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,36991,0.0029616991300189,0.00525748066180464,-0.0073429629671182,0.013266361227156,0.573219482356051
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39477,0.00667352292790862,0.0118875250158038,-0.0166260261030668,0.029973071958884,0.574540600101985
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DNLZ,DNL-type zinc finger protein,36991,-0.00468481639313637,0.00842029486646117,-0.0211885943314003,0.0118189615451275,0.577966048931567
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL3RA,Interleukin-3 receptor subunit alpha,39587,-0.00159667672323021,0.00287219005135609,-0.00722616922388815,0.00403281577742773,0.578280872678558
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC12A2,Solute carrier family 12 member 2,37021,-0.00144922009048208,0.00261629091144916,-0.00657715027692244,0.00367871009595827,0.579641901497451
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAGEA3,Melanoma-associated antigen 3,37169,0.00433755776537802,0.00785358554010607,-0.0110554698932299,0.0197305854239859,0.580750145080232
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37056,0.00183041333842837,0.00332362474218333,-0.00468389115625095,0.00834471783310769,0.581829443161803
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX1,ATP-dependent RNA helicase DDX1,37382,0.00253468560627376,0.00469741184915168,-0.00667224161806354,0.0117416128306111,0.589487356309799
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CGN,Cingulin,37039,-0.00196110575587372,0.00364563859228982,-0.00910655739676175,0.00518434588501432,0.590633060649685
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TP53BP1,TP53-binding protein 1,37056,-0.0044211011445982,0.0082547954967675,-0.0206005003182625,0.0117582980290661,0.592258066770352
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC25A,M-phase inducer phosphatase 1,36962,0.00209628955241728,0.00391802798122046,-0.00558304529077482,0.00977562439560937,0.592633420288856
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBP1,Retinol-binding protein 1,37039,-0.00348753516028232,0.00658814653144133,-0.0164003023619073,0.00942523204134269,0.596561086859352
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39862,0.0018674688785642,0.00353248068355367,-0.005056193261201,0.00879113101832939,0.597051089550561
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSLP,Thymic stromal lymphopoietin,39585,0.00292229002617109,0.00562852352554122,-0.00810961608388971,0.0139541961362319,0.603633465471382
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39788,-0.00208099594945669,0.0040143818961044,-0.00994918446582131,0.00578719256690793,0.604196776451577
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FOLR3,Folate receptor gamma,39858,-0.0090582534161181,0.0177220496112247,-0.0437934706541184,0.0256769638218822,0.609267787343021
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EFNB2,Ephrin-B2,37039,-0.00288789975326097,0.00565012688095542,-0.0139621484399336,0.00818634893341166,0.609274739138384
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37411,-0.00548795968451288,0.0108493081082118,-0.0267526035766081,0.0157766842075823,0.612980719310776
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RSPO1,R-spondin-1,39749,-0.00167094787746548,0.00330572819311517,-0.00815017513597121,0.00480827938104025,0.613235468181578
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36962,0.00271061148904499,0.00541487701909427,-0.00790254746837977,0.0133237704464698,0.616670943794633
NMR metabolomics,X23503.Total Lipids in Medium VLDL,F3,Tissue factor,39931,-0.00126390675046395,0.00254321240229766,-0.00624860305896737,0.00372078955803947,0.619215207611966
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TSPAN7,Tetraspanin-7,36991,0.00436584477821775,0.00883371928909208,-0.0129482450284027,0.0216799345848382,0.621155564230832
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBM25,RNA-binding protein 25,36962,-0.00212167964274182,0.00429394772974812,-0.0105378171930481,0.0062944579075645,0.621237251458236
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PFDN6,Prefoldin subunit 6,37039,0.00302712662659285,0.00619019008290021,-0.00910564593589156,0.0151598991890773,0.624835689984712
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DAND5,DAN domain family member 5,37056,0.00244973147436271,0.00503899904379521,-0.0074267066514759,0.0123261696002013,0.626865783717279
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GUCY2C,Heat-stable enterotoxin receptor,37169,-0.00389037143521528,0.00802872854976415,-0.019626679392753,0.0118459365223225,0.627999054369048
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMMR,Hyaluronan mediated motility receptor,36942,-0.00215736080080062,0.00446566988264504,-0.0109100737707849,0.00659535216918366,0.62903350540182
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37021,-0.00196739338652953,0.00407870685447468,-0.0099616588212999,0.00602687204824084,0.629560282112107
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFAP2A,Transcription factor AP-2-alpha,36991,-0.00267828941555729,0.00555901944937747,-0.0135739675363371,0.00821738870522256,0.629961957534562
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SAP18,Histone deacetylase complex subunit SAP18,37169,0.00329523235841026,0.00684754386574524,-0.0101259536184504,0.0167164183352709,0.630362112694808
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DBH,Dopamine beta-hydroxylase,37430,0.00488669917370184,0.0102177125725443,-0.015140017468485,0.0249134158158887,0.632474541410432
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NMI,N-myc-interactor,37311,0.00321873933805502,0.00676448672542398,-0.010039654643776,0.016477133319886,0.634203894826023
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPSD1,Tryptase delta,37411,-0.00163029945786833,0.00343124587816859,-0.00835554137907876,0.0050949424633421,0.634699564190544
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL13,Interleukin-13,39587,0.00216550391788863,0.00456568851517045,-0.00678324557184546,0.0111142534076227,0.635292911468877
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36991,-0.00239694874283754,0.00505449502197588,-0.0123037589859103,0.00750986150023518,0.635350055655983
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PYDC1,Pyrin domain-containing protein 1,37043,-0.00182804935057248,0.00387013288008104,-0.00941350979553132,0.00575741109438635,0.63668626536487
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PGR,Progesterone receptor,37056,0.00463066470684939,0.00985689869493114,-0.0146888567352157,0.0239501861489144,0.638513382864645
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SHC1,SHC-transforming protein 1,36962,-0.00509077271169537,0.010866880332183,-0.026389858162774,0.0162083127393833,0.639458597358756
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,36991,0.00251576057460135,0.00550598196047231,-0.00827596406792437,0.0133074852171271,0.647740375586159
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MFAP3,Microfibril-associated glycoprotein 3,39585,-0.00209956444270964,0.00459724695736672,-0.0111101684791484,0.00691103959372914,0.647892724172162
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,39788,-0.00140936920623542,0.00310267663492643,-0.00749061541069121,0.00467187699822038,0.649660111752603
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYPLA2,Acyl-protein thioesterase 2,36991,0.00445722856660987,0.00985883995591406,-0.0148660977469817,0.0237805548802014,0.651200975782633
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PMCH,Pro-MCH,37021,0.00349165996840711,0.00778446619348728,-0.011765893770828,0.0187492137076422,0.653769472351259
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,37382,0.00113927626362224,0.00254397150211785,-0.00384690788052875,0.00612546040777323,0.654280368012626
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,39477,0.00219143872729102,0.00489515158664757,-0.00740305838253822,0.0117859358371203,0.654393719510861
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RGS8,Regulator of G-protein signaling 8,39587,-0.00275433827423383,0.0061612106680719,-0.0148303111836548,0.0093216346351871,0.654848742732564
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL20RB,Interleukin-20 receptor subunit beta,37056,-0.00181192302501061,0.00405436521395952,-0.00975847884437127,0.00613463279435005,0.654949752254821
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39866,0.00621546084208156,0.0139679565872709,-0.0211617340689694,0.0335926557531325,0.656340249639221
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL5,Interleukin-5,39587,-0.0059850573957016,0.0135141034279369,-0.032472700114458,0.0205025853230548,0.657862304367691
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39866,-0.00134640872278352,0.00306968899282602,-0.00736299914872251,0.00467018170315548,0.660947134403053
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FZD10,Frizzled-10,37039,-0.0024595477141639,0.00561767270443584,-0.0134701862148581,0.00855109078653035,0.661521591514197
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGAP30,Rho GTPase-activating protein 30,37169,-0.00161435373513645,0.00368785396343473,-0.00884254750346853,0.00561384003319563,0.661575476188697
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,40052,-0.00120145884121486,0.0027458111219398,-0.00658324864021688,0.00418033095778716,0.661710652870675
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PAPPA,Pappalysin-1,39587,0.00193925281389803,0.00444479923722985,-0.00677255369107247,0.0106510593188685,0.662627207849836
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PADI2,Protein-arginine deiminase type-2,39587,0.00232545148499272,0.00533829362208467,-0.00813760401429324,0.0127885069842787,0.663120608581767
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIRREL1,Kin of IRRE-like protein 1,36991,0.00245914315042014,0.00564696998403012,-0.0086089180182789,0.0135272043191192,0.663221125813491
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,39587,0.00153627423112865,0.00353328952357677,-0.00538897323508182,0.00846152169733912,0.66371358175129
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UBQLN3,Ubiquilin-3,37021,-0.00189754701517638,0.00441383398877424,-0.0105486616331739,0.00675356760282114,0.667268867191522
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,37039,-0.0033734599683587,0.00787351490699221,-0.0188055491860634,0.012058629249346,0.668325676650832
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,36991,-0.00114332874457572,0.00269977305929892,-0.0064348839408016,0.00414822645165017,0.671944228883339
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DUOX2,Dual oxidase 2,39585,-0.0028241290586417,0.00668217120829767,-0.0159211846269051,0.0102729265096217,0.672566313602778
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39868,0.00130021187544222,0.00307790470090018,-0.00473248133832213,0.00733290508920657,0.672713872285613
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36991,-0.00126256246415417,0.00302020844942313,-0.0071821710250235,0.00465704609671516,0.675926033450422
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPO,Erythropoietin,39866,-0.00301137868299222,0.00722246902155989,-0.0171674179652496,0.0111446605992652,0.676723587351882
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP112,Centrosomal protein of 112 kDa,37021,0.00182140947169464,0.00438248565143932,-0.00676826240512642,0.0104110813485157,0.677701413981343
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37021,-0.00238172275153828,0.00581081466927815,-0.0137709195033234,0.0090074740002469,0.681902411546333
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MORN4,MORN repeat-containing protein 4,36962,0.00306363985951305,0.00749836364745175,-0.0116331528894924,0.0177604326085185,0.682858655909257
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36962,0.0012775499318294,0.00315832198019762,-0.00491276114935794,0.00746786101301674,0.685849657793399
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TPBGL,Trophoblast glycoprotein-like,37039,0.00151604464551587,0.00380251419708394,-0.00593688318076866,0.00896897247180039,0.690124169965801
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37368,0.00175990503638667,0.00450253080043942,-0.00706505533247458,0.0105848654052479,0.695899359300409
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCG3,Secretogranin-3,39885,-0.00115462875555951,0.0030358607990308,-0.00710491592165989,0.00479565841054086,0.703705554303824
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37368,0.00346727652809266,0.00915244358055802,-0.0144715128898011,0.0214060659459864,0.704815491826799
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCIN,Adseverin,36991,-0.00261283166879109,0.006930775251668,-0.0161971511620604,0.0109714878244782,0.706187267093484
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,37039,0.00125892844200049,0.00335844272680874,-0.00532361930254464,0.00784147618654563,0.70777447361631
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,37437,-0.000943910452845646,0.00252109172694872,-0.00588525023766514,0.00399742933197385,0.708108544767094
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC4D,C-type lectin domain family 4 member D,39866,0.00211945798357061,0.00566931249321984,-0.00899239450314029,0.0132313104702815,0.708522771219131
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HK2,Hexokinase-2,39585,-0.000947413708721611,0.00256245500883556,-0.00596982552603931,0.00407499810859609,0.711589464334283
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37039,0.00145078486502064,0.00392527017310921,-0.0062427446742734,0.00914431440431469,0.71168553858759
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MKI67,Proliferation marker protein Ki-67,37056,0.00136175571809185,0.00368756104982379,-0.00586586393956277,0.00858937537574648,0.711922294039398
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SCN3B,Sodium channel subunit beta-3,36991,0.00153091802576687,0.00417012313995543,-0.00664252332854577,0.0097043593800795,0.713538570116999
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BRD2,Bromodomain-containing protein 2,36991,-0.00116399510420648,0.00317384560768009,-0.00738473249525946,0.0050567422868465,0.713814418197268
NMR metabolomics,X23503.Total Lipids in Medium VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,39489,0.00221250426156671,0.00604944410686557,-0.0096444061878898,0.0140694147110232,0.714566441545039
NMR metabolomics,X23503.Total Lipids in Medium VLDL,S100G,Protein S100-G,37411,-0.00152672168518958,0.00421466238662239,-0.00978745996296947,0.0067340165925903,0.717177917100804
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GSTM4,Glutathione S-transferase Mu 4,37021,0.00237194584450145,0.00672705992899406,-0.0108130916163269,0.0155569833053298,0.724395709970666
NMR metabolomics,X23503.Total Lipids in Medium VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36962,0.00186139470741804,0.00530162997609238,-0.00852980004572302,0.0122525894605591,0.725520045386696
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NPHS2,Podocin,37056,-0.00332472245912826,0.00957613991319488,-0.0220939566889902,0.0154445117707337,0.728455496997155
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK3,Prostate-specific antigen,37437,0.0025253303269472,0.00737999670744022,-0.0119394632196356,0.01699012387353,0.732216342025506
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36991,0.00101273932459422,0.00299162942318653,-0.00485085434485139,0.00687633299403982,0.734973513498115
NMR metabolomics,X23503.Total Lipids in Medium VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37021,0.000640573131314379,0.0018944193882692,-0.00307248886969326,0.00435363513232202,0.735265405075959
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,37348,0.00129958830930532,0.00384588393340114,-0.00623834420016092,0.00883752081877156,0.73543124047993
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLHL41,Kelch-like protein 41,37411,0.00160241308491497,0.00479444100550528,-0.00779469128587538,0.0109995174557053,0.738216362688322
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RBP7,Retinoid-binding protein 7,37382,-0.00188789727989744,0.00565669722443561,-0.0129750238397912,0.00919922927999636,0.738576782523746
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FH,"Fumarate hydratase, mitochondrial",36991,0.00256288852725538,0.00775453137695647,-0.0126359929715793,0.0177617700260901,0.741025915850932
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NOS2,"Nitric oxide synthase, inducible",37021,0.00122746315458863,0.00371662114467563,-0.0060571142889756,0.00851204059815286,0.741206360982903
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OSM,Oncostatin-M,39785,0.00217639914224055,0.00668937849047583,-0.0109347826990921,0.0152875809835732,0.744919352799386
NMR metabolomics,X23503.Total Lipids in Medium VLDL,STEAP4,Metalloreductase STEAP4,36991,-0.00227447290451741,0.00704547246640979,-0.0160835989386806,0.0115346531296458,0.746830956283965
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MSLNL,Mesothelin-like protein,37039,-0.00108950478583538,0.0034033140791023,-0.00776000038087589,0.00558099080920513,0.748874447706634
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,39537,0.00150367388374556,0.00469756669121029,-0.00770355683102661,0.0107109045985177,0.748899569345492
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAG,Myelin-associated glycoprotein,37039,-0.00136846644978864,0.00432803978028819,-0.00985142441915349,0.00711449151957622,0.75186618934593
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD58,Lymphocyte function-associated antigen 3,39835,-0.000514484336755964,0.00163068295097013,-0.00371062292065742,0.00268165424714549,0.752384372721339
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,37039,0.00103564125011157,0.00330088485947645,-0.00543409307446228,0.00750537557468541,0.753718505272126
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL2RB,Interleukin-2 receptor subunit beta,39587,-0.00105894373804429,0.00340014158400499,-0.00772322124269407,0.00560533376660548,0.755469462867929
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,40052,0.00119466647640012,0.00384635714081998,-0.00634419351960705,0.00873352647240729,0.756111107227997
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37169,-0.00146271092919786,0.00477153930457983,-0.0108149279661743,0.00788950610777862,0.759191421015269
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RAB6B,Ras-related protein Rab-6B,39489,0.00134738398692626,0.0044032530763828,-0.00728299204278402,0.00997776001663655,0.759610702131793
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39489,-0.00133034054149078,0.00438819354412724,-0.00993119988798017,0.00727051880499862,0.761769224366544
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD5L,CD5 antigen-like,37380,-0.00132945919350317,0.0043863686113452,-0.00992674167173977,0.00726782328473343,0.761826853441621
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTN1,Contactin-1,40052,0.000750408640782039,0.002495018103992,-0.00413982684304227,0.00564064412460635,0.763599235601306
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37169,-0.00190084322966339,0.00636981430384107,-0.0143856792651919,0.0105839928058651,0.765391688377085
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,37169,-0.00183351067606362,0.00615146065474911,-0.0138903735593719,0.0102233522072446,0.765661239553729
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC11A,C-type lectin domain family 11 member A,39822,-0.00131313329896903,0.00443134768011251,-0.00999857475198954,0.00737230815405149,0.766983304242325
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PNMA2,Paraneoplastic antigen Ma2,36991,0.0011982677209019,0.00407100758288177,-0.00678090714154637,0.00917744258335017,0.768501383469135
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TFRC,Transferrin receptor protein 1,39918,-0.00107279045378804,0.00365803389740533,-0.00824253689270249,0.00609695598512641,0.769319811993425
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL4,Interleukin-4,39587,-0.00246377996460932,0.00845516770498386,-0.0190359086663777,0.014108348737159,0.770754313740563
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANXA10,Annexin A10,39489,-0.00212300786674832,0.00733660964603992,-0.0165027627729866,0.0122567470394899,0.772300718535609
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MLLT1,Protein ENL,36962,-0.00193807756814038,0.00671058238188455,-0.0150908190366341,0.0112146639003533,0.772732001676225
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLEC1A,C-type lectin domain family 1 member A,39585,-0.000864440645773952,0.00300288004546839,-0.00675008553489199,0.00502120424334409,0.773449646044891
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AOC3,Membrane primary amine oxidase,39931,0.000809126466485615,0.00281347493851882,-0.00470528441301126,0.00632353734598249,0.773664523903004
NMR metabolomics,X23503.Total Lipids in Medium VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37056,0.000793577118570313,0.00279488998332069,-0.00468440724873824,0.00627156148587886,0.776461897910826
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DCDC2C,Doublecortin domain-containing protein 2C,36962,-0.0016900794780839,0.00596738721317129,-0.0133861584158996,0.0100059994597318,0.777013177158054
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAD2,Glutamate decarboxylase 2,37056,0.00123468711752858,0.004371670271201,-0.00733378661402537,0.00980316084908253,0.777618895615103
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37021,-0.000972674633543436,0.00344494259278261,-0.00772476211539735,0.00577941284831048,0.777680682128198
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD164L2,CD164 sialomucin-like 2 protein,37039,0.000973854101937824,0.00345397345140253,-0.00579593386281114,0.00774364206668679,0.777984881023958
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,36962,-0.000675687695543634,0.00240956358236123,-0.00539843231697164,0.00404705692588437,0.779160398197977
NMR metabolomics,X23503.Total Lipids in Medium VLDL,REXO2,"Oligoribonuclease, mitochondrial",37021,-0.0012391395348752,0.00448696460716336,-0.0100335901649154,0.007555311095165,0.782426195793758
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",37411,0.000899041321481457,0.00338163474987537,-0.00572896278827427,0.00752704543123718,0.79035109784893
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PRC1,Protein regulator of cytokinesis 1,37368,-0.0011436825075803,0.00432779225437362,-0.00962615532615259,0.00733879031099199,0.791580028696119
NMR metabolomics,X23503.Total Lipids in Medium VLDL,COL4A4,Collagen alpha-4(IV) chain,37147,-0.00129429653682251,0.00491228918096582,-0.0109223833315155,0.00833379025787049,0.792183689720282
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL6,Interleukin-6,39788,-0.00173499473203877,0.00663997799676982,-0.0147493516057076,0.0112793621416301,0.793868205185471
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ERVV_1,,37021,-0.00118044448003047,0.00451870184403138,-0.010037100094332,0.00767621113427103,0.793915136903082
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,37056,-0.0010070257532234,0.00388852123591987,-0.00862852737562634,0.00661447586917954,0.795659369546608
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,37056,-0.00101082201384143,0.0039092164733666,-0.00867288630163996,0.0066512422739571,0.795967924958844
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ART3,Ecto-ADP-ribosyltransferase 3,39931,-0.000791463165960346,0.00309127652987381,-0.00685036516451302,0.00526743883259233,0.79793004120861
NMR metabolomics,X23503.Total Lipids in Medium VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,37169,-0.000990715401525165,0.00389087450939814,-0.00861682943994551,0.00663539863689518,0.799016388544318
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PITHD1,PITH domain-containing protein 1,36931,0.00189293584084499,0.00743458103680022,-0.0126788429912834,0.0164647146729734,0.799026557019842
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CASQ2,Calsequestrin-2,37021,0.00116522742445657,0.00458025767352861,-0.00781207761565951,0.0101425324645727,0.799188860523241
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPA33,Cell surface A33 antigen,39788,-0.00304419145368229,0.0123116563799396,-0.0271750379583638,0.0210866550509993,0.8047094899545
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KHDC3L,KH domain-containing protein 3,36962,0.00154186956399512,0.00625062149048937,-0.010709348557364,0.0137930876853543,0.805163929055173
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH4,Cadherin-4,36991,0.00107133866459261,0.00438799129811982,-0.00752912427972224,0.00967180160890746,0.807116595174969
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GID8,Glucose-induced degradation protein 8 homolog,37411,0.000762916020910577,0.00314084949576115,-0.00539314899078127,0.00691898103260243,0.808085634660126
NMR metabolomics,X23503.Total Lipids in Medium VLDL,FGF20,Fibroblast growth factor 20,37056,0.000979462387807007,0.00403277415244314,-0.00692477495098154,0.00888369972659556,0.808105553322832
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DPEP2,Dipeptidase 2,39788,0.00065230598677293,0.0027267515949699,-0.00469212713936808,0.00599673911291394,0.810934526997173
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,36962,-0.00109161713416523,0.0045645094361698,-0.010038055629058,0.00785482136072758,0.810990515088634
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PALM3,Paralemmin-3,37021,0.00167981825352511,0.00710662443624371,-0.0122491656415126,0.0156088021485628,0.813146474612356
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CLINT1,Clathrin interactor 1,36962,-0.0010756147418671,0.00459943136937008,-0.0100905002258325,0.00793927074209826,0.815098718612353
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SOD3,Extracellular superoxide dismutase,37445,-0.00133130372889951,0.00571183096389125,-0.0125264924181264,0.00986388496032734,0.81570413310825
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLA2G1B,Phospholipase A2,40031,0.000887417427219924,0.00382574359778841,-0.00661104002444537,0.00838587487888521,0.816572434774473
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37021,-0.00138136362045954,0.00605072222225605,-0.0132407791760814,0.0104780519351623,0.819418660702479
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37368,0.00128549716089655,0.00574122917215835,-0.00996731201653383,0.0125383063383269,0.822833629550009
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEPTIN7,Septin-7,37169,0.00105956052807935,0.00481111722776641,-0.00837022923834282,0.0104893502945015,0.825694087166056
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37437,0.000720783518833839,0.00333912708406876,-0.00582390556594093,0.00726547260360861,0.829100225946686
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37056,-0.000727057468954332,0.00340178958183309,-0.00739456504934719,0.00594045011143852,0.83076252620534
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KIAA2013,Uncharacterized protein KIAA2013,37368,0.00114110652999539,0.00537521780619119,-0.00939432037013935,0.0116765334301301,0.831883775825996
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,37043,0.000642500553372725,0.00307638074724241,-0.0053872057112224,0.00667220681796785,0.834568961606254
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,39720,0.000631545099586884,0.00309367611697782,-0.00543206008968965,0.00669515028886342,0.838246196657657
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CRX,Cone-rod homeobox protein,39585,-0.00199891941082053,0.0101401281074358,-0.0218735705013948,0.0178757316797537,0.843728667174493
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPINT1,Kunitz-type protease inhibitor 1,39794,0.000469024490330586,0.0024346209023463,-0.00430283247826816,0.00524088145892933,0.847237220541768
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PFDN4,Prefoldin subunit 4,36962,-0.000967051250284723,0.0051156212076396,-0.0109936688172583,0.00905956631668889,0.850065280512641
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DKKL1,Dickkopf-like protein 1,39788,0.00146139695445906,0.00789136499768132,-0.0140056784409963,0.0169284723499145,0.853082860133383
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL3,Interleukin-3,36962,0.00103056357423934,0.00560584561363804,-0.00995689382849122,0.0120180209769699,0.854143931195412
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD160,CD160 antigen,40058,-0.000758589424281518,0.00419850682375424,-0.00898766279883983,0.0074704839502768,0.856620418106793
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ALMS1,Alstrom syndrome protein 1,37169,0.000750498148240897,0.00419910857323993,-0.00747975465530936,0.00898075095179116,0.858154026904226
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37021,0.00081578081528033,0.00486842623780961,-0.0087263346108265,0.0103578962413872,0.866927601903272
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DEFB118,Beta-defensin 118,36991,0.000909092175000551,0.00544661004128135,-0.0097662635059109,0.011584447855912,0.867443652438203
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,37056,0.00141912970650314,0.00853762664044743,-0.0153146185087738,0.0181528779217801,0.867985868913939
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37411,0.000670600337004696,0.00406436290350666,-0.00729555095386835,0.00863675162787774,0.868950227639759
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANK2,Ankyrin-2,37021,-0.00109292827213746,0.00667189037842326,-0.0141698334138471,0.0119839768695721,0.869882537277154
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GIPR,Gastric inhibitory polypeptide receptor,37056,0.000697150674897192,0.00428755568575149,-0.00770645846917573,0.00910075981897012,0.870836956451102
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,37021,-0.000522235592309232,0.00324610257840303,-0.00688459664597917,0.00584012546136071,0.87218975089868
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39489,-0.00119191431462505,0.00744339678215918,-0.015780972007657,0.0133971433784069,0.872780401550878
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,37021,0.000736795644872325,0.00461229076293353,-0.0083032942504774,0.00977688554022205,0.873083504733409
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,36991,-0.000913460662065651,0.00586735837572417,-0.012413483078485,0.0105865617543537,0.876283583602038
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDH22,Cadherin-22,37169,-0.000414507335066342,0.00271735780307357,-0.00574052862909054,0.00491151395895785,0.878762899125332
NMR metabolomics,X23503.Total Lipids in Medium VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37411,0.000446500332131256,0.00298983941843972,-0.00541358492801059,0.0063065855922731,0.881288179530135
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CDC123,Cell division cycle protein 123 homolog,36962,0.000890786415500868,0.00598198128729796,-0.0108338969076031,0.0126154697386049,0.88162567816754
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GPHA2,Glycoprotein hormone alpha-2,37382,-0.000642647852543853,0.00436597034714584,-0.00919994973294969,0.00791465402786199,0.882980509902126
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGB2,Integrin beta-2,39731,-0.000379591595105237,0.00269199744743291,-0.00565590659207374,0.00489672340186327,0.887865875918044
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DDI2,Protein DDI1 homolog 2,37124,-0.000975653933626659,0.00705494726134203,-0.014803350565857,0.0128520426986037,0.890010496237427
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEP350,Centrosome-associated protein 350,36962,-0.000469941756383301,0.0034033301552631,-0.00714046886069897,0.00620058534793237,0.890177008434256
NMR metabolomics,X23503.Total Lipids in Medium VLDL,AXL,Tyrosine-protein kinase receptor UFO,39931,-0.000348476275679945,0.0025522947868087,-0.005350974057825,0.00465402150646511,0.891400468293091
NMR metabolomics,X23503.Total Lipids in Medium VLDL,UGDH,UDP-glucose 6-dehydrogenase,37021,-0.00127447235340803,0.009406745268675,-0.019711693080011,0.017162748373195,0.892230539666687
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,37445,-0.000308169960718558,0.00232555296063386,-0.00486625376356093,0.00424991384212381,0.894579156565703
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BCL2L15,Bcl-2-like protein 15,37056,0.000702077237879867,0.00530762719208008,-0.0097008720585971,0.0111050265343568,0.894767180456274
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39885,0.000412012751189047,0.00311510535471458,-0.00569359374405154,0.00651761924642963,0.89477804123794
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,39721,0.000692663989755444,0.00549478960719191,-0.0100771236403407,0.0114624516198516,0.899687351588484
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNNI3,"Troponin I, cardiac muscle",39585,0.000986911992587424,0.00788662452240069,-0.0144708720713179,0.0164446960564928,0.90041634408897
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36991,-0.000845685379174641,0.00676770785907615,-0.0141103927829639,0.0124190220246146,0.900557995342872
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SERPINB5,Serpin B5,39585,-0.000565413449809033,0.00455969264352856,-0.00950241103112501,0.00837158413150695,0.901314852273014
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,37021,-0.000590206523023745,0.00477177565536312,-0.00994288680753546,0.00876247376148797,0.901565009241491
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36991,-0.000544768214973473,0.00451768218967356,-0.00939942530673365,0.0083098888767867,0.904020980264004
NMR metabolomics,X23503.Total Lipids in Medium VLDL,PLIN3,Perilipin-3,39868,-0.000473135618502923,0.00401976385396015,-0.00835187277226482,0.00740560153525898,0.906304988007628
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNXB,Tenascin-X,39858,0.000267351364423046,0.00240832365688353,-0.00445296300306867,0.00498766573191476,0.911608704696453
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ACHE,Acetylcholinesterase,37124,-0.000334309660987997,0.00306942920558028,-0.00635039090392535,0.00568177158194936,0.91327083856047
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37169,0.000360384327487346,0.00336003638169701,-0.00622528698063879,0.00694605563561348,0.91458744405599
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IL15,Interleukin-15,39866,-0.000325039635221658,0.00303727219022591,-0.00627809312806445,0.00562801385762113,0.914776866456194
NMR metabolomics,X23503.Total Lipids in Medium VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39749,0.000311893679302524,0.00297042490501916,-0.00551013913453503,0.00613392649314008,0.916377384049624
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37043,-0.000203653164044385,0.00196279679371952,-0.00405073487973464,0.00364342855164587,0.917364069914765
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,37039,0.000394949423968313,0.00383273577621748,-0.00711721269741794,0.00790711154535457,0.917927754320842
NMR metabolomics,X23503.Total Lipids in Medium VLDL,OMP,Olfactory marker protein,36991,0.00046359444781913,0.00455770607048442,-0.00846950945033033,0.00939669834596859,0.918983164298871
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BLVRB,Flavin reductase,39858,-0.0006066575785826,0.00603845055931735,-0.0124420206748446,0.0112287055176794,0.919975816666822
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CAPN3,Calpain-3,37368,-0.00031444678560118,0.00353060546605807,-0.00723443349907501,0.00660553992787265,0.929033056564873
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SEZ6L2,Seizure 6-like protein 2,39788,0.000189591731905028,0.00225177048315198,-0.00422387841507286,0.00460306187888291,0.932901068927921
NMR metabolomics,X23503.Total Lipids in Medium VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36931,-0.000685689451408876,0.00825717757627041,-0.0168697575008989,0.0154983785980811,0.93381971279977
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CA11,Carbonic anhydrase-related protein 11,39477,-0.000242765793002793,0.00293771837773108,-0.0060006938133557,0.00551516222735012,0.934140817116368
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CD82,CD82 antigen,37169,-0.00030854125717501,0.00395088298792824,-0.00805227191351436,0.00743518939916434,0.937754252359646
NMR metabolomics,X23503.Total Lipids in Medium VLDL,MORC3,MORC family CW-type zinc finger protein 3,37388,-0.000202732452905434,0.00262657796617811,-0.00535082526661454,0.00494536036080367,0.938477505904828
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CNTNAP4,Contactin-associated protein-like 4,37039,0.000734735058735359,0.00970079213989204,-0.018278817535453,0.0197482876529238,0.939627342550557
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ITGAX,Integrin alpha-X,37169,-0.000371251253750234,0.00495671574920267,-0.0100864141221875,0.00934391161468701,0.940296486689258
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,36991,0.000513452708767079,0.00700634718569405,-0.0132189877751933,0.0142458931927274,0.941581289615035
NMR metabolomics,X23503.Total Lipids in Medium VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,37039,-0.000468364764293912,0.0066616147851905,-0.0135251297432673,0.0125884002146795,0.943949587684174
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,37388,-0.00037517962912391,0.00539396009344207,-0.0109473414122704,0.0101969821540225,0.944548479443926
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTLA,B- and T-lymphocyte attenuator,36962,0.000566697873555878,0.00815538597195462,-0.0154178586314752,0.0165512543785869,0.944602594700038
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GAD1,Glutamate decarboxylase 1,36962,0.000163604531895463,0.00243829703519688,-0.00461545765709043,0.00494266672088136,0.946504815207993
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZP4,Zona pellucida sperm-binding protein 4,36962,-0.000201115747719561,0.00302655250958518,-0.00613315866650652,0.0057309271710674,0.947020227019951
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37056,0.000249834244098651,0.00472528894008787,-0.00901173207847358,0.00951140056667088,0.957834902125446
NMR metabolomics,X23503.Total Lipids in Medium VLDL,IKZF2,Zinc finger protein Helios,39477,0.000447234931817801,0.00880605081723043,-0.0168126246699538,0.0177070945335894,0.959495715925581
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARG2,"Arginase-2, mitochondrial",37368,0.000204359880812574,0.0041133363325924,-0.00785777933106853,0.00826649909269368,0.960376321107962
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37169,0.000198981419593308,0.0040540561064702,-0.00774696854908828,0.00814493138827489,0.960854637799477
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NCLN,Nicalin,39587,-0.000223898100819495,0.0049371766469475,-0.0099007643288366,0.00945296812719761,0.963829371679719
NMR metabolomics,X23503.Total Lipids in Medium VLDL,NENF,Neudesin,37368,0.000418338289877902,0.010297018197034,-0.0197638173763088,0.0206004939560646,0.967593756364439
NMR metabolomics,X23503.Total Lipids in Medium VLDL,BTNL10,Butyrophilin-like protein 10,36962,0.00014979044269878,0.00371166051713621,-0.0071250641708882,0.00742464505628576,0.967809349786635
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SLK,STE20-like serine/threonine-protein kinase,37169,0.000209348820444764,0.00719263046480682,-0.0138882068905766,0.0143069045314661,0.97678047383173
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ZPR1,Zinc finger protein ZPR1,36991,0.000257695344983477,0.00900356786466654,-0.0173892976697629,0.0179046883597299,0.977166923698105
NMR metabolomics,X23503.Total Lipids in Medium VLDL,WFDC12,WAP four-disulfide core domain protein 12,39990,-0.00014963693625906,0.00582527162838886,-0.0115671693279012,0.0112678954553831,0.979506874741766
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,37039,-0.000186272348960509,0.00730947505153696,-0.0145128434499729,0.0141402987520519,0.979669548751628
NMR metabolomics,X23503.Total Lipids in Medium VLDL,KLK1,Kallikrein-1,39720,0.000292420914111289,0.0117756437241426,-0.0227878407852082,0.0233726826134308,0.98018872838972
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ANKRA2,Ankyrin repeat family A protein 2,36962,0.000125437542973574,0.00511072630142757,-0.00989158600782446,0.0101424610937716,0.980419080381754
NMR metabolomics,X23503.Total Lipids in Medium VLDL,RUVBL1,RuvB-like 1,39477,-0.000230171413590246,0.00951077086151929,-0.018871282302168,0.0184109394749876,0.980692485016906
NMR metabolomics,X23503.Total Lipids in Medium VLDL,SPRING1,SREBP regulating gene protein,36962,0.000128330326459118,0.00562982888041853,-0.0109061342791612,0.0111627949320794,0.981814373476926
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,37135,-0.00010539381265636,0.00475018410469218,-0.00941575465785304,0.00920496703254032,0.982298872818835
NMR metabolomics,X23503.Total Lipids in Medium VLDL,GJA8,Gap junction alpha-8 protein,36962,-0.000105616652744803,0.00561627995306794,-0.011113525360758,0.0109022920552684,0.984996595185177
NMR metabolomics,X23503.Total Lipids in Medium VLDL,DIPK1C,Divergent protein kinase domain 1C,37039,-5.71211268108902e-05,0.00401314993843946,-0.00792289500615222,0.00780865275253044,0.988643917522798
NMR metabolomics,X23503.Total Lipids in Medium VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,37437,-3.39966939470997e-05,0.00277653047940594,-0.00547599643358273,0.00540800304568853,0.990230879819219
NMR metabolomics,X23503.Total Lipids in Medium VLDL,EPHA2,Ephrin type-A receptor 2,39248,-1.59933703113478e-05,0.00275247360618025,-0.00541084163842464,0.00537885489780195,0.995363957680895
NMR metabolomics,X23503.Total Lipids in Medium VLDL,ARG1,Arginase-1,39754,2.41316256068469e-05,0.00484593746622288,-0.00947390580818999,0.00952216905940368,0.996026801996552
